data_1lv3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1lv3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 108.618 -0.882 . . . . 2.94 108.618 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 17' ' ' VAL . 20.1 p -120.41 120.57 36.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 2.82 110.474 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.34 132.93 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.495 -0.928 . . . . 2.63 108.495 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -91.41 135.28 33.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 3.63 110.286 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.4 t -66.68 118.27 52.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.791 -0.818 . . . . 2.51 108.791 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.9 Cg_endo -76.35 -15.65 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.524 2.149 . . . . 3.1 111.849 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 HG23 ' HA ' ' A' ' 32' ' ' CYS . 87.7 m -81.17 -50.39 9.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.921 . . . . 2.59 110.708 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.9 p -110.78 -26.1 9.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 3.12 110.789 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.18 74.4 1.26 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.839 -1.705 . . . . 3.39 108.839 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 28' ' ' CYS . 6.2 tmtt? -140.08 128.62 22.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.063 -0.669 . . . . 3.57 109.521 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.407 HG23 ' HB ' ' A' ' 6' ' ' THR . 40.0 m -70.6 115.86 10.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.635 -0.666 . . . . 3.61 109.75 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.93 123.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.926 -0.768 . . . . 1.9 108.926 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' HA ' ' CG2' ' A' ' 6' ' ' THR . 9.8 p -53.07 136.95 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.28 0.562 . . . . 2.02 110.322 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.518 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -112.11 156.59 22.0 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.647 -0.658 . . . . 2.98 109.809 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.76 -100.64 0.91 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.869 -1.692 . . . . 2.11 108.869 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.89 57.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.848 -0.795 . . . . 4.29 109.226 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.35 -52.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.594 -0.691 . . . . 3.09 109.366 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.1 m -93.47 166.77 15.33 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 2.84 110.007 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 36.2 Cg_endo -78.27 -32.87 2.16 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.488 2.126 . . . . 3.79 109.753 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.96 66.68 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.37 -0.604 . . . . 3.58 109.37 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -51.69 -55.43 29.96 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.282 -0.886 . . . . 4.0 109.322 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.2 Cg_endo -77.73 119.96 4.98 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.253 1.969 . . . . 2.56 109.545 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 82.8 m-85 68.0 159.45 0.16 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.345 0.593 . . . . 2.28 110.051 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 32.0 p -90.28 -35.4 15.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 1.57 110.0 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 165.6 24.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.455 -0.778 . . . . 2.26 109.543 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -72.4 -36.83 68.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.531 -0.73 . . . . 3.98 109.887 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -34.85 72.04 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.397 -0.814 . . . . 2.51 108.893 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.8 m -66.85 -56.15 11.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -58.11 -33.7 69.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.103 -0.702 . . . . 2.42 109.103 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.552 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.9 tp -62.84 -65.77 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.734 -0.839 . . . . 2.69 108.734 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.5 -28.41 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.75 -0.593 . . . . 2.1 110.301 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -39.64 83.34 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.446 -0.784 . . . . 2.82 110.458 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -64.0 -60.0 3.8 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.793 -0.817 . . . . 3.52 108.793 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.7 24.63 5.19 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.912 -0.875 . . . . 2.71 110.912 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -126.1 40.6 3.7 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.329 -1.1 . . . . 3.42 109.215 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.5 m95 . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.537 -0.727 . . . . 3.03 109.681 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 121.176 0.512 . . . . 1.78 109.934 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.549 HG21 ' HA ' ' A' ' 17' ' ' VAL . 34.2 p -122.42 128.36 50.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 1.54 109.908 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 18' ' ' TRP . 25.3 m -91.2 138.36 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 1.38 109.371 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.89 137.15 33.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.766 . . . . 2.3 110.097 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.68 120.72 75.48 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 109.095 -0.705 . . . . 1.07 109.095 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 -2.21 12.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.704 2.269 . . . . 1.37 112.05 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.6 m -98.78 -51.31 3.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.147 -0.971 . . . . 1.13 110.023 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.3 p -107.54 -30.03 8.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.617 -0.677 . . . . 1.51 110.763 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 71.16 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.814 -1.714 . . . . 1.65 108.814 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 135.08 40.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.786 -0.832 . . . . 2.61 109.66 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -76.54 112.27 12.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.566 -0.709 . . . . 1.79 109.685 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.26 127.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.853 -0.795 . . . . 1.4 108.853 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 ' HA ' HG21 ' A' ' 6' ' ' THR . 9.6 p -60.68 137.86 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.705 . . . . 1.72 110.371 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.518 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.1 t-105 -106.92 156.02 19.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.776 -0.577 . . . . 1.45 109.543 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.33 -179.23 26.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.744 -1.342 . . . . 1.21 109.744 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.15 103.65 3.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.583 -0.951 . . . . 4.41 109.721 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 17' ' ' VAL . 3.7 tt -174.99 -40.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.748 -0.595 . . . . 2.02 109.761 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.75 157.23 50.58 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 1.78 109.651 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.23 -35.61 2.23 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.579 2.186 . . . . 2.31 110.681 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.26 68.52 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.519 -0.738 . . . . 2.38 109.066 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.664 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -56.06 -54.17 55.32 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.599 -0.688 . . . . 1.79 109.854 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -78.0 128.69 9.3 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.291 1.994 . . . . 1.38 109.44 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 62.0 m-85 65.54 173.48 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.373 0.606 . . . . 1.14 109.661 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -104.08 -31.88 9.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.897 . . . . 1.16 110.341 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -138.41 164.21 29.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.328 -0.858 . . . . 1.41 110.419 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -38.66 90.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 2.48 109.487 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -42.0 98.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 2.68 109.897 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -59.38 -50.35 74.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.582 -0.699 . . . . 0.82 109.304 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.04 -35.32 78.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.169 -0.678 . . . . 1.86 109.169 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 10.5 tp -66.04 -66.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.24 -0.652 . . . . 2.1 109.24 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 mt -50.2 -30.93 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.634 -0.666 . . . . 1.35 110.542 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.8 -41.67 64.37 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.598 -0.688 . . . . 1.39 110.081 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.408 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.5 -59.11 4.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.943 -0.762 . . . . 2.45 108.943 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.05 26.71 5.39 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.992 -0.843 . . . . 1.65 110.992 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.32 47.21 2.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 2.51 109.118 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.515 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 7.7 m95 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.512 -0.743 . . . . 2.26 109.93 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.552 -0.536 . . . . 1.79 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.419 ' HB ' HG21 ' A' ' 15' ' ' THR . 45.1 p -126.17 130.68 51.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.408 -0.808 . . . . 1.57 110.046 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 18' ' ' TRP . 42.8 t -97.49 131.08 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.286 -0.635 . . . . 1.6 109.286 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.07 140.46 36.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.563 -0.711 . . . . 2.11 109.804 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 16.1 t -73.01 125.48 91.04 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.71 -0.619 . . . . 1.36 109.519 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.57 -3.71 13.54 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.809 2.339 . . . . 1.89 111.783 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.5 m -97.39 -54.89 3.0 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.237 -0.914 . . . . 1.86 109.901 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.9 p -102.07 -30.71 11.02 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.585 -0.697 . . . . 1.59 110.688 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.45 62.59 1.09 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.346 -1.502 . . . . 1.52 109.346 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 140.46 46.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.877 -0.778 . . . . 3.21 109.341 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.419 HG21 ' HB ' ' A' ' 6' ' ' THR . 35.5 m -73.71 116.61 14.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.79 109.827 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.7 t -116.0 137.47 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.136 -0.69 . . . . 1.41 109.136 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.87 139.46 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.429 -0.795 . . . . 1.22 110.256 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.528 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 57.5 t-105 -116.47 152.72 33.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 1.34 109.646 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 -145.46 16.61 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.686 -1.366 . . . . 1.19 109.686 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 89.02 2.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.454 -1.027 . . . . 1.99 109.344 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -153.8 -42.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.66 -0.65 . . . . 1.72 110.073 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 55.8 p -131.4 161.24 63.23 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.524 -0.735 . . . . 1.08 109.818 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.91 -15.82 18.59 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.737 2.291 . . . . 1.28 110.679 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 27' ' ' PHE . 61.8 m-85 -119.41 76.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.485 -0.931 . . . . 1.37 108.485 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.686 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -73.9 -48.91 6.18 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 2.52 110.483 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.69 -43.03 0.23 Allowed 'Trans proline' 0 C--N 1.326 -0.657 0 C-N-CA 122.171 1.914 . . . . 1.18 111.015 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 97.4 m-85 -99.08 163.66 12.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.671 -0.643 . . . . 1.27 109.809 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -80.38 -49.95 10.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.365 -0.834 . . . . 1.15 109.507 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.49 -172.8 3.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.669 -0.644 . . . . 1.49 110.074 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -36.13 82.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 2.94 110.165 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -64.57 -41.04 96.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.645 -0.66 . . . . 2.35 110.3 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 43.7 m -58.95 -48.23 82.27 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.122 -0.696 . . . . 1.22 109.122 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -66.4 -33.76 76.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.641 -0.662 . . . . 2.11 109.227 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -62.2 -66.63 0.51 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 1.64 109.328 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.4 mt -50.13 -30.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.605 -0.684 . . . . 2.05 110.356 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -56.53 -43.54 79.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.452 -0.78 . . . . 1.62 110.289 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.69 -61.18 2.7 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.847 -0.797 . . . . 2.43 108.847 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.57 18.84 8.22 Favored Glycine 0 N--CA 1.499 2.85 0 C-N-CA 120.457 -0.878 . . . . 1.95 111.339 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.14 40.22 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -1.127 . . . . 2.52 109.284 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 8.2 m95 . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.814 -0.81 . . . . 1.85 108.814 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.139 -1.06 . . . . 2.1 108.139 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 25.3 p -88.41 121.3 30.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.54 110.385 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 26' ' ' PRO . 22.7 t -112.13 115.07 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.509 -0.923 . . . . 1.67 108.509 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 5.7 p-10 -81.59 145.23 30.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 1.28 110.335 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 8.6 t -74.85 121.79 86.05 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.709 -0.619 . . . . 0.79 109.331 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.87 -8.29 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.672 2.248 . . . . 1.38 111.537 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.0 m -93.6 -56.84 2.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 2.34 109.83 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.1 p -98.01 -31.56 12.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.441 -0.787 . . . . 1.48 110.755 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.34 69.96 1.03 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.258 -1.537 . . . . 1.11 109.258 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -139.78 117.33 11.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.839 -0.8 . . . . 1.9 109.389 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 9.0 m -69.36 107.15 3.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.596 -0.69 . . . . 1.3 109.517 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 28' ' ' CYS . 87.7 t -104.65 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.925 -0.769 . . . . 1.17 108.925 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.681 HG12 ' HB2' ' A' ' 22' ' ' SER . 7.3 p -63.72 114.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.439 0.637 . . . . 2.15 109.309 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 25' ' ' ARG . 14.5 t-105 -86.92 147.25 25.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.505 -0.747 . . . . 2.25 110.052 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.46 -87.54 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.011 -1.635 . . . . 2.34 109.011 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 35.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.801 -0.823 . . . . 3.02 109.796 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.539 ' HB ' HG11 ' A' ' 17' ' ' VAL . 2.4 mp -117.27 -56.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 2.58 109.572 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.681 ' HB2' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -104.1 118.05 57.96 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.98 109.491 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.8 46.14 2.14 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.856 2.371 . . . . 2.05 110.479 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -117.72 24.25 11.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 2.0 109.741 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.672 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 63.26 174.37 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.638 -0.664 . . . . 1.87 110.631 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 31.7 Cg_endo -71.74 -18.33 28.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 122.153 1.902 . . . . 1.65 111.1 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.39 -69.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.181 -0.95 . . . . 1.5 108.803 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.657 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER 167.59 -40.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.155 -0.683 . . . . 0.9 109.155 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.75 159.81 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.749 -0.594 . . . . 1.19 109.485 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -62.69 -38.6 91.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 3.54 109.875 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -38.0 62.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.659 -0.65 . . . . 2.75 110.185 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 4.3 m -60.23 -49.42 77.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.56 -0.713 . . . . 1.33 109.643 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 2.28 109.22 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 8.3 tp -63.86 -66.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.969 -0.752 . . . . 2.25 108.969 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 mt -50.28 -30.38 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.747 -0.596 . . . . 2.23 110.121 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -44.75 63.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.691 . . . . 1.9 110.299 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.94 -58.09 6.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.757 -0.831 . . . . 2.89 108.757 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.44 26.0 6.1 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 111.001 -0.839 . . . . 2.55 111.001 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.71 42.77 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.391 -1.064 . . . . 2.95 108.823 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.493 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 6.8 m95 . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.676 -0.64 . . . . 2.63 109.446 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.166 -0.679 . . . . 2.15 109.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 17' ' ' VAL . 29.9 p -117.51 121.11 40.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.34 -0.85 . . . . 1.44 109.926 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.83 132.64 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.64 -0.662 . . . . 1.59 109.251 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.59 132.9 36.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.396 -0.815 . . . . 2.06 109.977 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 t -64.32 120.3 63.77 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.53 -10.37 17.3 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.694 2.262 . . . . 1.8 111.877 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.4 m -89.13 -51.0 5.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.242 -0.911 . . . . 1.97 110.194 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.21 -29.83 8.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.485 -0.76 . . . . 1.53 110.821 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.92 78.4 1.41 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.905 -1.678 . . . . 1.51 108.905 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -142.96 136.12 28.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.881 -0.776 . . . . 3.27 109.786 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -79.39 112.85 17.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.669 . . . . 1.5 109.681 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.56 132.27 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.828 -0.804 . . . . 1.34 108.828 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 6' ' ' THR . 9.2 p -60.5 139.01 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.704 . . . . 1.5 110.167 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.0 t-105 -118.58 148.26 42.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.776 -0.577 . . . . 1.9 109.546 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.09 -97.49 0.42 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.669 -1.372 . . . . 1.74 109.669 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.96 52.47 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.848 . . . . 2.82 109.573 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.05 -59.59 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 1.88 109.645 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -91.77 164.76 22.7 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 1.31 109.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.68 -40.62 0.71 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.565 2.177 . . . . 1.48 110.358 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.92 64.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.981 -0.748 . . . . 1.24 108.981 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.3 mtm180 -56.61 -52.28 74.72 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.549 -0.72 . . . . 2.92 110.088 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.09 124.23 7.8 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.162 1.908 . . . . 1.14 109.459 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 47.2 m-85 65.96 173.95 0.23 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.469 -0.567 . . . . 1.49 109.469 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -102.15 -29.83 11.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 1.01 110.147 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.31 163.7 32.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.372 -0.83 . . . . 1.91 110.087 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -35.39 80.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.59 -0.694 . . . . 2.03 109.891 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -65.79 -44.71 84.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.667 -0.646 . . . . 4.74 110.129 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.59 -46.26 84.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.75 -0.833 . . . . 1.35 108.75 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -66.01 -34.81 78.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.127 -0.694 . . . . 1.65 109.127 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 9.9 tp -63.76 -67.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.125 -0.695 . . . . 2.55 109.125 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 mt -49.16 -33.08 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.759 -0.588 . . . . 2.19 110.298 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.78 -42.1 71.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 2.01 110.266 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -60.84 3.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 3.56 109.015 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.15 22.35 5.93 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 120.407 -0.902 . . . . 2.52 111.353 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.75 41.35 3.5 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.29 -1.123 . . . . 3.06 109.212 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.498 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 . . . . . 0 N--CA 1.5 2.041 0 O-C-N 121.431 -0.793 . . . . 2.49 109.888 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.675 -0.491 . . . . 2.46 109.675 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -121.38 126.48 49.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 2.83 109.801 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -90.76 134.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.22 109.262 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.0 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.525 -0.735 . . . . 3.18 110.254 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 t -67.93 119.79 69.32 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.025 -0.731 . . . . 2.2 109.025 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.43 -10.1 17.44 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.71 2.274 . . . . 2.64 111.819 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 m -88.1 -52.05 5.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.168 -0.957 . . . . 2.06 110.044 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -109.26 -30.07 8.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.522 -0.737 . . . . 2.42 110.78 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.1 73.57 1.12 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.894 -1.682 . . . . 2.74 108.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 129.36 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.892 -0.77 . . . . 3.09 109.791 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -72.86 114.44 11.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.529 -0.732 . . . . 3.21 109.661 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 28' ' ' CYS . 23.8 t -116.18 127.35 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.151 -0.685 . . . . 1.9 109.151 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.5 p -58.43 138.81 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 2.53 110.453 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.514 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -111.28 155.27 23.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.807 -0.558 . . . . 1.51 109.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.07 -103.82 0.97 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.258 -1.537 . . . . 1.18 109.258 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.82 51.46 0.55 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.807 . . . . 2.45 109.307 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.461 HD13 HG22 ' A' ' 17' ' ' VAL . 3.5 mp -115.45 -55.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.764 . . . . 2.73 109.449 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.541 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 80.5 p -89.12 162.08 38.69 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.831 -0.543 . . . . 2.12 109.977 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.84 -30.52 5.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.567 2.178 . . . . 2.44 110.056 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -116.72 69.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.791 -0.818 . . . . 1.67 108.791 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -53.05 -54.64 42.04 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.412 -0.805 . . . . 2.69 110.044 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.14 123.02 6.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.226 1.951 . . . . 1.1 109.425 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 59.9 m-85 66.83 167.92 0.23 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.297 0.57 . . . . 1.93 109.689 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.524 ' HA ' HG22 ' A' ' 16' ' ' VAL . 31.0 p -96.41 -34.65 11.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -0.877 . . . . 1.39 110.448 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 160.98 36.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.387 -0.821 . . . . 1.51 109.866 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -38.06 88.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.682 -0.637 . . . . 3.64 109.48 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.754 -0.591 . . . . 3.32 109.604 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -61.51 -52.01 66.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.35 -34.2 72.08 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.055 -0.72 . . . . 1.96 109.055 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.3 tp -65.85 -67.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.04 -0.726 . . . . 2.63 109.04 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.15 -29.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.659 -0.65 . . . . 2.22 110.546 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -53.71 -43.99 69.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.48 -0.762 . . . . 2.52 109.766 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -58.29 6.67 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.882 -0.784 . . . . 3.43 108.882 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.73 26.39 5.59 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.79 -0.924 . . . . 3.16 110.79 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -124.44 40.77 3.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -1.045 . . . . 3.73 109.505 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.534 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 5.0 m95 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.788 . . . . 3.19 109.473 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.8 pt . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 109.022 -0.732 . . . . 3.15 109.022 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 17' ' ' VAL . 30.8 p -126.23 119.92 28.69 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.248 -0.908 . . . . 3.42 110.903 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.71 136.23 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.905 -0.776 . . . . 1.91 108.905 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.08 135.69 34.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.882 . . . . 3.68 110.299 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 24.3 t -65.04 119.44 58.57 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.998 -0.741 . . . . 2.14 108.998 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.4 Cg_endo -76.6 -6.31 16.85 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.685 2.257 . . . . 1.98 111.91 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.6 m -93.16 -52.41 4.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 2.03 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -108.31 -26.66 10.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.539 -0.726 . . . . 3.16 110.912 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.49 76.73 1.34 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.369 -1.892 . . . . 3.5 108.369 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 129.48 28.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.997 -0.708 . . . . 5.89 109.704 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 m -74.1 107.04 6.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.58 -0.7 . . . . 4.34 109.409 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 28' ' ' CYS . 24.8 t -110.07 126.31 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.735 -0.603 . . . . 2.8 109.48 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 21' ' ' ILE . 14.0 p -53.94 135.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.428 0.632 . . . . 3.27 110.461 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 74.2 t-105 -117.4 154.13 31.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.675 -0.64 . . . . 2.02 110.443 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.21 -114.68 2.65 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.127 -1.589 . . . . 2.45 109.127 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.71 93.6 2.58 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.542 -0.91 . . . . 4.68 108.542 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.538 HG22 HG11 ' A' ' 17' ' ' VAL . 5.9 tt -169.52 -42.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.6 -0.688 . . . . 3.93 110.353 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.46 162.9 18.62 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.518 -0.739 . . . . 3.67 110.211 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 -40.72 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.665 2.243 . . . . 4.53 110.184 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.4 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -110.99 65.61 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.674 -0.641 . . . . 3.1 109.37 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.624 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -53.54 -53.39 57.42 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 3.16 109.787 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.1 Cg_endo -76.57 127.32 9.55 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 122.38 2.054 . . . . 1.92 109.527 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.0 m-85 66.56 166.75 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.734 -0.604 . . . . 1.88 109.526 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HA ' HG23 ' A' ' 16' ' ' VAL . 31.2 p -97.93 -29.43 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.298 -0.876 . . . . 2.91 110.617 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.77 161.65 37.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.342 -0.849 . . . . 3.45 109.969 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.91 92.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 3.6 109.42 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -42.82 99.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.825 -0.547 . . . . 3.04 109.7 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -60.99 -52.99 62.65 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.729 -0.841 . . . . 2.05 108.729 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 20.2 tt0 -58.54 -33.54 70.01 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.142 -0.688 . . . . 2.11 109.142 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.542 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 tp -68.03 -66.9 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.8 -0.815 . . . . 3.11 108.8 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.32 -28.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.737 -0.602 . . . . 1.88 110.313 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.17 -42.7 66.44 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.539 -0.726 . . . . 1.42 109.702 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.434 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.2 mt -65.09 -57.42 8.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 3.03 108.788 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.87 23.57 7.04 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.039 -0.824 . . . . 2.28 111.039 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -122.97 45.37 2.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.354 -1.086 . . . . 3.25 109.14 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.542 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m95 . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.305 -0.872 . . . . 3.52 110.215 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.502 2.131 0 N-CA-C 109.478 -0.564 . . . . 1.78 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 p -135.94 127.24 28.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 1.64 109.995 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 18' ' ' TRP . 79.1 t -95.95 120.36 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 1.66 109.016 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.6 133.18 34.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.687 -0.633 . . . . 2.32 109.608 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 t -69.19 118.86 65.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.266 -0.642 . . . . 1.39 109.266 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.4 -12.33 15.55 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.8 2.333 . . . . 1.53 111.509 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.8 m -83.74 -54.75 4.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -0.875 . . . . 1.84 110.217 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.71 -30.39 9.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.552 -0.717 . . . . 1.67 110.658 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.36 77.41 1.35 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.072 -1.611 . . . . 1.64 109.072 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -146.65 129.25 16.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.837 -0.802 . . . . 2.53 109.616 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -74.99 116.26 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.65 -0.656 . . . . 1.83 109.705 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.31 139.62 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.734 -0.839 . . . . 1.65 108.734 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.79 143.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.45 -0.781 . . . . 1.42 110.179 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.498 ' HB2' HG21 ' A' ' 7' ' ' VAL . 72.7 t-105 -125.27 149.71 47.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.813 -0.554 . . . . 1.33 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.43 -100.9 0.53 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.32 -1.512 . . . . 1.16 109.32 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 83.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.72 -0.871 . . . . 2.4 109.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 tt -156.18 -43.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.542 -0.724 . . . . 1.64 109.844 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.96 162.48 19.79 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.677 . . . . 1.45 109.726 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.67 -39.76 0.92 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.694 2.263 . . . . 1.58 110.384 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.27 65.04 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 2.04 109.184 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.605 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mtm105 -58.11 -51.12 84.13 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.543 -0.723 . . . . 1.79 109.962 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.24 126.96 8.85 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.291 1.994 . . . . 1.04 109.315 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 38.0 m-85 65.53 175.31 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.526 -0.546 . . . . 1.13 109.526 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 p -103.49 -28.81 11.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.141 -0.975 . . . . 1.33 110.582 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.59 162.14 39.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.266 -0.896 . . . . 2.16 110.443 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -40.06 96.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 2.08 109.668 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -44.79 94.07 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.735 -0.603 . . . . 3.63 109.904 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.44 -50.03 75.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 1.33 109.428 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -63.81 -34.3 77.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.638 -0.664 . . . . 2.0 109.39 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 7.0 tp -65.7 -67.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.424 -0.584 . . . . 1.78 109.424 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -49.9 -28.78 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.576 -0.702 . . . . 1.98 110.62 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.52 -43.46 71.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.46 -0.775 . . . . 1.23 110.33 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -63.95 -59.71 4.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.472 -0.768 . . . . 1.81 108.971 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.57 20.49 8.11 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.582 -0.818 . . . . 1.19 111.081 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.89 45.96 2.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.288 -1.125 . . . . 1.34 109.137 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.488 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m95 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.523 -0.735 . . . . 1.34 109.128 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 pt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.257 0.551 . . . . 2.35 110.004 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 17' ' ' VAL . 46.4 p -121.83 126.33 48.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 1.44 110.164 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.26 135.67 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.931 -0.766 . . . . 1.72 108.931 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -91.33 133.05 35.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 1.55 109.97 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 13' ' ' GLY . 8.7 t -64.69 121.52 73.69 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.196 -0.668 . . . . 1.4 109.196 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.05 -11.28 16.44 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.66 2.24 . . . . 1.88 111.881 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.9 m -88.71 -54.82 3.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.227 -0.92 . . . . 2.32 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 p -103.09 -31.05 10.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.526 -0.734 . . . . 1.72 110.278 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 9' ' ' CYS . . . 95.37 75.14 1.26 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.845 -1.302 . . . . 1.54 109.845 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -143.85 137.81 28.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.56 -0.965 . . . . 3.38 110.656 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.2 m -72.59 112.43 8.64 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.215 0.531 . . . . 1.47 110.571 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.69 131.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.486 -0.931 . . . . 1.54 108.486 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -56.18 140.98 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 1.39 110.6 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.52 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.0 t-105 -122.15 151.44 40.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.695 -0.628 . . . . 1.47 109.542 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.29 -98.43 0.55 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.375 -1.49 . . . . 1.06 109.375 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.5 52.74 0.37 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.902 . . . . 1.32 109.727 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 17' ' ' VAL . 3.4 mt -118.11 -55.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 1.57 109.434 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.3 163.66 22.5 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.76 -0.588 . . . . 1.31 109.664 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.18 -38.14 1.24 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.538 2.158 . . . . 1.44 110.528 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.31 66.58 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.122 -0.696 . . . . 1.47 109.122 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.617 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.5 mtm180 -56.51 -51.26 82.54 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.574 -0.704 . . . . 2.66 110.188 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -76.69 127.13 9.36 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 122.179 1.919 . . . . 1.28 109.53 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 71.3 m-85 65.71 172.64 0.22 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.35 0.595 . . . . 1.52 109.636 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.28 -29.69 12.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.256 -0.902 . . . . 1.26 110.247 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.1 p -145.42 162.99 35.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.321 -0.862 . . . . 1.6 110.427 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -34.94 77.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.311 -0.626 . . . . 2.06 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -47.08 84.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.797 -0.564 . . . . 3.62 109.855 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.74 -47.24 85.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.753 -0.592 . . . . 1.62 109.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -64.23 -34.88 79.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.606 -0.684 . . . . 1.76 109.183 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD11 ' CZ2' ' A' ' 40' ' ' TRP . 10.4 tp -63.56 -67.2 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.161 -0.681 . . . . 2.55 109.161 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.15 -30.25 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.707 -0.621 . . . . 2.22 110.717 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.06 -42.6 65.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 1.83 110.199 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.51 -58.95 4.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.53 -0.732 . . . . 3.03 109.095 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 23.58 6.43 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.584 -0.817 . . . . 2.5 111.133 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.07 44.54 2.64 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.299 -1.118 . . . . 2.72 109.091 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.482 ' CZ2' HD11 ' A' ' 34' ' ' LEU . 9.9 m95 . . . . . 0 N--CA 1.499 1.984 0 O-C-N 121.591 -0.693 . . . . 2.6 109.447 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.264 -0.643 . . . . 2.11 109.264 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -137.48 126.51 24.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.56 -0.712 . . . . 1.67 109.866 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.62 124.45 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.01 -0.737 . . . . 1.59 109.01 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.45 134.02 33.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.605 -0.684 . . . . 2.26 109.868 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -68.87 120.35 75.56 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.74 -11.99 16.67 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.707 2.271 . . . . 1.35 111.734 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -85.64 -52.19 5.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.205 -0.935 . . . . 1.63 110.229 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.2 p -107.32 -29.58 9.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.507 -0.746 . . . . 1.64 110.954 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 78.17 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.657 -1.777 . . . . 1.64 108.657 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 134.12 24.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.834 -0.803 . . . . 2.78 109.882 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -78.61 110.8 14.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.444 -0.785 . . . . 1.77 109.239 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.96 135.49 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.727 -0.842 . . . . 1.89 108.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.71 138.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.423 -0.798 . . . . 1.57 110.005 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.553 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -111.26 153.45 25.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.748 -0.595 . . . . 1.56 109.49 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.41 -108.13 1.47 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.486 -1.446 . . . . 1.56 109.486 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.75 52.56 0.87 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.877 . . . . 2.56 109.485 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.93 -51.23 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.499 -0.751 . . . . 2.11 109.505 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.541 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 84.2 p -94.57 162.67 25.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.733 -0.604 . . . . 1.84 109.899 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -76.28 -29.93 5.86 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.559 2.172 . . . . 2.36 110.334 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.0 72.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.72 -0.844 . . . . 1.84 108.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -54.32 -55.16 40.07 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.644 -0.66 . . . . 2.92 110.227 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.0 126.64 8.82 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 122.286 1.99 . . . . 1.59 109.75 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 42.9 m-85 65.56 172.45 0.22 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.282 0.563 . . . . 1.48 109.771 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -98.43 -31.63 11.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.352 -0.842 . . . . 1.62 110.333 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.49 164.34 30.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 2.21 110.283 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -40.77 92.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.656 -0.653 . . . . 2.36 109.655 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -61.52 -42.18 98.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.757 -0.589 . . . . 2.46 109.683 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.66 -49.21 78.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.546 -0.721 . . . . 1.43 109.336 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -63.5 -32.85 74.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.371 -0.603 . . . . 1.96 109.371 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.0 tp -64.74 -67.43 0.44 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 2.24 109.437 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.24 -30.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.675 -0.64 . . . . 1.85 110.408 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.13 -41.62 68.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.751 . . . . 1.35 110.236 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.15 -59.16 4.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.462 -0.774 . . . . 2.33 109.142 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.85 25.61 5.86 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.584 -0.817 . . . . 1.61 111.149 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.25 43.48 3.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.267 -1.137 . . . . 1.92 109.112 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.46 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.6 m95 . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.575 -0.703 . . . . 1.98 109.863 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.47 0 N-CA-C 109.442 -0.577 . . . . 2.49 109.442 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 p -132.2 122.48 25.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.628 -0.67 . . . . 1.6 109.827 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.34 136.68 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.166 -0.679 . . . . 1.53 109.166 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.05 135.42 34.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 2.08 109.681 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.2 t -68.14 117.96 54.18 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.739 -0.601 . . . . 1.21 109.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 36.7 Cg_endo -80.64 19.42 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.927 2.418 . . . . 1.9 112.007 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.6 m -122.16 -48.31 2.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 1.44 109.366 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 -25.84 10.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.692 -0.63 . . . . 1.18 110.35 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.81 75.02 1.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.599 -1.8 . . . . 1.36 108.599 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -144.31 137.63 27.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.801 -0.823 . . . . 2.59 109.838 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -81.29 115.02 20.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.448 -0.783 . . . . 1.72 109.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.2 t -115.3 137.16 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.967 -0.753 . . . . 1.36 108.967 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.78 141.09 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.491 -0.756 . . . . 1.51 110.07 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.49 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.7 t-105 -124.88 150.98 45.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.854 -0.529 . . . . 1.62 109.783 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.27 -98.77 0.53 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.347 -1.501 . . . . 1.1 109.347 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.68 92.84 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.752 -0.852 . . . . 1.74 109.202 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -165.64 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.689 -0.632 . . . . 1.78 109.842 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 88.5 p -102.65 160.59 25.82 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.658 -0.652 . . . . 1.14 109.818 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.6 Cg_endo -75.27 -31.58 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.592 2.195 . . . . 1.48 110.355 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.87 64.46 0.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.679 . . . . 2.32 109.344 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 29.3 mtm180 -60.12 -53.02 69.13 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.488 -0.757 . . . . 1.68 109.661 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.68 125.63 7.63 Favored 'Trans proline' 0 C--N 1.324 -0.717 0 C-N-CA 122.285 1.99 . . . . 1.11 109.398 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 63.9 m-85 65.61 165.98 0.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.396 0.617 . . . . 1.47 109.734 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.2 p -95.5 -27.98 15.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.87 110.508 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.12 157.07 44.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.278 -0.889 . . . . 1.7 110.513 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -36.1 78.11 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.241 -0.652 . . . . 2.66 109.241 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HD3' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.7 -48.53 68.97 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 4.35 109.681 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.72 -43.87 65.96 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.551 -0.718 . . . . 0.79 109.812 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.94 -34.57 78.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.687 . . . . 2.32 109.289 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.578 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 11.5 tp -62.32 -66.64 0.51 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.893 -0.78 . . . . 1.65 108.893 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD13 ' HD3' ' A' ' 31' ' ' ARG . 3.0 mt -52.39 -27.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.55 -0.719 . . . . 1.54 110.167 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.76 -45.7 74.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.435 -0.791 . . . . 1.47 109.472 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 15.6 mt -62.97 -58.66 6.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.466 -0.938 . . . . 1.93 108.466 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.97 19.48 7.24 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 120.6 -0.81 . . . . 1.15 111.913 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.22 33.64 4.97 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.716 1.258 . . . . 1.76 109.113 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.578 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 108.999 -0.741 . . . . 1.4 108.999 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.6 pt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.178 -0.675 . . . . 1.68 109.178 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 17' ' ' VAL . 32.0 p -121.51 127.87 51.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.465 -0.772 . . . . 1.69 109.982 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.32 136.1 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.085 -0.709 . . . . 1.46 109.085 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.25 136.96 32.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 1.5 110.156 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.45 122.04 84.27 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.084 -0.71 . . . . 1.06 109.084 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.84 -5.06 15.06 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.723 2.282 . . . . 1.32 111.862 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -94.82 -52.04 4.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.253 -0.904 . . . . 1.67 109.931 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.0 p -107.14 -31.66 8.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.498 -0.751 . . . . 1.36 110.764 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.2 68.97 0.94 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.909 -1.676 . . . . 1.47 108.909 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 131.36 40.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.884 -0.774 . . . . 3.66 109.737 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -76.08 104.34 6.56 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.56 -0.712 . . . . 1.71 109.248 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.34 129.49 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.133 -0.691 . . . . 1.56 109.133 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.5 p -64.27 135.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.637 -0.664 . . . . 1.87 110.258 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.521 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 60.6 t-105 -109.92 153.14 24.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.75 -0.594 . . . . 1.08 109.435 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.03 -165.69 12.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.761 -1.335 . . . . 1.31 109.761 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.7 92.65 9.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.456 -1.026 . . . . 2.57 109.439 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.415 HG22 HG22 ' A' ' 17' ' ' VAL . 4.1 tt -165.48 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.751 -0.593 . . . . 1.91 109.961 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.52 158.6 46.64 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.55 -0.719 . . . . 1.82 109.814 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.49 -36.67 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.768 2.312 . . . . 1.75 110.619 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.77 68.59 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.572 -0.705 . . . . 1.22 109.244 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.704 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -58.52 -51.59 80.72 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.559 -0.713 . . . . 2.11 110.148 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -77.55 125.86 7.88 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.205 1.936 . . . . 0.79 109.626 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 61.9 m-85 65.55 172.31 0.22 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.34 0.59 . . . . 0.86 109.824 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.35 -32.72 11.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.248 -0.908 . . . . 1.12 110.092 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 p -140.49 163.35 33.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 1.2 110.239 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -31.79 72.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.665 -0.647 . . . . 1.88 110.276 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -34.94 72.05 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.399 -0.813 . . . . 2.73 109.655 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.57 -47.37 76.01 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.603 -0.888 . . . . 1.03 108.603 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.88 -33.64 76.49 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.979 -0.748 . . . . 1.47 108.979 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 8.1 tp -65.33 -67.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.213 -0.662 . . . . 1.54 109.213 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.66 -29.48 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.645 -0.659 . . . . 1.52 110.506 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -54.87 -42.43 72.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.415 -0.803 . . . . 1.03 110.208 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.415 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -64.52 -59.57 4.15 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.902 -0.777 . . . . 1.77 108.902 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.19 24.92 6.04 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.982 -0.847 . . . . 1.19 110.982 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -125.58 44.18 2.89 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.381 -1.07 . . . . 1.55 109.09 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 11.9 m95 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.443 -0.785 . . . . 1.19 109.471 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 109.282 -0.636 . . . . 1.64 109.282 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 p -138.43 124.14 19.78 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 1.63 109.871 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 18' ' ' TRP . 78.3 t -97.73 124.44 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.158 -0.682 . . . . 1.37 109.158 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.5 136.17 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.394 -0.816 . . . . 1.63 109.94 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.31 122.69 87.14 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.355 -0.609 . . . . 1.13 109.355 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -8.78 16.56 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.698 2.265 . . . . 1.39 111.621 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 m -88.93 -55.87 3.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.282 -0.887 . . . . 1.76 109.8 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.81 -27.12 13.19 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.485 -0.759 . . . . 1.8 110.653 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 73.23 1.27 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.944 -1.662 . . . . 1.9 108.944 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -140.86 135.29 31.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.76 -0.847 . . . . 3.53 109.687 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 109.55 10.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.604 -0.685 . . . . 1.88 109.933 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.93 129.17 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 1.76 108.732 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG11 HG23 ' A' ' 21' ' ' ILE . 9.3 p -58.1 135.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 1.95 110.448 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.619 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.2 t-105 -107.64 154.14 21.88 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.404 -0.591 . . . . 1.67 109.404 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.91 -167.88 13.62 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.72 -1.352 . . . . 1.44 109.72 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.79 97.94 10.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -1.081 . . . . 2.8 109.591 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG23 HG11 ' A' ' 17' ' ' VAL . 5.5 tt -169.35 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 2.65 110.318 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 75.7 p -107.47 159.85 28.74 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.512 -0.742 . . . . 2.66 110.125 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 35.6 Cg_endo -77.52 -32.35 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.784 2.323 . . . . 3.25 110.41 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.92 71.71 0.8 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.143 -0.688 . . . . 2.27 109.143 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.636 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -58.01 -54.29 57.04 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.541 -0.724 . . . . 4.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.07 124.89 8.24 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 122.263 1.976 . . . . 1.52 108.898 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.9 m-85 65.72 175.43 0.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.059 -0.719 . . . . 1.12 109.059 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 p -102.31 -32.86 9.83 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.986 -1.072 . . . . 1.99 110.265 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.39 165.84 26.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 2.64 110.274 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -62.74 -40.57 97.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.706 -0.621 . . . . 2.46 109.908 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -62.2 -39.9 94.29 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.7 -0.625 . . . . 1.75 110.075 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.52 -48.41 79.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 1.79 109.438 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -65.08 -33.78 76.84 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.931 -0.766 . . . . 1.78 108.931 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.1 tp -65.13 -66.3 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.083 -0.71 . . . . 1.71 109.083 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.4 mt -49.88 -29.36 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.79 -0.569 . . . . 1.86 110.563 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -54.12 -42.93 70.03 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.494 -0.754 . . . . 0.89 110.106 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 3.2 mt -66.0 -58.77 4.76 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.808 -0.812 . . . . 1.8 108.808 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.33 25.71 5.43 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 111.03 -0.828 . . . . 0.98 111.03 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -123.8 38.0 4.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.377 -1.072 . . . . 1.42 109.383 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.501 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 3.5 m95 . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.508 -0.745 . . . . 1.37 109.916 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.501 2.096 0 N-CA-C 109.077 -0.712 . . . . 2.84 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 p -102.85 125.15 49.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 2.06 110.469 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.98 139.79 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.197 -0.668 . . . . 2.16 109.197 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -88.27 135.76 33.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.265 -0.897 . . . . 2.22 110.412 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.36 120.28 73.86 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.053 -0.721 . . . . 1.25 109.053 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.03 3.02 7.38 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 122.832 2.355 . . . . 1.67 112.038 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.3 m -104.49 -50.9 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.118 -0.989 . . . . 1.82 109.847 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -107.97 -25.51 11.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.605 -0.684 . . . . 1.2 110.763 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.95 80.39 1.39 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.55 -1.82 . . . . 1.47 108.55 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -150.06 137.15 19.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.757 -0.849 . . . . 3.4 109.725 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -77.65 108.5 10.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.343 -0.848 . . . . 2.18 109.567 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -108.83 128.87 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.962 -0.755 . . . . 1.51 108.962 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.89 133.28 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.461 0.648 . . . . 1.79 110.214 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 28.5 t-105 -118.65 153.86 33.63 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.426 -0.583 . . . . 2.36 109.426 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 25' ' ' ARG . . . 122.6 -125.17 5.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.986 -1.245 . . . . 1.97 109.986 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.48 87.07 2.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.977 . . . . 2.35 109.049 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -166.19 -45.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.509 -0.744 . . . . 1.78 110.462 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -111.17 159.97 30.81 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.521 -0.737 . . . . 1.5 110.041 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.73 -32.07 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 122.824 2.349 . . . . 1.78 110.857 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.15 68.58 0.67 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.581 -0.699 . . . . 2.75 109.579 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.726 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 2.3 mtt180 -63.75 -50.31 71.91 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.307 -0.871 . . . . 3.66 110.227 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.77 119.16 4.69 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 122.194 1.93 . . . . 1.73 109.944 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 66.0 m-85 66.02 161.4 0.14 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.374 0.607 . . . . 1.93 110.019 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.54 -32.05 22.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.348 -0.845 . . . . 1.32 110.29 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -140.16 168.49 19.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.48 -0.763 . . . . 1.73 110.18 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -38.25 77.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.669 -0.645 . . . . 4.87 109.631 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.42 98.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.829 -0.544 . . . . 3.26 110.122 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.67 -51.29 70.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.571 -0.706 . . . . 1.62 109.414 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 19.2 tt0 -60.48 -34.99 74.83 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.156 -0.683 . . . . 3.27 109.156 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -63.44 -67.26 0.44 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.277 -0.638 . . . . 2.85 109.277 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.5 mt -49.43 -29.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.66 -0.65 . . . . 2.09 110.466 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -53.34 -45.25 69.02 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.52 -0.737 . . . . 2.0 110.374 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mt -63.58 -59.91 4.02 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.868 . . . . 3.17 108.655 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.21 22.47 6.49 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 120.575 -0.821 . . . . 2.64 111.107 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.23 40.73 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -1.149 . . . . 3.23 109.248 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.486 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 7.5 m95 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.504 -0.748 . . . . 3.17 109.445 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.1 pt . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 109.472 -0.566 . . . . 2.04 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -115.55 125.29 52.81 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 2.02 110.112 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' TRP . 89.5 t -98.86 120.83 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.958 -0.756 . . . . 1.52 108.958 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.88 131.28 34.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.555 -0.715 . . . . 2.29 109.723 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.83 119.4 60.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.153 -0.684 . . . . 0.86 109.153 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.83 -7.86 16.63 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.769 2.312 . . . . 0.9 111.784 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.5 m -91.88 -50.82 5.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.18 -0.95 . . . . 1.63 110.068 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.0 p -108.72 -32.1 7.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 1.3 110.873 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.48 73.37 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.24 -1.544 . . . . 1.13 109.24 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 130.67 26.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.769 -0.842 . . . . 2.39 109.571 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -76.73 112.85 13.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.644 -0.66 . . . . 1.71 109.634 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.6 127.07 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.821 -0.807 . . . . 1.8 108.821 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.66 139.38 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -0.784 . . . . 2.14 110.429 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.498 ' HB3' HG13 ' A' ' 5' ' ' ILE . 66.3 t-105 -108.23 151.6 25.72 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.2 -0.667 . . . . 1.74 109.2 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.3 -119.21 1.75 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.002 -1.239 . . . . 1.45 110.002 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.1 32.25 1.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.92 -0.753 . . . . 2.77 109.162 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 tt -109.34 -34.23 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 2.73 110.042 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.6 153.66 39.04 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 2.47 109.974 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.29 -40.74 0.57 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.642 2.228 . . . . 2.18 110.005 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.57 68.21 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.694 -0.854 . . . . 1.64 108.694 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.638 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 22.9 mtm180 -59.34 -48.88 95.13 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.553 -0.717 . . . . 2.73 110.408 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.0 Cg_endo -76.18 118.83 5.1 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.992 1.795 . . . . 1.26 109.105 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 39.2 m-85 67.99 163.93 0.22 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.344 -0.613 . . . . 1.01 109.344 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -86.42 -31.45 21.42 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.195 -0.941 . . . . 1.44 110.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.68 157.35 43.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.431 -0.793 . . . . 2.39 109.876 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -63.7 -29.4 70.63 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.577 -0.702 . . . . 2.66 109.713 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -42.94 79.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 3.27 109.204 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.34 -46.79 88.79 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.005 -0.739 . . . . 1.37 109.005 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -61.75 -36.02 79.78 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.694 -0.854 . . . . 1.77 108.694 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 2.9 tp -61.96 -65.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.872 -0.788 . . . . 2.19 108.872 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 35' ' ' ILE . 33.2 mm -49.54 -33.24 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.693 -0.629 . . . . 2.52 110.156 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.38 -45.34 72.81 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.602 -0.686 . . . . 1.47 109.766 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.5 mt -62.04 -58.86 6.25 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.959 -0.756 . . . . 2.25 108.959 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.22 33.2 4.34 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.0 -1.24 . . . . 2.46 110.0 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.43 40.02 3.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.763 -0.845 . . . . 4.59 108.836 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.592 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 8.0 m95 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.89 . . . . 2.62 110.546 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 108.923 -0.769 . . . . 1.83 108.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 17' ' ' VAL . 33.9 p -109.77 120.71 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 1.59 110.169 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -88.34 136.2 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.817 -0.809 . . . . 1.62 108.817 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.45 134.9 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.371 -0.83 . . . . 1.99 110.072 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.66 120.65 67.65 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.4 -6.59 16.47 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.703 2.268 . . . . 1.04 111.865 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.1 m -93.35 -49.73 5.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.224 -0.923 . . . . 1.23 109.945 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -109.97 -33.87 6.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.465 -0.772 . . . . 1.18 110.756 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.77 74.0 1.07 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.117 -1.593 . . . . 1.2 109.117 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 132.29 31.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.804 -0.821 . . . . 2.12 109.695 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -75.02 113.43 12.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.668 -0.645 . . . . 1.66 109.71 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.72 131.82 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.133 -0.691 . . . . 1.47 109.133 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.527 ' HA ' HG21 ' A' ' 6' ' ' THR . 8.2 p -60.05 140.05 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.73 -0.606 . . . . 1.36 110.389 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.5 t-105 -123.5 150.75 43.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.714 -0.616 . . . . 1.73 109.677 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.89 -97.61 0.49 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.276 -1.53 . . . . 1.3 109.276 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 91.65 0.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.801 -0.823 . . . . 2.72 109.337 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 tt -167.63 -42.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.631 -0.668 . . . . 1.91 110.031 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.0 161.91 21.52 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.535 -0.728 . . . . 1.67 109.809 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 -42.64 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.704 2.269 . . . . 2.25 110.451 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.98 65.36 0.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.698 . . . . 2.06 109.127 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.555 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 15.2 mtm105 -58.33 -49.87 91.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.502 -0.749 . . . . 1.86 110.098 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.25 125.64 7.94 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.188 1.926 . . . . 1.53 109.262 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 57.6 m-85 65.87 173.12 0.23 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.751 -0.593 . . . . 1.24 109.458 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.08 -26.78 12.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.2 -0.937 . . . . 1.22 110.511 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.78 159.97 42.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.257 -0.902 . . . . 2.18 110.4 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.38 88.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.507 -0.553 . . . . 2.43 109.507 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -43.58 94.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.865 -0.522 . . . . 2.71 109.684 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -59.3 -48.6 81.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.634 -0.666 . . . . 1.02 109.32 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -63.59 -35.98 82.31 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.165 -0.679 . . . . 1.75 109.165 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 9.6 tp -64.87 -67.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.397 -0.594 . . . . 2.13 109.397 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -49.03 -33.64 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.693 -0.63 . . . . 1.41 110.708 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -50.98 -41.37 59.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.487 -0.758 . . . . 1.3 110.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.36 -59.04 4.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.508 -0.745 . . . . 2.46 109.105 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.64 10.25 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.519 -0.848 . . . . 1.55 111.572 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 43.45 2.1 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.531 1.165 . . . . 2.76 109.161 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 4.4 m95 . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.564 -0.71 . . . . 1.94 109.41 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.181 0.515 . . . . 2.72 109.658 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -118.79 121.33 39.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.669 -0.644 . . . . 2.65 110.156 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.8 t -83.5 115.68 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.601 -0.889 . . . . 2.51 108.601 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -83.45 129.97 35.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.458 -0.776 . . . . 2.61 109.704 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.6 t -68.75 118.55 61.82 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.293 -0.632 . . . . 2.29 109.293 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.92 -20.91 9.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.659 2.239 . . . . 2.32 111.068 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -71.83 -51.71 21.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 2.56 110.235 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.3 p -109.07 -34.01 6.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 2.51 110.856 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.9 74.32 1.05 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.105 -1.598 . . . . 2.54 109.105 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 127.1 15.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.678 -0.895 . . . . 3.45 109.714 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -74.34 117.22 15.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.664 -0.647 . . . . 2.73 109.604 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.6 131.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.985 -0.746 . . . . 2.78 108.985 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.565 ' HA ' HG21 ' A' ' 6' ' ' THR . 11.2 p -60.84 141.23 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.497 -0.752 . . . . 3.09 110.291 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 68.0 t-105 -120.85 149.8 42.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.788 -0.57 . . . . 2.38 109.675 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.11 -99.2 0.41 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.314 -1.515 . . . . 2.49 109.314 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.42 83.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.649 -0.912 . . . . 2.88 109.332 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tt -157.25 -41.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.704 -0.622 . . . . 3.31 109.941 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 70.3 p -106.54 161.11 23.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.453 -0.779 . . . . 2.77 109.66 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 33.0 Cg_endo -75.03 -38.99 1.33 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.607 2.205 . . . . 2.85 110.334 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.91 64.82 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.879 -0.785 . . . . 2.67 108.879 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.571 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.4 mtm105 -58.94 -50.82 85.95 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.588 -0.695 . . . . 2.68 110.331 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.8 Cg_endo -76.6 118.52 4.88 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.061 1.841 . . . . 2.31 109.369 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 37.0 m-85 66.4 -171.19 0.19 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.27 -0.641 . . . . 2.39 109.27 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -117.64 -31.66 5.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.037 -1.039 . . . . 2.62 111.447 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.14 166.46 23.35 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.023 -1.048 . . . . 2.82 110.887 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -42.26 93.24 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.614 -0.513 . . . . 3.66 109.614 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -40.42 95.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.692 -0.63 . . . . 2.79 109.761 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 49.9 m -62.92 -48.4 79.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 2.38 109.372 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 29.3 tt0 -63.96 -36.58 84.42 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.118 -0.697 . . . . 3.3 109.118 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 12.2 tp -60.95 -64.97 0.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.453 -0.943 . . . . 3.16 108.453 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.81 -34.71 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.948 -0.47 . . . . 2.81 110.323 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -44.33 61.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.53 -0.731 . . . . 2.17 110.769 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.455 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.7 mt -57.99 -61.78 2.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.42 -0.8 . . . . 2.94 109.381 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.6 19.69 3.7 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 120.295 -0.955 . . . . 2.11 111.575 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.44 30.58 6.69 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.184 -1.186 . . . . 2.48 109.851 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.536 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 O-C-N 121.215 -0.928 . . . . 2.83 109.68 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.515 -0.55 . . . . 1.65 109.515 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -88.46 119.8 29.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.411 -0.806 . . . . 1.37 109.622 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.57 123.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.047 -0.723 . . . . 1.48 109.047 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.01 130.78 34.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.571 -0.706 . . . . 2.4 110.019 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -59.67 119.31 39.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.318 -0.623 . . . . 1.58 109.318 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 35.5 Cg_endo -77.43 -10.9 17.43 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.72 2.28 . . . . 1.92 111.77 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 95.1 m -86.33 -46.99 9.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 1.95 109.838 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -118.03 -33.77 4.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.506 -0.746 . . . . 2.29 110.88 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.31 88.29 2.04 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.877 -1.689 . . . . 2.06 108.877 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HD2' ' HB2' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -149.63 126.59 11.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.966 -0.726 . . . . 4.37 109.701 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -70.25 115.25 9.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.534 -0.729 . . . . 1.83 109.18 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG11 ' O ' ' A' ' 25' ' ' ARG . 36.1 t -117.62 109.74 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.948 -0.76 . . . . 1.42 108.948 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.416 HG23 HG21 ' A' ' 21' ' ' ILE . 7.1 p -55.86 133.62 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.634 -0.666 . . . . 1.63 110.292 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 25' ' ' ARG . 69.6 t-105 -135.07 156.25 49.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.755 -0.591 . . . . 1.41 109.726 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.19 -105.36 0.92 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.684 -1.366 . . . . 1.16 109.684 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.74 22.79 8.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.626 -0.926 . . . . 1.61 109.893 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.416 HG21 HG23 ' A' ' 17' ' ' VAL . 6.3 tt -160.35 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.365 -0.976 . . . . 1.85 108.365 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -115.25 99.15 52.0 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.674 . . . . 1.44 109.582 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.56 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.7 2.267 . . . . 1.46 110.828 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.64 49.78 1.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.563 -0.711 . . . . 2.68 109.146 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.595 ' HG2' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 63.27 -176.83 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.661 -0.866 . . . . 4.01 108.661 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' A' ' 25' ' ' ARG . 32.2 Cg_endo -74.27 -12.49 23.14 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.094 1.862 . . . . 0.73 110.678 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 27.0 m-85 -93.45 154.31 18.0 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.839 -0.8 . . . . 1.28 108.839 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.432 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 19.5 p -69.67 -33.56 72.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.296 -0.878 . . . . 1.33 109.699 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 166.76 25.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 1.91 109.773 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -70.34 -38.01 74.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.59 -0.694 . . . . 3.95 109.672 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -41.67 95.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.212 -0.662 . . . . 3.18 109.212 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.29 -48.09 82.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.102 -0.703 . . . . 1.27 109.102 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -62.11 -35.87 80.03 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.906 -0.776 . . . . 1.32 108.906 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 4.7 tp -63.19 -65.53 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.976 -0.75 . . . . 1.55 108.976 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.4 mm -51.02 -32.0 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.596 -0.69 . . . . 1.99 110.219 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.09 -40.94 74.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.744 . . . . 1.52 109.913 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -65.23 -58.49 5.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.082 -0.71 . . . . 2.12 109.082 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 29.34 5.23 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.683 -0.967 . . . . 1.56 110.683 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -130.67 40.74 3.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.504 -0.998 . . . . 2.31 109.286 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.439 -0.788 . . . . 1.36 109.613 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.11 -0.7 . . . . 2.28 109.11 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 17' ' ' VAL . 21.5 p -124.85 123.37 39.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.346 -0.846 . . . . 1.35 109.796 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.89 133.12 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.306 -0.627 . . . . 1.57 109.306 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -93.3 136.91 33.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.557 -0.714 . . . . 1.42 110.15 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 12.2 t -65.05 118.02 45.15 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.307 -0.627 . . . . 0.89 109.307 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 -7.7 16.23 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.676 2.251 . . . . 1.17 111.425 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.593 HG23 HD11 ' A' ' 35' ' ' ILE . 52.9 m -94.92 -56.08 2.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.268 -0.895 . . . . 1.59 110.091 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -104.77 -29.86 10.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.412 -0.805 . . . . 1.35 110.905 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.01 86.17 1.87 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.324 -1.511 . . . . 1.19 109.324 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.47 124.83 8.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.836 -0.803 . . . . 1.96 109.73 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.5 m -75.2 110.95 9.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.563 -0.711 . . . . 1.46 109.841 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.649 HG23 ' HA ' ' A' ' 28' ' ' CYS . 73.2 t -113.42 119.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.656 -0.868 . . . . 1.37 108.656 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.591 HG12 HG12 ' A' ' 21' ' ' ILE . 13.9 p -63.66 137.69 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.465 0.65 . . . . 1.29 109.635 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.478 ' CZ3' ' HB3' ' A' ' 22' ' ' SER . 73.9 t-105 -133.52 154.6 50.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 1.51 109.634 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.69 93.88 2.15 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.434 -1.467 . . . . 1.23 109.434 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.57 24.81 14.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.929 -0.748 . . . . 2.59 110.364 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.591 HG12 HG12 ' A' ' 17' ' ' VAL . 6.4 tt -177.53 103.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.732 -0.84 . . . . 1.7 108.732 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.478 ' HB3' ' CZ3' ' A' ' 18' ' ' TRP . 16.7 p -127.81 91.7 44.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 1.99 110.107 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 -38.27 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.662 2.241 . . . . 1.01 110.128 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.78 35.26 4.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.746 -0.596 . . . . 1.88 109.716 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.588 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 2.4 mtm105 65.77 178.28 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.62 -0.675 . . . . 3.43 110.859 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 36.4 Cg_endo -78.21 14.05 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.807 2.338 . . . . 1.05 111.47 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -131.03 -69.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 1.61 109.02 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 0.4 OUTLIER 168.74 -38.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.179 -0.674 . . . . 1.35 109.179 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.31 174.35 11.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.729 -0.607 . . . . 1.48 109.953 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -46.74 70.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 3.95 109.519 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HD3' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -64.91 -43.19 93.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.92 -0.487 . . . . 3.89 109.933 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.7 m -59.85 -44.75 93.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.654 . . . . 0.87 109.322 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -33.17 75.13 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.074 -0.713 . . . . 1.81 109.074 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.584 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.0 tp -61.53 -62.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.403 -0.962 . . . . 1.28 108.403 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.593 HD11 HG23 ' A' ' 11' ' ' THR . 9.0 mt -50.9 -29.93 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.825 -0.547 . . . . 1.68 110.128 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -30.83 70.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 1.49 110.558 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.33 -58.98 2.97 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.353 -0.842 . . . . 2.08 109.055 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.68 24.67 5.74 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.464 -0.874 . . . . 1.24 111.335 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 42.02 3.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.217 -1.167 . . . . 1.81 109.035 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.584 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 11.8 m95 . . . . . 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 1.16 109.567 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.394 -0.595 . . . . 2.08 109.394 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 17' ' ' VAL . 6.7 p -140.68 123.6 16.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.537 -0.727 . . . . 1.41 109.897 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 18' ' ' TRP . 71.6 t -97.86 123.99 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.981 -0.748 . . . . 1.66 108.981 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.95 134.23 34.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.556 -0.715 . . . . 1.58 110.027 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.9 t -68.78 120.26 74.74 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 109.162 -0.681 . . . . 0.81 109.162 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -9.05 16.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.712 2.274 . . . . 1.21 111.781 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.7 m -89.15 -51.47 5.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.244 -0.91 . . . . 1.89 110.071 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.77 -23.68 12.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.515 -0.741 . . . . 1.42 110.844 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.9 79.03 1.27 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.464 -1.855 . . . . 1.29 108.464 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -147.73 134.26 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.886 -0.773 . . . . 4.37 109.886 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -76.63 111.58 12.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 1.41 109.691 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.19 138.48 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.608 -0.886 . . . . 1.27 108.608 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HA ' HG21 ' A' ' 6' ' ' THR . 9.7 p -64.1 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.396 -0.815 . . . . 1.38 110.039 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.488 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -115.55 153.13 31.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.468 -0.568 . . . . 1.68 109.468 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.58 -104.89 1.08 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.484 -1.447 . . . . 1.61 109.484 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 53.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.743 -0.857 . . . . 3.62 109.652 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 17' ' ' VAL . 2.7 mp -114.84 -53.69 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.406 -0.809 . . . . 2.08 109.487 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.4 m -94.19 165.72 17.04 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.684 -0.635 . . . . 1.41 109.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 34.7 Cg_endo -76.47 -23.83 11.1 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.705 2.27 . . . . 1.94 110.702 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' HZ ' ' HG2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -120.48 74.36 1.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.708 . . . . 2.15 109.181 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.513 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -58.17 -55.97 39.86 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.606 -0.684 . . . . 2.23 109.947 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.67 123.9 6.65 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 122.363 2.042 . . . . 1.27 109.721 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 43.9 m-85 66.01 167.1 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.334 0.588 . . . . 0.91 109.653 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.79 -31.37 15.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 1.09 110.208 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -144.15 163.97 32.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 1.54 110.24 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.14 -32.01 73.29 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -50.43 70.17 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.913 -0.492 . . . . 6.17 109.979 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 2.7 m -56.44 -48.44 77.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.692 -0.63 . . . . 1.15 109.815 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -64.15 -37.52 87.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 1.84 109.44 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.6 tp -62.3 -66.9 0.47 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.89 -0.781 . . . . 1.87 108.89 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.2 mt -50.43 -29.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.828 -0.545 . . . . 1.81 110.697 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.85 -42.5 68.61 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.454 -0.779 . . . . 1.21 110.287 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.41 -58.34 6.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.494 -0.754 . . . . 2.08 109.056 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.49 22.39 6.77 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 120.624 -0.798 . . . . 1.49 111.277 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.65 40.01 3.62 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.349 -1.089 . . . . 2.07 109.224 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.487 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 2.6 m95 . . . . . 0 N--CA 1.5 2.073 0 O-C-N 121.581 -0.699 . . . . 1.51 109.318 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.551 ' HE1' ' HB2' ' A' ' 3' ' ' GLU . 16.3 ttp . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.161 0.505 . . . . 6.77 109.685 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.85 39.28 0.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.795 -1.187 . . . . 3.68 107.795 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 0.4 OUTLIER -60.71 121.73 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 3.34 111.598 -178.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.483 ' CG2' HD12 ' A' ' 21' ' ' ILE . 91.7 m -100.71 101.03 11.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.65 -1.611 . . . . 1.98 106.65 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -77.22 149.3 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.618 -0.882 . . . . 2.94 108.618 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 17' ' ' VAL . 20.1 p -120.41 120.57 36.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 2.82 110.474 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.34 132.93 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.495 -0.928 . . . . 2.63 108.495 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -91.41 135.28 33.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 3.63 110.286 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.4 t -66.68 118.27 52.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.791 -0.818 . . . . 2.51 108.791 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.9 Cg_endo -76.35 -15.65 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.524 2.149 . . . . 3.1 111.849 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.796 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 87.7 m -81.17 -50.39 9.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.921 . . . . 2.59 110.708 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.9 p -110.78 -26.1 9.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 3.12 110.789 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.18 74.4 1.26 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.839 -1.705 . . . . 3.39 108.839 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 28' ' ' CYS . 6.2 tmtt? -140.08 128.62 22.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.063 -0.669 . . . . 3.57 109.521 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.407 HG23 ' HB ' ' A' ' 6' ' ' THR . 40.0 m -70.6 115.86 10.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.635 -0.666 . . . . 3.61 109.75 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.93 123.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.926 -0.768 . . . . 1.9 108.926 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' HA ' ' CG2' ' A' ' 6' ' ' THR . 9.8 p -53.07 136.95 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.28 0.562 . . . . 2.02 110.322 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.518 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -112.11 156.59 22.0 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.647 -0.658 . . . . 2.98 109.809 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.76 -100.64 0.91 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.869 -1.692 . . . . 2.11 108.869 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.89 57.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.848 -0.795 . . . . 4.29 109.226 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.483 HD12 ' CG2' ' A' ' 4' ' ' THR . 3.4 mp -120.35 -52.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.594 -0.691 . . . . 3.09 109.366 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.1 m -93.47 166.77 15.33 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 2.84 110.007 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 36.2 Cg_endo -78.27 -32.87 2.16 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.488 2.126 . . . . 3.79 109.753 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.96 66.68 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.37 -0.604 . . . . 3.58 109.37 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -51.69 -55.43 29.96 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.282 -0.886 . . . . 4.0 109.322 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.2 Cg_endo -77.73 119.96 4.98 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.253 1.969 . . . . 2.56 109.545 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 82.8 m-85 68.0 159.45 0.16 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.345 0.593 . . . . 2.28 110.051 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 32.0 p -90.28 -35.4 15.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 1.57 110.0 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 165.6 24.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.455 -0.778 . . . . 2.26 109.543 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -72.4 -36.83 68.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.531 -0.73 . . . . 3.98 109.887 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -34.85 72.04 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.397 -0.814 . . . . 2.51 108.893 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.8 m -66.85 -56.15 11.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -58.11 -33.7 69.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.103 -0.702 . . . . 2.42 109.103 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.552 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.9 tp -62.84 -65.77 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.734 -0.839 . . . . 2.69 108.734 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 60' ' ' SER . 40.2 mt -49.5 -28.41 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.75 -0.593 . . . . 2.1 110.301 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HA ' ' OE1' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -59.22 -39.64 83.34 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.446 -0.784 . . . . 2.82 110.458 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -64.0 -60.0 3.8 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.793 -0.817 . . . . 3.52 108.793 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.7 24.63 5.19 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.912 -0.875 . . . . 2.71 110.912 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -126.1 40.6 3.7 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.329 -1.1 . . . . 3.42 109.215 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.5 m95 -137.43 -179.14 5.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.537 -0.727 . . . . 3.03 109.681 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.47 84.94 2.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -0.789 . . . . 1.86 109.595 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 35' ' ' ILE . . . -162.71 59.36 0.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 1.73 109.512 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.91 77.85 0.2 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.55 -0.719 . . . . 2.23 109.666 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -167.73 -38.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.324 -0.86 . . . . 2.02 110.858 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -138.52 117.95 12.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 4.4 109.646 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 128.08 41.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.633 -0.667 . . . . 3.31 110.024 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.56 99.1 51.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.796 -0.565 . . . . 3.43 109.588 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.514 ' HG3' ' HB2' ' A' ' 53' ' ' LEU . 31.2 Cg_endo -75.33 171.05 19.01 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.887 2.391 . . . . 1.98 111.91 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.29 -32.79 74.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.879 -0.513 . . . . 3.41 110.03 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.13 -41.33 83.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.281 -0.887 . . . . 3.74 108.793 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.76 -104.74 0.25 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.029 -1.628 . . . . 3.89 109.029 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 124.53 36.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.821 -0.811 . . . . 3.87 109.658 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -126.65 139.46 53.15 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.521 -0.737 . . . . 5.35 110.876 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.74 81.28 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.455 0.645 . . . . 4.61 110.393 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.37 129.95 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.484 -0.932 . . . . 4.82 108.484 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.29 67.73 0.39 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.465 0.65 . . . . 3.68 109.662 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.82 112.16 9.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.802 . . . . 3.41 108.985 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 66.57 94.98 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.401 0.62 . . . . 1.43 109.5 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -100.64 167.79 10.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.532 -0.73 . . . . 2.31 109.732 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.56 ' HB2' ' CG2' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -67.33 -39.44 85.82 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.754 -0.832 . . . . 2.74 108.754 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 11' ' ' THR . 2.4 mp0 -67.98 -57.82 5.54 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.577 0.703 . . . . 3.26 109.18 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -124.82 107.45 28.73 Favored Pre-proline 0 N--CA 1.485 1.312 0 CA-C-N 116.169 -0.469 . . . . 1.88 109.867 -178.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 30.3 Cg_endo -76.11 -49.11 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.367 2.045 . . . . 2.98 110.768 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 63' ' ' PRO . 8.4 tptt -154.48 133.32 12.26 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.478 -0.764 . . . . 5.01 110.257 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 2.8 tt0 . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 117.768 -1.11 . . . . 4.04 109.864 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.66 -0.496 . . . . 4.86 109.66 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.76 -50.54 5.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.292 -0.88 . . . . 3.52 109.034 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.8 OUTLIER -102.28 120.17 40.03 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.574 -0.899 . . . . 3.45 108.574 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 88.4 m 68.13 130.67 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.314 0.578 . . . . 1.57 109.836 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt -79.17 150.17 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.288 -0.882 . . . . 1.78 109.934 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.549 HG21 ' HA ' ' A' ' 17' ' ' VAL . 34.2 p -122.42 128.36 50.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 1.54 109.908 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 18' ' ' TRP . 25.3 m -91.2 138.36 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 1.38 109.371 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.89 137.15 33.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.766 . . . . 2.3 110.097 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.68 120.72 75.48 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 109.095 -0.705 . . . . 1.07 109.095 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 -2.21 12.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.704 2.269 . . . . 1.37 112.05 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.6 m -98.78 -51.31 3.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.147 -0.971 . . . . 1.13 110.023 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.3 p -107.54 -30.03 8.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.617 -0.677 . . . . 1.51 110.763 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 71.16 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.814 -1.714 . . . . 1.65 108.814 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 135.08 40.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.786 -0.832 . . . . 2.61 109.66 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -76.54 112.27 12.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.566 -0.709 . . . . 1.79 109.685 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.26 127.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.853 -0.795 . . . . 1.4 108.853 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 ' HA ' HG21 ' A' ' 6' ' ' THR . 9.6 p -60.68 137.86 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.705 . . . . 1.72 110.371 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.518 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.1 t-105 -106.92 156.02 19.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.776 -0.577 . . . . 1.45 109.543 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.33 -179.23 26.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.744 -1.342 . . . . 1.21 109.744 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.15 103.65 3.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.583 -0.951 . . . . 4.41 109.721 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.462 HG23 HG13 ' A' ' 17' ' ' VAL . 3.7 tt -174.99 -40.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.748 -0.595 . . . . 2.02 109.761 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.75 157.23 50.58 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 1.78 109.651 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.23 -35.61 2.23 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.579 2.186 . . . . 2.31 110.681 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.26 68.52 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.519 -0.738 . . . . 2.38 109.066 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.664 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -56.06 -54.17 55.32 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.599 -0.688 . . . . 1.79 109.854 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -78.0 128.69 9.3 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.291 1.994 . . . . 1.38 109.44 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 62.0 m-85 65.54 173.48 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.373 0.606 . . . . 1.14 109.661 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -104.08 -31.88 9.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.897 . . . . 1.16 110.341 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -138.41 164.21 29.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.328 -0.858 . . . . 1.41 110.419 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -38.66 90.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 2.48 109.487 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -42.0 98.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 2.68 109.897 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -59.38 -50.35 74.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.582 -0.699 . . . . 0.82 109.304 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.04 -35.32 78.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.169 -0.678 . . . . 1.86 109.169 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 10.5 tp -66.04 -66.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.24 -0.652 . . . . 2.1 109.24 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 43' ' ' GLU . 14.4 mt -50.2 -30.93 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.634 -0.666 . . . . 1.35 110.542 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.8 -41.67 64.37 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.598 -0.688 . . . . 1.39 110.081 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.408 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.5 -59.11 4.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.943 -0.762 . . . . 2.45 108.943 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.05 26.71 5.39 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.992 -0.843 . . . . 1.65 110.992 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.32 47.21 2.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 2.51 109.118 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.515 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 7.7 m95 -140.02 -54.4 0.53 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.512 -0.743 . . . . 2.26 109.93 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 58.08 53.1 6.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.906 -0.775 . . . . 2.01 108.906 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.5 -37.18 7.69 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.858 -0.793 . . . . 1.98 108.858 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' HB2' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -104.79 103.37 12.97 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.224 -0.658 . . . . 3.75 109.224 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -147.5 88.83 1.73 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.327 -0.858 . . . . 3.72 110.587 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -118.19 78.05 1.22 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.508 -0.923 . . . . 3.62 108.508 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.41 173.89 9.81 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.241 0.543 . . . . 3.94 110.019 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pt -91.8 128.66 45.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.579 -0.897 . . . . 4.42 108.579 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -72.63 -41.41 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 122.535 2.157 . . . . 3.55 110.704 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.38 130.78 21.02 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.964 -0.754 . . . . 3.48 108.964 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.1 p -82.59 160.25 22.56 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 3.72 109.604 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 55' ' ' GLU . . . 97.41 -36.36 3.97 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.182 -1.567 . . . . 2.51 109.182 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.66 -39.24 5.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.758 -0.848 . . . . 2.98 109.797 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.19 -59.4 1.76 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.586 -0.696 . . . . 4.57 109.832 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.49 -55.39 18.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.833 -0.542 . . . . 4.66 110.229 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.618 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -86.88 126.07 34.42 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.332 0.587 . . . . 3.39 110.559 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.18 -51.67 2.93 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.751 -0.833 . . . . 4.31 108.751 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 96.55 7.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 4.44 108.785 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.88 135.61 57.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 2.25 108.379 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.604 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 7.4 m95 -96.85 56.34 1.44 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.657 -0.817 . . . . 5.91 112.414 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 61' ' ' GLU . 9.2 p -77.68 59.44 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.055 -1.461 . . . . 3.63 107.055 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 2.0 mp0 -10.17 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 113.011 0.745 . . . . 7.36 113.011 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -107.5 91.25 6.86 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.329 -0.857 . . . . 5.92 111.069 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 61' ' ' GLU . 34.0 Cg_endo -75.49 -22.28 14.14 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.246 1.297 . . . . 3.91 110.117 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 168.61 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 118.714 0.688 . . . . 7.23 111.112 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.817 -1.087 . . . . 5.82 110.464 178.059 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.79 -0.448 . . . . 3.57 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -103.25 -48.11 4.11 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.638 -0.664 . . . . 2.09 110.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.18 94.11 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.379 0.609 . . . . 1.84 109.747 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 m -96.52 124.7 40.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 1.47 109.476 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 pt -95.44 165.69 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.686 . . . . 1.79 109.552 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.419 ' HB ' HG21 ' A' ' 15' ' ' THR . 45.1 p -126.17 130.68 51.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.408 -0.808 . . . . 1.57 110.046 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 18' ' ' TRP . 42.8 t -97.49 131.08 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.286 -0.635 . . . . 1.6 109.286 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.07 140.46 36.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.563 -0.711 . . . . 2.11 109.804 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 16.1 t -73.01 125.48 91.04 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.71 -0.619 . . . . 1.36 109.519 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.57 -3.71 13.54 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.809 2.339 . . . . 1.89 111.783 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.5 m -97.39 -54.89 3.0 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.237 -0.914 . . . . 1.86 109.901 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.9 p -102.07 -30.71 11.02 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.585 -0.697 . . . . 1.59 110.688 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.45 62.59 1.09 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.346 -1.502 . . . . 1.52 109.346 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 140.46 46.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.877 -0.778 . . . . 3.21 109.341 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.419 HG21 ' HB ' ' A' ' 6' ' ' THR . 35.5 m -73.71 116.61 14.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.79 109.827 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.7 t -116.0 137.47 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.136 -0.69 . . . . 1.41 109.136 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.87 139.46 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.429 -0.795 . . . . 1.22 110.256 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.528 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 57.5 t-105 -116.47 152.72 33.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 1.34 109.646 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 -145.46 16.61 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.686 -1.366 . . . . 1.19 109.686 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 89.02 2.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.454 -1.027 . . . . 1.99 109.344 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -153.8 -42.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.66 -0.65 . . . . 1.72 110.073 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 55.8 p -131.4 161.24 63.23 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.524 -0.735 . . . . 1.08 109.818 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.91 -15.82 18.59 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.737 2.291 . . . . 1.28 110.679 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 27' ' ' PHE . 61.8 m-85 -119.41 76.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.485 -0.931 . . . . 1.37 108.485 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.686 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -73.9 -48.91 6.18 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 2.52 110.483 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.69 -43.03 0.23 Allowed 'Trans proline' 0 C--N 1.326 -0.657 0 C-N-CA 122.171 1.914 . . . . 1.18 111.015 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 97.4 m-85 -99.08 163.66 12.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.671 -0.643 . . . . 1.27 109.809 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -80.38 -49.95 10.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.365 -0.834 . . . . 1.15 109.507 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.49 -172.8 3.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.669 -0.644 . . . . 1.49 110.074 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -36.13 82.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 2.94 110.165 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -64.57 -41.04 96.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.645 -0.66 . . . . 2.35 110.3 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.417 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 43.7 m -58.95 -48.23 82.27 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.122 -0.696 . . . . 1.22 109.122 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -66.4 -33.76 76.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.641 -0.662 . . . . 2.11 109.227 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -62.2 -66.63 0.51 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 1.64 109.328 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.429 HG12 ' CB ' ' A' ' 48' ' ' PRO . 11.4 mt -50.13 -30.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.605 -0.684 . . . . 2.05 110.356 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -56.53 -43.54 79.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.452 -0.78 . . . . 1.62 110.289 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.69 -61.18 2.7 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.847 -0.797 . . . . 2.43 108.847 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.57 18.84 8.22 Favored Glycine 0 N--CA 1.499 2.85 0 C-N-CA 120.457 -0.878 . . . . 1.95 111.339 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.14 40.22 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -1.127 . . . . 2.52 109.284 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 8.2 m95 -132.36 133.03 43.49 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.814 -0.81 . . . . 1.85 108.814 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . . . -96.14 153.28 17.88 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.537 -0.727 . . . . 2.18 111.113 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . . . -91.67 -45.03 8.68 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.986 -0.746 . . . . 3.73 108.986 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.01 -48.46 57.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 120.988 0.423 . . . . 5.57 110.371 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -58.52 -46.07 87.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.801 -0.562 . . . . 4.37 111.271 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -174.37 142.56 0.79 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.415 -0.803 . . . . 2.78 110.977 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 5.0 ttp180 64.62 122.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.422 0.629 . . . . 2.74 110.362 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.29 113.29 59.64 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.441 -0.787 . . . . 2.43 109.706 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 35.0 Cg_endo -77.63 56.25 5.52 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.737 2.291 . . . . 2.56 109.866 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.21 137.26 28.86 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.04 -0.726 . . . . 2.43 109.04 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.49 -59.56 2.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.647 -0.658 . . . . 4.9 109.335 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.7 85.21 0.39 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.079 -1.208 . . . . 2.68 110.079 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.89 155.92 17.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.743 -0.857 . . . . 2.76 109.426 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.63 80.67 1.98 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.415 -0.803 . . . . 3.17 110.058 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 -53.4 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.518 -0.919 . . . . 3.27 108.518 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -78.38 115.67 18.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.407 -0.59 . . . . 4.54 109.407 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.3 171.31 0.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.518 0.675 . . . . 3.42 110.353 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 -12.95 17.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.699 -0.626 . . . . 3.12 110.581 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.26 27.25 8.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.287 -0.883 . . . . 5.03 110.001 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -96.51 131.0 43.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.064 -1.022 . . . . 4.39 109.739 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -41.88 81.77 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.29 -0.633 . . . . 2.85 109.29 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 0.6 OUTLIER 55.69 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.78 -0.822 . . . . 3.24 108.78 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.3 mp0 66.54 79.69 0.23 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.98 -1.118 . . . . 4.75 107.98 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.75 93.5 0.78 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.475 2.116 . . . . 4.7 110.332 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -133.14 124.34 27.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.054 -0.721 . . . . 6.12 109.054 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.903 -1.046 . . . . 6.4 109.631 -179.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 109.295 -0.631 . . . . 5.59 109.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 3' ' ' GLU . 8.7 m 52.85 84.76 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.263 0.554 . . . . 4.44 109.654 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -37.19 106.46 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.593 0.711 . . . . 3.32 110.193 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.574 HG23 ' CG2' ' A' ' 17' ' ' VAL . 1.6 m -65.0 95.27 0.15 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.384 0.611 . . . . 2.92 111.26 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.67 123.79 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.139 -1.06 . . . . 2.1 108.139 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 25.3 p -88.41 121.3 30.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.54 110.385 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 26' ' ' PRO . 22.7 t -112.13 115.07 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.509 -0.923 . . . . 1.67 108.509 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 5.7 p-10 -81.59 145.23 30.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 1.28 110.335 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 8.6 t -74.85 121.79 86.05 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.709 -0.619 . . . . 0.79 109.331 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.87 -8.29 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.672 2.248 . . . . 1.38 111.537 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.0 m -93.6 -56.84 2.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 2.34 109.83 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.1 p -98.01 -31.56 12.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.441 -0.787 . . . . 1.48 110.755 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.34 69.96 1.03 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.258 -1.537 . . . . 1.11 109.258 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -139.78 117.33 11.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.839 -0.8 . . . . 1.9 109.389 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 9.0 m -69.36 107.15 3.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.596 -0.69 . . . . 1.3 109.517 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 28' ' ' CYS . 87.7 t -104.65 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.925 -0.769 . . . . 1.17 108.925 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.681 HG12 ' HB2' ' A' ' 22' ' ' SER . 7.3 p -63.72 114.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.439 0.637 . . . . 2.15 109.309 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 25' ' ' ARG . 14.5 t-105 -86.92 147.25 25.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.505 -0.747 . . . . 2.25 110.052 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.46 -87.54 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.011 -1.635 . . . . 2.34 109.011 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 35.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.801 -0.823 . . . . 3.02 109.796 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.539 ' HB ' HG11 ' A' ' 17' ' ' VAL . 2.4 mp -117.27 -56.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 2.58 109.572 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.681 ' HB2' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -104.1 118.05 57.96 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.98 109.491 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.8 46.14 2.14 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.856 2.371 . . . . 2.05 110.479 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -117.72 24.25 11.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 2.0 109.741 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.672 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 63.26 174.37 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.638 -0.664 . . . . 1.87 110.631 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 31.7 Cg_endo -71.74 -18.33 28.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 122.153 1.902 . . . . 1.65 111.1 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.39 -69.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.181 -0.95 . . . . 1.5 108.803 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.657 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER 167.59 -40.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.155 -0.683 . . . . 0.9 109.155 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.75 159.81 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.749 -0.594 . . . . 1.19 109.485 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -62.69 -38.6 91.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 3.54 109.875 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -38.0 62.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.659 -0.65 . . . . 2.75 110.185 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 4.3 m -60.23 -49.42 77.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.56 -0.713 . . . . 1.33 109.643 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 2.28 109.22 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 8.3 tp -63.86 -66.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.969 -0.752 . . . . 2.25 108.969 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 mt -50.28 -30.38 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.747 -0.596 . . . . 2.23 110.121 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -44.75 63.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.691 . . . . 1.9 110.299 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.94 -58.09 6.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.757 -0.831 . . . . 2.89 108.757 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.44 26.0 6.1 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 111.001 -0.839 . . . . 2.55 111.001 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.71 42.77 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.391 -1.064 . . . . 2.95 108.823 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.493 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 6.8 m95 -138.12 -58.4 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.676 -0.64 . . . . 2.63 109.446 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.81 120.79 43.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.438 -0.578 . . . . 2.66 109.438 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.46 73.99 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.442 -0.786 . . . . 3.76 109.489 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 50' ' ' SER . 1.6 mp0 -98.03 -53.35 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.434 -0.791 . . . . 3.99 109.427 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.93 62.4 0.99 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 3.13 108.876 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -103.95 110.47 22.63 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.698 -0.626 . . . . 4.51 109.553 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.17 19.41 10.0 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.673 -0.642 . . . . 5.12 111.075 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 pt -133.47 149.27 71.82 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.978 -1.076 . . . . 2.86 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.27 -42.12 0.41 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.887 2.391 . . . . 2.19 109.972 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -139.18 144.81 38.72 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.787 -0.82 . . . . 2.46 108.787 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 1.5 p -96.57 -69.47 0.75 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.309 -0.869 . . . . 4.38 110.559 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.61 -79.78 0.09 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.522 -1.431 . . . . 2.91 109.522 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' SER . 7.9 t70 -110.28 149.89 29.52 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.294 -1.002 . . . . 2.42 108.294 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.69 143.6 29.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.437 -0.789 . . . . 3.02 111.821 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.83 74.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.681 0.753 . . . . 3.04 109.224 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.66 151.2 32.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.798 -0.564 . . . . 4.13 110.474 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.88 82.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.571 0.7 . . . . 3.7 110.059 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.48 109.3 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.665 -0.865 . . . . 3.43 108.665 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -115.08 153.94 29.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.435 -0.791 . . . . 3.57 110.969 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -123.49 -49.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.692 -0.485 . . . . 5.68 109.692 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 p -67.51 130.11 42.0 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.767 -0.827 . . . . 3.05 108.767 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.67 125.2 18.92 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.586 -0.696 . . . . 3.1 110.248 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.17 91.93 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.259 -0.645 . . . . 3.9 109.259 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 37.1 Cg_endo -75.77 150.17 34.6 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.912 2.408 . . . . 4.03 110.663 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -52.2 -31.32 31.23 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.043 -0.725 . . . . 5.62 109.043 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.492 -0.755 . . . . 7.73 109.119 178.208 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.42 -0.585 . . . . 6.11 109.42 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.85 74.48 1.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.175 -0.676 . . . . 3.75 109.175 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.3 112.65 24.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.532 -0.73 . . . . 2.78 109.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -75.98 98.73 4.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.683 -0.636 . . . . 1.93 109.477 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -83.56 156.71 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.493 -0.754 . . . . 2.15 109.166 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 17' ' ' VAL . 29.9 p -117.51 121.11 40.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.34 -0.85 . . . . 1.44 109.926 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.83 132.64 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.64 -0.662 . . . . 1.59 109.251 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.59 132.9 36.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.396 -0.815 . . . . 2.06 109.977 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 t -64.32 120.3 63.77 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.53 -10.37 17.3 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.694 2.262 . . . . 1.8 111.877 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.4 m -89.13 -51.0 5.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.242 -0.911 . . . . 1.97 110.194 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.21 -29.83 8.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.485 -0.76 . . . . 1.53 110.821 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.92 78.4 1.41 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.905 -1.678 . . . . 1.51 108.905 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -142.96 136.12 28.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.881 -0.776 . . . . 3.27 109.786 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -79.39 112.85 17.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.669 . . . . 1.5 109.681 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.56 132.27 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.828 -0.804 . . . . 1.34 108.828 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 6' ' ' THR . 9.2 p -60.5 139.01 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.704 . . . . 1.5 110.167 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.0 t-105 -118.58 148.26 42.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.776 -0.577 . . . . 1.9 109.546 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.09 -97.49 0.42 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.669 -1.372 . . . . 1.74 109.669 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.96 52.47 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.848 . . . . 2.82 109.573 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.05 -59.59 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 1.88 109.645 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -91.77 164.76 22.7 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 1.31 109.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.68 -40.62 0.71 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.565 2.177 . . . . 1.48 110.358 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.92 64.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.981 -0.748 . . . . 1.24 108.981 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.3 mtm180 -56.61 -52.28 74.72 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.549 -0.72 . . . . 2.92 110.088 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.09 124.23 7.8 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.162 1.908 . . . . 1.14 109.459 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 47.2 m-85 65.96 173.95 0.23 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.469 -0.567 . . . . 1.49 109.469 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -102.15 -29.83 11.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 1.01 110.147 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.31 163.7 32.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.372 -0.83 . . . . 1.91 110.087 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -35.39 80.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.59 -0.694 . . . . 2.03 109.891 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -65.79 -44.71 84.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.667 -0.646 . . . . 4.74 110.129 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.59 -46.26 84.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.75 -0.833 . . . . 1.35 108.75 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -66.01 -34.81 78.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.127 -0.694 . . . . 1.65 109.127 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 9.9 tp -63.76 -67.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.125 -0.695 . . . . 2.55 109.125 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 mt -49.16 -33.08 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.759 -0.588 . . . . 2.19 110.298 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.78 -42.1 71.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 2.01 110.266 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -60.84 3.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 3.56 109.015 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.15 22.35 5.93 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 120.407 -0.902 . . . . 2.52 111.353 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.75 41.35 3.5 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.29 -1.123 . . . . 3.06 109.212 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.498 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 -139.34 168.25 20.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.431 -0.793 . . . . 2.49 109.888 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.61 72.88 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.479 -0.763 . . . . 2.66 109.311 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.55 50.2 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.561 -0.712 . . . . 1.9 109.467 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.43 76.37 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.6 0.714 . . . . 2.96 110.02 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.664 -0.647 . . . . 2.12 109.646 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -123.04 145.73 48.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 2.8 110.397 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -49.85 39.67 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.381 -0.97 . . . . 6.77 108.381 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.87 152.47 84.74 Favored Pre-proline 0 N--CA 1.498 1.931 0 CA-C-N 116.423 -0.353 . . . . 3.02 110.202 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 58' ' ' ASP . 35.9 Cg_endo -77.32 118.2 4.58 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.768 2.312 . . . . 2.59 109.989 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -62.54 -50.21 72.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.566 -0.709 . . . . 3.02 109.806 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.668 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -82.65 -43.45 16.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.604 . . . . 2.42 109.808 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.24 -78.38 0.35 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.931 -1.268 . . . . 2.48 109.931 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.55 43.26 3.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.69 -0.888 . . . . 2.7 109.585 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 50' ' ' SER . 0.2 OUTLIER -106.62 122.88 47.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 3.95 109.525 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.8 -170.06 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.319 0.58 . . . . 3.27 110.473 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.82 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 2.0 mt-10 -86.71 129.99 34.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.548 -0.72 . . . . 4.01 110.476 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER 67.01 117.25 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.513 0.673 . . . . 3.11 110.848 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -117.61 92.83 3.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.09 109.203 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER 74.91 -14.65 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.961 -0.462 . . . . 2.49 111.386 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -131.08 128.46 40.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.981 -1.074 . . . . 3.44 109.328 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -77.55 -32.58 54.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.805 -0.559 . . . . 3.03 110.414 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.13 85.35 5.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.412 -0.805 . . . . 2.74 110.163 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.86 129.56 24.91 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 3.73 108.939 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -73.25 -19.38 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.507 2.138 . . . . 5.18 110.892 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.77 -54.77 3.01 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.4 -0.812 . . . . 8.08 109.534 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.82 ' HB3' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm100 . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 117.902 -1.047 . . . . 4.84 110.512 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.156 0.503 . . . . 3.89 109.698 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 p -81.27 -50.65 9.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.512 -0.743 . . . . 3.74 109.404 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.48 95.07 7.39 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.035 -0.728 . . . . 3.06 109.035 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.529 HG23 HD13 ' A' ' 21' ' ' ILE . 38.6 m -110.09 116.65 31.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.635 -0.666 . . . . 2.35 109.738 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt -84.52 152.94 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 2.46 109.675 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -121.38 126.48 49.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 2.83 109.801 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -90.76 134.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.22 109.262 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.0 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.525 -0.735 . . . . 3.18 110.254 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 t -67.93 119.79 69.32 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.025 -0.731 . . . . 2.2 109.025 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.43 -10.1 17.44 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.71 2.274 . . . . 2.64 111.819 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 m -88.1 -52.05 5.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.168 -0.957 . . . . 2.06 110.044 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -109.26 -30.07 8.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.522 -0.737 . . . . 2.42 110.78 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.1 73.57 1.12 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.894 -1.682 . . . . 2.74 108.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 129.36 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.892 -0.77 . . . . 3.09 109.791 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -72.86 114.44 11.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.529 -0.732 . . . . 3.21 109.661 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 28' ' ' CYS . 23.8 t -116.18 127.35 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.151 -0.685 . . . . 1.9 109.151 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.5 p -58.43 138.81 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 2.53 110.453 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.514 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -111.28 155.27 23.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.807 -0.558 . . . . 1.51 109.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.07 -103.82 0.97 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.258 -1.537 . . . . 1.18 109.258 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.82 51.46 0.55 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.807 . . . . 2.45 109.307 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.529 HD13 HG23 ' A' ' 4' ' ' THR . 3.5 mp -115.45 -55.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.764 . . . . 2.73 109.449 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.541 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 80.5 p -89.12 162.08 38.69 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.831 -0.543 . . . . 2.12 109.977 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.84 -30.52 5.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.567 2.178 . . . . 2.44 110.056 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -116.72 69.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.791 -0.818 . . . . 1.67 108.791 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -53.05 -54.64 42.04 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.412 -0.805 . . . . 2.69 110.044 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.14 123.02 6.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.226 1.951 . . . . 1.1 109.425 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 59.9 m-85 66.83 167.92 0.23 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.297 0.57 . . . . 1.93 109.689 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.524 ' HA ' HG22 ' A' ' 16' ' ' VAL . 31.0 p -96.41 -34.65 11.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -0.877 . . . . 1.39 110.448 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 160.98 36.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.387 -0.821 . . . . 1.51 109.866 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -38.06 88.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.682 -0.637 . . . . 3.64 109.48 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.754 -0.591 . . . . 3.32 109.604 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -61.51 -52.01 66.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.35 -34.2 72.08 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.055 -0.72 . . . . 1.96 109.055 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.3 tp -65.85 -67.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.04 -0.726 . . . . 2.63 109.04 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.15 -29.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.659 -0.65 . . . . 2.22 110.546 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -53.71 -43.99 69.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.48 -0.762 . . . . 2.52 109.766 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -58.29 6.67 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.882 -0.784 . . . . 3.43 108.882 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.73 26.39 5.59 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.79 -0.924 . . . . 3.16 110.79 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -124.44 40.77 3.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -1.045 . . . . 3.73 109.505 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.534 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 5.0 m95 -137.23 -63.41 0.6 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.788 . . . . 3.19 109.473 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.78 121.04 42.8 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.235 -0.654 . . . . 2.87 109.235 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 59.22 85.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.546 0.688 . . . . 3.45 109.188 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.06 118.07 23.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.735 . . . . 3.91 109.984 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 1.0 OUTLIER -89.97 102.56 15.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.03 -0.73 . . . . 4.06 109.03 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -119.6 106.76 12.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.613 -0.884 . . . . 4.92 108.613 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -95.66 94.95 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.346 0.593 . . . . 6.96 110.591 -178.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.83 97.01 21.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.578 -1.267 . . . . 3.43 107.578 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -70.6 -20.46 30.87 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.921 1.748 . . . . 3.76 110.782 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.7 -144.88 0.51 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.931 -1.137 . . . . 2.31 107.931 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.478 ' HB2' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -111.45 121.59 45.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.068 -1.086 . . . . 3.32 108.068 178.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' SER . . . -35.7 -65.52 0.46 Allowed Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.435 -1.066 . . . . 3.85 110.435 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' ASP . 15.6 t70 -149.33 138.91 21.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.712 -0.875 . . . . 4.02 109.075 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 50' ' ' SER . 3.8 mp -114.3 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 3.59 109.501 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -71.83 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.812 -0.44 . . . . 4.19 109.812 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.48 -53.77 1.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.565 -0.71 . . . . 4.37 110.266 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.05 133.33 42.91 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.583 -0.698 . . . . 3.97 110.337 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -71.57 -41.34 69.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.887 -0.508 . . . . 4.37 109.853 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.45 168.48 18.92 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.713 -0.617 . . . . 4.91 110.489 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -75.68 98.09 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.822 -1.177 . . . . 3.82 107.822 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.74 27.3 7.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.277 -0.89 . . . . 4.67 111.243 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 7.4 mp0 -89.44 -64.96 1.07 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.904 -1.122 . . . . 2.87 110.088 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 2.9 mp0 68.05 116.47 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.618 -1.253 . . . . 3.81 107.618 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.93 -48.72 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.374 2.05 . . . . 3.99 111.87 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -44.53 10.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.395 -0.816 . . . . 6.15 110.304 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.112 -0.946 . . . . 4.85 110.06 -179.671 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.458 -0.571 . . . . 5.6 109.458 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 126.89 39.65 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 3.64 109.252 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -105.61 130.94 53.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.607 . . . . 6.82 110.745 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.42 HG23 HG22 ' A' ' 17' ' ' VAL . 16.6 m -99.08 113.95 26.42 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.263 -1.014 . . . . 3.46 108.263 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.8 pt -78.44 163.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.396 -0.815 . . . . 3.15 109.022 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 17' ' ' VAL . 30.8 p -126.23 119.92 28.69 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.248 -0.908 . . . . 3.42 110.903 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.71 136.23 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.905 -0.776 . . . . 1.91 108.905 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.08 135.69 34.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.882 . . . . 3.68 110.299 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 24.3 t -65.04 119.44 58.57 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.998 -0.741 . . . . 2.14 108.998 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.4 Cg_endo -76.6 -6.31 16.85 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.685 2.257 . . . . 1.98 111.91 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.6 m -93.16 -52.41 4.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 2.03 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -108.31 -26.66 10.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.539 -0.726 . . . . 3.16 110.912 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.49 76.73 1.34 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.369 -1.892 . . . . 3.5 108.369 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 129.48 28.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.997 -0.708 . . . . 5.89 109.704 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 m -74.1 107.04 6.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.58 -0.7 . . . . 4.34 109.409 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 28' ' ' CYS . 24.8 t -110.07 126.31 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.735 -0.603 . . . . 2.8 109.48 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 21' ' ' ILE . 14.0 p -53.94 135.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.428 0.632 . . . . 3.27 110.461 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 74.2 t-105 -117.4 154.13 31.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.675 -0.64 . . . . 2.02 110.443 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.21 -114.68 2.65 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.127 -1.589 . . . . 2.45 109.127 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.71 93.6 2.58 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.542 -0.91 . . . . 4.68 108.542 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.538 HG22 HG11 ' A' ' 17' ' ' VAL . 5.9 tt -169.52 -42.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.6 -0.688 . . . . 3.93 110.353 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.46 162.9 18.62 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.518 -0.739 . . . . 3.67 110.211 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 -40.72 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.665 2.243 . . . . 4.53 110.184 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' O ' HG12 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -110.99 65.61 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.674 -0.641 . . . . 3.1 109.37 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.624 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -53.54 -53.39 57.42 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 3.16 109.787 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.1 Cg_endo -76.57 127.32 9.55 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 122.38 2.054 . . . . 1.92 109.527 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.0 m-85 66.56 166.75 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.734 -0.604 . . . . 1.88 109.526 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HA ' HG23 ' A' ' 16' ' ' VAL . 31.2 p -97.93 -29.43 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.298 -0.876 . . . . 2.91 110.617 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.77 161.65 37.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.342 -0.849 . . . . 3.45 109.969 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.91 92.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 3.6 109.42 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -42.82 99.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.825 -0.547 . . . . 3.04 109.7 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -60.99 -52.99 62.65 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.729 -0.841 . . . . 2.05 108.729 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 20.2 tt0 -58.54 -33.54 70.01 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.142 -0.688 . . . . 2.11 109.142 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 tp -68.03 -66.9 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.8 -0.815 . . . . 3.11 108.8 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.32 -28.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.737 -0.602 . . . . 1.88 110.313 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.17 -42.7 66.44 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.539 -0.726 . . . . 1.42 109.702 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.434 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.2 mt -65.09 -57.42 8.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 3.03 108.788 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.87 23.57 7.04 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.039 -0.824 . . . . 2.28 111.039 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -122.97 45.37 2.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.354 -1.086 . . . . 3.25 109.14 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.542 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m95 -138.78 117.6 12.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.305 -0.872 . . . . 3.52 110.215 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.21 130.6 49.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.565 -0.71 . . . . 2.95 109.757 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 65.1 71.06 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.216 0.532 . . . . 3.6 111.129 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.13 -58.18 1.94 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.508 -0.923 . . . . 3.28 108.508 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.57 118.56 13.52 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.01 0.433 . . . . 3.47 110.343 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.5 132.77 56.18 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 3.79 109.194 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -65.7 -54.76 22.98 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.443 -0.786 . . . . 8.13 109.497 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mt -93.71 108.33 33.67 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.508 -0.923 . . . . 3.07 108.508 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 32.7 Cg_endo -72.53 -24.81 18.52 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.032 1.821 . . . . 3.76 110.326 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.22 76.08 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 3.92 109.657 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.4 -85.7 0.23 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -0.944 . . . . 3.98 108.925 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.22 84.49 1.27 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 107.226 -2.35 . . . . 2.42 107.226 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 14.2 m-20 -88.84 147.86 24.18 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.192 0.996 . . . . 5.12 112.95 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.83 128.61 34.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.537 -0.912 . . . . 3.72 108.537 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.46 53.58 12.68 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.597 -0.689 . . . . 5.14 109.723 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -138.64 44.83 2.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.816 . . . . 5.23 109.777 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.544 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER 53.71 34.51 19.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.662 -0.649 . . . . 4.37 109.992 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.96 -66.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.268 -0.895 . . . . 3.34 109.861 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.25 153.98 21.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.483 -0.761 . . . . 3.07 109.901 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.63 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 4.2 m-90 -152.56 160.85 43.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.645 . . . . 5.64 109.667 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.72 -41.51 21.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.75 . . . . 3.27 109.126 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -31.25 68.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.654 -0.654 . . . . 4.08 110.398 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -70.22 125.34 91.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.629 -0.67 . . . . 4.09 110.274 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -35.85 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.571 2.18 . . . . 3.77 110.402 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -72.14 -65.27 0.8 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.478 -0.764 . . . . 5.59 109.484 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 117.879 -1.058 . . . . 3.52 109.408 179.679 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.551 ' HB3' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.397 0.618 . . . . 3.79 110.173 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -45.63 7.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.54 -0.725 . . . . 4.29 109.815 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.85 -48.84 11.85 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.638 -0.664 . . . . 2.49 109.882 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 1' ' ' MET . 54.8 m -111.81 108.5 17.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.526 -0.734 . . . . 1.92 109.452 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.46 158.18 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.234 -0.916 . . . . 1.78 109.478 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 p -135.94 127.24 28.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 1.64 109.995 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 18' ' ' TRP . 79.1 t -95.95 120.36 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 1.66 109.016 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.6 133.18 34.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.687 -0.633 . . . . 2.32 109.608 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 t -69.19 118.86 65.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.266 -0.642 . . . . 1.39 109.266 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.4 -12.33 15.55 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.8 2.333 . . . . 1.53 111.509 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.8 m -83.74 -54.75 4.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -0.875 . . . . 1.84 110.217 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.71 -30.39 9.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.552 -0.717 . . . . 1.67 110.658 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.36 77.41 1.35 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.072 -1.611 . . . . 1.64 109.072 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -146.65 129.25 16.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.837 -0.802 . . . . 2.53 109.616 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -74.99 116.26 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.65 -0.656 . . . . 1.83 109.705 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.31 139.62 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.734 -0.839 . . . . 1.65 108.734 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.79 143.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.45 -0.781 . . . . 1.42 110.179 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.498 ' HB2' HG21 ' A' ' 7' ' ' VAL . 72.7 t-105 -125.27 149.71 47.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.813 -0.554 . . . . 1.33 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.43 -100.9 0.53 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.32 -1.512 . . . . 1.16 109.32 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 83.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.72 -0.871 . . . . 2.4 109.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 tt -156.18 -43.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.542 -0.724 . . . . 1.64 109.844 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.96 162.48 19.79 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.677 . . . . 1.45 109.726 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.67 -39.76 0.92 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.694 2.263 . . . . 1.58 110.384 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.27 65.04 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 2.04 109.184 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.605 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mtm105 -58.11 -51.12 84.13 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.543 -0.723 . . . . 1.79 109.962 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.24 126.96 8.85 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.291 1.994 . . . . 1.04 109.315 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 38.0 m-85 65.53 175.31 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.526 -0.546 . . . . 1.13 109.526 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 p -103.49 -28.81 11.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.141 -0.975 . . . . 1.33 110.582 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.59 162.14 39.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.266 -0.896 . . . . 2.16 110.443 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -40.06 96.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 2.08 109.668 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -44.79 94.07 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.735 -0.603 . . . . 3.63 109.904 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.44 -50.03 75.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 1.33 109.428 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -63.81 -34.3 77.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.638 -0.664 . . . . 2.0 109.39 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 7.0 tp -65.7 -67.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.424 -0.584 . . . . 1.78 109.424 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -49.9 -28.78 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.576 -0.702 . . . . 1.98 110.62 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.52 -43.46 71.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.46 -0.775 . . . . 1.23 110.33 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.439 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -63.95 -59.71 4.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.472 -0.768 . . . . 1.81 108.971 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.57 20.49 8.11 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.582 -0.818 . . . . 1.19 111.081 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.89 45.96 2.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.288 -1.125 . . . . 1.34 109.137 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.488 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m95 -132.43 118.82 19.82 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.523 -0.735 . . . . 1.34 109.128 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.97 99.05 12.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 2.33 110.506 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.65 12.68 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.795 -0.817 . . . . 2.7 108.795 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 53.46 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.276 0.56 . . . . 3.02 110.521 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -24.59 14.9 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.198 -0.939 . . . . 5.91 111.031 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.91 129.61 51.45 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.197 -0.94 . . . . 5.77 111.645 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -88.99 176.92 6.8 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.609 -0.682 . . . . 4.53 109.322 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 27.4 mm 67.59 104.29 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.665 -0.647 . . . . 3.84 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 52' ' ' ASP . 32.8 Cg_endo -72.69 90.06 0.83 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.488 2.125 . . . . 2.91 110.008 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.8 p -150.64 -49.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.935 -0.478 . . . . 3.56 109.85 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.28 -59.54 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.555 -0.715 . . . . 4.45 110.724 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.19 -34.09 64.57 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.789 -0.924 . . . . 4.61 110.789 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 2.0 t70 -55.57 137.67 48.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.661 -0.905 . . . . 4.2 110.566 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.64 84.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.712 -0.847 . . . . 3.23 108.712 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.17 104.44 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.775 -0.824 . . . . 2.36 108.775 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 137.69 32.13 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.004 -0.739 . . . . 3.07 109.004 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.98 102.69 10.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 4.0 110.416 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.26 -45.58 19.48 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.663 -0.866 . . . . 2.41 108.663 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 58.54 -173.08 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.189 0.519 . . . . 4.12 110.778 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -91.28 118.18 30.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.455 -0.778 . . . . 5.41 109.697 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.82 90.28 4.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.722 -0.844 . . . . 3.55 108.722 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -42.25 82.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.659 -0.651 . . . . 4.23 109.806 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.89 129.61 43.61 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.652 -0.655 . . . . 6.43 109.744 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.65 126.83 6.86 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.732 2.288 . . . . 4.83 109.598 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.4 122.79 47.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 6.04 110.29 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.383 -0.818 . . . . 5.15 109.185 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.268 -0.642 . . . . 5.44 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.05 89.77 3.2 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.51 0.671 . . . . 5.55 111.369 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -94.56 -32.8 13.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.594 -1.632 . . . . 3.13 106.594 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 m -106.62 117.87 35.18 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.504 -0.924 . . . . 1.96 108.504 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 pt -88.43 155.43 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.51 -0.744 . . . . 2.35 110.004 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 17' ' ' VAL . 46.4 p -121.83 126.33 48.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 1.44 110.164 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.26 135.67 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.931 -0.766 . . . . 1.72 108.931 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -91.33 133.05 35.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 1.55 109.97 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 13' ' ' GLY . 8.7 t -64.69 121.52 73.69 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.196 -0.668 . . . . 1.4 109.196 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.05 -11.28 16.44 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.66 2.24 . . . . 1.88 111.881 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.9 m -88.71 -54.82 3.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.227 -0.92 . . . . 2.32 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 p -103.09 -31.05 10.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.526 -0.734 . . . . 1.72 110.278 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 9' ' ' CYS . . . 95.37 75.14 1.26 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.845 -1.302 . . . . 1.54 109.845 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -143.85 137.81 28.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.56 -0.965 . . . . 3.38 110.656 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.2 m -72.59 112.43 8.64 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.215 0.531 . . . . 1.47 110.571 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.69 131.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.486 -0.931 . . . . 1.54 108.486 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -56.18 140.98 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 1.39 110.6 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.52 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.0 t-105 -122.15 151.44 40.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.695 -0.628 . . . . 1.47 109.542 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.29 -98.43 0.55 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.375 -1.49 . . . . 1.06 109.375 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.5 52.74 0.37 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.902 . . . . 1.32 109.727 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 17' ' ' VAL . 3.4 mt -118.11 -55.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 1.57 109.434 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.3 163.66 22.5 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.76 -0.588 . . . . 1.31 109.664 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.18 -38.14 1.24 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.538 2.158 . . . . 1.44 110.528 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.31 66.58 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.122 -0.696 . . . . 1.47 109.122 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.617 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.5 mtm180 -56.51 -51.26 82.54 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.574 -0.704 . . . . 2.66 110.188 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -76.69 127.13 9.36 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 122.179 1.919 . . . . 1.28 109.53 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 71.3 m-85 65.71 172.64 0.22 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.35 0.595 . . . . 1.52 109.636 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.28 -29.69 12.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.256 -0.902 . . . . 1.26 110.247 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.1 p -145.42 162.99 35.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.321 -0.862 . . . . 1.6 110.427 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -34.94 77.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.311 -0.626 . . . . 2.06 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -47.08 84.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.797 -0.564 . . . . 3.62 109.855 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.74 -47.24 85.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.753 -0.592 . . . . 1.62 109.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -64.23 -34.88 79.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.606 -0.684 . . . . 1.76 109.183 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD11 ' CZ2' ' A' ' 40' ' ' TRP . 10.4 tp -63.56 -67.2 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.161 -0.681 . . . . 2.55 109.161 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.15 -30.25 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.707 -0.621 . . . . 2.22 110.717 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.06 -42.6 65.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 1.83 110.199 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.51 -58.95 4.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.53 -0.732 . . . . 3.03 109.095 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 23.58 6.43 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.584 -0.817 . . . . 2.5 111.133 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.07 44.54 2.64 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.299 -1.118 . . . . 2.72 109.091 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.482 ' CZ2' HD11 ' A' ' 34' ' ' LEU . 9.9 m95 -136.26 145.64 45.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.591 -0.693 . . . . 2.6 109.447 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.45 25.75 11.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.535 -0.728 . . . . 3.24 110.455 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.97 -53.05 3.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -0.909 . . . . 2.87 108.745 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 1.2 mp0 53.18 61.54 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.376 0.608 . . . . 2.24 110.599 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 129.86 35.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.268 -0.895 . . . . 2.98 109.145 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -147.93 89.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.653 -0.655 . . . . 5.46 110.463 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 63.65 34.0 12.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.871 -0.518 . . . . 4.01 112.384 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 HD11 ' H ' ' A' ' 45' ' ' LYS . 10.0 mt -93.39 112.73 57.77 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.036 -1.098 . . . . 3.68 108.036 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 36.0 Cg_endo -77.26 -53.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.473 2.115 . . . . 3.57 111.028 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -120.57 110.09 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.508 -0.745 . . . . 2.87 109.919 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 -42.95 8.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.68 -0.637 . . . . 3.59 109.402 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.69 85.2 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.381 -1.488 . . . . 2.98 109.381 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.78 159.0 16.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.745 -0.856 . . . . 2.87 109.947 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.37 118.21 21.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.674 -0.641 . . . . 4.19 109.774 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -38.61 85.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.681 -0.489 . . . . 4.68 109.681 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.03 164.42 25.6 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.491 -0.755 . . . . 5.41 110.274 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.83 111.4 2.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.883 -0.784 . . . . 3.4 108.883 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -123.21 138.93 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.66 -0.65 . . . . 4.04 109.915 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.5 118.55 10.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.7 -0.852 . . . . 4.57 108.7 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 60.84 81.72 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.472 0.654 . . . . 3.29 109.433 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -65.36 131.47 46.55 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.76 101.6 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.527 -0.733 . . . . 3.06 109.164 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER 52.07 76.43 0.54 Allowed Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.527 -0.545 . . . . 2.88 109.527 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 60' ' ' SER . 34.4 Cg_endo -74.69 81.13 2.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.967 2.445 . . . . 3.35 109.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.79 143.69 30.78 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.555 0.693 . . . . 4.43 110.524 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.719 -1.134 . . . . 6.5 108.907 179.057 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.485 -0.561 . . . . 4.76 109.485 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.19 36.13 26.91 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.127 -0.694 . . . . 2.56 109.127 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -56.67 3.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 3.02 110.038 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 m 64.83 108.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.306 -0.627 . . . . 1.84 109.306 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.95 159.22 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.465 -0.772 . . . . 2.11 109.264 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -137.48 126.51 24.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.56 -0.712 . . . . 1.67 109.866 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.62 124.45 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.01 -0.737 . . . . 1.59 109.01 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.45 134.02 33.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.605 -0.684 . . . . 2.26 109.868 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -68.87 120.35 75.56 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.74 -11.99 16.67 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.707 2.271 . . . . 1.35 111.734 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -85.64 -52.19 5.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.205 -0.935 . . . . 1.63 110.229 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.2 p -107.32 -29.58 9.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.507 -0.746 . . . . 1.64 110.954 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 78.17 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.657 -1.777 . . . . 1.64 108.657 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 134.12 24.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.834 -0.803 . . . . 2.78 109.882 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -78.61 110.8 14.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.444 -0.785 . . . . 1.77 109.239 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.96 135.49 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.727 -0.842 . . . . 1.89 108.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.71 138.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.423 -0.798 . . . . 1.57 110.005 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.553 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -111.26 153.45 25.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.748 -0.595 . . . . 1.56 109.49 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.41 -108.13 1.47 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.486 -1.446 . . . . 1.56 109.486 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.75 52.56 0.87 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.877 . . . . 2.56 109.485 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.93 -51.23 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.499 -0.751 . . . . 2.11 109.505 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.541 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 84.2 p -94.57 162.67 25.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.733 -0.604 . . . . 1.84 109.899 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -76.28 -29.93 5.86 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.559 2.172 . . . . 2.36 110.334 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.0 72.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.72 -0.844 . . . . 1.84 108.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -54.32 -55.16 40.07 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.644 -0.66 . . . . 2.92 110.227 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.0 126.64 8.82 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 122.286 1.99 . . . . 1.59 109.75 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 42.9 m-85 65.56 172.45 0.22 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.282 0.563 . . . . 1.48 109.771 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -98.43 -31.63 11.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.352 -0.842 . . . . 1.62 110.333 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.49 164.34 30.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 2.21 110.283 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -40.77 92.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.656 -0.653 . . . . 2.36 109.655 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -61.52 -42.18 98.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.757 -0.589 . . . . 2.46 109.683 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.66 -49.21 78.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.546 -0.721 . . . . 1.43 109.336 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -63.5 -32.85 74.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.371 -0.603 . . . . 1.96 109.371 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.0 tp -64.74 -67.43 0.44 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 2.24 109.437 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.24 -30.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.675 -0.64 . . . . 1.85 110.408 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.13 -41.62 68.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.751 . . . . 1.35 110.236 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.15 -59.16 4.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.462 -0.774 . . . . 2.33 109.142 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.85 25.61 5.86 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.584 -0.817 . . . . 1.61 111.149 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.25 43.48 3.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.267 -1.137 . . . . 1.92 109.112 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.46 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.6 m95 -137.49 -47.72 0.57 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.575 -0.703 . . . . 1.98 109.863 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 59.5 59.65 2.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.315 0.579 . . . . 2.33 110.261 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.82 -61.44 1.97 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 2.23 108.613 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.14 113.07 24.95 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.507 -1.294 . . . . 3.02 107.507 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 140.57 50.78 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.47 -0.769 . . . . 3.44 111.312 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -66.25 0.57 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.814 -0.81 . . . . 5.05 108.814 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.27 37.75 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.17 -0.678 . . . . 6.34 109.17 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG13 ' HB3' ' A' ' 55' ' ' GLU . 1.5 pt -119.39 149.33 47.41 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.381 -0.824 . . . . 2.9 110.332 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.48 122.83 6.69 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.025 2.484 . . . . 3.96 111.007 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -75.07 81.49 2.25 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.081 -0.711 . . . . 3.99 109.081 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.37 47.2 2.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.863 -0.791 . . . . 4.92 108.863 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.34 16.58 26.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.044 -1.222 . . . . 4.57 110.044 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -133.97 33.07 3.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -1.01 . . . . 3.56 109.543 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 74.3 150.89 0.11 Allowed 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.499 0.666 . . . . 5.14 110.518 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.16 129.71 42.17 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.805 -0.559 . . . . 2.54 110.193 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HB3' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -72.01 147.94 46.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.666 -0.646 . . . . 3.5 110.298 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.48 78.56 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.611 -0.68 . . . . 2.95 110.013 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.09 118.87 20.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.818 . . . . 3.04 109.25 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 57.25 39.65 28.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.267 -0.642 . . . . 4.6 109.267 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.556 ' NE1' ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -139.39 131.68 28.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.71 . . . . 5.87 109.41 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -132.08 -52.45 0.97 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.099 -0.704 . . . . 3.37 109.099 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -58.57 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.374 -0.972 . . . . 3.37 108.374 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -146.3 110.03 4.27 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.69 -0.856 . . . . 3.77 108.69 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HG3' ' NE1' ' A' ' 59' ' ' TRP . 37.7 Cg_endo -79.21 -30.06 2.84 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.813 2.342 . . . . 4.01 111.494 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 -57.4 2.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.489 -0.757 . . . . 5.52 111.013 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 117.702 -1.142 . . . . 4.98 110.337 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtp . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.09 -0.707 . . . . 5.28 109.09 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 73.41 -70.52 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 109.556 -0.535 . . . . 2.87 109.556 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 4' ' ' THR . 1.1 mp0 -120.09 98.36 6.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.668 -0.864 . . . . 3.98 108.668 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 96.8 m 71.91 132.14 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.294 0.569 . . . . 1.94 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.74 158.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 121.44 -0.788 . . . . 2.49 109.442 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.7 p -132.2 122.48 25.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.628 -0.67 . . . . 1.6 109.827 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.34 136.68 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.166 -0.679 . . . . 1.53 109.166 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.05 135.42 34.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 2.08 109.681 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.2 t -68.14 117.96 54.18 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.739 -0.601 . . . . 1.21 109.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 36.7 Cg_endo -80.64 19.42 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.927 2.418 . . . . 1.9 112.007 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.6 m -122.16 -48.31 2.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 1.44 109.366 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.572 ' HB2' HD12 ' A' ' 47' ' ' ILE . 24.6 p -108.09 -25.84 10.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.692 -0.63 . . . . 1.18 110.35 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.81 75.02 1.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.599 -1.8 . . . . 1.36 108.599 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -144.31 137.63 27.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.801 -0.823 . . . . 2.59 109.838 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -81.29 115.02 20.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.448 -0.783 . . . . 1.72 109.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.2 t -115.3 137.16 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.967 -0.753 . . . . 1.36 108.967 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.78 141.09 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.491 -0.756 . . . . 1.51 110.07 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.49 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.7 t-105 -124.88 150.98 45.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.854 -0.529 . . . . 1.62 109.783 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.27 -98.77 0.53 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.347 -1.501 . . . . 1.1 109.347 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.68 92.84 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.752 -0.852 . . . . 1.74 109.202 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -165.64 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.689 -0.632 . . . . 1.78 109.842 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.504 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 88.5 p -102.65 160.59 25.82 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.658 -0.652 . . . . 1.14 109.818 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.6 Cg_endo -75.27 -31.58 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.592 2.195 . . . . 1.48 110.355 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.87 64.46 0.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.679 . . . . 2.32 109.344 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.585 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 29.3 mtm180 -60.12 -53.02 69.13 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.488 -0.757 . . . . 1.68 109.661 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.68 125.63 7.63 Favored 'Trans proline' 0 C--N 1.324 -0.717 0 C-N-CA 122.285 1.99 . . . . 1.11 109.398 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 63.9 m-85 65.61 165.98 0.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.396 0.617 . . . . 1.47 109.734 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.2 p -95.5 -27.98 15.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.87 110.508 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.12 157.07 44.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.278 -0.889 . . . . 1.7 110.513 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -36.1 78.11 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.241 -0.652 . . . . 2.66 109.241 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HD3' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -66.7 -48.53 68.97 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 4.35 109.681 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.72 -43.87 65.96 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.551 -0.718 . . . . 0.79 109.812 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.94 -34.57 78.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.687 . . . . 2.32 109.289 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.578 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 11.5 tp -62.32 -66.64 0.51 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.893 -0.78 . . . . 1.65 108.893 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.569 HD13 ' HD3' ' A' ' 31' ' ' ARG . 3.0 mt -52.39 -27.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.55 -0.719 . . . . 1.54 110.167 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 16.5 t70 -54.76 -45.7 74.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.435 -0.791 . . . . 1.47 109.472 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 15.6 mt -62.97 -58.66 6.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.466 -0.938 . . . . 1.93 108.466 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.424 ' HA3' ' OG ' ' A' ' 54' ' ' SER . . . 111.97 19.48 7.24 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 120.6 -0.81 . . . . 1.15 111.913 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.22 33.64 4.97 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.716 1.258 . . . . 1.76 109.113 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.578 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -143.71 -59.51 0.4 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.999 -0.741 . . . . 1.4 108.999 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.66 149.99 33.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.235 0.54 . . . . 1.54 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.77 -37.85 48.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.633 -0.667 . . . . 1.94 110.034 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.23 169.32 13.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.601 -0.687 . . . . 1.82 110.546 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 150.3 21.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.371 -0.603 . . . . 2.47 109.371 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -60.78 -56.19 24.16 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.42 -0.8 . . . . 3.96 109.793 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -58.27 -60.98 2.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 3.73 109.534 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 12' ' ' CYS . 2.9 mt -98.91 109.29 53.23 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.582 -0.525 . . . . 2.88 109.582 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.41 77.31 3.3 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.253 1.969 . . . . 1.96 109.562 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.9 96.13 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 3.04 109.7 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.2 p -87.05 129.98 34.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.992 -0.744 . . . . 3.09 108.992 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.97 64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.271 -1.531 . . . . 2.73 109.271 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -126.51 110.7 13.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.829 -0.807 . . . . 2.31 109.097 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.76 79.56 1.26 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.655 . . . . 3.93 109.827 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.424 ' OG ' ' HA3' ' A' ' 38' ' ' GLY . 20.9 p -148.5 126.07 11.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.543 -0.723 . . . . 2.27 109.299 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.53 -35.78 10.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.55 -0.719 . . . . 2.22 110.361 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.86 93.1 1.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.177 -0.952 . . . . 2.02 109.846 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.63 67.58 0.98 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.592 0.711 . . . . 2.67 110.052 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -118.43 -46.55 2.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.64 -0.662 . . . . 2.59 109.299 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HZ3' ' HA ' ' A' ' 64' ' ' LYS . 6.8 m0 -88.99 121.62 31.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.614 -0.679 . . . . 3.44 109.316 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 -50.71 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.58 -0.7 . . . . 2.3 110.933 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.6 42.83 2.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.263 -0.898 . . . . 3.4 110.667 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.71 141.44 35.25 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.184 -0.947 . . . . 2.73 109.95 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 34.7 Cg_endo -76.88 153.99 33.5 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 122.684 2.256 . . . . 2.36 111.483 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -71.98 126.08 28.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.737 -0.602 . . . . 2.83 109.767 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 12.6 mt-30 . . . . . 0 N--CA 1.505 2.278 0 CA-C-O 117.73 -1.128 . . . . 4.42 110.507 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.795 -0.446 . . . . 3.25 109.795 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 p -67.44 -46.52 72.88 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.156 -0.683 . . . . 2.85 109.156 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 128.39 36.69 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.652 -0.87 . . . . 2.2 108.652 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -82.65 90.31 6.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 2.11 109.651 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.6 pt -90.96 162.36 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 109.178 -0.675 . . . . 1.68 109.178 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 17' ' ' VAL . 32.0 p -121.51 127.87 51.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.465 -0.772 . . . . 1.69 109.982 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.32 136.1 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.085 -0.709 . . . . 1.46 109.085 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.25 136.96 32.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 1.5 110.156 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.45 122.04 84.27 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.084 -0.71 . . . . 1.06 109.084 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.84 -5.06 15.06 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.723 2.282 . . . . 1.32 111.862 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -94.82 -52.04 4.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.253 -0.904 . . . . 1.67 109.931 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.0 p -107.14 -31.66 8.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.498 -0.751 . . . . 1.36 110.764 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.2 68.97 0.94 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.909 -1.676 . . . . 1.47 108.909 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 131.36 40.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.884 -0.774 . . . . 3.66 109.737 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -76.08 104.34 6.56 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.56 -0.712 . . . . 1.71 109.248 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.34 129.49 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.133 -0.691 . . . . 1.56 109.133 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.5 p -64.27 135.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.637 -0.664 . . . . 1.87 110.258 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.521 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 60.6 t-105 -109.92 153.14 24.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.75 -0.594 . . . . 1.08 109.435 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.03 -165.69 12.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.761 -1.335 . . . . 1.31 109.761 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.7 92.65 9.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.456 -1.026 . . . . 2.57 109.439 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.415 HG22 HG22 ' A' ' 17' ' ' VAL . 4.1 tt -165.48 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.751 -0.593 . . . . 1.91 109.961 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.52 158.6 46.64 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.55 -0.719 . . . . 1.82 109.814 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.49 -36.67 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.768 2.312 . . . . 1.75 110.619 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.77 68.59 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.572 -0.705 . . . . 1.22 109.244 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.704 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -58.52 -51.59 80.72 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.559 -0.713 . . . . 2.11 110.148 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -77.55 125.86 7.88 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.205 1.936 . . . . 0.79 109.626 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 61.9 m-85 65.55 172.31 0.22 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.34 0.59 . . . . 0.86 109.824 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.35 -32.72 11.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.248 -0.908 . . . . 1.12 110.092 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 p -140.49 163.35 33.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 1.2 110.239 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -31.79 72.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.665 -0.647 . . . . 1.88 110.276 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -34.94 72.05 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.399 -0.813 . . . . 2.73 109.655 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.57 -47.37 76.01 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.603 -0.888 . . . . 1.03 108.603 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.88 -33.64 76.49 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.979 -0.748 . . . . 1.47 108.979 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 8.1 tp -65.33 -67.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.213 -0.662 . . . . 1.54 109.213 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.66 -29.48 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.645 -0.659 . . . . 1.52 110.506 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -54.87 -42.43 72.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.415 -0.803 . . . . 1.03 110.208 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.415 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -64.52 -59.57 4.15 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.902 -0.777 . . . . 1.77 108.902 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.19 24.92 6.04 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.982 -0.847 . . . . 1.19 110.982 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -125.58 44.18 2.89 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.381 -1.07 . . . . 1.55 109.09 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 11.9 m95 -135.53 123.37 22.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.443 -0.785 . . . . 1.19 109.471 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.87 -43.72 10.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.66 -0.65 . . . . 2.09 109.732 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.6 54.75 10.47 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.694 0.759 . . . . 2.17 109.153 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.97 102.77 4.92 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.723 -0.843 . . . . 3.04 108.723 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.22 -40.49 9.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.505 -0.747 . . . . 4.35 110.963 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -131.59 137.86 48.6 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.272 -0.892 . . . . 6.78 110.333 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.49 103.16 15.07 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.337 -0.852 . . . . 4.67 109.673 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.38 118.9 72.93 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 3.55 108.341 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -71.42 113.49 3.63 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.294 1.996 . . . . 3.11 109.964 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.0 141.89 28.01 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.283 0.563 . . . . 3.31 110.475 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.24 128.6 35.15 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.018 -0.734 . . . . 2.12 109.018 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.49 64.21 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.988 -1.245 . . . . 2.42 109.988 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.34 124.18 50.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.554 -0.968 . . . . 3.03 109.507 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.7 160.5 40.19 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.674 -0.641 . . . . 2.7 109.56 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.91 115.48 27.98 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.429 -0.795 . . . . 2.68 109.84 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.03 -60.72 1.73 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.657 -0.652 . . . . 3.75 109.467 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.15 114.03 25.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.643 -0.661 . . . . 3.11 109.664 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -124.89 117.95 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.635 . . . . 2.57 109.284 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 133.22 42.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.648 . . . . 2.8 109.734 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -109.7 124.11 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.653 . . . . 4.52 109.311 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.5 m -120.07 83.02 1.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.85 109.773 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -55.37 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.727 . . . . 2.06 109.356 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 55.53 79.05 0.35 Allowed Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.794 -0.566 . . . . 1.85 109.876 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.11 114.36 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.775 2.317 . . . . 1.71 110.74 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 1.7 mppt? -92.72 -51.92 4.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.623 -0.673 . . . . 3.38 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.329 -0.843 . . . . 2.78 109.718 179.809 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.839 -0.43 . . . . 3.1 109.839 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -96.58 129.69 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 2.83 109.837 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.68 114.91 27.73 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.337 -0.616 . . . . 2.02 109.337 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -93.8 122.49 36.32 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.449 -0.782 . . . . 1.92 109.489 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -90.97 161.07 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 1.64 109.282 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 p -138.43 124.14 19.78 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 1.63 109.871 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 18' ' ' TRP . 78.3 t -97.73 124.44 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.158 -0.682 . . . . 1.37 109.158 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.5 136.17 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.394 -0.816 . . . . 1.63 109.94 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.31 122.69 87.14 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.355 -0.609 . . . . 1.13 109.355 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -8.78 16.56 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.698 2.265 . . . . 1.39 111.621 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 m -88.93 -55.87 3.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.282 -0.887 . . . . 1.76 109.8 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.81 -27.12 13.19 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.485 -0.759 . . . . 1.8 110.653 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 73.23 1.27 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.944 -1.662 . . . . 1.9 108.944 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -140.86 135.29 31.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.76 -0.847 . . . . 3.53 109.687 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 109.55 10.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.604 -0.685 . . . . 1.88 109.933 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.93 129.17 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 1.76 108.732 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG11 HG23 ' A' ' 21' ' ' ILE . 9.3 p -58.1 135.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 1.95 110.448 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.619 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.2 t-105 -107.64 154.14 21.88 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.404 -0.591 . . . . 1.67 109.404 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.91 -167.88 13.62 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.72 -1.352 . . . . 1.44 109.72 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.79 97.94 10.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -1.081 . . . . 2.8 109.591 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG23 HG11 ' A' ' 17' ' ' VAL . 5.5 tt -169.35 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 2.65 110.318 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 75.7 p -107.47 159.85 28.74 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.512 -0.742 . . . . 2.66 110.125 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 35.6 Cg_endo -77.52 -32.35 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.784 2.323 . . . . 3.25 110.41 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.92 71.71 0.8 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.143 -0.688 . . . . 2.27 109.143 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.636 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -58.01 -54.29 57.04 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.541 -0.724 . . . . 4.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.07 124.89 8.24 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 122.263 1.976 . . . . 1.52 108.898 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.9 m-85 65.72 175.43 0.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.059 -0.719 . . . . 1.12 109.059 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 p -102.31 -32.86 9.83 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.986 -1.072 . . . . 1.99 110.265 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.39 165.84 26.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 2.64 110.274 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -62.74 -40.57 97.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.706 -0.621 . . . . 2.46 109.908 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -62.2 -39.9 94.29 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.7 -0.625 . . . . 1.75 110.075 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.52 -48.41 79.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 1.79 109.438 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -65.08 -33.78 76.84 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.931 -0.766 . . . . 1.78 108.931 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.1 tp -65.13 -66.3 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.083 -0.71 . . . . 1.71 109.083 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.4 mt -49.88 -29.36 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.79 -0.569 . . . . 1.86 110.563 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -54.12 -42.93 70.03 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.494 -0.754 . . . . 0.89 110.106 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 3.2 mt -66.0 -58.77 4.76 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.808 -0.812 . . . . 1.8 108.808 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.33 25.71 5.43 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 111.03 -0.828 . . . . 0.98 111.03 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -123.8 38.0 4.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.377 -1.072 . . . . 1.42 109.383 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.501 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 3.5 m95 -138.2 169.23 18.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.508 -0.745 . . . . 1.37 109.916 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.98 88.79 5.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.54 -0.725 . . . . 2.3 109.286 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.17 8.54 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.498 -0.751 . . . . 2.66 109.717 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.72 120.73 19.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.13 -0.693 . . . . 2.48 109.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.19 -40.13 12.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.734 -0.604 . . . . 2.74 110.202 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 148.82 51.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.627 -0.671 . . . . 6.04 109.501 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 61.08 0.61 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.5 -0.75 . . . . 3.43 109.136 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.55 ' O ' HG21 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.57 111.77 34.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.204 -0.935 . . . . 4.33 110.902 -178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.61 82.68 2.34 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.754 2.303 . . . . 4.9 110.852 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 p -172.68 -52.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.421 -0.955 . . . . 4.1 108.421 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -142.12 92.28 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.626 -0.879 . . . . 2.83 108.626 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.34 65.39 0.78 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.255 -1.538 . . . . 3.44 109.255 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -107.28 121.71 45.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.965 -0.727 . . . . 3.39 109.685 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.53 62.31 0.92 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 4.31 109.882 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.98 -41.9 3.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.476 -0.765 . . . . 3.82 109.101 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.47 115.88 21.01 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.393 -0.595 . . . . 3.72 109.393 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.12 -57.26 2.06 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.634 -0.666 . . . . 3.9 109.945 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -118.89 121.65 40.48 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.595 -0.691 . . . . 3.23 110.26 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 124.47 25.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.486 -0.561 . . . . 4.59 109.486 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.06 116.38 30.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.711 -0.618 . . . . 3.37 109.389 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.4 p -94.32 -10.34 33.03 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.566 -0.709 . . . . 4.07 110.892 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.62 170.93 8.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 3.61 110.274 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 1.7 mm-40 -103.18 118.4 58.02 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.257 -0.646 . . . . 4.52 109.257 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.63 120.69 6.85 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.403 2.069 . . . . 3.3 109.793 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.3 mttt 65.99 43.83 2.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.632 0.729 . . . . 4.02 109.214 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.336 -0.84 . . . . 3.93 109.586 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.846 -0.427 . . . . 3.59 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 57.1 83.18 0.11 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.166 -0.679 . . . . 2.63 109.166 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 68.84 104.05 0.06 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.804 -0.813 . . . . 2.83 108.804 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 58.65 1.76 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.357 -0.839 . . . . 2.42 109.849 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.62 147.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.352 -0.843 . . . . 2.84 109.077 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 p -102.85 125.15 49.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 2.06 110.469 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.98 139.79 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.197 -0.668 . . . . 2.16 109.197 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -88.27 135.76 33.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.265 -0.897 . . . . 2.22 110.412 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.36 120.28 73.86 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.053 -0.721 . . . . 1.25 109.053 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.03 3.02 7.38 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 122.832 2.355 . . . . 1.67 112.038 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.3 m -104.49 -50.9 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.118 -0.989 . . . . 1.82 109.847 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -107.97 -25.51 11.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.605 -0.684 . . . . 1.2 110.763 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.95 80.39 1.39 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.55 -1.82 . . . . 1.47 108.55 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -150.06 137.15 19.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.757 -0.849 . . . . 3.4 109.725 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -77.65 108.5 10.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.343 -0.848 . . . . 2.18 109.567 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -108.83 128.87 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.962 -0.755 . . . . 1.51 108.962 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.89 133.28 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.461 0.648 . . . . 1.79 110.214 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 28.5 t-105 -118.65 153.86 33.63 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.426 -0.583 . . . . 2.36 109.426 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 25' ' ' ARG . . . 122.6 -125.17 5.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.986 -1.245 . . . . 1.97 109.986 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.48 87.07 2.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.977 . . . . 2.35 109.049 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -166.19 -45.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.509 -0.744 . . . . 1.78 110.462 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -111.17 159.97 30.81 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.521 -0.737 . . . . 1.5 110.041 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.73 -32.07 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 122.824 2.349 . . . . 1.78 110.857 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.15 68.58 0.67 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.581 -0.699 . . . . 2.75 109.579 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.726 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 2.3 mtt180 -63.75 -50.31 71.91 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.307 -0.871 . . . . 3.66 110.227 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.77 119.16 4.69 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 122.194 1.93 . . . . 1.73 109.944 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 66.0 m-85 66.02 161.4 0.14 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.374 0.607 . . . . 1.93 110.019 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.54 -32.05 22.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.348 -0.845 . . . . 1.32 110.29 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -140.16 168.49 19.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.48 -0.763 . . . . 1.73 110.18 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -38.25 77.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.669 -0.645 . . . . 4.87 109.631 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.42 98.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.829 -0.544 . . . . 3.26 110.122 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.67 -51.29 70.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.571 -0.706 . . . . 1.62 109.414 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 19.2 tt0 -60.48 -34.99 74.83 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.156 -0.683 . . . . 3.27 109.156 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -63.44 -67.26 0.44 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.277 -0.638 . . . . 2.85 109.277 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.5 mt -49.43 -29.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.66 -0.65 . . . . 2.09 110.466 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -53.34 -45.25 69.02 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.52 -0.737 . . . . 2.0 110.374 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mt -63.58 -59.91 4.02 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.868 . . . . 3.17 108.655 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.21 22.47 6.49 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 120.575 -0.821 . . . . 2.64 111.107 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.23 40.73 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -1.149 . . . . 3.23 109.248 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.486 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 7.5 m95 -134.89 113.68 11.79 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.504 -0.748 . . . . 3.17 109.445 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.29 -175.07 2.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 3.22 109.657 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.46 69.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.56 -0.713 . . . . 3.26 109.31 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.11 161.52 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.267 0.555 . . . . 2.24 109.865 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.14 -69.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 2.27 109.714 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.25 96.12 2.73 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.257 -1.016 . . . . 5.16 108.257 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 66.09 158.67 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.148 -1.056 . . . . 5.14 108.148 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.54 HG12 ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -114.41 112.28 46.3 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.81 -1.181 . . . . 4.06 109.394 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.37 -33.75 5.24 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.709 2.273 . . . . 5.02 109.941 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.2 p -74.14 123.97 25.45 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.362 -0.977 . . . . 4.41 108.362 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.57 139.42 17.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.255 -0.903 . . . . 2.65 109.83 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.57 -126.13 5.8 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.031 -1.628 . . . . 2.13 109.031 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 47.1 -131.18 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.075 -0.662 . . . . 2.55 109.292 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.99 113.22 14.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.991 -1.068 . . . . 2.62 108.916 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.36 46.79 20.3 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.759 0.79 . . . . 3.2 109.09 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.66 136.19 50.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 2.75 109.388 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.54 ' OG ' HG12 ' A' ' 47' ' ' ILE . 2.4 m 62.85 80.34 0.23 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.368 0.604 . . . . 3.69 110.221 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.93 90.28 8.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.884 -0.784 . . . . 5.15 108.884 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -45.74 1.63 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.65 -0.656 . . . . 4.78 110.213 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.8 121.66 2.52 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 4.11 110.541 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.88 81.42 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.276 0.56 . . . . 4.71 111.281 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 1.9 mp0 -101.41 -59.8 1.64 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.431 -0.951 . . . . 4.43 108.431 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.2 mt-10 68.44 160.45 0.14 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.775 -0.578 . . . . 5.84 110.541 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.25 -7.78 15.13 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.071 2.514 . . . . 4.7 111.569 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -33.74 20.31 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.353 -0.842 . . . . 5.83 110.744 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 CA-C-O 117.813 -1.089 . . . . 8.11 110.068 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.191 0.519 . . . . 3.38 109.708 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.85 129.5 36.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.933 -0.48 . . . . 2.1 110.044 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.84 100.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.439 0.638 . . . . 3.89 110.063 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -85.54 106.97 17.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.571 -0.706 . . . . 2.26 109.539 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.1 pt -80.84 168.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 2.04 109.472 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -115.55 125.29 52.81 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 2.02 110.112 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' TRP . 89.5 t -98.86 120.83 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.958 -0.756 . . . . 1.52 108.958 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.88 131.28 34.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.555 -0.715 . . . . 2.29 109.723 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.83 119.4 60.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.153 -0.684 . . . . 0.86 109.153 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.83 -7.86 16.63 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.769 2.312 . . . . 0.9 111.784 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.5 m -91.88 -50.82 5.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.18 -0.95 . . . . 1.63 110.068 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.0 p -108.72 -32.1 7.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 1.3 110.873 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.48 73.37 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.24 -1.544 . . . . 1.13 109.24 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 130.67 26.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.769 -0.842 . . . . 2.39 109.571 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -76.73 112.85 13.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.644 -0.66 . . . . 1.71 109.634 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.6 127.07 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.821 -0.807 . . . . 1.8 108.821 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.66 139.38 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -0.784 . . . . 2.14 110.429 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.498 ' HB3' HG13 ' A' ' 5' ' ' ILE . 66.3 t-105 -108.23 151.6 25.72 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.2 -0.667 . . . . 1.74 109.2 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.428 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 138.3 -119.21 1.75 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.002 -1.239 . . . . 1.45 110.002 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.1 32.25 1.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.92 -0.753 . . . . 2.77 109.162 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 tt -109.34 -34.23 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 2.73 110.042 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.6 153.66 39.04 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 2.47 109.974 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.29 -40.74 0.57 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.642 2.228 . . . . 2.18 110.005 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.57 68.21 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.694 -0.854 . . . . 1.64 108.694 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.638 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 22.9 mtm180 -59.34 -48.88 95.13 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.553 -0.717 . . . . 2.73 110.408 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.0 Cg_endo -76.18 118.83 5.1 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.992 1.795 . . . . 1.26 109.105 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 39.2 m-85 67.99 163.93 0.22 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.344 -0.613 . . . . 1.01 109.344 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -86.42 -31.45 21.42 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.195 -0.941 . . . . 1.44 110.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.68 157.35 43.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.431 -0.793 . . . . 2.39 109.876 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -63.7 -29.4 70.63 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.577 -0.702 . . . . 2.66 109.713 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -42.94 79.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 3.27 109.204 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.34 -46.79 88.79 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.005 -0.739 . . . . 1.37 109.005 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -61.75 -36.02 79.78 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.694 -0.854 . . . . 1.77 108.694 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 2.9 tp -61.96 -65.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.872 -0.788 . . . . 2.19 108.872 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 35' ' ' ILE . 33.2 mm -49.54 -33.24 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.693 -0.629 . . . . 2.52 110.156 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.38 -45.34 72.81 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.602 -0.686 . . . . 1.47 109.766 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.5 mt -62.04 -58.86 6.25 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.959 -0.756 . . . . 2.25 108.959 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.22 33.2 4.34 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.0 -1.24 . . . . 2.46 110.0 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.43 40.02 3.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.763 -0.845 . . . . 4.59 108.836 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.592 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 8.0 m95 -137.45 127.35 25.68 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.89 . . . . 2.62 110.546 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.56 -52.59 1.17 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.279 -0.638 . . . . 3.18 109.279 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.77 82.31 1.72 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 3.36 110.077 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -80.33 -69.92 0.56 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.966 -1.124 . . . . 2.78 107.966 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -78.16 120.78 23.45 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.055 -1.091 . . . . 2.96 108.055 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -103.87 128.45 51.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.199 -0.938 . . . . 5.45 111.503 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -49.58 2.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.265 -1.013 . . . . 4.26 108.265 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.621 HG22 ' HA2' ' A' ' 51' ' ' GLY . 1.8 pt -76.08 147.87 80.64 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.893 -0.504 . . . . 2.64 109.644 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.67 -48.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.848 2.365 . . . . 2.38 110.956 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.16 -53.63 0.85 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.635 -0.665 . . . . 2.85 109.699 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.91 146.63 49.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.623 -0.673 . . . . 2.43 109.372 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.621 ' HA2' HG22 ' A' ' 47' ' ' ILE . . . -88.66 69.28 2.74 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.577 -1.009 . . . . 2.42 110.577 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -91.9 -142.18 0.19 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.767 -0.827 . . . . 3.32 108.767 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.63 164.62 24.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.061 -1.024 . . . . 3.61 109.602 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.15 73.74 1.24 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.247 -1.02 . . . . 5.48 108.247 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.45 79.61 1.48 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.644 -0.66 . . . . 4.08 111.258 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 63.97 5.71 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.101 -0.999 . . . . 6.46 108.556 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.05 -49.16 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.738 -0.601 . . . . 6.86 109.458 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -127.21 154.58 44.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.266 -0.896 . . . . 5.44 109.893 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -67.14 -43.39 82.46 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.429 -0.795 . . . . 4.68 109.526 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -78.48 86.43 4.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.008 -0.433 . . . . 5.08 112.094 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -62.89 -52.5 62.84 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.294 -1.373 . . . . 2.61 107.294 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 66.66 146.57 0.1 Allowed Pre-proline 0 N--CA 1.5 2.038 0 CA-C-O 121.117 0.484 . . . . 4.54 112.106 177.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 33.5 Cg_endo -79.14 112.27 3.03 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.947 2.432 . . . . 3.82 108.413 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 2.7 tttp 83.14 116.33 0.05 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.478 -0.934 . . . . 6.01 108.478 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 117.972 -1.013 . . . . 3.59 109.733 -179.207 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.297 -0.631 . . . . 8.08 109.297 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t 55.4 28.32 11.35 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.874 -0.787 . . . . 4.95 108.874 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.46 106.66 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.764 -0.585 . . . . 5.1 109.657 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.449 HG22 ' CG2' ' A' ' 17' ' ' VAL . 3.7 m -92.54 94.12 8.9 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.693 -0.855 . . . . 2.13 108.693 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt -78.94 149.79 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.923 -0.769 . . . . 1.83 108.923 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 17' ' ' VAL . 33.9 p -109.77 120.71 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 1.59 110.169 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -88.34 136.2 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.817 -0.809 . . . . 1.62 108.817 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.45 134.9 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.371 -0.83 . . . . 1.99 110.072 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.66 120.65 67.65 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.4 -6.59 16.47 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.703 2.268 . . . . 1.04 111.865 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.1 m -93.35 -49.73 5.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.224 -0.923 . . . . 1.23 109.945 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -109.97 -33.87 6.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.465 -0.772 . . . . 1.18 110.756 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.77 74.0 1.07 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.117 -1.593 . . . . 1.2 109.117 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 132.29 31.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.804 -0.821 . . . . 2.12 109.695 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -75.02 113.43 12.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.668 -0.645 . . . . 1.66 109.71 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.72 131.82 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.133 -0.691 . . . . 1.47 109.133 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' HA ' HG21 ' A' ' 6' ' ' THR . 8.2 p -60.05 140.05 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.73 -0.606 . . . . 1.36 110.389 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.5 t-105 -123.5 150.75 43.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.714 -0.616 . . . . 1.73 109.677 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.89 -97.61 0.49 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.276 -1.53 . . . . 1.3 109.276 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 91.65 0.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.801 -0.823 . . . . 2.72 109.337 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 tt -167.63 -42.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.631 -0.668 . . . . 1.91 110.031 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.0 161.91 21.52 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.535 -0.728 . . . . 1.67 109.809 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 -42.64 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.704 2.269 . . . . 2.25 110.451 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.98 65.36 0.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.698 . . . . 2.06 109.127 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.555 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 15.2 mtm105 -58.33 -49.87 91.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.502 -0.749 . . . . 1.86 110.098 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.25 125.64 7.94 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.188 1.926 . . . . 1.53 109.262 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 57.6 m-85 65.87 173.12 0.23 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.751 -0.593 . . . . 1.24 109.458 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.08 -26.78 12.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.2 -0.937 . . . . 1.22 110.511 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.78 159.97 42.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.257 -0.902 . . . . 2.18 110.4 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.38 88.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.507 -0.553 . . . . 2.43 109.507 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -43.58 94.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.865 -0.522 . . . . 2.71 109.684 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -59.3 -48.6 81.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.634 -0.666 . . . . 1.02 109.32 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -63.59 -35.98 82.31 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.165 -0.679 . . . . 1.75 109.165 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 9.6 tp -64.87 -67.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.397 -0.594 . . . . 2.13 109.397 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -49.03 -33.64 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.693 -0.63 . . . . 1.41 110.708 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -50.98 -41.37 59.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.487 -0.758 . . . . 1.3 110.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.36 -59.04 4.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.508 -0.745 . . . . 2.46 109.105 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.64 10.25 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.519 -0.848 . . . . 1.55 111.572 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 43.45 2.1 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.531 1.165 . . . . 2.76 109.161 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 4.4 m95 -139.79 -56.63 0.56 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.564 -0.71 . . . . 1.94 109.41 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.4 131.05 55.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.816 -0.553 . . . . 1.79 109.672 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.04 62.98 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.847 -0.797 . . . . 2.49 108.847 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.91 132.19 34.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 3.66 109.938 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.3 OUTLIER -66.75 -61.21 2.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.061 -0.718 . . . . 2.48 109.061 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.6 -61.27 2.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.131 -0.356 . . . . 4.72 110.968 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.34 165.3 14.37 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.764 0.792 . . . . 4.63 111.502 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.39 112.88 55.28 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 108.744 -0.836 . . . . 2.22 108.744 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -41.26 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.466 2.111 . . . . 1.4 111.383 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 2.8 m -81.37 -63.83 1.32 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 1.85 109.036 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.56 93.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.405 0.621 . . . . 2.13 110.19 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.37 -45.05 1.51 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.647 -1.381 . . . . 2.2 109.647 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -91.94 134.08 35.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.703 -0.881 . . . . 2.45 109.846 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -47.8 27.94 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.61 -0.885 . . . . 2.67 108.61 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m 56.02 -173.12 0.06 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.355 0.598 . . . . 3.31 111.031 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.92 -40.84 2.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 4.43 109.862 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.38 94.58 5.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.355 -0.84 . . . . 5.89 109.124 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -155.28 143.03 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.037 -0.727 . . . . 3.79 109.037 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.24 111.66 6.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.501 -0.749 . . . . 3.03 109.612 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.97 79.24 8.54 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.301 -0.629 . . . . 3.74 109.301 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -98.34 100.16 11.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.815 . . . . 2.01 110.386 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.34 123.79 32.68 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.476 -0.935 . . . . 5.66 108.476 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 68.32 85.14 0.14 Allowed Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.734 -0.839 . . . . 3.86 108.734 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.17 -32.59 6.62 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 123.017 2.478 . . . . 3.35 111.007 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 -51.8 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.235 -0.654 . . . . 4.4 109.235 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 117.689 -1.148 . . . . 4.64 110.227 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttm . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 121.451 0.643 . . . . 8.47 109.949 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.87 61.78 3.01 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.721 0.772 . . . . 4.36 108.94 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.03 145.93 50.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 4.12 110.211 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.0 m -93.26 102.93 15.22 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.636 -1.246 . . . . 2.71 107.636 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.04 159.44 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.692 -0.63 . . . . 2.72 109.658 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -118.79 121.33 39.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.669 -0.644 . . . . 2.65 110.156 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.8 t -83.5 115.68 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.601 -0.889 . . . . 2.51 108.601 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -83.45 129.97 35.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.458 -0.776 . . . . 2.61 109.704 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.6 t -68.75 118.55 61.82 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.293 -0.632 . . . . 2.29 109.293 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.92 -20.91 9.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.659 2.239 . . . . 2.32 111.068 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 m -71.83 -51.71 21.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 2.56 110.235 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.3 p -109.07 -34.01 6.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 2.51 110.856 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.9 74.32 1.05 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.105 -1.598 . . . . 2.54 109.105 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 127.1 15.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.678 -0.895 . . . . 3.45 109.714 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -74.34 117.22 15.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.664 -0.647 . . . . 2.73 109.604 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.6 131.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.985 -0.746 . . . . 2.78 108.985 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.565 ' HA ' HG21 ' A' ' 6' ' ' THR . 11.2 p -60.84 141.23 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.497 -0.752 . . . . 3.09 110.291 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 68.0 t-105 -120.85 149.8 42.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.788 -0.57 . . . . 2.38 109.675 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.11 -99.2 0.41 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.314 -1.515 . . . . 2.49 109.314 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.42 83.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.649 -0.912 . . . . 2.88 109.332 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tt -157.25 -41.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.704 -0.622 . . . . 3.31 109.941 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 70.3 p -106.54 161.11 23.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.453 -0.779 . . . . 2.77 109.66 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 33.0 Cg_endo -75.03 -38.99 1.33 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.607 2.205 . . . . 2.85 110.334 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.91 64.82 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.879 -0.785 . . . . 2.67 108.879 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.571 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.4 mtm105 -58.94 -50.82 85.95 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.588 -0.695 . . . . 2.68 110.331 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.8 Cg_endo -76.6 118.52 4.88 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.061 1.841 . . . . 2.31 109.369 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 37.0 m-85 66.4 -171.19 0.19 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.27 -0.641 . . . . 2.39 109.27 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -117.64 -31.66 5.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.037 -1.039 . . . . 2.62 111.447 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.14 166.46 23.35 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.023 -1.048 . . . . 2.82 110.887 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -42.26 93.24 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.614 -0.513 . . . . 3.66 109.614 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -40.42 95.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.692 -0.63 . . . . 2.79 109.761 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 49.9 m -62.92 -48.4 79.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 2.38 109.372 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 29.3 tt0 -63.96 -36.58 84.42 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.118 -0.697 . . . . 3.3 109.118 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 12.2 tp -60.95 -64.97 0.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.453 -0.943 . . . . 3.16 108.453 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.81 -34.71 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.948 -0.47 . . . . 2.81 110.323 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -44.33 61.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.53 -0.731 . . . . 2.17 110.769 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.455 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.7 mt -57.99 -61.78 2.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.42 -0.8 . . . . 2.94 109.381 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' HA2' ' HG2' ' A' ' 46' ' ' ARG . . . 120.6 19.69 3.7 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 120.295 -0.955 . . . . 2.11 111.575 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.44 30.58 6.69 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.184 -1.186 . . . . 2.48 109.851 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.536 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.89 128.92 18.58 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.215 -0.928 . . . . 2.83 109.68 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.24 82.32 2.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.715 . . . . 2.17 109.453 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.73 -64.2 1.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.146 -0.687 . . . . 2.46 109.146 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.97 -31.28 11.19 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.6 -0.688 . . . . 2.69 109.95 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.8 151.55 31.87 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 3.18 109.254 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -103.74 111.1 23.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.359 -0.838 . . . . 3.52 109.607 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.59 -50.67 3.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.709 -0.619 . . . . 3.33 109.72 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 50' ' ' SER . 5.6 pt -70.94 141.4 86.8 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.463 -0.773 . . . . 3.47 110.426 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.56 -46.11 0.14 Allowed 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.335 2.023 . . . . 3.9 110.423 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.1 p -94.58 117.87 30.79 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.495 -0.753 . . . . 2.96 109.009 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.429 ' HA ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -104.49 -40.3 6.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.736 . . . . 4.11 110.638 -179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 72.0 1.2 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.785 -1.726 . . . . 2.63 108.785 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.94 -41.95 5.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.937 -0.743 . . . . 4.19 110.414 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.553 ' CD1' ' HB2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -127.25 19.46 6.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.23 -0.919 . . . . 3.3 110.771 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.1 -53.18 8.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.043 -1.036 . . . . 3.34 109.709 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.01 48.32 2.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.611 -0.68 . . . . 5.99 109.558 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.05 92.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.449 0.643 . . . . 5.72 109.71 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -129.35 -44.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.049 -0.722 . . . . 6.0 109.049 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -44.23 2.39 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.065 -0.717 . . . . 5.92 109.065 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.553 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . 8.5 t-105 -79.64 131.99 36.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.558 -0.714 . . . . 6.44 109.654 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.01 21.94 3.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.817 -0.552 . . . . 6.4 109.984 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.2 104.8 1.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.839 . . . . 6.95 108.832 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.04 108.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 109.164 -0.68 . . . . 8.14 109.164 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.68 128.83 13.81 Favored 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 122.196 1.931 . . . . 8.69 108.602 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -107.23 140.43 40.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.717 0.77 . . . . 11.49 111.267 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.327 -0.844 . . . . 10.65 109.307 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.971 -0.381 . . . . 3.16 109.971 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -123.5 83.35 2.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.086 -0.709 . . . . 2.88 109.086 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -126.46 112.03 15.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.623 -0.673 . . . . 1.49 109.279 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -136.73 66.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.084 -0.71 . . . . 1.59 109.084 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.06 127.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.406 -0.809 . . . . 1.65 109.515 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.1 p -88.46 119.8 29.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.411 -0.806 . . . . 1.37 109.622 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.57 123.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.047 -0.723 . . . . 1.48 109.047 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.01 130.78 34.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.571 -0.706 . . . . 2.4 110.019 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -59.67 119.31 39.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.318 -0.623 . . . . 1.58 109.318 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 35.5 Cg_endo -77.43 -10.9 17.43 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.72 2.28 . . . . 1.92 111.77 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 95.1 m -86.33 -46.99 9.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 1.95 109.838 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -118.03 -33.77 4.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.506 -0.746 . . . . 2.29 110.88 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.31 88.29 2.04 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.877 -1.689 . . . . 2.06 108.877 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HD2' ' HB2' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -149.63 126.59 11.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.966 -0.726 . . . . 4.37 109.701 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -70.25 115.25 9.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.534 -0.729 . . . . 1.83 109.18 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG11 ' O ' ' A' ' 25' ' ' ARG . 36.1 t -117.62 109.74 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.948 -0.76 . . . . 1.42 108.948 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG23 HG21 ' A' ' 21' ' ' ILE . 7.1 p -55.86 133.62 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.634 -0.666 . . . . 1.63 110.292 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.512 ' HZ3' ' HA ' ' A' ' 25' ' ' ARG . 69.6 t-105 -135.07 156.25 49.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.755 -0.591 . . . . 1.41 109.726 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.19 -105.36 0.92 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.684 -1.366 . . . . 1.16 109.684 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.74 22.79 8.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.626 -0.926 . . . . 1.61 109.893 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 HG21 HG23 ' A' ' 17' ' ' VAL . 6.3 tt -160.35 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.365 -0.976 . . . . 1.85 108.365 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -115.25 99.15 52.0 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.674 . . . . 1.44 109.582 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.56 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.7 2.267 . . . . 1.46 110.828 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.64 49.78 1.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.563 -0.711 . . . . 2.68 109.146 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.595 ' HG2' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 63.27 -176.83 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.661 -0.866 . . . . 4.01 108.661 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' A' ' 25' ' ' ARG . 32.2 Cg_endo -74.27 -12.49 23.14 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.094 1.862 . . . . 0.73 110.678 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 27.0 m-85 -93.45 154.31 18.0 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.839 -0.8 . . . . 1.28 108.839 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.432 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 19.5 p -69.67 -33.56 72.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.296 -0.878 . . . . 1.33 109.699 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 166.76 25.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 1.91 109.773 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -70.34 -38.01 74.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.59 -0.694 . . . . 3.95 109.672 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -41.67 95.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.212 -0.662 . . . . 3.18 109.212 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.29 -48.09 82.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.102 -0.703 . . . . 1.27 109.102 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -62.11 -35.87 80.03 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.906 -0.776 . . . . 1.32 108.906 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 4.7 tp -63.19 -65.53 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.976 -0.75 . . . . 1.55 108.976 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.4 mm -51.02 -32.0 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.596 -0.69 . . . . 1.99 110.219 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.09 -40.94 74.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.744 . . . . 1.52 109.913 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -65.23 -58.49 5.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.082 -0.71 . . . . 2.12 109.082 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 29.34 5.23 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.683 -0.967 . . . . 1.56 110.683 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -130.67 40.74 3.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.504 -0.998 . . . . 2.31 109.286 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 -138.68 -59.28 0.61 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.439 -0.788 . . . . 1.36 109.613 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.0 138.58 53.28 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.62 -0.511 . . . . 2.15 109.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 60.83 77.81 0.31 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.508 0.67 . . . . 2.32 109.674 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.61 120.37 36.79 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.734 -0.839 . . . . 1.83 108.734 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.61 7.99 21.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.57 -0.706 . . . . 3.2 110.706 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 101.19 11.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.108 -0.995 . . . . 3.56 108.624 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.66 127.68 37.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.886 . . . . 4.64 110.991 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -126.77 86.17 59.22 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.168 -1.049 . . . . 2.83 108.168 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 33.4 Cg_endo -76.16 155.29 37.61 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.919 2.412 . . . . 2.92 111.494 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.66 -41.49 42.99 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.414 -0.587 . . . . 3.68 109.414 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 p -102.87 127.38 50.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.599 -0.889 . . . . 3.82 108.599 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.79 -68.17 0.76 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.133 -1.587 . . . . 3.56 109.133 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER 56.49 70.16 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.036 -0.685 . . . . 2.57 109.548 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.95 117.36 21.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.349 -0.844 . . . . 4.58 109.673 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.29 114.69 19.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.774 -0.579 . . . . 3.03 110.167 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.26 117.56 12.94 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.939 -1.134 . . . . 4.77 107.939 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.73 120.03 10.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 3.19 111.69 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -120.48 -54.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.81 -0.811 . . . . 3.56 108.81 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 56.51 70.72 0.62 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.19 -0.67 . . . . 4.71 109.19 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.675 ' CE3' ' HB2' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 71.54 132.3 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.057 -1.09 . . . . 5.22 108.057 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.17 50.64 0.77 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.755 -1.215 . . . . 5.36 110.801 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.675 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 1.1 tm-20 -104.21 -45.39 4.71 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.747 -1.205 . . . . 3.83 107.747 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 65' ' ' GLN . 1.7 mm-40 -126.05 148.74 64.14 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 108.449 -0.945 . . . . 5.78 108.449 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HG2' ' CD ' ' A' ' 64' ' ' LYS . 34.8 Cg_endo -78.56 -28.32 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.04 1.826 . . . . 7.26 109.834 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.16 101.93 10.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.65 -0.656 . . . . 7.91 110.227 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.456 ' CD ' ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 118.485 -0.769 . . . . 4.79 109.958 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.292 0.568 . . . . 2.75 110.175 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -48.51 26.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.726 -0.608 . . . . 3.15 109.576 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -54.49 7.42 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 2.09 109.367 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 m -86.68 98.5 11.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.655 -0.653 . . . . 1.5 109.514 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.41 159.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.11 -0.7 . . . . 2.28 109.11 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 17' ' ' VAL . 21.5 p -124.85 123.37 39.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.346 -0.846 . . . . 1.35 109.796 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.89 133.12 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.306 -0.627 . . . . 1.57 109.306 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -93.3 136.91 33.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.557 -0.714 . . . . 1.42 110.15 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 12.2 t -65.05 118.02 45.15 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.307 -0.627 . . . . 0.89 109.307 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 -7.7 16.23 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.676 2.251 . . . . 1.17 111.425 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.593 HG23 HD11 ' A' ' 35' ' ' ILE . 52.9 m -94.92 -56.08 2.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.268 -0.895 . . . . 1.59 110.091 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -104.77 -29.86 10.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.412 -0.805 . . . . 1.35 110.905 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.01 86.17 1.87 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.324 -1.511 . . . . 1.19 109.324 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.47 124.83 8.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.836 -0.803 . . . . 1.96 109.73 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.5 m -75.2 110.95 9.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.563 -0.711 . . . . 1.46 109.841 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.649 HG23 ' HA ' ' A' ' 28' ' ' CYS . 73.2 t -113.42 119.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.656 -0.868 . . . . 1.37 108.656 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.591 HG12 HG12 ' A' ' 21' ' ' ILE . 13.9 p -63.66 137.69 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.465 0.65 . . . . 1.29 109.635 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.478 ' CZ3' ' HB3' ' A' ' 22' ' ' SER . 73.9 t-105 -133.52 154.6 50.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 1.51 109.634 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.69 93.88 2.15 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.434 -1.467 . . . . 1.23 109.434 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.57 24.81 14.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.929 -0.748 . . . . 2.59 110.364 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.591 HG12 HG12 ' A' ' 17' ' ' VAL . 6.4 tt -177.53 103.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.732 -0.84 . . . . 1.7 108.732 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.478 ' HB3' ' CZ3' ' A' ' 18' ' ' TRP . 16.7 p -127.81 91.7 44.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 1.99 110.107 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 -38.27 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.662 2.241 . . . . 1.01 110.128 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.78 35.26 4.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.746 -0.596 . . . . 1.88 109.716 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.588 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 2.4 mtm105 65.77 178.28 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.62 -0.675 . . . . 3.43 110.859 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 36.4 Cg_endo -78.21 14.05 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.807 2.338 . . . . 1.05 111.47 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -131.03 -69.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 1.61 109.02 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.649 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER 168.74 -38.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.179 -0.674 . . . . 1.35 109.179 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.31 174.35 11.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.729 -0.607 . . . . 1.48 109.953 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -46.74 70.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 3.95 109.519 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HD3' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -64.91 -43.19 93.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.92 -0.487 . . . . 3.89 109.933 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.7 m -59.85 -44.75 93.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.654 . . . . 0.87 109.322 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -33.17 75.13 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.074 -0.713 . . . . 1.81 109.074 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.584 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.0 tp -61.53 -62.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.403 -0.962 . . . . 1.28 108.403 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.593 HD11 HG23 ' A' ' 11' ' ' THR . 9.0 mt -50.9 -29.93 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.825 -0.547 . . . . 1.68 110.128 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -30.83 70.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 1.49 110.558 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.33 -58.98 2.97 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.353 -0.842 . . . . 2.08 109.055 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.68 24.67 5.74 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.464 -0.874 . . . . 1.24 111.335 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 42.02 3.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.217 -1.167 . . . . 1.81 109.035 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.584 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 11.8 m95 -134.98 138.78 44.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 1.16 109.567 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.13 -46.36 5.09 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 2.0 110.233 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.35 19.7 6.86 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.51 -0.744 . . . . 1.91 110.774 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 40' ' ' TRP . 23.3 mm-40 -109.42 -66.13 1.09 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.039 -1.038 . . . . 1.46 109.03 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' CA ' HG12 ' A' ' 35' ' ' ILE . 1.8 pt-20 -73.93 126.93 31.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.268 -1.012 . . . . 1.3 108.268 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -57.69 1.07 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.688 . . . . 4.33 109.881 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -83.58 -52.37 6.52 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.59 -0.444 . . . . 3.63 109.963 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.1 mt -114.03 121.82 35.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.784 -0.572 . . . . 2.51 109.984 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.44 -56.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.568 2.178 . . . . 1.92 109.952 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.31 175.48 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.336 0.589 . . . . 2.38 110.818 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 69.54 108.38 0.06 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.41 -0.589 . . . . 3.52 109.41 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.0 -59.17 4.93 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.936 -1.666 . . . . 1.89 108.936 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.81 152.16 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.764 -0.845 . . . . 1.71 109.427 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.06 120.06 24.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 3.65 108.919 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -103.83 -75.93 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.718 -0.614 . . . . 2.79 110.034 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 169.12 19.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.47 -0.769 . . . . 2.18 110.84 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 p -149.1 36.47 0.76 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.515 -0.55 . . . . 2.35 109.515 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.13 155.08 46.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.295 -0.878 . . . . 2.58 110.209 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -46.63 28.18 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.406 -0.59 . . . . 2.6 109.406 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -94.46 -48.46 6.11 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.774 -0.578 . . . . 1.83 109.477 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.04 101.91 0.74 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.719 -0.613 . . . . 1.97 109.55 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 136.16 47.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.667 -0.646 . . . . 1.54 109.68 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.54 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -145.12 126.27 7.6 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.539 -0.725 . . . . 3.7 110.307 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.54 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 36.4 Cg_endo -79.47 -49.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.098 2.532 . . . . 1.75 111.447 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -147.19 -58.44 0.27 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.723 -0.611 . . . . 3.71 109.402 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.948 -1.025 . . . . 5.47 109.443 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.438 -0.578 . . . . 4.81 109.438 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.23 117.86 30.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.583 -0.698 . . . . 2.66 110.065 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.38 -47.62 9.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.617 -0.883 . . . . 3.89 108.617 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -113.08 124.11 51.84 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.047 -0.723 . . . . 1.99 109.047 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.29 159.73 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.732 . . . . 2.08 109.394 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 17' ' ' VAL . 6.7 p -140.68 123.6 16.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.537 -0.727 . . . . 1.41 109.897 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 18' ' ' TRP . 71.6 t -97.86 123.99 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.981 -0.748 . . . . 1.66 108.981 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.95 134.23 34.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.556 -0.715 . . . . 1.58 110.027 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.9 t -68.78 120.26 74.74 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 109.162 -0.681 . . . . 0.81 109.162 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -9.05 16.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.712 2.274 . . . . 1.21 111.781 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.7 m -89.15 -51.47 5.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.244 -0.91 . . . . 1.89 110.071 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.77 -23.68 12.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.515 -0.741 . . . . 1.42 110.844 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.9 79.03 1.27 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.464 -1.855 . . . . 1.29 108.464 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -147.73 134.26 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.886 -0.773 . . . . 4.37 109.886 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -76.63 111.58 12.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 1.41 109.691 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.19 138.48 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.608 -0.886 . . . . 1.27 108.608 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HA ' HG21 ' A' ' 6' ' ' THR . 9.7 p -64.1 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.396 -0.815 . . . . 1.38 110.039 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.488 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -115.55 153.13 31.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.468 -0.568 . . . . 1.68 109.468 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.58 -104.89 1.08 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.484 -1.447 . . . . 1.61 109.484 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 53.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.743 -0.857 . . . . 3.62 109.652 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 17' ' ' VAL . 2.7 mp -114.84 -53.69 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.406 -0.809 . . . . 2.08 109.487 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.4 m -94.19 165.72 17.04 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.684 -0.635 . . . . 1.41 109.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 34.7 Cg_endo -76.47 -23.83 11.1 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.705 2.27 . . . . 1.94 110.702 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' HZ ' ' HG2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -120.48 74.36 1.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.708 . . . . 2.15 109.181 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.513 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -58.17 -55.97 39.86 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.606 -0.684 . . . . 2.23 109.947 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.67 123.9 6.65 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 122.363 2.042 . . . . 1.27 109.721 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 43.9 m-85 66.01 167.1 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.334 0.588 . . . . 0.91 109.653 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.79 -31.37 15.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 1.09 110.208 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -144.15 163.97 32.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 1.54 110.24 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.14 -32.01 73.29 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -50.43 70.17 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.913 -0.492 . . . . 6.17 109.979 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 2.7 m -56.44 -48.44 77.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.692 -0.63 . . . . 1.15 109.815 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -64.15 -37.52 87.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 1.84 109.44 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.6 tp -62.3 -66.9 0.47 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.89 -0.781 . . . . 1.87 108.89 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.2 mt -50.43 -29.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.828 -0.545 . . . . 1.81 110.697 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.85 -42.5 68.61 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.454 -0.779 . . . . 1.21 110.287 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.41 -58.34 6.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.494 -0.754 . . . . 2.08 109.056 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.49 22.39 6.77 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 120.624 -0.798 . . . . 1.49 111.277 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.65 40.01 3.62 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.349 -1.089 . . . . 2.07 109.224 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.487 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 2.6 m95 -139.77 -60.24 0.55 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.581 -0.699 . . . . 1.51 109.318 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.51 55.36 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.277 -0.638 . . . . 1.89 109.277 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.43 -43.87 59.47 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 1.96 110.272 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.01 122.38 43.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 2.35 109.656 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.09 -42.96 7.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 3.48 109.981 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HE2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -140.4 129.02 22.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.642 -0.661 . . . . 5.0 109.969 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -136.47 157.16 47.43 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.606 -0.684 . . . . 3.85 109.942 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.478 ' O ' HG21 ' A' ' 47' ' ' ILE . 2.3 tt -67.63 125.95 91.93 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.402 -0.811 . . . . 2.62 110.278 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 47' ' ' ILE . 34.3 Cg_endo -77.87 99.63 1.3 Allowed 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 122.987 2.458 . . . . 2.75 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.74 104.05 15.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.743 -0.598 . . . . 2.4 109.851 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 p -111.53 108.5 18.04 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.09 -0.707 . . . . 3.82 109.09 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.09 -67.91 3.07 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.588 -1.405 . . . . 2.93 109.588 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.38 142.54 33.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.615 -0.932 . . . . 1.9 110.113 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 172.73 8.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 2.57 109.935 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 p -57.06 -47.85 79.99 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.147 -0.686 . . . . 1.82 109.147 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.78 87.36 2.7 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.324 -0.991 . . . . 2.67 108.324 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 104.09 6.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 3.4 109.95 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -138.19 137.23 37.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.666 -0.646 . . . . 2.39 109.35 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.37 132.79 35.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.69 . . . . 2.34 109.592 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -87.6 -29.4 21.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.557 -0.714 . . . . 2.57 110.057 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.06 -56.37 3.59 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.431 -0.793 . . . . 2.74 109.146 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.32 -163.66 0.65 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.207 -0.664 . . . . 2.85 109.207 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 122.61 85.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.336 -0.853 . . . . 3.75 109.595 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.92 98.14 1.2 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.819 2.346 . . . . 2.51 110.193 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -89.04 118.02 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.913 -0.773 . . . . 4.71 108.913 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.789 -1.101 . . . . 5.24 109.711 -179.853 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 18' ' ' TRP . 4.3 pt . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 108.618 -0.882 . . . . 2.46 108.618 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.973 HG22 ' HA ' ' A' ' 17' ' ' VAL . 20.1 p -120.41 120.57 36.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 2.59 110.474 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.34 132.93 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.495 -0.928 . . . . 2.14 108.495 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.41 135.28 33.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 3.63 110.286 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HG ' ' HD2' ' A' ' 27' ' ' PHE . 22.4 t -66.68 118.27 52.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.791 -0.818 . . . . 2.51 108.791 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.9 Cg_endo -76.35 -15.65 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.524 2.149 . . . . 3.02 111.849 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.596 HG21 ' HA ' ' A' ' 32' ' ' CYS . 87.7 m -81.17 -50.39 9.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.921 . . . . 2.59 110.708 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.9 p -110.78 -26.1 9.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 3.12 110.789 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.18 74.4 1.26 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.839 -1.705 . . . . 3.36 108.839 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 28' ' ' CYS . 6.2 tmtt? -140.08 128.62 22.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.063 -0.669 . . . . 3.22 109.521 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 m -70.6 115.86 10.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.635 -0.666 . . . . 3.42 109.75 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 24' ' ' PHE . 19.5 t -116.93 123.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.926 -0.768 . . . . 1.82 108.926 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.973 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.8 p -53.07 136.95 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.28 0.562 . . . . 1.6 110.322 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.527 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -112.11 156.59 22.0 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.647 -0.658 . . . . 2.59 109.809 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.76 -100.64 0.91 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.869 -1.692 . . . . 2.11 108.869 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.89 57.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.848 -0.795 . . . . 4.29 109.226 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.35 -52.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.594 -0.691 . . . . 3.09 109.366 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.1 m -93.47 166.77 15.33 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 2.6 110.007 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 36.2 Cg_endo -78.27 -32.87 2.16 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.488 2.126 . . . . 3.45 109.753 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.594 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -113.96 66.68 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.37 -0.604 . . . . 3.05 109.37 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.582 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -51.69 -55.43 29.96 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.282 -0.886 . . . . 3.52 109.322 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.2 Cg_endo -77.73 119.96 4.98 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.253 1.969 . . . . 2.2 109.545 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 82.8 m-85 68.0 159.45 0.16 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.345 0.593 . . . . 1.96 110.051 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 32.0 p -90.28 -35.4 15.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 1.4 110.0 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 165.6 24.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.455 -0.778 . . . . 1.98 109.543 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -72.4 -36.83 68.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.531 -0.73 . . . . 3.52 109.887 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -34.85 72.04 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.397 -0.814 . . . . 2.06 108.893 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.596 ' HA ' HG21 ' A' ' 11' ' ' THR . 33.8 m -66.85 -56.15 11.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -58.11 -33.7 69.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.103 -0.702 . . . . 2.27 109.103 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.56 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.9 tp -62.84 -65.77 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.734 -0.839 . . . . 2.11 108.734 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.5 -28.41 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.75 -0.593 . . . . 2.03 110.301 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -39.64 83.34 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.446 -0.784 . . . . 2.82 110.458 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -64.0 -60.0 3.8 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.793 -0.817 . . . . 2.95 108.793 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.7 24.63 5.19 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.912 -0.875 . . . . 2.71 110.912 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -126.1 40.6 3.7 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.329 -1.1 . . . . 3.4 109.215 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.5 m95 . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.537 -0.727 . . . . 2.8 109.681 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 121.176 0.512 . . . . 1.28 109.934 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.752 HG22 ' HA ' ' A' ' 17' ' ' VAL . 34.2 p -122.42 128.36 50.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 1.27 109.908 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.3 m -91.2 138.36 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.89 109.371 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.89 137.15 33.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.766 . . . . 1.96 110.097 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.68 120.72 75.48 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 109.095 -0.705 . . . . 1.07 109.095 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 -2.21 12.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.704 2.269 . . . . 1.33 112.05 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.6 m -98.78 -51.31 3.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.147 -0.971 . . . . 1.07 110.023 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.3 p -107.54 -30.03 8.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.617 -0.677 . . . . 1.51 110.763 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 71.16 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.814 -1.714 . . . . 1.65 108.814 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 135.08 40.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.786 -0.832 . . . . 2.03 109.66 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -76.54 112.27 12.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.566 -0.709 . . . . 1.59 109.685 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.26 127.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.853 -0.795 . . . . 0.9 108.853 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.752 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.6 p -60.68 137.86 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.705 . . . . 1.24 110.371 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.535 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.1 t-105 -106.92 156.02 19.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.776 -0.577 . . . . 1.24 109.543 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.33 -179.23 26.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.744 -1.342 . . . . 1.21 109.744 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.15 103.65 3.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.583 -0.951 . . . . 4.41 109.721 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 tt -174.99 -40.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.748 -0.595 . . . . 1.92 109.761 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.75 157.23 50.58 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 1.68 109.651 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.23 -35.61 2.23 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.579 2.186 . . . . 2.14 110.681 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.26 68.52 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.519 -0.738 . . . . 2.01 109.066 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.698 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -56.06 -54.17 55.32 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.599 -0.688 . . . . 1.63 109.854 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.698 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -78.0 128.69 9.3 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.291 1.994 . . . . 1.22 109.44 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 62.0 m-85 65.54 173.48 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.373 0.606 . . . . 0.96 109.661 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -104.08 -31.88 9.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.897 . . . . 1.16 110.341 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -138.41 164.21 29.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.328 -0.858 . . . . 1.2 110.419 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -38.66 90.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 2.07 109.487 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -42.0 98.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 2.29 109.897 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -59.38 -50.35 74.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.582 -0.699 . . . . 0.75 109.304 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.04 -35.32 78.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.169 -0.678 . . . . 1.65 109.169 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 10.5 tp -66.04 -66.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.24 -0.652 . . . . 1.78 109.24 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 mt -50.2 -30.93 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.634 -0.666 . . . . 0.88 110.542 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.8 -41.67 64.37 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.598 -0.688 . . . . 1.39 110.081 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.5 -59.11 4.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.943 -0.762 . . . . 2.0 108.943 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.05 26.71 5.39 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.992 -0.843 . . . . 1.65 110.992 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.32 47.21 2.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 2.51 109.118 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 7.7 m95 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.512 -0.743 . . . . 2.1 109.93 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.552 -0.536 . . . . 1.22 109.552 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 17' ' ' VAL . 45.1 p -126.17 130.68 51.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.408 -0.808 . . . . 1.17 110.046 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 18' ' ' TRP . 42.8 t -97.49 131.08 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.286 -0.635 . . . . 1.07 109.286 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.07 140.46 36.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.563 -0.711 . . . . 1.87 109.804 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 16.1 t -73.01 125.48 91.04 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.71 -0.619 . . . . 1.36 109.519 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.57 -3.71 13.54 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.809 2.339 . . . . 1.89 111.783 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HB ' ' A' ' 35' ' ' ILE . 55.5 m -97.39 -54.89 3.0 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.237 -0.914 . . . . 1.57 109.901 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.9 p -102.07 -30.71 11.02 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.585 -0.697 . . . . 1.59 110.688 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.45 62.59 1.09 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.346 -1.502 . . . . 1.46 109.346 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 140.46 46.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.877 -0.778 . . . . 2.79 109.341 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 m -73.71 116.61 14.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.45 109.827 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.7 t -116.0 137.47 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.136 -0.69 . . . . 0.96 109.136 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.6 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -58.87 139.46 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.429 -0.795 . . . . 0.92 110.256 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 57.5 t-105 -116.47 152.72 33.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 1.19 109.646 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 -145.46 16.61 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.686 -1.366 . . . . 1.19 109.686 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 89.02 2.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.454 -1.027 . . . . 1.99 109.344 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -153.8 -42.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.66 -0.65 . . . . 1.24 110.073 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 55.8 p -131.4 161.24 63.23 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.524 -0.735 . . . . 0.98 109.818 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.91 -15.82 18.59 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.737 2.291 . . . . 1.16 110.679 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 27' ' ' PHE . 61.8 m-85 -119.41 76.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.485 -0.931 . . . . 1.15 108.485 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.695 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -73.9 -48.91 6.18 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 2.1 110.483 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.69 -43.03 0.23 Allowed 'Trans proline' 0 C--N 1.326 -0.657 0 C-N-CA 122.171 1.914 . . . . 1.1 111.015 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 97.4 m-85 -99.08 163.66 12.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.671 -0.643 . . . . 1.17 109.809 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -80.38 -49.95 10.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.365 -0.834 . . . . 1.15 109.507 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.49 -172.8 3.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.669 -0.644 . . . . 1.23 110.074 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -36.13 82.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 2.46 110.165 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -64.57 -41.04 96.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.645 -0.66 . . . . 1.86 110.3 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 43.7 m -58.95 -48.23 82.27 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.122 -0.696 . . . . 1.22 109.122 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -66.4 -33.76 76.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.641 -0.662 . . . . 1.76 109.227 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -62.2 -66.63 0.51 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 1.36 109.328 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' HB ' HG21 ' A' ' 11' ' ' THR . 11.4 mt -50.13 -30.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.605 -0.684 . . . . 1.58 110.356 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -56.53 -43.54 79.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.452 -0.78 . . . . 1.62 110.289 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.69 -61.18 2.7 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.847 -0.797 . . . . 1.91 108.847 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.57 18.84 8.22 Favored Glycine 0 N--CA 1.499 2.85 0 C-N-CA 120.457 -0.878 . . . . 1.89 111.339 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.14 40.22 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -1.127 . . . . 2.52 109.284 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 8.2 m95 . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.814 -0.81 . . . . 1.85 108.814 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.139 -1.06 . . . . 1.62 108.139 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 25.3 p -88.41 121.3 30.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.06 110.385 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 26' ' ' PRO . 22.7 t -112.13 115.07 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.509 -0.923 . . . . 1.03 108.509 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 5.7 p-10 -81.59 145.23 30.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 1.09 110.335 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 8.6 t -74.85 121.79 86.05 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.709 -0.619 . . . . 0.79 109.331 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.87 -8.29 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.672 2.248 . . . . 1.38 111.537 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.0 m -93.6 -56.84 2.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 1.65 109.83 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.1 p -98.01 -31.56 12.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.441 -0.787 . . . . 1.34 110.755 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.34 69.96 1.03 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.258 -1.537 . . . . 1.11 109.258 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -139.78 117.33 11.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.839 -0.8 . . . . 1.48 109.389 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 9.0 m -69.36 107.15 3.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.596 -0.69 . . . . 0.77 109.517 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.997 HG21 ' HA ' ' A' ' 28' ' ' CYS . 87.7 t -104.65 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.925 -0.769 . . . . 0.79 108.925 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 7.3 p -63.72 114.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.439 0.637 . . . . 1.53 109.309 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.52 ' CZ3' ' HA ' ' A' ' 25' ' ' ARG . 14.5 t-105 -86.92 147.25 25.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.505 -0.747 . . . . 2.05 110.052 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.46 -87.54 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.011 -1.635 . . . . 2.34 109.011 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 35.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.801 -0.823 . . . . 3.02 109.796 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.27 -56.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 2.32 109.572 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.511 ' HB2' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -104.1 118.05 57.96 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.79 109.491 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.8 46.14 2.14 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.856 2.371 . . . . 1.84 110.479 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -117.72 24.25 11.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 1.74 109.741 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 63.26 174.37 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.638 -0.664 . . . . 1.48 110.631 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 31.7 Cg_endo -71.74 -18.33 28.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 122.153 1.902 . . . . 1.45 111.1 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.39 -69.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.181 -0.95 . . . . 1.34 108.803 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.997 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 167.59 -40.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.155 -0.683 . . . . 0.72 109.155 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.75 159.81 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.749 -0.594 . . . . 1.08 109.485 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -62.69 -38.6 91.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 3.0 109.875 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -38.0 62.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.659 -0.65 . . . . 2.22 110.185 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 4.3 m -60.23 -49.42 77.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.56 -0.713 . . . . 1.33 109.643 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 2.01 109.22 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 8.3 tp -63.86 -66.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.969 -0.752 . . . . 1.77 108.969 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 mt -50.28 -30.38 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.747 -0.596 . . . . 1.79 110.121 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -44.75 63.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.691 . . . . 1.9 110.299 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 4.7 mt -65.94 -58.09 6.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.757 -0.831 . . . . 2.47 108.757 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.44 26.0 6.1 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 111.001 -0.839 . . . . 2.55 111.001 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.71 42.77 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.391 -1.064 . . . . 2.95 108.823 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.503 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 6.8 m95 . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.676 -0.64 . . . . 2.63 109.446 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.166 -0.679 . . . . 1.76 109.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 17' ' ' VAL . 29.9 p -117.51 121.11 40.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.34 -0.85 . . . . 1.12 109.926 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.83 132.64 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.64 -0.662 . . . . 1.12 109.251 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -92.59 132.9 36.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.396 -0.815 . . . . 1.78 109.977 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 9.1 t -64.32 120.3 63.77 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.53 -10.37 17.3 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.694 2.262 . . . . 1.8 111.877 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.4 m -89.13 -51.0 5.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.242 -0.911 . . . . 1.74 110.194 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.21 -29.83 8.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.485 -0.76 . . . . 1.52 110.821 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.92 78.4 1.41 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.905 -1.678 . . . . 1.43 108.905 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -142.96 136.12 28.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.881 -0.776 . . . . 2.77 109.786 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -79.39 112.85 17.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.669 . . . . 0.99 109.681 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.56 132.27 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.828 -0.804 . . . . 0.77 108.828 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.605 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.2 p -60.5 139.01 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.704 . . . . 1.01 110.167 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.536 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.0 t-105 -118.58 148.26 42.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.776 -0.577 . . . . 1.72 109.546 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.09 -97.49 0.42 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.669 -1.372 . . . . 1.7 109.669 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.96 52.47 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.848 . . . . 2.82 109.573 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.422 HD13 ' CG2' ' A' ' 17' ' ' VAL . 3.3 mp -118.05 -59.59 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 1.57 109.645 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -91.77 164.76 22.7 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 1.26 109.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.68 -40.62 0.71 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.565 2.177 . . . . 1.33 110.358 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.92 64.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.981 -0.748 . . . . 1.02 108.981 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.612 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.3 mtm180 -56.61 -52.28 74.72 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.549 -0.72 . . . . 2.5 110.088 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.09 124.23 7.8 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.162 1.908 . . . . 1.02 109.459 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 47.2 m-85 65.96 173.95 0.23 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.469 -0.567 . . . . 1.31 109.469 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -102.15 -29.83 11.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 1.01 110.147 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.31 163.7 32.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.372 -0.83 . . . . 1.51 110.087 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -35.39 80.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.59 -0.694 . . . . 1.51 109.891 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -65.79 -44.71 84.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.667 -0.646 . . . . 4.05 110.129 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.408 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -57.59 -46.26 84.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.75 -0.833 . . . . 1.35 108.75 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -66.01 -34.81 78.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.127 -0.694 . . . . 1.54 109.127 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 9.9 tp -63.76 -67.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.125 -0.695 . . . . 1.94 109.125 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 mt -49.16 -33.08 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.759 -0.588 . . . . 1.84 110.298 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.78 -42.1 71.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 2.01 110.266 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.68 -60.84 3.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 2.92 109.015 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.15 22.35 5.93 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 120.407 -0.902 . . . . 2.52 111.353 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.75 41.35 3.5 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.29 -1.123 . . . . 3.06 109.212 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 . . . . . 0 N--CA 1.5 2.041 0 O-C-N 121.431 -0.793 . . . . 2.38 109.888 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.488 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.0 pt . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.675 -0.491 . . . . 2.2 109.675 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.777 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -121.38 126.48 49.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 2.62 109.801 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 18' ' ' TRP . 35.9 m -90.76 134.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 1.9 109.262 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.0 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.525 -0.735 . . . . 3.18 110.254 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 t -67.93 119.79 69.32 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.025 -0.731 . . . . 2.2 109.025 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.43 -10.1 17.44 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.71 2.274 . . . . 2.54 111.819 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 m -88.1 -52.05 5.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.168 -0.957 . . . . 2.06 110.044 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -109.26 -30.07 8.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.522 -0.737 . . . . 2.42 110.78 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.1 73.57 1.12 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.894 -1.682 . . . . 2.71 108.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 129.36 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.892 -0.77 . . . . 2.65 109.791 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -72.86 114.44 11.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.529 -0.732 . . . . 3.02 109.661 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 24' ' ' PHE . 23.8 t -116.18 127.35 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.151 -0.685 . . . . 1.89 109.151 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.5 p -58.43 138.81 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 1.96 110.453 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.549 ' HB2' HG13 ' A' ' 7' ' ' VAL . 76.7 t-105 -111.28 155.27 23.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.807 -0.558 . . . . 1.34 109.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.07 -103.82 0.97 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.258 -1.537 . . . . 1.18 109.258 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.82 51.46 0.55 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.807 . . . . 2.45 109.307 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.45 -55.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.764 . . . . 2.41 109.449 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 80.5 p -89.12 162.08 38.69 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.831 -0.543 . . . . 1.85 109.977 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.84 -30.52 5.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.567 2.178 . . . . 2.15 110.056 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.434 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -116.72 69.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.791 -0.818 . . . . 1.33 108.791 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -53.05 -54.64 42.04 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.412 -0.805 . . . . 2.31 110.044 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.14 123.02 6.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.226 1.951 . . . . 0.95 109.425 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 59.9 m-85 66.83 167.92 0.23 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.297 0.57 . . . . 1.68 109.689 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -96.41 -34.65 11.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -0.877 . . . . 1.21 110.448 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 160.98 36.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.387 -0.821 . . . . 1.15 109.866 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -38.06 88.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.682 -0.637 . . . . 3.25 109.48 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.754 -0.591 . . . . 2.96 109.604 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -61.51 -52.01 66.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.35 -34.2 72.08 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.055 -0.72 . . . . 1.96 109.055 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.54 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.3 tp -65.85 -67.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.04 -0.726 . . . . 2.25 109.04 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.15 -29.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.659 -0.65 . . . . 2.14 110.546 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -53.71 -43.99 69.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.48 -0.762 . . . . 2.52 109.766 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.72 -58.29 6.67 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.882 -0.784 . . . . 3.1 108.882 179.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.73 26.39 5.59 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.79 -0.924 . . . . 3.16 110.79 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -124.44 40.77 3.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -1.045 . . . . 3.73 109.505 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.54 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 5.0 m95 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.788 . . . . 3.03 109.473 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.661 HD11 ' CD1' ' A' ' 18' ' ' TRP . 1.8 pt . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 109.022 -0.732 . . . . 2.7 109.022 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 17' ' ' VAL . 30.8 p -126.23 119.92 28.69 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.248 -0.908 . . . . 3.26 110.903 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.71 136.23 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.905 -0.776 . . . . 1.87 108.905 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.08 135.69 34.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.882 . . . . 3.37 110.299 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 24.3 t -65.04 119.44 58.57 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.998 -0.741 . . . . 2.08 108.998 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.4 Cg_endo -76.6 -6.31 16.85 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.685 2.257 . . . . 1.83 111.91 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.6 m -93.16 -52.41 4.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 2.03 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -108.31 -26.66 10.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.539 -0.726 . . . . 3.16 110.912 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.49 76.73 1.34 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.369 -1.892 . . . . 3.5 108.369 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 129.48 28.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.997 -0.708 . . . . 5.36 109.704 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 m -74.1 107.04 6.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.58 -0.7 . . . . 3.99 109.409 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -110.07 126.31 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.735 -0.603 . . . . 2.59 109.48 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.922 ' HA ' HG22 ' A' ' 6' ' ' THR . 14.0 p -53.94 135.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.428 0.632 . . . . 2.85 110.461 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.661 ' CD1' HD11 ' A' ' 5' ' ' ILE . 74.2 t-105 -117.4 154.13 31.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.675 -0.64 . . . . 1.63 110.443 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.21 -114.68 2.65 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.127 -1.589 . . . . 2.45 109.127 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.71 93.6 2.58 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.542 -0.91 . . . . 4.68 108.542 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 tt -169.52 -42.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.6 -0.688 . . . . 3.93 110.353 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.46 162.9 18.62 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.518 -0.739 . . . . 3.46 110.211 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 -40.72 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.665 2.243 . . . . 4.15 110.184 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.99 65.61 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.674 -0.641 . . . . 2.99 109.37 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -53.54 -53.39 57.42 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 2.78 109.787 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.1 Cg_endo -76.57 127.32 9.55 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 122.38 2.054 . . . . 1.62 109.527 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 60.0 m-85 66.56 166.75 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.734 -0.604 . . . . 1.88 109.526 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.93 -29.43 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.298 -0.876 . . . . 2.88 110.617 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.77 161.65 37.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.342 -0.849 . . . . 3.22 109.969 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.91 92.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 3.21 109.42 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -42.82 99.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.825 -0.547 . . . . 2.69 109.7 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -60.99 -52.99 62.65 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.729 -0.841 . . . . 1.99 108.729 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 20.2 tt0 -58.54 -33.54 70.01 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.142 -0.688 . . . . 2.11 109.142 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 tp -68.03 -66.9 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.8 -0.815 . . . . 2.74 108.8 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.32 -28.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.737 -0.602 . . . . 1.44 110.313 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.17 -42.7 66.44 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.539 -0.726 . . . . 1.42 109.702 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.2 mt -65.09 -57.42 8.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 2.56 108.788 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.87 23.57 7.04 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.039 -0.824 . . . . 2.28 111.039 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -122.97 45.37 2.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.354 -1.086 . . . . 3.11 109.14 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m95 . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.305 -0.872 . . . . 3.23 110.215 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.502 2.131 0 N-CA-C 109.478 -0.564 . . . . 1.35 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 17' ' ' VAL . 8.6 p -135.94 127.24 28.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 1.27 109.995 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 18' ' ' TRP . 79.1 t -95.95 120.36 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 1.19 109.016 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.6 133.18 34.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.687 -0.633 . . . . 1.98 109.608 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 t -69.19 118.86 65.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.266 -0.642 . . . . 1.39 109.266 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.4 -12.33 15.55 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.8 2.333 . . . . 1.53 111.509 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.8 m -83.74 -54.75 4.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -0.875 . . . . 1.53 110.217 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.71 -30.39 9.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.552 -0.717 . . . . 1.67 110.658 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.36 77.41 1.35 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.072 -1.611 . . . . 1.64 109.072 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -146.65 129.25 16.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.837 -0.802 . . . . 2.04 109.616 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -74.99 116.26 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.65 -0.656 . . . . 1.55 109.705 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.31 139.62 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.734 -0.839 . . . . 1.15 108.734 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -62.79 143.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.45 -0.781 . . . . 1.03 110.179 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.601 ' HB2' HG23 ' A' ' 7' ' ' VAL . 72.7 t-105 -125.27 149.71 47.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.813 -0.554 . . . . 1.23 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.43 -100.9 0.53 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.32 -1.512 . . . . 1.1 109.32 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 83.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.72 -0.871 . . . . 2.4 109.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 tt -156.18 -43.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.542 -0.724 . . . . 1.18 109.844 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.96 162.48 19.79 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.677 . . . . 1.22 109.726 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.67 -39.76 0.92 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.694 2.263 . . . . 1.42 110.384 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.27 65.04 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 1.64 109.184 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mtm105 -58.11 -51.12 84.13 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.543 -0.723 . . . . 1.53 109.962 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.24 126.96 8.85 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.291 1.994 . . . . 0.97 109.315 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 38.0 m-85 65.53 175.31 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.526 -0.546 . . . . 1.03 109.526 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 p -103.49 -28.81 11.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.141 -0.975 . . . . 1.26 110.582 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.59 162.14 39.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.266 -0.896 . . . . 1.85 110.443 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -40.06 96.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 1.54 109.668 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.551 HH21 HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.29 -44.79 94.07 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.735 -0.603 . . . . 3.14 109.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.44 -50.03 75.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 1.33 109.428 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 18.2 tt0 -63.81 -34.3 77.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.638 -0.664 . . . . 1.69 109.39 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 HH21 ' A' ' 31' ' ' ARG . 7.0 tp -65.7 -67.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.424 -0.584 . . . . 1.2 109.424 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -49.9 -28.78 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.576 -0.702 . . . . 1.4 110.62 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.52 -43.46 71.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.46 -0.775 . . . . 1.23 110.33 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -63.95 -59.71 4.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.472 -0.768 . . . . 1.21 108.971 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.57 20.49 8.11 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.582 -0.818 . . . . 1.19 111.081 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.89 45.96 2.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.288 -1.125 . . . . 1.34 109.137 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m95 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.523 -0.735 . . . . 1.34 109.128 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 18' ' ' TRP . 5.3 pt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.257 0.551 . . . . 1.9 110.004 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 17' ' ' VAL . 46.4 p -121.83 126.33 48.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 1.07 110.164 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.26 135.67 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.931 -0.766 . . . . 1.3 108.931 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -91.33 133.05 35.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 1.39 109.97 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' O ' ' HA2' ' A' ' 13' ' ' GLY . 8.7 t -64.69 121.52 73.69 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.196 -0.668 . . . . 1.4 109.196 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.05 -11.28 16.44 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.66 2.24 . . . . 1.88 111.881 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.9 m -88.71 -54.82 3.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.227 -0.92 . . . . 1.78 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 p -103.09 -31.05 10.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.526 -0.734 . . . . 1.62 110.278 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 9' ' ' CYS . . . 95.37 75.14 1.26 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.845 -1.302 . . . . 1.45 109.845 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -143.85 137.81 28.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.56 -0.965 . . . . 2.91 110.656 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.2 m -72.59 112.43 8.64 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.215 0.531 . . . . 0.94 110.571 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.69 131.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.486 -0.931 . . . . 0.84 108.486 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.68 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -56.18 140.98 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 0.76 110.6 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.541 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.0 t-105 -122.15 151.44 40.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.695 -0.628 . . . . 1.34 109.542 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.29 -98.43 0.55 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.375 -1.49 . . . . 1.06 109.375 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.5 52.74 0.37 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.902 . . . . 1.32 109.727 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 17' ' ' VAL . 3.4 mt -118.11 -55.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 1.04 109.434 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.3 163.66 22.5 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.76 -0.588 . . . . 1.0 109.664 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.18 -38.14 1.24 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.538 2.158 . . . . 1.3 110.528 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.31 66.58 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.122 -0.696 . . . . 1.31 109.122 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.5 mtm180 -56.51 -51.26 82.54 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.574 -0.704 . . . . 2.2 110.188 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -76.69 127.13 9.36 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 122.179 1.919 . . . . 1.19 109.53 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 71.3 m-85 65.71 172.64 0.22 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.35 0.595 . . . . 1.44 109.636 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.28 -29.69 12.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.256 -0.902 . . . . 1.26 110.247 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.1 p -145.42 162.99 35.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.321 -0.862 . . . . 1.46 110.427 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -34.94 77.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.311 -0.626 . . . . 1.7 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -47.08 84.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.797 -0.564 . . . . 3.25 109.855 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.74 -47.24 85.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.753 -0.592 . . . . 1.62 109.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -64.23 -34.88 79.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.606 -0.684 . . . . 1.75 109.183 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 10.4 tp -63.56 -67.2 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.161 -0.681 . . . . 2.12 109.161 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.15 -30.25 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.707 -0.621 . . . . 1.93 110.717 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.06 -42.6 65.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 1.83 110.199 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -64.51 -58.95 4.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.53 -0.732 . . . . 2.45 109.095 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 23.58 6.43 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.584 -0.817 . . . . 2.5 111.133 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.07 44.54 2.64 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.299 -1.118 . . . . 2.63 109.091 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 9.9 m95 . . . . . 0 N--CA 1.499 1.984 0 O-C-N 121.591 -0.693 . . . . 2.56 109.447 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.264 -0.643 . . . . 1.62 109.264 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 17' ' ' VAL . 7.0 p -137.48 126.51 24.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.56 -0.712 . . . . 1.3 109.866 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 58.8 t -96.62 124.45 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.01 -0.737 . . . . 1.16 109.01 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -86.45 134.02 33.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.605 -0.684 . . . . 2.05 109.868 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -68.87 120.35 75.56 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.172 -0.677 . . . . 1.2 109.172 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.74 -11.99 16.67 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.707 2.271 . . . . 1.35 111.734 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -85.64 -52.19 5.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.205 -0.935 . . . . 1.36 110.229 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.2 p -107.32 -29.58 9.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.507 -0.746 . . . . 1.6 110.954 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 78.17 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.657 -1.777 . . . . 1.64 108.657 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 134.12 24.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.834 -0.803 . . . . 2.17 109.882 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -78.61 110.8 14.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.444 -0.785 . . . . 1.54 109.239 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.96 135.49 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.8 p -63.71 138.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.423 -0.798 . . . . 1.32 110.005 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -111.26 153.45 25.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.748 -0.595 . . . . 1.44 109.49 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.41 -108.13 1.47 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.486 -1.446 . . . . 1.56 109.486 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.75 52.56 0.87 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.877 . . . . 2.56 109.485 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' CG2' ' A' ' 17' ' ' VAL . 2.8 mp -115.93 -51.23 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.499 -0.751 . . . . 1.86 109.505 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 84.2 p -94.57 162.67 25.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.733 -0.604 . . . . 1.76 109.899 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -76.28 -29.93 5.86 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.559 2.172 . . . . 2.21 110.334 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.0 72.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.72 -0.844 . . . . 1.73 108.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -54.32 -55.16 40.07 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.644 -0.66 . . . . 2.58 110.227 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.0 126.64 8.82 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 122.286 1.99 . . . . 1.5 109.75 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 42.9 m-85 65.56 172.45 0.22 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.282 0.563 . . . . 1.35 109.771 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -98.43 -31.63 11.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.352 -0.842 . . . . 1.62 110.333 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.49 164.34 30.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 1.94 110.283 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -40.77 92.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.656 -0.653 . . . . 1.95 109.655 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -61.52 -42.18 98.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.757 -0.589 . . . . 2.02 109.683 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.66 -49.21 78.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.546 -0.721 . . . . 1.39 109.336 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -63.5 -32.85 74.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.371 -0.603 . . . . 1.77 109.371 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.0 tp -64.74 -67.43 0.44 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 1.71 109.437 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.24 -30.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.675 -0.64 . . . . 1.34 110.408 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.13 -41.62 68.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.751 . . . . 1.35 110.236 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -65.15 -59.16 4.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.462 -0.774 . . . . 1.77 109.142 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.85 25.61 5.86 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.584 -0.817 . . . . 1.61 111.149 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.25 43.48 3.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.267 -1.137 . . . . 1.92 109.112 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.6 m95 . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.575 -0.703 . . . . 1.85 109.863 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.707 HD12 ' HD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.47 0 N-CA-C 109.442 -0.577 . . . . 2.01 109.442 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -132.2 122.48 25.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.628 -0.67 . . . . 1.32 109.827 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.34 136.68 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.166 -0.679 . . . . 1.09 109.166 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.05 135.42 34.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 1.96 109.681 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.2 t -68.14 117.96 54.18 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.739 -0.601 . . . . 1.21 109.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 36.7 Cg_endo -80.64 19.42 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.927 2.418 . . . . 1.9 112.007 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.6 m -122.16 -48.31 2.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 1.11 109.366 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 -25.84 10.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.692 -0.63 . . . . 1.18 110.35 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.81 75.02 1.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.599 -1.8 . . . . 1.36 108.599 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -144.31 137.63 27.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.801 -0.823 . . . . 2.19 109.838 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -81.29 115.02 20.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.448 -0.783 . . . . 1.5 109.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.2 t -115.3 137.16 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.7 p -61.78 141.09 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.491 -0.756 . . . . 1.0 110.07 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.707 ' HD1' HD12 ' A' ' 5' ' ' ILE . 75.7 t-105 -124.88 150.98 45.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.854 -0.529 . . . . 1.44 109.783 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.27 -98.77 0.53 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.347 -1.501 . . . . 1.1 109.347 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.68 92.84 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.752 -0.852 . . . . 1.74 109.202 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -165.64 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.689 -0.632 . . . . 1.37 109.842 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.52 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 88.5 p -102.65 160.59 25.82 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.658 -0.652 . . . . 0.98 109.818 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.6 Cg_endo -75.27 -31.58 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.592 2.195 . . . . 1.29 110.355 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.87 64.46 0.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.679 . . . . 1.84 109.344 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 29.3 mtm180 -60.12 -53.02 69.13 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.488 -0.757 . . . . 1.44 109.661 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.68 125.63 7.63 Favored 'Trans proline' 0 C--N 1.324 -0.717 0 C-N-CA 122.285 1.99 . . . . 1.01 109.398 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 63.9 m-85 65.61 165.98 0.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.396 0.617 . . . . 1.24 109.734 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.2 p -95.5 -27.98 15.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.83 110.508 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.12 157.07 44.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.278 -0.889 . . . . 1.39 110.513 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -36.1 78.11 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.241 -0.652 . . . . 2.15 109.241 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -48.53 68.97 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 3.67 109.681 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.72 -43.87 65.96 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.551 -0.718 . . . . 0.79 109.812 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.94 -34.57 78.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.687 . . . . 1.94 109.289 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 11.5 tp -62.32 -66.64 0.51 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.893 -0.78 . . . . 1.19 108.893 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.39 -27.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.55 -0.719 . . . . 1.0 110.167 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.76 -45.7 74.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.435 -0.791 . . . . 1.47 109.472 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 15.6 mt -62.97 -58.66 6.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.466 -0.938 . . . . 1.47 108.466 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.97 19.48 7.24 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 120.6 -0.81 . . . . 1.05 111.913 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.22 33.64 4.97 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.716 1.258 . . . . 1.76 109.113 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 108.999 -0.741 . . . . 1.25 108.999 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.6 pt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 17' ' ' VAL . 32.0 p -121.51 127.87 51.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.465 -0.772 . . . . 1.22 109.982 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.32 136.1 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.085 -0.709 . . . . 1.12 109.085 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.25 136.96 32.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 1.35 110.156 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.45 122.04 84.27 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.084 -0.71 . . . . 1.06 109.084 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.84 -5.06 15.06 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.723 2.282 . . . . 1.32 111.862 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -94.82 -52.04 4.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.253 -0.904 . . . . 1.22 109.931 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.0 p -107.14 -31.66 8.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.498 -0.751 . . . . 1.36 110.764 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.2 68.97 0.94 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.909 -1.676 . . . . 1.47 108.909 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 131.36 40.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.884 -0.774 . . . . 3.12 109.737 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -76.08 104.34 6.56 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.56 -0.712 . . . . 1.34 109.248 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.34 129.49 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.133 -0.691 . . . . 1.09 109.133 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.5 p -64.27 135.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.637 -0.664 . . . . 1.31 110.258 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 60.6 t-105 -109.92 153.14 24.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.75 -0.594 . . . . 1.08 109.435 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.03 -165.69 12.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.761 -1.335 . . . . 1.31 109.761 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.7 92.65 9.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.456 -1.026 . . . . 2.57 109.439 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 tt -165.48 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.751 -0.593 . . . . 1.61 109.961 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.52 158.6 46.64 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.55 -0.719 . . . . 1.52 109.814 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.49 -36.67 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.768 2.312 . . . . 1.59 110.619 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.77 68.59 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.572 -0.705 . . . . 1.12 109.244 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.728 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -58.52 -51.59 80.72 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.559 -0.713 . . . . 1.78 110.148 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -77.55 125.86 7.88 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.205 1.936 . . . . 0.74 109.626 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 61.9 m-85 65.55 172.31 0.22 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.34 0.59 . . . . 0.86 109.824 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.35 -32.72 11.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.248 -0.908 . . . . 1.06 110.092 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 p -140.49 163.35 33.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 1.04 110.239 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -31.79 72.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.665 -0.647 . . . . 1.52 110.276 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -34.94 72.05 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.399 -0.813 . . . . 2.29 109.655 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.57 -47.37 76.01 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.603 -0.888 . . . . 1.03 108.603 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -64.88 -33.64 76.49 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.979 -0.748 . . . . 1.23 108.979 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 8.1 tp -65.33 -67.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.213 -0.662 . . . . 0.93 109.213 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.66 -29.48 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.645 -0.659 . . . . 1.02 110.506 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -54.87 -42.43 72.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.415 -0.803 . . . . 1.03 110.208 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -64.52 -59.57 4.15 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.19 24.92 6.04 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.982 -0.847 . . . . 1.19 110.982 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -125.58 44.18 2.89 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.381 -1.07 . . . . 1.55 109.09 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 11.9 m95 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.443 -0.785 . . . . 1.19 109.471 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 109.282 -0.636 . . . . 1.09 109.282 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 17' ' ' VAL . 4.1 p -138.43 124.14 19.78 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 1.21 109.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 18' ' ' TRP . 78.3 t -97.73 124.44 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.158 -0.682 . . . . 0.73 109.158 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.5 136.17 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.394 -0.816 . . . . 1.45 109.94 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.31 122.69 87.14 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.355 -0.609 . . . . 1.12 109.355 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -8.78 16.56 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.698 2.265 . . . . 1.39 111.621 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 m -88.93 -55.87 3.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.282 -0.887 . . . . 1.41 109.8 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.81 -27.12 13.19 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.485 -0.759 . . . . 1.8 110.653 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 73.23 1.27 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.944 -1.662 . . . . 1.9 108.944 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -140.86 135.29 31.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.76 -0.847 . . . . 3.07 109.687 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 109.55 10.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.604 -0.685 . . . . 1.66 109.933 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.93 129.17 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 1.24 108.732 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.683 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.3 p -58.1 135.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 1.58 110.448 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.634 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.2 t-105 -107.64 154.14 21.88 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.404 -0.591 . . . . 1.46 109.404 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.91 -167.88 13.62 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.72 -1.352 . . . . 1.44 109.72 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.79 97.94 10.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -1.081 . . . . 2.8 109.591 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 22' ' ' SER . 5.5 tt -169.35 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 2.65 110.318 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 75.7 p -107.47 159.85 28.74 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.512 -0.742 . . . . 2.48 110.125 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 35.6 Cg_endo -77.52 -32.35 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.784 2.323 . . . . 3.0 110.41 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.92 71.71 0.8 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.143 -0.688 . . . . 2.2 109.143 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.675 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -58.01 -54.29 57.04 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.541 -0.724 . . . . 3.51 109.983 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.675 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.07 124.89 8.24 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 122.263 1.976 . . . . 1.38 108.898 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.9 m-85 65.72 175.43 0.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.059 -0.719 . . . . 1.12 109.059 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 p -102.31 -32.86 9.83 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.986 -1.072 . . . . 1.89 110.265 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.39 165.84 26.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 2.43 110.274 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -62.74 -40.57 97.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.706 -0.621 . . . . 2.0 109.908 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -62.2 -39.9 94.29 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.7 -0.625 . . . . 1.47 110.075 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.52 -48.41 79.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 1.79 109.438 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.08 -33.78 76.84 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.931 -0.766 . . . . 1.61 108.931 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.1 tp -65.13 -66.3 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.083 -0.71 . . . . 1.24 109.083 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.4 mt -49.88 -29.36 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.79 -0.569 . . . . 1.23 110.563 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -54.12 -42.93 70.03 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.494 -0.754 . . . . 0.89 110.106 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 3.2 mt -66.0 -58.77 4.76 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.808 -0.812 . . . . 1.31 108.808 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.33 25.71 5.43 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 111.03 -0.828 . . . . 0.98 111.03 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -123.8 38.0 4.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.377 -1.072 . . . . 1.4 109.383 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 3.5 m95 . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.508 -0.745 . . . . 1.21 109.916 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.501 2.096 0 N-CA-C 109.077 -0.712 . . . . 2.45 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 p -102.85 125.15 49.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 1.88 110.469 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.98 139.79 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.197 -0.668 . . . . 1.76 109.197 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -88.27 135.76 33.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.265 -0.897 . . . . 2.16 110.412 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.36 120.28 73.86 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.053 -0.721 . . . . 1.25 109.053 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.03 3.02 7.38 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 122.832 2.355 . . . . 1.65 112.038 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.3 m -104.49 -50.9 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.118 -0.989 . . . . 1.21 109.847 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -107.97 -25.51 11.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.605 -0.684 . . . . 1.2 110.763 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.95 80.39 1.39 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.55 -1.82 . . . . 1.47 108.55 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -150.06 137.15 19.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.757 -0.849 . . . . 2.98 109.725 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -77.65 108.5 10.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.343 -0.848 . . . . 1.9 109.567 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -108.83 128.87 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.962 -0.755 . . . . 1.21 108.962 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.89 133.28 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.461 0.648 . . . . 1.33 110.214 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 28.5 t-105 -118.65 153.86 33.63 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.426 -0.583 . . . . 2.19 109.426 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 25' ' ' ARG . . . 122.6 -125.17 5.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.986 -1.245 . . . . 1.88 109.986 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.48 87.07 2.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.977 . . . . 2.35 109.049 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -166.19 -45.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.509 -0.744 . . . . 1.3 110.462 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -111.17 159.97 30.81 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.521 -0.737 . . . . 1.18 110.041 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.73 -32.07 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 122.824 2.349 . . . . 1.63 110.857 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.15 68.58 0.67 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.581 -0.699 . . . . 2.38 109.579 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.739 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 2.3 mtt180 -63.75 -50.31 71.91 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.307 -0.871 . . . . 3.07 110.227 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.77 119.16 4.69 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 122.194 1.93 . . . . 1.6 109.944 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 66.0 m-85 66.02 161.4 0.14 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.374 0.607 . . . . 1.71 110.019 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.54 -32.05 22.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.348 -0.845 . . . . 1.32 110.29 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -140.16 168.49 19.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.48 -0.763 . . . . 1.64 110.18 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -38.25 77.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.669 -0.645 . . . . 4.4 109.631 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.42 98.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.829 -0.544 . . . . 2.83 110.122 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.67 -51.29 70.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.571 -0.706 . . . . 1.6 109.414 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 19.2 tt0 -60.48 -34.99 74.83 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.156 -0.683 . . . . 2.91 109.156 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 34' ' ' LEU . 6.8 tp -63.44 -67.26 0.44 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.277 -0.638 . . . . 2.5 109.277 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.5 mt -49.43 -29.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.66 -0.65 . . . . 1.9 110.466 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -53.34 -45.25 69.02 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.52 -0.737 . . . . 2.0 110.374 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mt -63.58 -59.91 4.02 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.868 . . . . 2.83 108.655 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.21 22.47 6.49 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 120.575 -0.821 . . . . 2.64 111.107 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.23 40.73 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -1.149 . . . . 3.1 109.248 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 7.5 m95 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.504 -0.748 . . . . 3.02 109.445 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.1 pt . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 109.472 -0.566 . . . . 1.69 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -115.55 125.29 52.81 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 1.59 110.112 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.86 120.83 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.958 -0.756 . . . . 1.13 108.958 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.88 131.28 34.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.555 -0.715 . . . . 1.86 109.723 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.83 119.4 60.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.153 -0.684 . . . . 0.79 109.153 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.83 -7.86 16.63 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.769 2.312 . . . . 0.9 111.784 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.5 m -91.88 -50.82 5.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.18 -0.95 . . . . 1.11 110.068 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.0 p -108.72 -32.1 7.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 1.14 110.873 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.48 73.37 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.24 -1.544 . . . . 1.13 109.24 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 130.67 26.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.769 -0.842 . . . . 1.9 109.571 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -76.73 112.85 13.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.644 -0.66 . . . . 1.33 109.634 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.6 127.07 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.821 -0.807 . . . . 1.26 108.821 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.66 139.38 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -0.784 . . . . 1.74 110.429 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.518 ' HB3' HG13 ' A' ' 5' ' ' ILE . 66.3 t-105 -108.23 151.6 25.72 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.2 -0.667 . . . . 1.53 109.2 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.3 -119.21 1.75 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.002 -1.239 . . . . 1.35 110.002 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.1 32.25 1.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.92 -0.753 . . . . 2.77 109.162 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 tt -109.34 -34.23 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 2.4 110.042 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.6 153.66 39.04 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 2.08 109.974 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.29 -40.74 0.57 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.642 2.228 . . . . 2.02 110.005 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.57 68.21 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.694 -0.854 . . . . 1.53 108.694 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.651 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 22.9 mtm180 -59.34 -48.88 95.13 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.553 -0.717 . . . . 2.17 110.408 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.0 Cg_endo -76.18 118.83 5.1 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.992 1.795 . . . . 1.12 109.105 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 39.2 m-85 67.99 163.93 0.22 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.344 -0.613 . . . . 1.01 109.344 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -86.42 -31.45 21.42 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.195 -0.941 . . . . 1.44 110.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.68 157.35 43.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.431 -0.793 . . . . 2.02 109.876 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -63.7 -29.4 70.63 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.577 -0.702 . . . . 2.3 109.713 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -42.94 79.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 2.86 109.204 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.34 -46.79 88.79 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.005 -0.739 . . . . 1.32 109.005 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -61.75 -36.02 79.78 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.694 -0.854 . . . . 1.47 108.694 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 2.9 tp -61.96 -65.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.872 -0.788 . . . . 1.76 108.872 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.54 -33.24 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.693 -0.629 . . . . 1.9 110.156 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.38 -45.34 72.81 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.602 -0.686 . . . . 1.47 109.766 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.5 mt -62.04 -58.86 6.25 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.959 -0.756 . . . . 1.94 108.959 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.22 33.2 4.34 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.0 -1.24 . . . . 2.46 110.0 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.43 40.02 3.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.763 -0.845 . . . . 4.59 108.836 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 8.0 m95 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.89 . . . . 2.62 110.546 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 108.923 -0.769 . . . . 1.37 108.923 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 17' ' ' VAL . 33.9 p -109.77 120.71 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 1.21 110.169 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -88.34 136.2 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.817 -0.809 . . . . 1.06 108.817 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.45 134.9 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.371 -0.83 . . . . 1.65 110.072 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.66 120.65 67.65 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.4 -6.59 16.47 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.703 2.268 . . . . 1.04 111.865 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.1 m -93.35 -49.73 5.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.224 -0.923 . . . . 0.94 109.945 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -109.97 -33.87 6.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.465 -0.772 . . . . 1.18 110.756 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.77 74.0 1.07 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.117 -1.593 . . . . 1.2 109.117 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 132.29 31.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.804 -0.821 . . . . 1.76 109.695 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -75.02 113.43 12.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.668 -0.645 . . . . 1.34 109.71 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.72 131.82 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.133 -0.691 . . . . 0.92 109.133 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.2 p -60.05 140.05 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.73 -0.606 . . . . 1.06 110.389 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.503 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.5 t-105 -123.5 150.75 43.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.714 -0.616 . . . . 1.52 109.677 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.89 -97.61 0.49 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.276 -1.53 . . . . 1.3 109.276 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 91.65 0.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.801 -0.823 . . . . 2.72 109.337 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 tt -167.63 -42.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.631 -0.668 . . . . 1.74 110.031 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.0 161.91 21.52 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.535 -0.728 . . . . 1.61 109.809 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 -42.64 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.704 2.269 . . . . 2.09 110.451 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.98 65.36 0.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.698 . . . . 1.78 109.127 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.576 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 15.2 mtm105 -58.33 -49.87 91.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.502 -0.749 . . . . 1.69 110.098 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.25 125.64 7.94 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.188 1.926 . . . . 1.39 109.262 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 57.6 m-85 65.87 173.12 0.23 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.751 -0.593 . . . . 1.1 109.458 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.08 -26.78 12.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.2 -0.937 . . . . 1.22 110.511 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.78 159.97 42.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.257 -0.902 . . . . 1.75 110.4 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.38 88.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.507 -0.553 . . . . 1.96 109.507 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -43.58 94.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.865 -0.522 . . . . 2.19 109.684 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -59.3 -48.6 81.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.634 -0.666 . . . . 0.97 109.32 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -63.59 -35.98 82.31 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.165 -0.679 . . . . 1.75 109.165 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 9.6 tp -64.87 -67.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.397 -0.594 . . . . 1.61 109.397 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -49.03 -33.64 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.693 -0.63 . . . . 1.04 110.708 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -50.98 -41.37 59.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.487 -0.758 . . . . 1.3 110.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.36 -59.04 4.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.508 -0.745 . . . . 2.16 109.105 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.64 10.25 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.519 -0.848 . . . . 1.55 111.572 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 43.45 2.1 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.531 1.165 . . . . 2.76 109.161 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 4.4 m95 . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.564 -0.71 . . . . 1.82 109.41 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.181 0.515 . . . . 2.31 109.658 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -118.79 121.33 39.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.669 -0.644 . . . . 2.36 110.156 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 18' ' ' TRP . 75.8 t -83.5 115.68 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.601 -0.889 . . . . 2.24 108.601 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -83.45 129.97 35.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.458 -0.776 . . . . 2.51 109.704 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.6 t -68.75 118.55 61.82 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.293 -0.632 . . . . 2.27 109.293 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.92 -20.91 9.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.659 2.239 . . . . 2.32 111.068 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.595 HG21 ' HA ' ' A' ' 32' ' ' CYS . 20.7 m -71.83 -51.71 21.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 2.36 110.235 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.3 p -109.07 -34.01 6.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 2.51 110.856 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.9 74.32 1.05 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.105 -1.598 . . . . 2.54 109.105 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 127.1 15.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.678 -0.895 . . . . 2.96 109.714 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -74.34 117.22 15.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.664 -0.647 . . . . 2.46 109.604 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.6 131.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.985 -0.746 . . . . 2.42 108.985 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -60.84 141.23 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.497 -0.752 . . . . 2.57 110.291 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' VAL . 68.0 t-105 -120.85 149.8 42.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.788 -0.57 . . . . 2.38 109.675 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.11 -99.2 0.41 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.314 -1.515 . . . . 2.49 109.314 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.42 83.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.649 -0.912 . . . . 2.88 109.332 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tt -157.25 -41.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.704 -0.622 . . . . 2.85 109.941 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 70.3 p -106.54 161.11 23.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.453 -0.779 . . . . 2.69 109.66 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 33.0 Cg_endo -75.03 -38.99 1.33 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.607 2.205 . . . . 2.76 110.334 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.91 64.82 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.879 -0.785 . . . . 2.55 108.879 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.591 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.4 mtm105 -58.94 -50.82 85.95 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.588 -0.695 . . . . 2.61 110.331 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.8 Cg_endo -76.6 118.52 4.88 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.061 1.841 . . . . 2.28 109.369 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 37.0 m-85 66.4 -171.19 0.19 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.27 -0.641 . . . . 2.39 109.27 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -117.64 -31.66 5.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.037 -1.039 . . . . 2.62 111.447 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.14 166.46 23.35 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.023 -1.048 . . . . 2.69 110.887 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -42.26 93.24 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.614 -0.513 . . . . 3.11 109.614 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -40.42 95.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.692 -0.63 . . . . 2.67 109.761 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.595 ' HA ' HG21 ' A' ' 11' ' ' THR . 49.9 m -62.92 -48.4 79.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 2.37 109.372 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 29.3 tt0 -63.96 -36.58 84.42 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.118 -0.697 . . . . 3.01 109.118 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 12.2 tp -60.95 -64.97 0.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.453 -0.943 . . . . 2.55 108.453 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.81 -34.71 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.948 -0.47 . . . . 2.36 110.323 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -44.33 61.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.53 -0.731 . . . . 2.17 110.769 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.7 mt -57.99 -61.78 2.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.42 -0.8 . . . . 2.59 109.381 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.6 19.69 3.7 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 120.295 -0.955 . . . . 2.04 111.575 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.44 30.58 6.69 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.184 -1.186 . . . . 2.42 109.851 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.537 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 O-C-N 121.215 -0.928 . . . . 2.68 109.68 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.515 -0.55 . . . . 1.1 109.515 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 17' ' ' VAL . 36.1 p -88.46 119.8 29.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.411 -0.806 . . . . 1.07 109.622 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.57 123.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.047 -0.723 . . . . 0.94 109.047 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.01 130.78 34.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.571 -0.706 . . . . 2.12 110.019 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -59.67 119.31 39.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.318 -0.623 . . . . 1.58 109.318 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 35.5 Cg_endo -77.43 -10.9 17.43 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.72 2.28 . . . . 1.92 111.77 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 95.1 m -86.33 -46.99 9.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 1.88 109.838 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -118.03 -33.77 4.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.506 -0.746 . . . . 2.29 110.88 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.31 88.29 2.04 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.877 -1.689 . . . . 2.05 108.877 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HD2' ' HB2' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -149.63 126.59 11.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.966 -0.726 . . . . 3.97 109.701 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -70.25 115.25 9.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.534 -0.729 . . . . 1.67 109.18 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 25' ' ' ARG . 36.1 t -117.62 109.74 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.948 -0.76 . . . . 1.02 108.948 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.548 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.1 p -55.86 133.62 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.634 -0.666 . . . . 1.0 110.292 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.508 ' HZ3' ' HA ' ' A' ' 25' ' ' ARG . 69.6 t-105 -135.07 156.25 49.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.755 -0.591 . . . . 1.22 109.726 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.19 -105.36 0.92 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.684 -1.366 . . . . 1.16 109.684 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.74 22.79 8.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.626 -0.926 . . . . 1.43 109.893 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.3 tt -160.35 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.365 -0.976 . . . . 1.33 108.365 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -115.25 99.15 52.0 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.674 . . . . 1.3 109.582 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.56 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.7 2.267 . . . . 1.31 110.828 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.64 49.78 1.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.563 -0.711 . . . . 2.17 109.146 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.676 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 63.27 -176.83 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.661 -0.866 . . . . 3.35 108.661 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' ARG . 32.2 Cg_endo -74.27 -12.49 23.14 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.094 1.862 . . . . 0.72 110.678 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 27.0 m-85 -93.45 154.31 18.0 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.839 -0.8 . . . . 1.05 108.839 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 19.5 p -69.67 -33.56 72.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.296 -0.878 . . . . 1.33 109.699 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 166.76 25.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 1.65 109.773 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -70.34 -38.01 74.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.59 -0.694 . . . . 3.5 109.672 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -41.67 95.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.212 -0.662 . . . . 2.82 109.212 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.29 -48.09 82.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.102 -0.703 . . . . 1.27 109.102 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 34.5 tt0 -62.11 -35.87 80.03 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.906 -0.776 . . . . 1.16 108.906 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 4.7 tp -63.19 -65.53 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.976 -0.75 . . . . 0.96 108.976 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.4 mm -51.02 -32.0 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.596 -0.69 . . . . 1.39 110.219 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.09 -40.94 74.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.744 . . . . 1.52 109.913 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mm? -65.23 -58.49 5.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.082 -0.71 . . . . 1.65 109.082 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 29.34 5.23 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.683 -0.967 . . . . 1.41 110.683 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -130.67 40.74 3.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.504 -0.998 . . . . 2.31 109.286 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.501 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.439 -0.788 . . . . 1.19 109.613 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.11 -0.7 . . . . 1.9 109.11 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 17' ' ' VAL . 21.5 p -124.85 123.37 39.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.346 -0.846 . . . . 1.16 109.796 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.89 133.12 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.306 -0.627 . . . . 0.93 109.306 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.3 136.91 33.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.557 -0.714 . . . . 1.35 110.15 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 12.2 t -65.05 118.02 45.15 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.307 -0.627 . . . . 0.89 109.307 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 -7.7 16.23 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.676 2.251 . . . . 1.17 111.425 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.9 m -94.92 -56.08 2.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.268 -0.895 . . . . 1.18 110.091 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -104.77 -29.86 10.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.412 -0.805 . . . . 1.35 110.905 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.01 86.17 1.87 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.324 -1.511 . . . . 1.16 109.324 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.47 124.83 8.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.836 -0.803 . . . . 1.53 109.73 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.5 m -75.2 110.95 9.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.563 -0.711 . . . . 1.12 109.841 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 28' ' ' CYS . 73.2 t -113.42 119.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.656 -0.868 . . . . 0.61 108.656 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 6' ' ' THR . 13.9 p -63.66 137.69 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.465 0.65 . . . . 0.62 109.635 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 22' ' ' SER . 73.9 t-105 -133.52 154.6 50.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 1.33 109.634 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 21' ' ' ILE . . . 100.69 93.88 2.15 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.434 -1.467 . . . . 1.07 109.434 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.57 24.81 14.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.929 -0.748 . . . . 2.59 110.364 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 6.4 tt -177.53 103.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.732 -0.84 . . . . 1.18 108.732 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 18' ' ' TRP . 16.7 p -127.81 91.7 44.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 1.65 110.107 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 -38.27 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.662 2.241 . . . . 0.92 110.128 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.78 35.26 4.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.746 -0.596 . . . . 1.57 109.716 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' O ' HG11 ' A' ' 16' ' ' VAL . 2.4 mtm105 65.77 178.28 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.62 -0.675 . . . . 2.98 110.859 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 36.4 Cg_endo -78.21 14.05 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.807 2.338 . . . . 0.97 111.47 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' A' ' 33' ' ' GLN . 26.2 m-85 -131.03 -69.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 1.27 109.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.702 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 0.4 OUTLIER 168.74 -38.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.179 -0.674 . . . . 0.92 109.179 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.31 174.35 11.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.729 -0.607 . . . . 1.11 109.953 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -46.74 70.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 3.45 109.519 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -43.19 93.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.92 -0.487 . . . . 3.39 109.933 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.7 m -59.85 -44.75 93.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.654 . . . . 0.87 109.322 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CD2' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -66.32 -33.17 75.13 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.074 -0.713 . . . . 1.46 109.074 179.065 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.595 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.0 tp -61.53 -62.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.403 -0.962 . . . . 0.82 108.403 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mt -50.9 -29.93 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.825 -0.547 . . . . 1.14 110.128 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -30.83 70.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 1.49 110.558 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.4 mt -72.33 -58.98 2.97 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.353 -0.842 . . . . 1.52 109.055 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.68 24.67 5.74 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.464 -0.874 . . . . 1.19 111.335 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 42.02 3.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.217 -1.167 . . . . 1.81 109.035 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.595 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 11.8 m95 . . . . . 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 1.16 109.567 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.394 -0.595 . . . . 1.69 109.394 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.544 HG22 ' HA ' ' A' ' 17' ' ' VAL . 6.7 p -140.68 123.6 16.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.537 -0.727 . . . . 1.01 109.897 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 71.6 t -97.86 123.99 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.981 -0.748 . . . . 1.11 108.981 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.95 134.23 34.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.556 -0.715 . . . . 1.33 110.027 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.9 t -68.78 120.26 74.74 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 109.162 -0.681 . . . . 0.81 109.162 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -9.05 16.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.712 2.274 . . . . 1.21 111.781 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.7 m -89.15 -51.47 5.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.244 -0.91 . . . . 1.27 110.071 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.77 -23.68 12.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.515 -0.741 . . . . 1.42 110.844 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.9 79.03 1.27 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.464 -1.855 . . . . 1.29 108.464 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -147.73 134.26 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.886 -0.773 . . . . 3.85 109.886 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -76.63 111.58 12.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 1.08 109.691 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.19 138.48 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.7 p -64.1 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.396 -0.815 . . . . 0.89 110.039 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.489 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -115.55 153.13 31.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.468 -0.568 . . . . 1.52 109.468 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.58 -104.89 1.08 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.484 -1.447 . . . . 1.61 109.484 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 53.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.743 -0.857 . . . . 3.62 109.652 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.84 -53.69 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.406 -0.809 . . . . 1.52 109.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.4 m -94.19 165.72 17.04 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.684 -0.635 . . . . 1.41 109.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 34.7 Cg_endo -76.47 -23.83 11.1 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.705 2.27 . . . . 1.77 110.702 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' HZ ' ' HG2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -120.48 74.36 1.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.708 . . . . 1.78 109.181 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -58.17 -55.97 39.86 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.606 -0.684 . . . . 1.97 109.947 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.67 123.9 6.65 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 122.363 2.042 . . . . 1.12 109.721 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 43.9 m-85 66.01 167.1 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.334 0.588 . . . . 0.75 109.653 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.79 -31.37 15.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 1.09 110.208 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -144.15 163.97 32.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 1.32 110.24 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.14 -32.01 73.29 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 2.05 109.323 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -50.43 70.17 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.913 -0.492 . . . . 5.45 109.979 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 2.7 m -56.44 -48.44 77.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.692 -0.63 . . . . 1.13 109.815 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.15 -37.52 87.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 1.82 109.44 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.6 tp -62.3 -66.9 0.47 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.89 -0.781 . . . . 1.33 108.89 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.2 mt -50.43 -29.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.828 -0.545 . . . . 1.38 110.697 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.85 -42.5 68.61 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.454 -0.779 . . . . 1.21 110.287 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.41 -58.34 6.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.494 -0.754 . . . . 1.54 109.056 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.49 22.39 6.77 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 120.624 -0.798 . . . . 1.49 111.277 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.65 40.01 3.62 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.349 -1.089 . . . . 2.07 109.224 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.496 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 2.6 m95 . . . . . 0 N--CA 1.5 2.073 0 O-C-N 121.581 -0.699 . . . . 1.41 109.318 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HE2' ' HB2' ' A' ' 3' ' ' GLU . 16.3 ttp . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.161 0.505 . . . . 6.33 109.685 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.85 39.28 0.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.795 -1.187 . . . . 3.38 107.795 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 0.4 OUTLIER -60.71 121.73 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 3.34 111.598 -178.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.7 m -100.71 101.03 11.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.65 -1.611 . . . . 1.98 106.65 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 18' ' ' TRP . 4.3 pt -77.22 149.3 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.618 -0.882 . . . . 2.46 108.618 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.973 HG22 ' HA ' ' A' ' 17' ' ' VAL . 20.1 p -120.41 120.57 36.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 2.59 110.474 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.34 132.93 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.495 -0.928 . . . . 2.14 108.495 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.41 135.28 33.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 3.63 110.286 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.4 t -66.68 118.27 52.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.791 -0.818 . . . . 2.51 108.791 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.9 Cg_endo -76.35 -15.65 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.524 2.149 . . . . 3.02 111.849 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.84 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 87.7 m -81.17 -50.39 9.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.921 . . . . 2.59 110.708 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.9 p -110.78 -26.1 9.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 3.12 110.789 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.18 74.4 1.26 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.839 -1.705 . . . . 3.36 108.839 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 28' ' ' CYS . 6.2 tmtt? -140.08 128.62 22.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.063 -0.669 . . . . 3.22 109.521 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 m -70.6 115.86 10.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.635 -0.666 . . . . 3.42 109.75 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 24' ' ' PHE . 19.5 t -116.93 123.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.926 -0.768 . . . . 1.82 108.926 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.973 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.8 p -53.07 136.95 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.28 0.562 . . . . 1.6 110.322 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.527 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -112.11 156.59 22.0 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.647 -0.658 . . . . 2.59 109.809 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.76 -100.64 0.91 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.869 -1.692 . . . . 2.11 108.869 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.89 57.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.848 -0.795 . . . . 4.29 109.226 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.35 -52.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.594 -0.691 . . . . 3.09 109.366 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.1 m -93.47 166.77 15.33 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 2.6 110.007 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 36.2 Cg_endo -78.27 -32.87 2.16 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.488 2.126 . . . . 3.45 109.753 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.594 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -113.96 66.68 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.37 -0.604 . . . . 3.05 109.37 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.582 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -51.69 -55.43 29.96 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.282 -0.886 . . . . 3.52 109.322 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.2 Cg_endo -77.73 119.96 4.98 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.253 1.969 . . . . 2.2 109.545 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 82.8 m-85 68.0 159.45 0.16 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.345 0.593 . . . . 1.96 110.051 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 32.0 p -90.28 -35.4 15.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 1.4 110.0 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 165.6 24.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.455 -0.778 . . . . 1.98 109.543 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -72.4 -36.83 68.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.531 -0.73 . . . . 3.52 109.887 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -34.85 72.04 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.397 -0.814 . . . . 2.06 108.893 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.596 ' HA ' HG21 ' A' ' 11' ' ' THR . 33.8 m -66.85 -56.15 11.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -58.11 -33.7 69.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.103 -0.702 . . . . 2.27 109.103 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.56 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.9 tp -62.84 -65.77 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.734 -0.839 . . . . 2.11 108.734 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.685 HG21 ' HB2' ' A' ' 60' ' ' SER . 40.2 mt -49.5 -28.41 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.75 -0.593 . . . . 2.03 110.301 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HA ' ' OE1' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -59.22 -39.64 83.34 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.446 -0.784 . . . . 2.82 110.458 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -64.0 -60.0 3.8 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.793 -0.817 . . . . 2.95 108.793 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.7 24.63 5.19 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.912 -0.875 . . . . 2.71 110.912 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -126.1 40.6 3.7 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.329 -1.1 . . . . 3.4 109.215 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.5 m95 -137.43 -179.14 5.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.537 -0.727 . . . . 2.8 109.681 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.47 84.94 2.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -0.789 . . . . 1.72 109.595 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB3' HG12 ' A' ' 35' ' ' ILE . . . -162.71 59.36 0.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 1.46 109.512 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.91 77.85 0.2 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.55 -0.719 . . . . 2.23 109.666 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -167.73 -38.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.324 -0.86 . . . . 2.02 110.858 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.52 117.95 12.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 3.86 109.646 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 128.08 41.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.633 -0.667 . . . . 2.71 110.024 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.56 99.1 51.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.796 -0.565 . . . . 2.96 109.588 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HG3' ' HB2' ' A' ' 53' ' ' LEU . 31.2 Cg_endo -75.33 171.05 19.01 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.887 2.391 . . . . 1.76 111.91 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.29 -32.79 74.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.879 -0.513 . . . . 3.11 110.03 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.13 -41.33 83.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.281 -0.887 . . . . 3.38 108.793 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.76 -104.74 0.25 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.029 -1.628 . . . . 3.3 109.029 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 124.53 36.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.821 -0.811 . . . . 3.77 109.658 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -126.65 139.46 53.15 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.521 -0.737 . . . . 4.99 110.876 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.74 81.28 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.455 0.645 . . . . 4.3 110.393 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.37 129.95 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.484 -0.932 . . . . 4.82 108.484 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 59' ' ' TRP . 0.6 OUTLIER 67.29 67.73 0.39 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.465 0.65 . . . . 3.47 109.662 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.82 112.16 9.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.802 . . . . 3.41 108.985 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 66.57 94.98 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.401 0.62 . . . . 1.35 109.5 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.417 ' HE1' ' HA ' ' A' ' 56' ' ' SER . 7.1 m-90 -100.64 167.79 10.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.532 -0.73 . . . . 2.04 109.732 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.685 ' HB2' HG21 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -67.33 -39.44 85.82 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.754 -0.832 . . . . 2.27 108.754 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.84 ' HG3' ' HA ' ' A' ' 11' ' ' THR . 2.4 mp0 -67.98 -57.82 5.54 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.577 0.703 . . . . 2.99 109.18 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -124.82 107.45 28.73 Favored Pre-proline 0 N--CA 1.485 1.312 0 CA-C-N 116.169 -0.469 . . . . 1.88 109.867 -178.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.547 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 30.3 Cg_endo -76.11 -49.11 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.367 2.045 . . . . 2.49 110.768 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 63' ' ' PRO . 8.4 tptt -154.48 133.32 12.26 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.478 -0.764 . . . . 4.48 110.257 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 2.8 tt0 . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 117.768 -1.11 . . . . 3.73 109.864 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.66 -0.496 . . . . 4.49 109.66 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.76 -50.54 5.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.292 -0.88 . . . . 3.08 109.034 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.8 OUTLIER -102.28 120.17 40.03 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.574 -0.899 . . . . 2.7 108.574 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 88.4 m 68.13 130.67 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.314 0.578 . . . . 1.43 109.836 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt -79.17 150.17 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.288 -0.882 . . . . 1.28 109.934 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.752 HG22 ' HA ' ' A' ' 17' ' ' VAL . 34.2 p -122.42 128.36 50.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 1.27 109.908 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.3 m -91.2 138.36 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.89 109.371 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.89 137.15 33.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.766 . . . . 1.96 110.097 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.68 120.72 75.48 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 109.095 -0.705 . . . . 1.07 109.095 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 -2.21 12.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.704 2.269 . . . . 1.33 112.05 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.6 m -98.78 -51.31 3.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.147 -0.971 . . . . 1.07 110.023 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.3 p -107.54 -30.03 8.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.617 -0.677 . . . . 1.51 110.763 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 71.16 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.814 -1.714 . . . . 1.65 108.814 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 135.08 40.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.786 -0.832 . . . . 2.03 109.66 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -76.54 112.27 12.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.566 -0.709 . . . . 1.59 109.685 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.26 127.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.853 -0.795 . . . . 0.9 108.853 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.752 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.6 p -60.68 137.86 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.705 . . . . 1.24 110.371 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.535 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.1 t-105 -106.92 156.02 19.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.776 -0.577 . . . . 1.24 109.543 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.33 -179.23 26.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.744 -1.342 . . . . 1.21 109.744 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.15 103.65 3.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.583 -0.951 . . . . 4.41 109.721 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 tt -174.99 -40.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.748 -0.595 . . . . 1.92 109.761 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.75 157.23 50.58 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 1.68 109.651 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.23 -35.61 2.23 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.579 2.186 . . . . 2.14 110.681 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.26 68.52 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.519 -0.738 . . . . 2.01 109.066 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.698 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -56.06 -54.17 55.32 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.599 -0.688 . . . . 1.63 109.854 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.698 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -78.0 128.69 9.3 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.291 1.994 . . . . 1.22 109.44 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 62.0 m-85 65.54 173.48 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.373 0.606 . . . . 0.96 109.661 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -104.08 -31.88 9.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.897 . . . . 1.16 110.341 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -138.41 164.21 29.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.328 -0.858 . . . . 1.2 110.419 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -38.66 90.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 2.07 109.487 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -42.0 98.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 2.29 109.897 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -59.38 -50.35 74.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.582 -0.699 . . . . 0.75 109.304 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.04 -35.32 78.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.169 -0.678 . . . . 1.65 109.169 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 10.5 tp -66.04 -66.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.24 -0.652 . . . . 1.78 109.24 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 mt -50.2 -30.93 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.634 -0.666 . . . . 0.88 110.542 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.8 -41.67 64.37 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.598 -0.688 . . . . 1.39 110.081 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.5 -59.11 4.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.943 -0.762 . . . . 2.0 108.943 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.05 26.71 5.39 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.992 -0.843 . . . . 1.65 110.992 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.32 47.21 2.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 2.51 109.118 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 7.7 m95 -140.02 -54.4 0.53 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.512 -0.743 . . . . 2.1 109.93 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 58.08 53.1 6.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.906 -0.775 . . . . 1.58 108.906 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.5 -37.18 7.69 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.858 -0.793 . . . . 1.63 108.858 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.79 103.37 12.97 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.224 -0.658 . . . . 3.75 109.224 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -147.5 88.83 1.73 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.327 -0.858 . . . . 3.72 110.587 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -118.19 78.05 1.22 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.508 -0.923 . . . . 3.62 108.508 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.41 173.89 9.81 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.241 0.543 . . . . 3.65 110.019 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pt -91.8 128.66 45.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.579 -0.897 . . . . 4.06 108.579 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' HD2' HD13 ' A' ' 53' ' ' LEU . 32.0 Cg_endo -72.63 -41.41 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 122.535 2.157 . . . . 3.4 110.704 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.38 130.78 21.02 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.964 -0.754 . . . . 3.27 108.964 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.1 p -82.59 160.25 22.56 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 3.48 109.604 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 55' ' ' GLU . . . 97.41 -36.36 3.97 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.182 -1.567 . . . . 2.51 109.182 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.66 -39.24 5.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.758 -0.848 . . . . 2.9 109.797 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -98.19 -59.4 1.76 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.586 -0.696 . . . . 4.01 109.832 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.49 -55.39 18.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.833 -0.542 . . . . 4.51 110.229 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -86.88 126.07 34.42 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.332 0.587 . . . . 3.27 110.559 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.18 -51.67 2.93 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.751 -0.833 . . . . 4.11 108.751 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 96.55 7.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 4.44 108.785 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.88 135.61 57.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 2.25 108.379 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.588 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 7.4 m95 -96.85 56.34 1.44 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.657 -0.817 . . . . 5.18 112.414 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 61' ' ' GLU . 9.2 p -77.68 59.44 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.055 -1.461 . . . . 3.63 107.055 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.537 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 2.0 mp0 -10.17 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 113.011 0.745 . . . . 7.25 113.011 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -107.5 91.25 6.86 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.329 -0.857 . . . . 5.92 111.069 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 61' ' ' GLU . 34.0 Cg_endo -75.49 -22.28 14.14 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.246 1.297 . . . . 3.91 110.117 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 168.61 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 118.714 0.688 . . . . 6.91 111.112 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.817 -1.087 . . . . 5.82 110.464 178.059 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.79 -0.448 . . . . 3.12 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -103.25 -48.11 4.11 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.638 -0.664 . . . . 1.87 110.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.18 94.11 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.379 0.609 . . . . 1.84 109.747 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 m -96.52 124.7 40.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 1.21 109.476 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt -95.44 165.69 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.686 . . . . 1.22 109.552 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 17' ' ' VAL . 45.1 p -126.17 130.68 51.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.408 -0.808 . . . . 1.17 110.046 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 18' ' ' TRP . 42.8 t -97.49 131.08 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.286 -0.635 . . . . 1.07 109.286 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.07 140.46 36.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.563 -0.711 . . . . 1.87 109.804 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 16.1 t -73.01 125.48 91.04 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.71 -0.619 . . . . 1.36 109.519 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.57 -3.71 13.54 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.809 2.339 . . . . 1.89 111.783 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HB ' ' A' ' 35' ' ' ILE . 55.5 m -97.39 -54.89 3.0 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.237 -0.914 . . . . 1.57 109.901 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.9 p -102.07 -30.71 11.02 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.585 -0.697 . . . . 1.59 110.688 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.45 62.59 1.09 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.346 -1.502 . . . . 1.46 109.346 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 140.46 46.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.877 -0.778 . . . . 2.79 109.341 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 m -73.71 116.61 14.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.45 109.827 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.7 t -116.0 137.47 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.136 -0.69 . . . . 0.96 109.136 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.6 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -58.87 139.46 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.429 -0.795 . . . . 0.92 110.256 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 57.5 t-105 -116.47 152.72 33.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 1.19 109.646 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 -145.46 16.61 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.686 -1.366 . . . . 1.19 109.686 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 89.02 2.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.454 -1.027 . . . . 1.99 109.344 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -153.8 -42.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.66 -0.65 . . . . 1.24 110.073 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 55.8 p -131.4 161.24 63.23 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.524 -0.735 . . . . 0.98 109.818 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.91 -15.82 18.59 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.737 2.291 . . . . 1.16 110.679 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 27' ' ' PHE . 61.8 m-85 -119.41 76.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.485 -0.931 . . . . 1.15 108.485 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.695 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -73.9 -48.91 6.18 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 2.1 110.483 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.69 -43.03 0.23 Allowed 'Trans proline' 0 C--N 1.326 -0.657 0 C-N-CA 122.171 1.914 . . . . 1.1 111.015 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 97.4 m-85 -99.08 163.66 12.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.671 -0.643 . . . . 1.17 109.809 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -80.38 -49.95 10.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.365 -0.834 . . . . 1.15 109.507 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.49 -172.8 3.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.669 -0.644 . . . . 1.23 110.074 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -36.13 82.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 2.46 110.165 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -64.57 -41.04 96.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.645 -0.66 . . . . 1.86 110.3 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 43.7 m -58.95 -48.23 82.27 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.122 -0.696 . . . . 1.22 109.122 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -66.4 -33.76 76.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.641 -0.662 . . . . 1.76 109.227 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -62.2 -66.63 0.51 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 1.36 109.328 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 48' ' ' PRO . 11.4 mt -50.13 -30.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.605 -0.684 . . . . 1.58 110.356 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -56.53 -43.54 79.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.452 -0.78 . . . . 1.62 110.289 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.69 -61.18 2.7 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.847 -0.797 . . . . 1.91 108.847 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.57 18.84 8.22 Favored Glycine 0 N--CA 1.499 2.85 0 C-N-CA 120.457 -0.878 . . . . 1.89 111.339 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.14 40.22 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -1.127 . . . . 2.52 109.284 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 8.2 m95 -132.36 133.03 43.49 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.814 -0.81 . . . . 1.85 108.814 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . . . -96.14 153.28 17.88 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.537 -0.727 . . . . 1.8 111.113 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . . . -91.67 -45.03 8.68 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.986 -0.746 . . . . 3.35 108.986 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.01 -48.46 57.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 120.988 0.423 . . . . 5.57 110.371 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -58.52 -46.07 87.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.801 -0.562 . . . . 4.37 111.271 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -174.37 142.56 0.79 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.415 -0.803 . . . . 2.28 110.977 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 5.0 ttp180 64.62 122.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.422 0.629 . . . . 2.16 110.362 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.29 113.29 59.64 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.441 -0.787 . . . . 2.06 109.706 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 35.0 Cg_endo -77.63 56.25 5.52 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.737 2.291 . . . . 2.21 109.866 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.21 137.26 28.86 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.04 -0.726 . . . . 2.27 109.04 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.49 -59.56 2.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.647 -0.658 . . . . 4.55 109.335 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.7 85.21 0.39 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.079 -1.208 . . . . 2.66 110.079 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.89 155.92 17.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.743 -0.857 . . . . 2.41 109.426 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.63 80.67 1.98 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.415 -0.803 . . . . 2.78 110.058 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 -53.4 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.518 -0.919 . . . . 3.14 108.518 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -78.38 115.67 18.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.407 -0.59 . . . . 4.54 109.407 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.3 171.31 0.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.518 0.675 . . . . 3.21 110.353 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 -12.95 17.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.699 -0.626 . . . . 3.12 110.581 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.26 27.25 8.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.287 -0.883 . . . . 5.03 110.001 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -96.51 131.0 43.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.064 -1.022 . . . . 4.03 109.739 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -41.88 81.77 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.29 -0.633 . . . . 2.39 109.29 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 0.6 OUTLIER 55.69 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.78 -0.822 . . . . 3.1 108.78 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.3 mp0 66.54 79.69 0.23 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.98 -1.118 . . . . 4.47 107.98 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.75 93.5 0.78 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.475 2.116 . . . . 4.67 110.332 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -133.14 124.34 27.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.054 -0.721 . . . . 5.92 109.054 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.903 -1.046 . . . . 6.4 109.631 -179.711 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 109.295 -0.631 . . . . 5.3 109.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 3' ' ' GLU . 8.7 m 52.85 84.76 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.263 0.554 . . . . 4.2 109.654 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -37.19 106.46 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.593 0.711 . . . . 3.32 110.193 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.607 HG22 ' CG2' ' A' ' 17' ' ' VAL . 1.6 m -65.0 95.27 0.15 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.384 0.611 . . . . 2.42 111.26 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.67 123.79 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.139 -1.06 . . . . 1.62 108.139 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 25.3 p -88.41 121.3 30.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.06 110.385 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 26' ' ' PRO . 22.7 t -112.13 115.07 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.509 -0.923 . . . . 1.03 108.509 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 5.7 p-10 -81.59 145.23 30.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 1.09 110.335 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 8.6 t -74.85 121.79 86.05 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.709 -0.619 . . . . 0.79 109.331 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.87 -8.29 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.672 2.248 . . . . 1.38 111.537 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.0 m -93.6 -56.84 2.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 1.65 109.83 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.1 p -98.01 -31.56 12.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.441 -0.787 . . . . 1.34 110.755 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.34 69.96 1.03 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.258 -1.537 . . . . 1.11 109.258 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -139.78 117.33 11.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.839 -0.8 . . . . 1.48 109.389 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 9.0 m -69.36 107.15 3.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.596 -0.69 . . . . 0.77 109.517 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.997 HG21 ' HA ' ' A' ' 28' ' ' CYS . 87.7 t -104.65 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.925 -0.769 . . . . 0.79 108.925 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 4' ' ' THR . 7.3 p -63.72 114.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.439 0.637 . . . . 1.53 109.309 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.52 ' CZ3' ' HA ' ' A' ' 25' ' ' ARG . 14.5 t-105 -86.92 147.25 25.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.505 -0.747 . . . . 2.05 110.052 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.46 -87.54 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.011 -1.635 . . . . 2.34 109.011 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 35.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.801 -0.823 . . . . 3.02 109.796 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.27 -56.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 2.32 109.572 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.511 ' HB2' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -104.1 118.05 57.96 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.79 109.491 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.8 46.14 2.14 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.856 2.371 . . . . 1.84 110.479 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -117.72 24.25 11.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 1.74 109.741 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 63.26 174.37 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.638 -0.664 . . . . 1.48 110.631 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 31.7 Cg_endo -71.74 -18.33 28.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 122.153 1.902 . . . . 1.45 111.1 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.39 -69.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.181 -0.95 . . . . 1.34 108.803 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.997 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 167.59 -40.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.155 -0.683 . . . . 0.72 109.155 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.75 159.81 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.749 -0.594 . . . . 1.08 109.485 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -62.69 -38.6 91.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 3.0 109.875 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -38.0 62.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.659 -0.65 . . . . 2.22 110.185 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 4.3 m -60.23 -49.42 77.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.56 -0.713 . . . . 1.33 109.643 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 2.01 109.22 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 8.3 tp -63.86 -66.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.969 -0.752 . . . . 1.77 108.969 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 mt -50.28 -30.38 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.747 -0.596 . . . . 1.79 110.121 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -44.75 63.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.691 . . . . 1.9 110.299 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 4.7 mt -65.94 -58.09 6.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.757 -0.831 . . . . 2.47 108.757 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.44 26.0 6.1 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 111.001 -0.839 . . . . 2.55 111.001 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.71 42.77 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.391 -1.064 . . . . 2.95 108.823 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.503 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 6.8 m95 -138.12 -58.4 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.676 -0.64 . . . . 2.63 109.446 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.81 120.79 43.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.438 -0.578 . . . . 2.54 109.438 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.46 73.99 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.442 -0.786 . . . . 3.71 109.489 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 50' ' ' SER . 1.6 mp0 -98.03 -53.35 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.434 -0.791 . . . . 3.85 109.427 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.93 62.4 0.99 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 3.02 108.876 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -103.95 110.47 22.63 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.698 -0.626 . . . . 4.05 109.553 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.17 19.41 10.0 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.673 -0.642 . . . . 4.58 111.075 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 pt -133.47 149.27 71.82 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.978 -1.076 . . . . 2.58 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.27 -42.12 0.41 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.887 2.391 . . . . 2.19 109.972 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -139.18 144.81 38.72 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.787 -0.82 . . . . 2.44 108.787 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 1.5 p -96.57 -69.47 0.75 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.309 -0.869 . . . . 3.74 110.559 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.61 -79.78 0.09 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.522 -1.431 . . . . 2.76 109.522 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 7.9 t70 -110.28 149.89 29.52 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.294 -1.002 . . . . 2.42 108.294 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.69 143.6 29.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.437 -0.789 . . . . 2.52 111.821 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.83 74.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.681 0.753 . . . . 2.59 109.224 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.66 151.2 32.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.798 -0.564 . . . . 4.13 110.474 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.88 82.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.571 0.7 . . . . 3.41 110.059 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.48 109.3 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.665 -0.865 . . . . 3.08 108.665 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -115.08 153.94 29.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.435 -0.791 . . . . 3.57 110.969 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -123.49 -49.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.692 -0.485 . . . . 5.23 109.692 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 p -67.51 130.11 42.0 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.767 -0.827 . . . . 2.8 108.767 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.67 125.2 18.92 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.586 -0.696 . . . . 3.1 110.248 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.17 91.93 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.259 -0.645 . . . . 3.9 109.259 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 37.1 Cg_endo -75.77 150.17 34.6 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.912 2.408 . . . . 4.03 110.663 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -52.2 -31.32 31.23 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.043 -0.725 . . . . 5.62 109.043 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.492 -0.755 . . . . 7.37 109.119 178.208 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.42 -0.585 . . . . 5.79 109.42 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.85 74.48 1.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.175 -0.676 . . . . 3.74 109.175 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.3 112.65 24.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.532 -0.73 . . . . 2.62 109.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -75.98 98.73 4.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.683 -0.636 . . . . 1.72 109.477 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -83.56 156.71 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.493 -0.754 . . . . 1.76 109.166 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 17' ' ' VAL . 29.9 p -117.51 121.11 40.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.34 -0.85 . . . . 1.12 109.926 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.83 132.64 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.64 -0.662 . . . . 1.12 109.251 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -92.59 132.9 36.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.396 -0.815 . . . . 1.78 109.977 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 t -64.32 120.3 63.77 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.53 -10.37 17.3 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.694 2.262 . . . . 1.8 111.877 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.4 m -89.13 -51.0 5.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.242 -0.911 . . . . 1.74 110.194 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.21 -29.83 8.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.485 -0.76 . . . . 1.52 110.821 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.92 78.4 1.41 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.905 -1.678 . . . . 1.43 108.905 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -142.96 136.12 28.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.881 -0.776 . . . . 2.77 109.786 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -79.39 112.85 17.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.669 . . . . 0.99 109.681 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.56 132.27 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.828 -0.804 . . . . 0.77 108.828 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.605 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.2 p -60.5 139.01 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.704 . . . . 1.01 110.167 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.536 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.0 t-105 -118.58 148.26 42.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.776 -0.577 . . . . 1.72 109.546 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.09 -97.49 0.42 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.669 -1.372 . . . . 1.7 109.669 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.96 52.47 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.848 . . . . 2.82 109.573 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.422 HD13 ' CG2' ' A' ' 17' ' ' VAL . 3.3 mp -118.05 -59.59 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 1.57 109.645 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -91.77 164.76 22.7 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 1.26 109.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.68 -40.62 0.71 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.565 2.177 . . . . 1.33 110.358 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.92 64.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.981 -0.748 . . . . 1.02 108.981 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.612 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.3 mtm180 -56.61 -52.28 74.72 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.549 -0.72 . . . . 2.5 110.088 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.09 124.23 7.8 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.162 1.908 . . . . 1.02 109.459 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 47.2 m-85 65.96 173.95 0.23 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.469 -0.567 . . . . 1.31 109.469 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -102.15 -29.83 11.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 1.01 110.147 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.31 163.7 32.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.372 -0.83 . . . . 1.51 110.087 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -35.39 80.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.59 -0.694 . . . . 1.51 109.891 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -65.79 -44.71 84.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.667 -0.646 . . . . 4.05 110.129 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.59 -46.26 84.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.75 -0.833 . . . . 1.35 108.75 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -66.01 -34.81 78.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.127 -0.694 . . . . 1.54 109.127 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 9.9 tp -63.76 -67.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.125 -0.695 . . . . 1.94 109.125 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.853 HG23 ' HB3' ' A' ' 44' ' ' GLU . 14.1 mt -49.16 -33.08 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.759 -0.588 . . . . 1.84 110.298 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.78 -42.1 71.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 2.01 110.266 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.68 -60.84 3.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 2.92 109.015 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.15 22.35 5.93 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 120.407 -0.902 . . . . 2.52 111.353 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.75 41.35 3.5 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.29 -1.123 . . . . 3.06 109.212 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 -139.34 168.25 20.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.431 -0.793 . . . . 2.38 109.888 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.61 72.88 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.479 -0.763 . . . . 2.28 109.311 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.55 50.2 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.561 -0.712 . . . . 1.73 109.467 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.43 76.37 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.6 0.714 . . . . 2.96 110.02 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.853 ' HB3' HG23 ' A' ' 35' ' ' ILE . 7.2 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.664 -0.647 . . . . 2.12 109.646 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -123.04 145.73 48.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 2.34 110.397 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -49.85 39.67 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.381 -0.97 . . . . 6.25 108.381 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.87 152.47 84.74 Favored Pre-proline 0 N--CA 1.498 1.931 0 CA-C-N 116.423 -0.353 . . . . 2.48 110.202 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 58' ' ' ASP . 35.9 Cg_endo -77.32 118.2 4.58 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.768 2.312 . . . . 2.33 109.989 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -62.54 -50.21 72.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.566 -0.709 . . . . 2.67 109.806 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -82.65 -43.45 16.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.604 . . . . 2.16 109.808 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.24 -78.38 0.35 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.931 -1.268 . . . . 2.22 109.931 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.55 43.26 3.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.69 -0.888 . . . . 2.7 109.585 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 50' ' ' SER . 0.2 OUTLIER -106.62 122.88 47.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 3.39 109.525 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.8 -170.06 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.319 0.58 . . . . 2.93 110.473 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.855 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 2.0 mt-10 -86.71 129.99 34.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.548 -0.72 . . . . 4.01 110.476 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER 67.01 117.25 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.513 0.673 . . . . 2.91 110.848 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -117.61 92.83 3.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.09 109.203 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER 74.91 -14.65 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.961 -0.462 . . . . 2.49 111.386 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -131.08 128.46 40.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.981 -1.074 . . . . 3.12 109.328 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -77.55 -32.58 54.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.805 -0.559 . . . . 2.71 110.414 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.13 85.35 5.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.412 -0.805 . . . . 2.74 110.163 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.86 129.56 24.91 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 3.73 108.939 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -73.25 -19.38 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.507 2.138 . . . . 5.18 110.892 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.77 -54.77 3.01 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.4 -0.812 . . . . 7.86 109.534 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.855 ' HB3' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm100 . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 117.902 -1.047 . . . . 4.59 110.512 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.156 0.503 . . . . 3.66 109.698 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 p -81.27 -50.65 9.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.512 -0.743 . . . . 3.3 109.404 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.48 95.07 7.39 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.035 -0.728 . . . . 3.06 109.035 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 m -110.09 116.65 31.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.635 -0.666 . . . . 2.25 109.738 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.488 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.0 pt -84.52 152.94 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 2.2 109.675 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.777 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -121.38 126.48 49.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 2.62 109.801 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 18' ' ' TRP . 35.9 m -90.76 134.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 1.9 109.262 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.0 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.525 -0.735 . . . . 3.18 110.254 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 t -67.93 119.79 69.32 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.025 -0.731 . . . . 2.2 109.025 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.43 -10.1 17.44 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.71 2.274 . . . . 2.54 111.819 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 m -88.1 -52.05 5.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.168 -0.957 . . . . 2.06 110.044 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -109.26 -30.07 8.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.522 -0.737 . . . . 2.42 110.78 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.1 73.57 1.12 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.894 -1.682 . . . . 2.71 108.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 129.36 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.892 -0.77 . . . . 2.65 109.791 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -72.86 114.44 11.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.529 -0.732 . . . . 3.02 109.661 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 24' ' ' PHE . 23.8 t -116.18 127.35 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.151 -0.685 . . . . 1.89 109.151 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.5 p -58.43 138.81 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 1.96 110.453 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.549 ' HB2' HG13 ' A' ' 7' ' ' VAL . 76.7 t-105 -111.28 155.27 23.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.807 -0.558 . . . . 1.34 109.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.07 -103.82 0.97 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.258 -1.537 . . . . 1.18 109.258 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.82 51.46 0.55 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.807 . . . . 2.45 109.307 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.45 -55.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.764 . . . . 2.41 109.449 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 80.5 p -89.12 162.08 38.69 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.831 -0.543 . . . . 1.85 109.977 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.84 -30.52 5.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.567 2.178 . . . . 2.15 110.056 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.434 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -116.72 69.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.791 -0.818 . . . . 1.33 108.791 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -53.05 -54.64 42.04 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.412 -0.805 . . . . 2.31 110.044 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.14 123.02 6.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.226 1.951 . . . . 0.95 109.425 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 59.9 m-85 66.83 167.92 0.23 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.297 0.57 . . . . 1.68 109.689 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -96.41 -34.65 11.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -0.877 . . . . 1.21 110.448 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 160.98 36.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.387 -0.821 . . . . 1.15 109.866 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -38.06 88.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.682 -0.637 . . . . 3.25 109.48 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.754 -0.591 . . . . 2.96 109.604 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -61.51 -52.01 66.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.35 -34.2 72.08 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.055 -0.72 . . . . 1.96 109.055 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.54 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.3 tp -65.85 -67.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.04 -0.726 . . . . 2.25 109.04 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.15 -29.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.659 -0.65 . . . . 2.14 110.546 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -53.71 -43.99 69.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.48 -0.762 . . . . 2.52 109.766 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.72 -58.29 6.67 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.882 -0.784 . . . . 3.1 108.882 179.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.73 26.39 5.59 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.79 -0.924 . . . . 3.16 110.79 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 23.1 mm-40 -124.44 40.77 3.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -1.045 . . . . 3.73 109.505 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.54 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 5.0 m95 -137.23 -63.41 0.6 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.788 . . . . 3.03 109.473 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.78 121.04 42.8 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.235 -0.654 . . . . 2.78 109.235 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 59.22 85.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.546 0.688 . . . . 3.29 109.188 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -83.06 118.07 23.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.735 . . . . 3.83 109.984 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 1.0 OUTLIER -89.97 102.56 15.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.03 -0.73 . . . . 4.06 109.03 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -119.6 106.76 12.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.613 -0.884 . . . . 4.61 108.613 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -95.66 94.95 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.346 0.593 . . . . 6.66 110.591 -178.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.83 97.01 21.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.578 -1.267 . . . . 3.1 107.578 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 29.2 Cg_endo -70.6 -20.46 30.87 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.921 1.748 . . . . 3.07 110.782 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.7 -144.88 0.51 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.931 -1.137 . . . . 1.88 107.931 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.75 ' OG ' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -111.45 121.59 45.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.068 -1.086 . . . . 2.78 108.068 178.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' SER . . . -35.7 -65.52 0.46 Allowed Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.435 -1.066 . . . . 3.51 110.435 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 57' ' ' ASP . 15.6 t70 -149.33 138.91 21.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.712 -0.875 . . . . 3.99 109.075 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.75 HD11 ' OG ' ' A' ' 50' ' ' SER . 3.8 mp -114.3 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 3.37 109.501 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -71.83 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.812 -0.44 . . . . 4.13 109.812 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.48 -53.77 1.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.565 -0.71 . . . . 4.21 110.266 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.05 133.33 42.91 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.583 -0.698 . . . . 3.65 110.337 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -71.57 -41.34 69.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.887 -0.508 . . . . 4.37 109.853 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.45 168.48 18.92 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.713 -0.617 . . . . 4.91 110.489 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -75.68 98.09 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.822 -1.177 . . . . 3.47 107.822 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.74 27.3 7.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.277 -0.89 . . . . 4.37 111.243 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.608 ' OE1' HD22 ' A' ' 53' ' ' LEU . 7.4 mp0 -89.44 -64.96 1.07 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.904 -1.122 . . . . 2.87 110.088 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 2.9 mp0 68.05 116.47 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.618 -1.253 . . . . 3.81 107.618 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.93 -48.72 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.374 2.05 . . . . 3.39 111.87 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -44.53 10.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.395 -0.816 . . . . 5.72 110.304 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.112 -0.946 . . . . 4.85 110.06 -179.671 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.458 -0.571 . . . . 5.05 109.458 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 126.89 39.65 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 3.64 109.252 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -105.61 130.94 53.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.607 . . . . 6.82 110.745 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 m -99.08 113.95 26.42 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.263 -1.014 . . . . 3.05 108.263 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.661 HD11 ' CD1' ' A' ' 18' ' ' TRP . 1.8 pt -78.44 163.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.396 -0.815 . . . . 2.7 109.022 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 17' ' ' VAL . 30.8 p -126.23 119.92 28.69 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.248 -0.908 . . . . 3.26 110.903 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.71 136.23 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.905 -0.776 . . . . 1.87 108.905 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.08 135.69 34.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.882 . . . . 3.37 110.299 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 24.3 t -65.04 119.44 58.57 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.998 -0.741 . . . . 2.08 108.998 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.4 Cg_endo -76.6 -6.31 16.85 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.685 2.257 . . . . 1.83 111.91 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.6 m -93.16 -52.41 4.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 2.03 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -108.31 -26.66 10.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.539 -0.726 . . . . 3.16 110.912 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.49 76.73 1.34 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.369 -1.892 . . . . 3.5 108.369 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 129.48 28.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.997 -0.708 . . . . 5.36 109.704 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 m -74.1 107.04 6.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.58 -0.7 . . . . 3.99 109.409 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -110.07 126.31 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.735 -0.603 . . . . 2.59 109.48 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' HA ' HG22 ' A' ' 6' ' ' THR . 14.0 p -53.94 135.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.428 0.632 . . . . 2.85 110.461 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.661 ' CD1' HD11 ' A' ' 5' ' ' ILE . 74.2 t-105 -117.4 154.13 31.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.675 -0.64 . . . . 1.63 110.443 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.21 -114.68 2.65 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.127 -1.589 . . . . 2.45 109.127 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.71 93.6 2.58 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.542 -0.91 . . . . 4.68 108.542 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 tt -169.52 -42.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.6 -0.688 . . . . 3.93 110.353 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.46 162.9 18.62 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.518 -0.739 . . . . 3.46 110.211 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 -40.72 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.665 2.243 . . . . 4.15 110.184 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.99 65.61 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.674 -0.641 . . . . 2.99 109.37 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -53.54 -53.39 57.42 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 2.78 109.787 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.1 Cg_endo -76.57 127.32 9.55 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 122.38 2.054 . . . . 1.62 109.527 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 60.0 m-85 66.56 166.75 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.734 -0.604 . . . . 1.88 109.526 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.93 -29.43 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.298 -0.876 . . . . 2.88 110.617 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.77 161.65 37.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.342 -0.849 . . . . 3.22 109.969 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.91 92.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 3.21 109.42 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -42.82 99.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.825 -0.547 . . . . 2.69 109.7 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.482 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -60.99 -52.99 62.65 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.729 -0.841 . . . . 1.99 108.729 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 20.2 tt0 -58.54 -33.54 70.01 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.142 -0.688 . . . . 2.11 109.142 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 tp -68.03 -66.9 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.8 -0.815 . . . . 2.74 108.8 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.32 -28.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.737 -0.602 . . . . 1.44 110.313 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.17 -42.7 66.44 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.539 -0.726 . . . . 1.42 109.702 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.2 mt -65.09 -57.42 8.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 2.56 108.788 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.87 23.57 7.04 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.039 -0.824 . . . . 2.28 111.039 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -122.97 45.37 2.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.354 -1.086 . . . . 3.11 109.14 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m95 -138.78 117.6 12.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.305 -0.872 . . . . 3.23 110.215 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.21 130.6 49.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.565 -0.71 . . . . 2.75 109.757 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 65.1 71.06 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.216 0.532 . . . . 3.26 111.129 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.13 -58.18 1.94 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.508 -0.923 . . . . 3.08 108.508 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.57 118.56 13.52 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.01 0.433 . . . . 3.23 110.343 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.5 132.77 56.18 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 3.31 109.194 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -65.7 -54.76 22.98 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.443 -0.786 . . . . 7.5 109.497 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mt -93.71 108.33 33.67 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.508 -0.923 . . . . 2.68 108.508 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 32.7 Cg_endo -72.53 -24.81 18.52 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.032 1.821 . . . . 3.42 110.326 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.22 76.08 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 3.77 109.657 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.4 -85.7 0.23 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -0.944 . . . . 3.7 108.925 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.22 84.49 1.27 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 107.226 -2.35 . . . . 2.38 107.226 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 14.2 m-20 -88.84 147.86 24.18 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.192 0.996 . . . . 5.12 112.95 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.83 128.61 34.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.537 -0.912 . . . . 3.72 108.537 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.46 53.58 12.68 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.597 -0.689 . . . . 4.88 109.723 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -138.64 44.83 2.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.816 . . . . 5.23 109.777 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER 53.71 34.51 19.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.662 -0.649 . . . . 4.31 109.992 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.96 -66.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.268 -0.895 . . . . 3.19 109.861 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.25 153.98 21.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.483 -0.761 . . . . 3.07 109.901 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.67 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 4.2 m-90 -152.56 160.85 43.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.645 . . . . 5.18 109.667 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.72 -41.51 21.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.75 . . . . 3.1 109.126 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -31.25 68.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.654 -0.654 . . . . 3.97 110.398 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -70.22 125.34 91.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.629 -0.67 . . . . 4.09 110.274 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -35.85 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.571 2.18 . . . . 3.57 110.402 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -72.14 -65.27 0.8 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.478 -0.764 . . . . 5.18 109.484 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 117.879 -1.058 . . . . 3.29 109.408 179.679 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HB3' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.397 0.618 . . . . 3.48 110.173 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -45.63 7.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.54 -0.725 . . . . 4.02 109.815 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.85 -48.84 11.85 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.638 -0.664 . . . . 2.49 109.882 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 1' ' ' MET . 54.8 m -111.81 108.5 17.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.526 -0.734 . . . . 1.41 109.452 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.46 158.18 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.234 -0.916 . . . . 1.35 109.478 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 17' ' ' VAL . 8.6 p -135.94 127.24 28.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 1.27 109.995 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 18' ' ' TRP . 79.1 t -95.95 120.36 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 1.19 109.016 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.6 133.18 34.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.687 -0.633 . . . . 1.98 109.608 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 t -69.19 118.86 65.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.266 -0.642 . . . . 1.39 109.266 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.4 -12.33 15.55 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.8 2.333 . . . . 1.53 111.509 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.8 m -83.74 -54.75 4.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -0.875 . . . . 1.53 110.217 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.71 -30.39 9.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.552 -0.717 . . . . 1.67 110.658 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.36 77.41 1.35 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.072 -1.611 . . . . 1.64 109.072 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -146.65 129.25 16.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.837 -0.802 . . . . 2.04 109.616 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -74.99 116.26 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.65 -0.656 . . . . 1.55 109.705 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.31 139.62 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.734 -0.839 . . . . 1.15 108.734 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -62.79 143.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.45 -0.781 . . . . 1.03 110.179 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.601 ' HB2' HG23 ' A' ' 7' ' ' VAL . 72.7 t-105 -125.27 149.71 47.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.813 -0.554 . . . . 1.23 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.43 -100.9 0.53 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.32 -1.512 . . . . 1.1 109.32 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 83.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.72 -0.871 . . . . 2.4 109.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 tt -156.18 -43.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.542 -0.724 . . . . 1.18 109.844 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.96 162.48 19.79 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.677 . . . . 1.22 109.726 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.67 -39.76 0.92 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.694 2.263 . . . . 1.42 110.384 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.27 65.04 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 1.64 109.184 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mtm105 -58.11 -51.12 84.13 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.543 -0.723 . . . . 1.53 109.962 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.24 126.96 8.85 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.291 1.994 . . . . 0.97 109.315 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 38.0 m-85 65.53 175.31 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.526 -0.546 . . . . 1.03 109.526 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 p -103.49 -28.81 11.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.141 -0.975 . . . . 1.26 110.582 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.59 162.14 39.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.266 -0.896 . . . . 1.85 110.443 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -40.06 96.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 1.54 109.668 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.551 HH21 HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.29 -44.79 94.07 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.735 -0.603 . . . . 3.14 109.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.44 -50.03 75.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 1.33 109.428 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 18.2 tt0 -63.81 -34.3 77.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.638 -0.664 . . . . 1.69 109.39 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 HH21 ' A' ' 31' ' ' ARG . 7.0 tp -65.7 -67.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.424 -0.584 . . . . 1.2 109.424 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -49.9 -28.78 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.576 -0.702 . . . . 1.4 110.62 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.52 -43.46 71.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.46 -0.775 . . . . 1.23 110.33 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -63.95 -59.71 4.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.472 -0.768 . . . . 1.21 108.971 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.57 20.49 8.11 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.582 -0.818 . . . . 1.19 111.081 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.89 45.96 2.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.288 -1.125 . . . . 1.34 109.137 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m95 -132.43 118.82 19.82 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.523 -0.735 . . . . 1.34 109.128 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.97 99.05 12.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 1.77 110.506 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.65 12.68 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.795 -0.817 . . . . 2.27 108.795 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 53.46 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.276 0.56 . . . . 3.02 110.521 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -24.59 14.9 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.198 -0.939 . . . . 5.34 111.031 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.91 129.61 51.45 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.197 -0.94 . . . . 5.37 111.645 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -88.99 176.92 6.8 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.609 -0.682 . . . . 4.26 109.322 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 27.4 mm 67.59 104.29 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.665 -0.647 . . . . 3.6 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 52' ' ' ASP . 32.8 Cg_endo -72.69 90.06 0.83 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.488 2.125 . . . . 2.78 110.008 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.8 p -150.64 -49.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.935 -0.478 . . . . 3.23 109.85 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.28 -59.54 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.555 -0.715 . . . . 4.25 110.724 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.19 -34.09 64.57 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.789 -0.924 . . . . 4.15 110.789 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 2.0 t70 -55.57 137.67 48.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.661 -0.905 . . . . 3.62 110.566 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.64 84.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.712 -0.847 . . . . 2.88 108.712 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.17 104.44 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.775 -0.824 . . . . 2.18 108.775 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 137.69 32.13 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.004 -0.739 . . . . 2.77 109.004 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.98 102.69 10.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 3.8 110.416 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.26 -45.58 19.48 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.663 -0.866 . . . . 2.41 108.663 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 58.54 -173.08 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.189 0.519 . . . . 4.12 110.778 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.535 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -91.28 118.18 30.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.455 -0.778 . . . . 4.46 109.697 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.82 90.28 4.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.722 -0.844 . . . . 3.27 108.722 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -42.25 82.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.659 -0.651 . . . . 3.92 109.806 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.89 129.61 43.61 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.652 -0.655 . . . . 6.43 109.744 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.65 126.83 6.86 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.732 2.288 . . . . 4.43 109.598 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.4 122.79 47.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 5.6 110.29 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.383 -0.818 . . . . 5.08 109.185 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.268 -0.642 . . . . 5.21 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.05 89.77 3.2 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.51 0.671 . . . . 5.29 111.369 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -94.56 -32.8 13.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.594 -1.632 . . . . 2.91 106.594 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.545 HG21 HD13 ' A' ' 21' ' ' ILE . 32.5 m -106.62 117.87 35.18 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.504 -0.924 . . . . 1.77 108.504 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 18' ' ' TRP . 5.3 pt -88.43 155.43 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.51 -0.744 . . . . 1.9 110.004 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 17' ' ' VAL . 46.4 p -121.83 126.33 48.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 1.07 110.164 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.26 135.67 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.931 -0.766 . . . . 1.3 108.931 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -91.33 133.05 35.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 1.39 109.97 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' O ' ' HA2' ' A' ' 13' ' ' GLY . 8.7 t -64.69 121.52 73.69 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.196 -0.668 . . . . 1.4 109.196 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.05 -11.28 16.44 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.66 2.24 . . . . 1.88 111.881 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.9 m -88.71 -54.82 3.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.227 -0.92 . . . . 1.78 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 p -103.09 -31.05 10.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.526 -0.734 . . . . 1.62 110.278 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 9' ' ' CYS . . . 95.37 75.14 1.26 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.845 -1.302 . . . . 1.45 109.845 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -143.85 137.81 28.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.56 -0.965 . . . . 2.91 110.656 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.2 m -72.59 112.43 8.64 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.215 0.531 . . . . 0.94 110.571 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.69 131.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.486 -0.931 . . . . 0.84 108.486 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.68 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -56.18 140.98 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 0.76 110.6 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.541 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.0 t-105 -122.15 151.44 40.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.695 -0.628 . . . . 1.34 109.542 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.29 -98.43 0.55 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.375 -1.49 . . . . 1.06 109.375 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.5 52.74 0.37 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.902 . . . . 1.32 109.727 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.545 HD13 HG21 ' A' ' 4' ' ' THR . 3.4 mt -118.11 -55.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 1.04 109.434 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.3 163.66 22.5 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.76 -0.588 . . . . 1.0 109.664 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.18 -38.14 1.24 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.538 2.158 . . . . 1.3 110.528 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.31 66.58 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.122 -0.696 . . . . 1.31 109.122 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.5 mtm180 -56.51 -51.26 82.54 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.574 -0.704 . . . . 2.2 110.188 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -76.69 127.13 9.36 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 122.179 1.919 . . . . 1.19 109.53 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 71.3 m-85 65.71 172.64 0.22 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.35 0.595 . . . . 1.44 109.636 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.28 -29.69 12.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.256 -0.902 . . . . 1.26 110.247 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.1 p -145.42 162.99 35.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.321 -0.862 . . . . 1.46 110.427 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -34.94 77.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.311 -0.626 . . . . 1.7 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -47.08 84.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.797 -0.564 . . . . 3.25 109.855 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.74 -47.24 85.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.753 -0.592 . . . . 1.62 109.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -64.23 -34.88 79.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.606 -0.684 . . . . 1.75 109.183 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 10.4 tp -63.56 -67.2 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.161 -0.681 . . . . 2.12 109.161 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.15 -30.25 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.707 -0.621 . . . . 1.93 110.717 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.06 -42.6 65.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 1.83 110.199 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -64.51 -58.95 4.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.53 -0.732 . . . . 2.45 109.095 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 23.58 6.43 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.584 -0.817 . . . . 2.5 111.133 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.07 44.54 2.64 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.299 -1.118 . . . . 2.63 109.091 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 9.9 m95 -136.26 145.64 45.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.591 -0.693 . . . . 2.56 109.447 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.45 25.75 11.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.535 -0.728 . . . . 2.92 110.455 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.97 -53.05 3.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -0.909 . . . . 2.61 108.745 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 1.2 mp0 53.18 61.54 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.376 0.608 . . . . 2.15 110.599 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 129.86 35.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.268 -0.895 . . . . 2.98 109.145 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -147.93 89.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.653 -0.655 . . . . 5.15 110.463 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 63.65 34.0 12.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.871 -0.518 . . . . 3.67 112.384 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mt -93.39 112.73 57.77 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.036 -1.098 . . . . 3.36 108.036 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 36.0 Cg_endo -77.26 -53.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.473 2.115 . . . . 3.16 111.028 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -120.57 110.09 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.508 -0.745 . . . . 2.52 109.919 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 -42.95 8.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.68 -0.637 . . . . 3.19 109.402 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.69 85.2 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.381 -1.488 . . . . 2.75 109.381 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.78 159.0 16.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.745 -0.856 . . . . 2.87 109.947 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD22 ' OD1' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -80.37 118.21 21.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.674 -0.641 . . . . 3.79 109.774 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -38.61 85.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.681 -0.489 . . . . 4.35 109.681 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.03 164.42 25.6 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.491 -0.755 . . . . 5.41 110.274 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.83 111.4 2.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.883 -0.784 . . . . 3.4 108.883 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 53' ' ' LEU . 2.6 t70 -123.21 138.93 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.66 -0.65 . . . . 4.04 109.915 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.5 118.55 10.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.7 -0.852 . . . . 4.57 108.7 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 60.84 81.72 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.472 0.654 . . . . 2.84 109.433 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -65.36 131.47 46.55 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 2.67 108.026 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.76 101.6 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.527 -0.733 . . . . 3.06 109.164 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER 52.07 76.43 0.54 Allowed Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.527 -0.545 . . . . 2.42 109.527 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 60' ' ' SER . 34.4 Cg_endo -74.69 81.13 2.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.967 2.445 . . . . 3.35 109.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.79 143.69 30.78 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.555 0.693 . . . . 3.99 110.524 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.719 -1.134 . . . . 6.48 108.907 179.057 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.485 -0.561 . . . . 4.46 109.485 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.19 36.13 26.91 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.127 -0.694 . . . . 2.26 109.127 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -56.67 3.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 3.02 110.038 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 m 64.83 108.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.306 -0.627 . . . . 1.32 109.306 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.95 159.22 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.465 -0.772 . . . . 1.62 109.264 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 17' ' ' VAL . 7.0 p -137.48 126.51 24.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.56 -0.712 . . . . 1.3 109.866 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 58.8 t -96.62 124.45 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.01 -0.737 . . . . 1.16 109.01 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -86.45 134.02 33.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.605 -0.684 . . . . 2.05 109.868 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -68.87 120.35 75.56 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.172 -0.677 . . . . 1.2 109.172 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.74 -11.99 16.67 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.707 2.271 . . . . 1.35 111.734 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -85.64 -52.19 5.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.205 -0.935 . . . . 1.36 110.229 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.2 p -107.32 -29.58 9.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.507 -0.746 . . . . 1.6 110.954 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 78.17 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.657 -1.777 . . . . 1.64 108.657 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 134.12 24.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.834 -0.803 . . . . 2.17 109.882 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -78.61 110.8 14.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.444 -0.785 . . . . 1.54 109.239 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.96 135.49 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.8 p -63.71 138.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.423 -0.798 . . . . 1.32 110.005 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -111.26 153.45 25.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.748 -0.595 . . . . 1.44 109.49 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.41 -108.13 1.47 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.486 -1.446 . . . . 1.56 109.486 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.75 52.56 0.87 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.877 . . . . 2.56 109.485 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' CG2' ' A' ' 17' ' ' VAL . 2.8 mp -115.93 -51.23 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.499 -0.751 . . . . 1.86 109.505 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 84.2 p -94.57 162.67 25.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.733 -0.604 . . . . 1.76 109.899 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -76.28 -29.93 5.86 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.559 2.172 . . . . 2.21 110.334 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.0 72.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.72 -0.844 . . . . 1.73 108.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -54.32 -55.16 40.07 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.644 -0.66 . . . . 2.58 110.227 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.0 126.64 8.82 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 122.286 1.99 . . . . 1.5 109.75 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 42.9 m-85 65.56 172.45 0.22 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.282 0.563 . . . . 1.35 109.771 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -98.43 -31.63 11.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.352 -0.842 . . . . 1.62 110.333 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.49 164.34 30.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 1.94 110.283 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -40.77 92.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.656 -0.653 . . . . 1.95 109.655 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -61.52 -42.18 98.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.757 -0.589 . . . . 2.02 109.683 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.66 -49.21 78.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.546 -0.721 . . . . 1.39 109.336 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -63.5 -32.85 74.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.371 -0.603 . . . . 1.77 109.371 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.0 tp -64.74 -67.43 0.44 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 1.71 109.437 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.24 -30.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.675 -0.64 . . . . 1.34 110.408 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.13 -41.62 68.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.751 . . . . 1.35 110.236 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -65.15 -59.16 4.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.462 -0.774 . . . . 1.77 109.142 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.85 25.61 5.86 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.584 -0.817 . . . . 1.61 111.149 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.25 43.48 3.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.267 -1.137 . . . . 1.92 109.112 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.6 m95 -137.49 -47.72 0.57 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.575 -0.703 . . . . 1.85 109.863 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 59.5 59.65 2.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.315 0.579 . . . . 1.99 110.261 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.82 -61.44 1.97 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 1.77 108.613 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.14 113.07 24.95 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.507 -1.294 . . . . 3.02 107.507 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 140.57 50.78 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.47 -0.769 . . . . 3.44 111.312 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -66.25 0.57 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.814 -0.81 . . . . 4.71 108.814 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.27 37.75 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.17 -0.678 . . . . 5.58 109.17 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.445 HG13 ' HB3' ' A' ' 55' ' ' GLU . 1.5 pt -119.39 149.33 47.41 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.381 -0.824 . . . . 2.5 110.332 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.48 122.83 6.69 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.025 2.484 . . . . 3.69 111.007 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -75.07 81.49 2.25 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.081 -0.711 . . . . 3.99 109.081 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.37 47.2 2.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.863 -0.791 . . . . 4.92 108.863 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.34 16.58 26.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.044 -1.222 . . . . 4.26 110.044 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -133.97 33.07 3.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -1.01 . . . . 3.47 109.543 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 74.3 150.89 0.11 Allowed 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.499 0.666 . . . . 4.61 110.518 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.16 129.71 42.17 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.805 -0.559 . . . . 2.36 110.193 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' HB3' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -72.01 147.94 46.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.666 -0.646 . . . . 3.5 110.298 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.48 78.56 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.611 -0.68 . . . . 2.95 110.013 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.09 118.87 20.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.818 . . . . 3.04 109.25 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 57.25 39.65 28.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.267 -0.642 . . . . 4.6 109.267 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.563 ' NE1' ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -139.39 131.68 28.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.71 . . . . 5.19 109.41 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -132.08 -52.45 0.97 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.099 -0.704 . . . . 2.78 109.099 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -58.57 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.374 -0.972 . . . . 3.37 108.374 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -146.3 110.03 4.27 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.69 -0.856 . . . . 3.77 108.69 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.563 ' HG3' ' NE1' ' A' ' 59' ' ' TRP . 37.7 Cg_endo -79.21 -30.06 2.84 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.813 2.342 . . . . 4.01 111.494 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 -57.4 2.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.489 -0.757 . . . . 5.04 111.013 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 117.702 -1.142 . . . . 4.63 110.337 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' N ' ' HA ' ' A' ' 5' ' ' ILE . 1.4 mtp . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.09 -0.707 . . . . 4.91 109.09 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 73.41 -70.52 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 109.556 -0.535 . . . . 2.74 109.556 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 4' ' ' THR . 1.1 mp0 -120.09 98.36 6.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.668 -0.864 . . . . 3.98 108.668 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 96.8 m 71.91 132.14 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.294 0.569 . . . . 1.62 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.707 HD12 ' HD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -89.74 158.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 121.44 -0.788 . . . . 2.01 109.442 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -132.2 122.48 25.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.628 -0.67 . . . . 1.32 109.827 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.34 136.68 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.166 -0.679 . . . . 1.09 109.166 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.05 135.42 34.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 1.96 109.681 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.2 t -68.14 117.96 54.18 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.739 -0.601 . . . . 1.21 109.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 36.7 Cg_endo -80.64 19.42 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.927 2.418 . . . . 1.9 112.007 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.6 m -122.16 -48.31 2.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 1.11 109.366 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 -25.84 10.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.692 -0.63 . . . . 1.18 110.35 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.81 75.02 1.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.599 -1.8 . . . . 1.36 108.599 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -144.31 137.63 27.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.801 -0.823 . . . . 2.19 109.838 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -81.29 115.02 20.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.448 -0.783 . . . . 1.5 109.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.2 t -115.3 137.16 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.7 p -61.78 141.09 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.491 -0.756 . . . . 1.0 110.07 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.707 ' HD1' HD12 ' A' ' 5' ' ' ILE . 75.7 t-105 -124.88 150.98 45.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.854 -0.529 . . . . 1.44 109.783 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.27 -98.77 0.53 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.347 -1.501 . . . . 1.1 109.347 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.68 92.84 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.752 -0.852 . . . . 1.74 109.202 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -165.64 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.689 -0.632 . . . . 1.37 109.842 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.52 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 88.5 p -102.65 160.59 25.82 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.658 -0.652 . . . . 0.98 109.818 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.6 Cg_endo -75.27 -31.58 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.592 2.195 . . . . 1.29 110.355 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.87 64.46 0.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.679 . . . . 1.84 109.344 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 29.3 mtm180 -60.12 -53.02 69.13 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.488 -0.757 . . . . 1.44 109.661 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.68 125.63 7.63 Favored 'Trans proline' 0 C--N 1.324 -0.717 0 C-N-CA 122.285 1.99 . . . . 1.01 109.398 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 63.9 m-85 65.61 165.98 0.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.396 0.617 . . . . 1.24 109.734 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.2 p -95.5 -27.98 15.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.83 110.508 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.12 157.07 44.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.278 -0.889 . . . . 1.39 110.513 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -36.1 78.11 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.241 -0.652 . . . . 2.15 109.241 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -48.53 68.97 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 3.67 109.681 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.72 -43.87 65.96 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.551 -0.718 . . . . 0.79 109.812 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.94 -34.57 78.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.687 . . . . 1.94 109.289 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 11.5 tp -62.32 -66.64 0.51 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.893 -0.78 . . . . 1.19 108.893 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.451 HD13 ' CG ' ' A' ' 44' ' ' GLU . 3.0 mt -52.39 -27.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.55 -0.719 . . . . 1.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 16.5 t70 -54.76 -45.7 74.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.435 -0.791 . . . . 1.47 109.472 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 15.6 mt -62.97 -58.66 6.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.466 -0.938 . . . . 1.47 108.466 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' HG ' ' A' ' 54' ' ' SER . . . 111.97 19.48 7.24 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 120.6 -0.81 . . . . 1.05 111.913 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.22 33.64 4.97 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.716 1.258 . . . . 1.76 109.113 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -143.71 -59.51 0.4 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.999 -0.741 . . . . 1.25 108.999 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.66 149.99 33.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.235 0.54 . . . . 0.95 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.77 -37.85 48.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.633 -0.667 . . . . 1.62 110.034 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.23 169.32 13.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.601 -0.687 . . . . 1.82 110.546 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' CG ' HD13 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -97.61 150.3 21.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.371 -0.603 . . . . 2.47 109.371 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -60.78 -56.19 24.16 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.42 -0.8 . . . . 3.57 109.793 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -58.27 -60.98 2.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 3.29 109.534 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 109.29 53.23 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.582 -0.525 . . . . 2.53 109.582 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.41 77.31 3.3 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.253 1.969 . . . . 1.96 109.562 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.9 96.13 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 2.71 109.7 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.2 p -87.05 129.98 34.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.992 -0.744 . . . . 2.81 108.992 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.97 64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.271 -1.531 . . . . 2.55 109.271 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -126.51 110.7 13.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.829 -0.807 . . . . 2.23 109.097 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.76 79.56 1.26 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.655 . . . . 3.54 109.827 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.45 ' HG ' ' HA3' ' A' ' 38' ' ' GLY . 20.9 p -148.5 126.07 11.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.543 -0.723 . . . . 1.98 109.299 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.53 -35.78 10.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.55 -0.719 . . . . 2.22 110.361 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.86 93.1 1.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.177 -0.952 . . . . 1.9 109.846 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.63 67.58 0.98 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.592 0.711 . . . . 2.67 110.052 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -118.43 -46.55 2.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.64 -0.662 . . . . 2.59 109.299 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.506 ' HZ3' ' HA ' ' A' ' 64' ' ' LYS . 6.8 m0 -88.99 121.62 31.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.614 -0.679 . . . . 3.02 109.316 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 -50.71 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.58 -0.7 . . . . 1.93 110.933 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.6 42.83 2.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.263 -0.898 . . . . 3.4 110.667 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -136.71 141.44 35.25 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.184 -0.947 . . . . 2.73 109.95 179.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 34.7 Cg_endo -76.88 153.99 33.5 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 122.684 2.256 . . . . 2.24 111.483 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -71.98 126.08 28.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.737 -0.602 . . . . 2.83 109.767 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 12.6 mt-30 . . . . . 0 N--CA 1.505 2.278 0 CA-C-O 117.73 -1.128 . . . . 4.01 110.507 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.795 -0.446 . . . . 2.89 109.795 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 p -67.44 -46.52 72.88 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.156 -0.683 . . . . 2.5 109.156 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 128.39 36.69 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.652 -0.87 . . . . 2.08 108.652 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -82.65 90.31 6.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 1.74 109.651 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.6 pt -90.96 162.36 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 17' ' ' VAL . 32.0 p -121.51 127.87 51.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.465 -0.772 . . . . 1.22 109.982 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.32 136.1 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.085 -0.709 . . . . 1.12 109.085 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.25 136.96 32.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 1.35 110.156 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.45 122.04 84.27 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.084 -0.71 . . . . 1.06 109.084 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.84 -5.06 15.06 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.723 2.282 . . . . 1.32 111.862 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -94.82 -52.04 4.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.253 -0.904 . . . . 1.22 109.931 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.0 p -107.14 -31.66 8.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.498 -0.751 . . . . 1.36 110.764 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.2 68.97 0.94 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.909 -1.676 . . . . 1.47 108.909 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 131.36 40.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.884 -0.774 . . . . 3.12 109.737 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -76.08 104.34 6.56 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.56 -0.712 . . . . 1.34 109.248 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.34 129.49 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.133 -0.691 . . . . 1.09 109.133 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.5 p -64.27 135.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.637 -0.664 . . . . 1.31 110.258 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 60.6 t-105 -109.92 153.14 24.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.75 -0.594 . . . . 1.08 109.435 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.03 -165.69 12.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.761 -1.335 . . . . 1.31 109.761 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.7 92.65 9.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.456 -1.026 . . . . 2.57 109.439 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 tt -165.48 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.751 -0.593 . . . . 1.61 109.961 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.52 158.6 46.64 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.55 -0.719 . . . . 1.52 109.814 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.49 -36.67 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.768 2.312 . . . . 1.59 110.619 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.77 68.59 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.572 -0.705 . . . . 1.12 109.244 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.728 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -58.52 -51.59 80.72 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.559 -0.713 . . . . 1.78 110.148 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -77.55 125.86 7.88 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.205 1.936 . . . . 0.74 109.626 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 61.9 m-85 65.55 172.31 0.22 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.34 0.59 . . . . 0.86 109.824 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.35 -32.72 11.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.248 -0.908 . . . . 1.06 110.092 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 p -140.49 163.35 33.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 1.04 110.239 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -31.79 72.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.665 -0.647 . . . . 1.52 110.276 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -34.94 72.05 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.399 -0.813 . . . . 2.29 109.655 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.57 -47.37 76.01 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.603 -0.888 . . . . 1.03 108.603 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -64.88 -33.64 76.49 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.979 -0.748 . . . . 1.23 108.979 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 8.1 tp -65.33 -67.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.213 -0.662 . . . . 0.93 109.213 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.66 -29.48 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.645 -0.659 . . . . 1.02 110.506 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -54.87 -42.43 72.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.415 -0.803 . . . . 1.03 110.208 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -64.52 -59.57 4.15 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.19 24.92 6.04 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.982 -0.847 . . . . 1.19 110.982 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -125.58 44.18 2.89 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.381 -1.07 . . . . 1.55 109.09 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 11.9 m95 -135.53 123.37 22.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.443 -0.785 . . . . 1.19 109.471 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.87 -43.72 10.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.66 -0.65 . . . . 1.67 109.732 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.6 54.75 10.47 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.694 0.759 . . . . 2.17 109.153 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.97 102.77 4.92 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.723 -0.843 . . . . 3.04 108.723 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.22 -40.49 9.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.505 -0.747 . . . . 3.99 110.963 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -131.59 137.86 48.6 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.272 -0.892 . . . . 6.39 110.333 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.49 103.16 15.07 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.337 -0.852 . . . . 4.07 109.673 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.38 118.9 72.93 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 3.13 108.341 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -71.42 113.49 3.63 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.294 1.996 . . . . 2.86 109.964 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.0 141.89 28.01 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.283 0.563 . . . . 3.08 110.475 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.24 128.6 35.15 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.018 -0.734 . . . . 2.04 109.018 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.49 64.21 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.988 -1.245 . . . . 2.42 109.988 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.34 124.18 50.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.554 -0.968 . . . . 3.03 109.507 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.7 160.5 40.19 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.674 -0.641 . . . . 2.27 109.56 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.91 115.48 27.98 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.429 -0.795 . . . . 2.31 109.84 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.03 -60.72 1.73 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.657 -0.652 . . . . 3.75 109.467 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.15 114.03 25.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.643 -0.661 . . . . 2.92 109.664 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -124.89 117.95 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.635 . . . . 2.5 109.284 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 133.22 42.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.648 . . . . 2.8 109.734 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -109.7 124.11 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.653 . . . . 3.97 109.311 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.5 m -120.07 83.02 1.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.44 109.773 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -55.37 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.727 . . . . 1.96 109.356 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 55.53 79.05 0.35 Allowed Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.794 -0.566 . . . . 1.82 109.876 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.11 114.36 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.775 2.317 . . . . 1.47 110.74 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 1.7 mppt? -92.72 -51.92 4.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.623 -0.673 . . . . 2.88 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.329 -0.843 . . . . 2.78 109.718 179.809 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.839 -0.43 . . . . 2.67 109.839 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -96.58 129.69 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 2.48 109.837 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.68 114.91 27.73 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.337 -0.616 . . . . 2.02 109.337 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -93.8 122.49 36.32 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.449 -0.782 . . . . 1.5 109.489 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -90.97 161.07 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 1.09 109.282 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 17' ' ' VAL . 4.1 p -138.43 124.14 19.78 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 1.21 109.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 18' ' ' TRP . 78.3 t -97.73 124.44 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.158 -0.682 . . . . 0.73 109.158 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.5 136.17 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.394 -0.816 . . . . 1.45 109.94 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.31 122.69 87.14 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.355 -0.609 . . . . 1.12 109.355 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -8.78 16.56 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.698 2.265 . . . . 1.39 111.621 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 m -88.93 -55.87 3.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.282 -0.887 . . . . 1.41 109.8 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.81 -27.12 13.19 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.485 -0.759 . . . . 1.8 110.653 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 73.23 1.27 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.944 -1.662 . . . . 1.9 108.944 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -140.86 135.29 31.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.76 -0.847 . . . . 3.07 109.687 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 109.55 10.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.604 -0.685 . . . . 1.66 109.933 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.93 129.17 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 1.24 108.732 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.683 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.3 p -58.1 135.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 1.58 110.448 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.634 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.2 t-105 -107.64 154.14 21.88 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.404 -0.591 . . . . 1.46 109.404 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.91 -167.88 13.62 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.72 -1.352 . . . . 1.44 109.72 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.79 97.94 10.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -1.081 . . . . 2.8 109.591 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 22' ' ' SER . 5.5 tt -169.35 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 2.65 110.318 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 75.7 p -107.47 159.85 28.74 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.512 -0.742 . . . . 2.48 110.125 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 35.6 Cg_endo -77.52 -32.35 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.784 2.323 . . . . 3.0 110.41 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.92 71.71 0.8 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.143 -0.688 . . . . 2.2 109.143 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.675 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -58.01 -54.29 57.04 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.541 -0.724 . . . . 3.51 109.983 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.675 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.07 124.89 8.24 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 122.263 1.976 . . . . 1.38 108.898 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.9 m-85 65.72 175.43 0.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.059 -0.719 . . . . 1.12 109.059 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 p -102.31 -32.86 9.83 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.986 -1.072 . . . . 1.89 110.265 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.39 165.84 26.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 2.43 110.274 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -62.74 -40.57 97.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.706 -0.621 . . . . 2.0 109.908 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -62.2 -39.9 94.29 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.7 -0.625 . . . . 1.47 110.075 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.52 -48.41 79.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 1.79 109.438 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.08 -33.78 76.84 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.931 -0.766 . . . . 1.61 108.931 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.1 tp -65.13 -66.3 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.083 -0.71 . . . . 1.24 109.083 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.4 mt -49.88 -29.36 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.79 -0.569 . . . . 1.23 110.563 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -54.12 -42.93 70.03 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.494 -0.754 . . . . 0.89 110.106 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 3.2 mt -66.0 -58.77 4.76 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.808 -0.812 . . . . 1.31 108.808 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.33 25.71 5.43 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 111.03 -0.828 . . . . 0.98 111.03 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -123.8 38.0 4.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.377 -1.072 . . . . 1.4 109.383 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 3.5 m95 -138.2 169.23 18.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.508 -0.745 . . . . 1.21 109.916 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.98 88.79 5.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.54 -0.725 . . . . 1.82 109.286 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.17 8.54 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.498 -0.751 . . . . 2.32 109.717 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.72 120.73 19.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.13 -0.693 . . . . 2.48 109.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.19 -40.13 12.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.734 -0.604 . . . . 2.74 110.202 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 148.82 51.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.627 -0.671 . . . . 5.63 109.501 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 61.08 0.61 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.5 -0.75 . . . . 3.26 109.136 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.57 111.77 34.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.204 -0.935 . . . . 4.01 110.902 -178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.61 82.68 2.34 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.754 2.303 . . . . 4.53 110.852 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 p -172.68 -52.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.421 -0.955 . . . . 3.76 108.421 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -142.12 92.28 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.626 -0.879 . . . . 2.66 108.626 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.34 65.39 0.78 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.255 -1.538 . . . . 2.91 109.255 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -107.28 121.71 45.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.965 -0.727 . . . . 3.39 109.685 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.53 62.31 0.92 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 3.81 109.882 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.98 -41.9 3.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.476 -0.765 . . . . 3.68 109.101 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.47 115.88 21.01 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.393 -0.595 . . . . 3.72 109.393 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.12 -57.26 2.06 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.634 -0.666 . . . . 3.62 109.945 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -118.89 121.65 40.48 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.595 -0.691 . . . . 3.12 110.26 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 124.47 25.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.486 -0.561 . . . . 4.59 109.486 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.06 116.38 30.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.711 -0.618 . . . . 3.03 109.389 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.4 p -94.32 -10.34 33.03 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.566 -0.709 . . . . 3.84 110.892 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.62 170.93 8.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 3.3 110.274 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 1.7 mm-40 -103.18 118.4 58.02 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.257 -0.646 . . . . 4.52 109.257 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.63 120.69 6.85 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.403 2.069 . . . . 2.93 109.793 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.3 mttt 65.99 43.83 2.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.632 0.729 . . . . 3.64 109.214 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.336 -0.84 . . . . 3.92 109.586 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.846 -0.427 . . . . 3.03 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 57.1 83.18 0.11 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.166 -0.679 . . . . 2.51 109.166 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 68.84 104.05 0.06 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.804 -0.813 . . . . 2.65 108.804 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 58.65 1.76 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.357 -0.839 . . . . 2.28 109.849 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.62 147.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.352 -0.843 . . . . 2.45 109.077 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 p -102.85 125.15 49.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 1.88 110.469 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.98 139.79 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.197 -0.668 . . . . 1.76 109.197 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -88.27 135.76 33.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.265 -0.897 . . . . 2.16 110.412 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.36 120.28 73.86 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.053 -0.721 . . . . 1.25 109.053 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.03 3.02 7.38 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 122.832 2.355 . . . . 1.65 112.038 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.3 m -104.49 -50.9 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.118 -0.989 . . . . 1.21 109.847 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -107.97 -25.51 11.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.605 -0.684 . . . . 1.2 110.763 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.95 80.39 1.39 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.55 -1.82 . . . . 1.47 108.55 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -150.06 137.15 19.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.757 -0.849 . . . . 2.98 109.725 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -77.65 108.5 10.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.343 -0.848 . . . . 1.9 109.567 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -108.83 128.87 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.962 -0.755 . . . . 1.21 108.962 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.89 133.28 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.461 0.648 . . . . 1.33 110.214 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 28.5 t-105 -118.65 153.86 33.63 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.426 -0.583 . . . . 2.19 109.426 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 25' ' ' ARG . . . 122.6 -125.17 5.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.986 -1.245 . . . . 1.88 109.986 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.48 87.07 2.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.977 . . . . 2.35 109.049 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -166.19 -45.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.509 -0.744 . . . . 1.3 110.462 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -111.17 159.97 30.81 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.521 -0.737 . . . . 1.18 110.041 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.73 -32.07 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 122.824 2.349 . . . . 1.63 110.857 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.15 68.58 0.67 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.581 -0.699 . . . . 2.38 109.579 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.739 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 2.3 mtt180 -63.75 -50.31 71.91 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.307 -0.871 . . . . 3.07 110.227 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.77 119.16 4.69 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 122.194 1.93 . . . . 1.6 109.944 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 66.0 m-85 66.02 161.4 0.14 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.374 0.607 . . . . 1.71 110.019 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.54 -32.05 22.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.348 -0.845 . . . . 1.32 110.29 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -140.16 168.49 19.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.48 -0.763 . . . . 1.64 110.18 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -38.25 77.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.669 -0.645 . . . . 4.4 109.631 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.42 98.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.829 -0.544 . . . . 2.83 110.122 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.67 -51.29 70.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.571 -0.706 . . . . 1.6 109.414 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 19.2 tt0 -60.48 -34.99 74.83 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.156 -0.683 . . . . 2.91 109.156 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 34' ' ' LEU . 6.8 tp -63.44 -67.26 0.44 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.277 -0.638 . . . . 2.5 109.277 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.5 mt -49.43 -29.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.66 -0.65 . . . . 1.9 110.466 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -53.34 -45.25 69.02 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.52 -0.737 . . . . 2.0 110.374 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mt -63.58 -59.91 4.02 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.868 . . . . 2.83 108.655 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.21 22.47 6.49 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 120.575 -0.821 . . . . 2.64 111.107 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.23 40.73 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -1.149 . . . . 3.1 109.248 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 7.5 m95 -134.89 113.68 11.79 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.504 -0.748 . . . . 3.02 109.445 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.29 -175.07 2.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 3.2 109.657 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.46 69.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.56 -0.713 . . . . 2.96 109.31 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.11 161.52 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.267 0.555 . . . . 2.24 109.865 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.14 -69.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 2.27 109.714 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.25 96.12 2.73 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.257 -1.016 . . . . 4.78 108.257 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 66.09 158.67 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.148 -1.056 . . . . 4.58 108.148 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.549 HG12 ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -114.41 112.28 46.3 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.81 -1.181 . . . . 3.55 109.394 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.37 -33.75 5.24 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.709 2.273 . . . . 4.51 109.941 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.2 p -74.14 123.97 25.45 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.362 -0.977 . . . . 3.8 108.362 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.57 139.42 17.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.255 -0.903 . . . . 2.45 109.83 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.57 -126.13 5.8 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.031 -1.628 . . . . 1.91 109.031 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 47.1 -131.18 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.075 -0.662 . . . . 2.55 109.292 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.99 113.22 14.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.991 -1.068 . . . . 2.22 108.916 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.36 46.79 20.3 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.759 0.79 . . . . 2.9 109.09 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.66 136.19 50.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 2.75 109.388 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.549 ' OG ' HG12 ' A' ' 47' ' ' ILE . 2.4 m 62.85 80.34 0.23 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.368 0.604 . . . . 3.49 110.221 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.93 90.28 8.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.884 -0.784 . . . . 4.76 108.884 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -45.74 1.63 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.65 -0.656 . . . . 4.7 110.213 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.8 121.66 2.52 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 3.76 110.541 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.88 81.42 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.276 0.56 . . . . 4.63 111.281 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 1.9 mp0 -101.41 -59.8 1.64 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.431 -0.951 . . . . 4.11 108.431 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.2 mt-10 68.44 160.45 0.14 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.775 -0.578 . . . . 5.84 110.541 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.25 -7.78 15.13 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.071 2.514 . . . . 4.55 111.569 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -33.74 20.31 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.353 -0.842 . . . . 5.33 110.744 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 CA-C-O 117.813 -1.089 . . . . 7.63 110.068 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.191 0.519 . . . . 2.94 109.708 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.85 129.5 36.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.933 -0.48 . . . . 1.75 110.044 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.84 100.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.439 0.638 . . . . 3.89 110.063 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -85.54 106.97 17.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.571 -0.706 . . . . 1.98 109.539 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.1 pt -80.84 168.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 1.69 109.472 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -115.55 125.29 52.81 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 1.59 110.112 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.86 120.83 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.958 -0.756 . . . . 1.13 108.958 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.88 131.28 34.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.555 -0.715 . . . . 1.86 109.723 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.83 119.4 60.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.153 -0.684 . . . . 0.79 109.153 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.83 -7.86 16.63 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.769 2.312 . . . . 0.9 111.784 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.5 m -91.88 -50.82 5.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.18 -0.95 . . . . 1.11 110.068 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.0 p -108.72 -32.1 7.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 1.14 110.873 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.48 73.37 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.24 -1.544 . . . . 1.13 109.24 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 130.67 26.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.769 -0.842 . . . . 1.9 109.571 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -76.73 112.85 13.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.644 -0.66 . . . . 1.33 109.634 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.6 127.07 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.821 -0.807 . . . . 1.26 108.821 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.66 139.38 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -0.784 . . . . 1.74 110.429 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.518 ' HB3' HG13 ' A' ' 5' ' ' ILE . 66.3 t-105 -108.23 151.6 25.72 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.2 -0.667 . . . . 1.53 109.2 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 138.3 -119.21 1.75 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.002 -1.239 . . . . 1.35 110.002 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.1 32.25 1.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.92 -0.753 . . . . 2.77 109.162 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 tt -109.34 -34.23 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 2.4 110.042 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.6 153.66 39.04 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 2.08 109.974 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.29 -40.74 0.57 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.642 2.228 . . . . 2.02 110.005 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.57 68.21 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.694 -0.854 . . . . 1.53 108.694 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.651 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 22.9 mtm180 -59.34 -48.88 95.13 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.553 -0.717 . . . . 2.17 110.408 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.0 Cg_endo -76.18 118.83 5.1 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.992 1.795 . . . . 1.12 109.105 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 39.2 m-85 67.99 163.93 0.22 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.344 -0.613 . . . . 1.01 109.344 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -86.42 -31.45 21.42 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.195 -0.941 . . . . 1.44 110.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.68 157.35 43.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.431 -0.793 . . . . 2.02 109.876 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -63.7 -29.4 70.63 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.577 -0.702 . . . . 2.3 109.713 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -42.94 79.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 2.86 109.204 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.34 -46.79 88.79 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.005 -0.739 . . . . 1.32 109.005 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -61.75 -36.02 79.78 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.694 -0.854 . . . . 1.47 108.694 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 2.9 tp -61.96 -65.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.872 -0.788 . . . . 1.76 108.872 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.54 -33.24 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.693 -0.629 . . . . 1.9 110.156 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.38 -45.34 72.81 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.602 -0.686 . . . . 1.47 109.766 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.5 mt -62.04 -58.86 6.25 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.959 -0.756 . . . . 1.94 108.959 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.22 33.2 4.34 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.0 -1.24 . . . . 2.46 110.0 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.43 40.02 3.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.763 -0.845 . . . . 4.59 108.836 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 8.0 m95 -137.45 127.35 25.68 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.89 . . . . 2.62 110.546 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.56 -52.59 1.17 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.279 -0.638 . . . . 3.04 109.279 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.77 82.31 1.72 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 2.85 110.077 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -80.33 -69.92 0.56 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.966 -1.124 . . . . 2.52 107.966 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -78.16 120.78 23.45 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.055 -1.091 . . . . 2.96 108.055 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -103.87 128.45 51.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.199 -0.938 . . . . 4.97 111.503 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -49.58 2.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.265 -1.013 . . . . 3.87 108.265 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pt -76.08 147.87 80.64 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.893 -0.504 . . . . 2.21 109.644 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.67 -48.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.848 2.365 . . . . 2.19 110.956 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.16 -53.63 0.85 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.635 -0.665 . . . . 2.66 109.699 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.91 146.63 49.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.623 -0.673 . . . . 2.21 109.372 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.66 69.28 2.74 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.577 -1.009 . . . . 2.42 110.577 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 53' ' ' LEU . 6.3 m-20 -91.9 -142.18 0.19 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.767 -0.827 . . . . 3.32 108.767 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' H ' ' HB3' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -70.63 164.62 24.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.061 -1.024 . . . . 3.06 109.602 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.15 73.74 1.24 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.247 -1.02 . . . . 5.17 108.247 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.45 79.61 1.48 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.644 -0.66 . . . . 4.08 111.258 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 63.97 5.71 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.101 -0.999 . . . . 6.31 108.556 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.05 -49.16 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.738 -0.601 . . . . 6.86 109.458 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -127.21 154.58 44.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.266 -0.896 . . . . 4.88 109.893 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -67.14 -43.39 82.46 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.429 -0.795 . . . . 4.08 109.526 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -78.48 86.43 4.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.008 -0.433 . . . . 4.62 112.094 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -62.89 -52.5 62.84 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.294 -1.373 . . . . 2.61 107.294 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 66.66 146.57 0.1 Allowed Pre-proline 0 N--CA 1.5 2.038 0 CA-C-O 121.117 0.484 . . . . 4.54 112.106 177.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 33.5 Cg_endo -79.14 112.27 3.03 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.947 2.432 . . . . 3.39 108.413 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 2.7 tttp 83.14 116.33 0.05 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.478 -0.934 . . . . 5.59 108.478 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 117.972 -1.013 . . . . 3.59 109.733 -179.207 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.297 -0.631 . . . . 7.72 109.297 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t 55.4 28.32 11.35 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.874 -0.787 . . . . 4.69 108.874 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.46 106.66 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.764 -0.585 . . . . 5.1 109.657 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 94.12 8.9 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.693 -0.855 . . . . 1.91 108.693 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt -78.94 149.79 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.923 -0.769 . . . . 1.37 108.923 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 17' ' ' VAL . 33.9 p -109.77 120.71 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 1.21 110.169 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -88.34 136.2 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.817 -0.809 . . . . 1.06 108.817 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.45 134.9 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.371 -0.83 . . . . 1.65 110.072 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.66 120.65 67.65 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.4 -6.59 16.47 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.703 2.268 . . . . 1.04 111.865 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.1 m -93.35 -49.73 5.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.224 -0.923 . . . . 0.94 109.945 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -109.97 -33.87 6.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.465 -0.772 . . . . 1.18 110.756 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.77 74.0 1.07 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.117 -1.593 . . . . 1.2 109.117 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 132.29 31.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.804 -0.821 . . . . 1.76 109.695 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -75.02 113.43 12.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.668 -0.645 . . . . 1.34 109.71 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.72 131.82 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.133 -0.691 . . . . 0.92 109.133 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.2 p -60.05 140.05 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.73 -0.606 . . . . 1.06 110.389 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.503 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.5 t-105 -123.5 150.75 43.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.714 -0.616 . . . . 1.52 109.677 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.89 -97.61 0.49 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.276 -1.53 . . . . 1.3 109.276 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 91.65 0.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.801 -0.823 . . . . 2.72 109.337 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 tt -167.63 -42.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.631 -0.668 . . . . 1.74 110.031 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.0 161.91 21.52 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.535 -0.728 . . . . 1.61 109.809 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 -42.64 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.704 2.269 . . . . 2.09 110.451 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.98 65.36 0.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.698 . . . . 1.78 109.127 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.576 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 15.2 mtm105 -58.33 -49.87 91.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.502 -0.749 . . . . 1.69 110.098 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.25 125.64 7.94 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.188 1.926 . . . . 1.39 109.262 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 57.6 m-85 65.87 173.12 0.23 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.751 -0.593 . . . . 1.1 109.458 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.08 -26.78 12.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.2 -0.937 . . . . 1.22 110.511 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.78 159.97 42.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.257 -0.902 . . . . 1.75 110.4 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.38 88.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.507 -0.553 . . . . 1.96 109.507 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -43.58 94.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.865 -0.522 . . . . 2.19 109.684 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -59.3 -48.6 81.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.634 -0.666 . . . . 0.97 109.32 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -63.59 -35.98 82.31 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.165 -0.679 . . . . 1.75 109.165 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 9.6 tp -64.87 -67.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.397 -0.594 . . . . 1.61 109.397 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -49.03 -33.64 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.693 -0.63 . . . . 1.04 110.708 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -50.98 -41.37 59.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.487 -0.758 . . . . 1.3 110.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.36 -59.04 4.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.508 -0.745 . . . . 2.16 109.105 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.64 10.25 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.519 -0.848 . . . . 1.55 111.572 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 43.45 2.1 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.531 1.165 . . . . 2.76 109.161 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 4.4 m95 -139.79 -56.63 0.56 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.564 -0.71 . . . . 1.82 109.41 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.4 131.05 55.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.816 -0.553 . . . . 1.55 109.672 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.04 62.98 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.847 -0.797 . . . . 2.11 108.847 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.91 132.19 34.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 3.66 109.938 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.3 OUTLIER -66.75 -61.21 2.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.061 -0.718 . . . . 2.48 109.061 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.6 -61.27 2.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.131 -0.356 . . . . 4.31 110.968 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.34 165.3 14.37 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.764 0.792 . . . . 3.99 111.502 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.39 112.88 55.28 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 108.744 -0.836 . . . . 1.76 108.744 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -41.26 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.466 2.111 . . . . 1.24 111.383 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 2.8 m -81.37 -63.83 1.32 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 1.64 109.036 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.56 93.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.405 0.621 . . . . 1.75 110.19 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.37 -45.05 1.51 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.647 -1.381 . . . . 2.2 109.647 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -91.94 134.08 35.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.703 -0.881 . . . . 2.45 109.846 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -47.8 27.94 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.61 -0.885 . . . . 2.29 108.61 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m 56.02 -173.12 0.06 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.355 0.598 . . . . 3.31 111.031 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.92 -40.84 2.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 4.43 109.862 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.38 94.58 5.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.355 -0.84 . . . . 5.65 109.124 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -155.28 143.03 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.037 -0.727 . . . . 3.66 109.037 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.24 111.66 6.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.501 -0.749 . . . . 3.03 109.612 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.97 79.24 8.54 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.301 -0.629 . . . . 3.41 109.301 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -98.34 100.16 11.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.815 . . . . 2.01 110.386 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.34 123.79 32.68 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.476 -0.935 . . . . 5.66 108.476 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 68.32 85.14 0.14 Allowed Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.734 -0.839 . . . . 3.19 108.734 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.17 -32.59 6.62 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 123.017 2.478 . . . . 3.22 111.007 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 -51.8 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.235 -0.654 . . . . 4.05 109.235 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 117.689 -1.148 . . . . 4.52 110.227 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttm . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 121.451 0.643 . . . . 8.17 109.949 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.87 61.78 3.01 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.721 0.772 . . . . 4.28 108.94 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.03 145.93 50.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 4.12 110.211 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.0 m -93.26 102.93 15.22 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.636 -1.246 . . . . 2.51 107.636 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.04 159.44 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.692 -0.63 . . . . 2.31 109.658 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -118.79 121.33 39.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.669 -0.644 . . . . 2.36 110.156 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 18' ' ' TRP . 75.8 t -83.5 115.68 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.601 -0.889 . . . . 2.24 108.601 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -83.45 129.97 35.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.458 -0.776 . . . . 2.51 109.704 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.6 t -68.75 118.55 61.82 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.293 -0.632 . . . . 2.27 109.293 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.92 -20.91 9.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.659 2.239 . . . . 2.32 111.068 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.595 HG21 ' HA ' ' A' ' 32' ' ' CYS . 20.7 m -71.83 -51.71 21.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 2.36 110.235 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.3 p -109.07 -34.01 6.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 2.51 110.856 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.9 74.32 1.05 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.105 -1.598 . . . . 2.54 109.105 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 127.1 15.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.678 -0.895 . . . . 2.96 109.714 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -74.34 117.22 15.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.664 -0.647 . . . . 2.46 109.604 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.6 131.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.985 -0.746 . . . . 2.42 108.985 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -60.84 141.23 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.497 -0.752 . . . . 2.57 110.291 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' VAL . 68.0 t-105 -120.85 149.8 42.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.788 -0.57 . . . . 2.38 109.675 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.11 -99.2 0.41 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.314 -1.515 . . . . 2.49 109.314 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.42 83.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.649 -0.912 . . . . 2.88 109.332 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tt -157.25 -41.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.704 -0.622 . . . . 2.85 109.941 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 70.3 p -106.54 161.11 23.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.453 -0.779 . . . . 2.69 109.66 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 33.0 Cg_endo -75.03 -38.99 1.33 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.607 2.205 . . . . 2.76 110.334 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.91 64.82 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.879 -0.785 . . . . 2.55 108.879 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.591 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.4 mtm105 -58.94 -50.82 85.95 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.588 -0.695 . . . . 2.61 110.331 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.8 Cg_endo -76.6 118.52 4.88 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.061 1.841 . . . . 2.28 109.369 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 37.0 m-85 66.4 -171.19 0.19 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.27 -0.641 . . . . 2.39 109.27 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -117.64 -31.66 5.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.037 -1.039 . . . . 2.62 111.447 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.14 166.46 23.35 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.023 -1.048 . . . . 2.69 110.887 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -42.26 93.24 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.614 -0.513 . . . . 3.11 109.614 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HD2' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.08 -40.42 95.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.692 -0.63 . . . . 2.67 109.761 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.595 ' HA ' HG21 ' A' ' 11' ' ' THR . 49.9 m -62.92 -48.4 79.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 2.37 109.372 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 29.3 tt0 -63.96 -36.58 84.42 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.118 -0.697 . . . . 3.01 109.118 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 12.2 tp -60.95 -64.97 0.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.453 -0.943 . . . . 2.55 108.453 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.81 -34.71 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.948 -0.47 . . . . 2.36 110.323 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -44.33 61.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.53 -0.731 . . . . 2.17 110.769 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.7 mt -57.99 -61.78 2.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.42 -0.8 . . . . 2.59 109.381 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' HA2' ' HG2' ' A' ' 46' ' ' ARG . . . 120.6 19.69 3.7 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 120.295 -0.955 . . . . 2.04 111.575 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.44 30.58 6.69 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.184 -1.186 . . . . 2.42 109.851 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.537 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.89 128.92 18.58 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.215 -0.928 . . . . 2.68 109.68 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.24 82.32 2.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.715 . . . . 1.75 109.453 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.73 -64.2 1.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.146 -0.687 . . . . 2.31 109.146 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -100.97 -31.28 11.19 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.6 -0.688 . . . . 2.69 109.95 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.8 151.55 31.87 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 3.18 109.254 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -103.74 111.1 23.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.359 -0.838 . . . . 3.04 109.607 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.53 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.59 -50.67 3.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.709 -0.619 . . . . 2.79 109.72 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 49' ' ' SER . 5.6 pt -70.94 141.4 86.8 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.463 -0.773 . . . . 3.0 110.426 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.56 -46.11 0.14 Allowed 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.335 2.023 . . . . 3.58 110.423 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.592 ' O ' HD12 ' A' ' 47' ' ' ILE . 46.1 p -94.58 117.87 30.79 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.495 -0.753 . . . . 2.79 109.009 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.49 -40.3 6.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.736 . . . . 3.81 110.638 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 72.0 1.2 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.785 -1.726 . . . . 2.63 108.785 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.94 -41.95 5.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.937 -0.743 . . . . 4.19 110.414 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -127.25 19.46 6.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.23 -0.919 . . . . 2.83 110.771 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.1 -53.18 8.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.043 -1.036 . . . . 3.34 109.709 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.01 48.32 2.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.611 -0.68 . . . . 5.81 109.558 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.05 92.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.449 0.643 . . . . 5.63 109.71 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -129.35 -44.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.049 -0.722 . . . . 6.0 109.049 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -44.23 2.39 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.065 -0.717 . . . . 5.76 109.065 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.599 ' HB2' HD11 ' A' ' 53' ' ' LEU . 8.5 t-105 -79.64 131.99 36.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.558 -0.714 . . . . 6.11 109.654 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.01 21.94 3.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.817 -0.552 . . . . 6.4 109.984 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.2 104.8 1.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.839 . . . . 6.95 108.832 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.04 108.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 109.164 -0.68 . . . . 8.14 109.164 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.68 128.83 13.81 Favored 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 122.196 1.931 . . . . 8.69 108.602 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -107.23 140.43 40.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.717 0.77 . . . . 11.31 111.267 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.327 -0.844 . . . . 10.65 109.307 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.971 -0.381 . . . . 2.63 109.971 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -123.5 83.35 2.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.086 -0.709 . . . . 2.49 109.086 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -126.46 112.03 15.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.623 -0.673 . . . . 1.43 109.279 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -136.73 66.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.084 -0.71 . . . . 0.96 109.084 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.06 127.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.406 -0.809 . . . . 1.1 109.515 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 17' ' ' VAL . 36.1 p -88.46 119.8 29.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.411 -0.806 . . . . 1.07 109.622 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.57 123.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.047 -0.723 . . . . 0.94 109.047 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.01 130.78 34.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.571 -0.706 . . . . 2.12 110.019 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -59.67 119.31 39.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.318 -0.623 . . . . 1.58 109.318 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 35.5 Cg_endo -77.43 -10.9 17.43 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.72 2.28 . . . . 1.92 111.77 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 95.1 m -86.33 -46.99 9.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 1.88 109.838 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -118.03 -33.77 4.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.506 -0.746 . . . . 2.29 110.88 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.31 88.29 2.04 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.877 -1.689 . . . . 2.05 108.877 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HD2' ' HB2' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -149.63 126.59 11.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.966 -0.726 . . . . 3.97 109.701 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -70.25 115.25 9.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.534 -0.729 . . . . 1.67 109.18 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 25' ' ' ARG . 36.1 t -117.62 109.74 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.948 -0.76 . . . . 1.02 108.948 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.1 p -55.86 133.62 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.634 -0.666 . . . . 1.0 110.292 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.508 ' HZ3' ' HA ' ' A' ' 25' ' ' ARG . 69.6 t-105 -135.07 156.25 49.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.755 -0.591 . . . . 1.22 109.726 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.19 -105.36 0.92 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.684 -1.366 . . . . 1.16 109.684 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.74 22.79 8.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.626 -0.926 . . . . 1.43 109.893 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.3 tt -160.35 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.365 -0.976 . . . . 1.33 108.365 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -115.25 99.15 52.0 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.674 . . . . 1.3 109.582 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.56 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.7 2.267 . . . . 1.31 110.828 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.64 49.78 1.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.563 -0.711 . . . . 2.17 109.146 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.676 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 63.27 -176.83 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.661 -0.866 . . . . 3.35 108.661 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' ARG . 32.2 Cg_endo -74.27 -12.49 23.14 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.094 1.862 . . . . 0.72 110.678 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 27.0 m-85 -93.45 154.31 18.0 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.839 -0.8 . . . . 1.05 108.839 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 19.5 p -69.67 -33.56 72.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.296 -0.878 . . . . 1.33 109.699 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 166.76 25.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 1.65 109.773 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -70.34 -38.01 74.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.59 -0.694 . . . . 3.5 109.672 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -41.67 95.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.212 -0.662 . . . . 2.82 109.212 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.29 -48.09 82.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.102 -0.703 . . . . 1.27 109.102 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 34.5 tt0 -62.11 -35.87 80.03 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.906 -0.776 . . . . 1.16 108.906 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 4.7 tp -63.19 -65.53 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.976 -0.75 . . . . 0.96 108.976 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.4 mm -51.02 -32.0 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.596 -0.69 . . . . 1.39 110.219 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.09 -40.94 74.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.744 . . . . 1.52 109.913 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mm? -65.23 -58.49 5.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.082 -0.71 . . . . 1.65 109.082 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 29.34 5.23 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.683 -0.967 . . . . 1.41 110.683 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -130.67 40.74 3.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.504 -0.998 . . . . 2.31 109.286 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.501 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 -138.68 -59.28 0.61 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.439 -0.788 . . . . 1.19 109.613 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.0 138.58 53.28 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.62 -0.511 . . . . 1.48 109.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 60.83 77.81 0.31 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.508 0.67 . . . . 1.97 109.674 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.61 120.37 36.79 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.734 -0.839 . . . . 1.83 108.734 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.61 7.99 21.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.57 -0.706 . . . . 3.09 110.706 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 101.19 11.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.108 -0.995 . . . . 3.19 108.624 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.66 127.68 37.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.886 . . . . 4.36 110.991 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -126.77 86.17 59.22 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.168 -1.049 . . . . 2.52 108.168 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.16 155.29 37.61 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.919 2.412 . . . . 2.64 111.494 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.66 -41.49 42.99 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.414 -0.587 . . . . 3.35 109.414 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 p -102.87 127.38 50.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.599 -0.889 . . . . 3.35 108.599 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.79 -68.17 0.76 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.133 -1.587 . . . . 3.18 109.133 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.49 70.16 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.036 -0.685 . . . . 2.57 109.548 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.95 117.36 21.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.349 -0.844 . . . . 4.24 109.673 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.29 114.69 19.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.774 -0.579 . . . . 2.72 110.167 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.26 117.56 12.94 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.939 -1.134 . . . . 4.77 107.939 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.73 120.03 10.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 3.02 111.69 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -120.48 -54.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.81 -0.811 . . . . 3.43 108.81 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 56.51 70.72 0.62 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.19 -0.67 . . . . 4.71 109.19 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.678 ' CE3' ' HB2' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 71.54 132.3 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.057 -1.09 . . . . 4.61 108.057 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.17 50.64 0.77 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.755 -1.215 . . . . 4.85 110.801 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.678 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 1.1 tm-20 -104.21 -45.39 4.71 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.747 -1.205 . . . . 3.83 107.747 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 65' ' ' GLN . 1.7 mm-40 -126.05 148.74 64.14 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 108.449 -0.945 . . . . 5.78 108.449 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HG2' ' CD ' ' A' ' 64' ' ' LYS . 34.8 Cg_endo -78.56 -28.32 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.04 1.826 . . . . 6.71 109.834 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.16 101.93 10.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.65 -0.656 . . . . 7.39 110.227 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 118.485 -0.769 . . . . 4.79 109.958 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.292 0.568 . . . . 2.23 110.175 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -48.51 26.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.726 -0.608 . . . . 2.86 109.576 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -54.49 7.42 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 2.09 109.367 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 m -86.68 98.5 11.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.655 -0.653 . . . . 1.24 109.514 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.41 159.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.11 -0.7 . . . . 1.9 109.11 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 17' ' ' VAL . 21.5 p -124.85 123.37 39.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.346 -0.846 . . . . 1.16 109.796 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.89 133.12 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.306 -0.627 . . . . 0.93 109.306 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -93.3 136.91 33.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.557 -0.714 . . . . 1.35 110.15 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 12.2 t -65.05 118.02 45.15 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.307 -0.627 . . . . 0.89 109.307 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 -7.7 16.23 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.676 2.251 . . . . 1.17 111.425 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.427 ' O ' HD13 ' A' ' 47' ' ' ILE . 52.9 m -94.92 -56.08 2.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.268 -0.895 . . . . 1.18 110.091 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -104.77 -29.86 10.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.412 -0.805 . . . . 1.35 110.905 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.01 86.17 1.87 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.324 -1.511 . . . . 1.16 109.324 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.47 124.83 8.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.836 -0.803 . . . . 1.53 109.73 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.5 m -75.2 110.95 9.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.563 -0.711 . . . . 1.12 109.841 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 28' ' ' CYS . 73.2 t -113.42 119.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.656 -0.868 . . . . 0.61 108.656 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 6' ' ' THR . 13.9 p -63.66 137.69 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.465 0.65 . . . . 0.62 109.635 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 22' ' ' SER . 73.9 t-105 -133.52 154.6 50.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 1.33 109.634 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 21' ' ' ILE . . . 100.69 93.88 2.15 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.434 -1.467 . . . . 1.07 109.434 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.57 24.81 14.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.929 -0.748 . . . . 2.59 110.364 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.4 tt -177.53 103.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.732 -0.84 . . . . 1.18 108.732 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 18' ' ' TRP . 16.7 p -127.81 91.7 44.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 1.65 110.107 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 -38.27 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.662 2.241 . . . . 0.92 110.128 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.78 35.26 4.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.746 -0.596 . . . . 1.57 109.716 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' O ' HG11 ' A' ' 16' ' ' VAL . 2.4 mtm105 65.77 178.28 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.62 -0.675 . . . . 2.98 110.859 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 36.4 Cg_endo -78.21 14.05 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.807 2.338 . . . . 0.97 111.47 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' A' ' 33' ' ' GLN . 26.2 m-85 -131.03 -69.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 1.27 109.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER 168.74 -38.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.179 -0.674 . . . . 0.92 109.179 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.31 174.35 11.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.729 -0.607 . . . . 1.11 109.953 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -46.74 70.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 3.45 109.519 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -43.19 93.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.92 -0.487 . . . . 3.39 109.933 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.7 m -59.85 -44.75 93.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.654 . . . . 0.87 109.322 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CD2' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -66.32 -33.17 75.13 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.074 -0.713 . . . . 1.46 109.074 179.065 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.73 HD23 ' HG3' ' A' ' 43' ' ' GLU . 6.0 tp -61.53 -62.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.403 -0.962 . . . . 0.82 108.403 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' ' 44' ' ' GLU . 9.0 mt -50.9 -29.93 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.825 -0.547 . . . . 1.14 110.128 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -30.83 70.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 1.49 110.558 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.4 mt -72.33 -58.98 2.97 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.353 -0.842 . . . . 1.52 109.055 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.68 24.67 5.74 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.464 -0.874 . . . . 1.19 111.335 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 42.02 3.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.217 -1.167 . . . . 1.81 109.035 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.595 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 11.8 m95 -134.98 138.78 44.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 1.16 109.567 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.13 -46.36 5.09 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 1.51 110.233 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.35 19.7 6.86 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.51 -0.744 . . . . 1.48 110.774 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.73 ' HG3' HD23 ' A' ' 34' ' ' LEU . 23.3 mm-40 -109.42 -66.13 1.09 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.039 -1.038 . . . . 1.46 109.03 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.836 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.8 pt-20 -73.93 126.93 31.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.268 -1.012 . . . . 1.27 108.268 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -57.69 1.07 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.688 . . . . 3.91 109.881 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.469 HH21 HD11 ' A' ' 47' ' ' ILE . 7.9 mtp180 -83.58 -52.37 6.52 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.59 -0.444 . . . . 3.24 109.963 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HH21 ' A' ' 46' ' ' ARG . 3.1 mt -114.03 121.82 35.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.784 -0.572 . . . . 1.96 109.984 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.44 -56.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.568 2.178 . . . . 1.92 109.952 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.31 175.48 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.336 0.589 . . . . 2.16 110.818 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 69.54 108.38 0.06 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.41 -0.589 . . . . 3.17 109.41 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.0 -59.17 4.93 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.936 -1.666 . . . . 1.72 108.936 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.81 152.16 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.764 -0.845 . . . . 1.4 109.427 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.06 120.06 24.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 3.26 108.919 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -103.83 -75.93 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.718 -0.614 . . . . 2.41 110.034 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 169.12 19.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.47 -0.769 . . . . 2.18 110.84 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 p -149.1 36.47 0.76 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.515 -0.55 . . . . 2.16 109.515 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.13 155.08 46.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.295 -0.878 . . . . 2.58 110.209 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -46.63 28.18 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.406 -0.59 . . . . 2.6 109.406 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -94.46 -48.46 6.11 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.774 -0.578 . . . . 1.51 109.477 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.04 101.91 0.74 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.719 -0.613 . . . . 1.62 109.55 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HB3' HH22 ' A' ' 46' ' ' ARG . 0.5 OUTLIER -107.24 136.16 47.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.667 -0.646 . . . . 1.54 109.68 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -145.12 126.27 7.6 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.539 -0.725 . . . . 3.7 110.307 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.549 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 36.4 Cg_endo -79.47 -49.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.098 2.532 . . . . 1.56 111.447 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -147.19 -58.44 0.27 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.723 -0.611 . . . . 3.28 109.402 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.948 -1.025 . . . . 4.99 109.443 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.438 -0.578 . . . . 4.81 109.438 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.23 117.86 30.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.583 -0.698 . . . . 2.24 110.065 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.38 -47.62 9.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.617 -0.883 . . . . 3.89 108.617 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -113.08 124.11 51.84 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.047 -0.723 . . . . 1.46 109.047 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.29 159.73 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.732 . . . . 1.69 109.394 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.544 HG22 ' HA ' ' A' ' 17' ' ' VAL . 6.7 p -140.68 123.6 16.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.537 -0.727 . . . . 1.01 109.897 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 71.6 t -97.86 123.99 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.981 -0.748 . . . . 1.11 108.981 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.95 134.23 34.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.556 -0.715 . . . . 1.33 110.027 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.9 t -68.78 120.26 74.74 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 109.162 -0.681 . . . . 0.81 109.162 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -9.05 16.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.712 2.274 . . . . 1.21 111.781 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.7 m -89.15 -51.47 5.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.244 -0.91 . . . . 1.27 110.071 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.77 -23.68 12.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.515 -0.741 . . . . 1.42 110.844 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.9 79.03 1.27 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.464 -1.855 . . . . 1.29 108.464 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -147.73 134.26 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.886 -0.773 . . . . 3.85 109.886 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -76.63 111.58 12.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 1.08 109.691 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.19 138.48 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.7 p -64.1 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.396 -0.815 . . . . 0.89 110.039 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.489 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -115.55 153.13 31.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.468 -0.568 . . . . 1.52 109.468 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.58 -104.89 1.08 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.484 -1.447 . . . . 1.61 109.484 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 53.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.743 -0.857 . . . . 3.62 109.652 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.84 -53.69 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.406 -0.809 . . . . 1.52 109.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.4 m -94.19 165.72 17.04 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.684 -0.635 . . . . 1.41 109.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 34.7 Cg_endo -76.47 -23.83 11.1 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.705 2.27 . . . . 1.77 110.702 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' HZ ' ' HG2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -120.48 74.36 1.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.708 . . . . 1.78 109.181 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -58.17 -55.97 39.86 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.606 -0.684 . . . . 1.97 109.947 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.67 123.9 6.65 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 122.363 2.042 . . . . 1.12 109.721 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 43.9 m-85 66.01 167.1 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.334 0.588 . . . . 0.75 109.653 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.79 -31.37 15.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 1.09 110.208 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -144.15 163.97 32.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 1.32 110.24 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.14 -32.01 73.29 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 2.05 109.323 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -50.43 70.17 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.913 -0.492 . . . . 5.45 109.979 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 2.7 m -56.44 -48.44 77.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.692 -0.63 . . . . 1.13 109.815 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -64.15 -37.52 87.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 1.82 109.44 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.6 tp -62.3 -66.9 0.47 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.89 -0.781 . . . . 1.33 108.89 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 HG23 ' CD ' ' A' ' 44' ' ' GLU . 43.2 mt -50.43 -29.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.828 -0.545 . . . . 1.38 110.697 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.85 -42.5 68.61 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.454 -0.779 . . . . 1.21 110.287 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.41 -58.34 6.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.494 -0.754 . . . . 1.54 109.056 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.49 22.39 6.77 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 120.624 -0.798 . . . . 1.49 111.277 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.65 40.01 3.62 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.349 -1.089 . . . . 2.07 109.224 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.496 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 2.6 m95 -139.77 -60.24 0.55 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.581 -0.699 . . . . 1.41 109.318 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.51 55.36 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.277 -0.638 . . . . 1.46 109.277 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.43 -43.87 59.47 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 1.91 110.272 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.01 122.38 43.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 2.35 109.656 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CD ' HG23 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -97.09 -42.96 7.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 3.48 109.981 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -140.4 129.02 22.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.642 -0.661 . . . . 4.55 109.969 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -136.47 157.16 47.43 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.606 -0.684 . . . . 3.29 109.942 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 48' ' ' PRO . 2.3 tt -67.63 125.95 91.93 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.402 -0.811 . . . . 2.13 110.278 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 47' ' ' ILE . 34.3 Cg_endo -77.87 99.63 1.3 Allowed 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 122.987 2.458 . . . . 2.44 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.74 104.05 15.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.743 -0.598 . . . . 2.4 109.851 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 p -111.53 108.5 18.04 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.09 -0.707 . . . . 3.35 109.09 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.09 -67.91 3.07 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.588 -1.405 . . . . 2.6 109.588 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.38 142.54 33.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.615 -0.932 . . . . 1.9 110.113 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 172.73 8.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 2.06 109.935 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 p -57.06 -47.85 79.99 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.147 -0.686 . . . . 1.55 109.147 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.78 87.36 2.7 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.324 -0.991 . . . . 2.67 108.324 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 104.09 6.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 3.03 109.95 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -138.19 137.23 37.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.666 -0.646 . . . . 2.09 109.35 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.37 132.79 35.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.69 . . . . 2.25 109.592 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -87.6 -29.4 21.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.557 -0.714 . . . . 2.57 110.057 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.06 -56.37 3.59 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.431 -0.793 . . . . 2.6 109.146 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.32 -163.66 0.65 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.207 -0.664 . . . . 2.85 109.207 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 122.61 85.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.336 -0.853 . . . . 3.75 109.595 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.92 98.14 1.2 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.819 2.346 . . . . 2.51 110.193 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -89.04 118.02 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.913 -0.773 . . . . 4.18 108.913 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.789 -1.101 . . . . 5.24 109.711 -179.853 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 18' ' ' TRP . 4.3 pt . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 108.618 -0.882 . . . . 2.46 108.618 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.973 HG22 ' HA ' ' A' ' 17' ' ' VAL . 20.1 p -120.41 120.57 36.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 2.59 110.474 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.34 132.93 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.495 -0.928 . . . . 2.14 108.495 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -91.41 135.28 33.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 3.63 110.286 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HG ' ' HD2' ' A' ' 27' ' ' PHE . 22.4 t -66.68 118.27 52.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.791 -0.818 . . . . 2.51 108.791 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.9 Cg_endo -76.35 -15.65 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.524 2.149 . . . . 3.02 111.849 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.596 HG21 ' HA ' ' A' ' 32' ' ' CYS . 87.7 m -81.17 -50.39 9.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.921 . . . . 2.59 110.708 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.9 p -110.78 -26.1 9.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 3.12 110.789 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.18 74.4 1.26 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.839 -1.705 . . . . 3.36 108.839 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 28' ' ' CYS . 6.2 tmtt? -140.08 128.62 22.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.063 -0.669 . . . . 3.22 109.521 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 m -70.6 115.86 10.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.635 -0.666 . . . . 3.42 109.75 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 24' ' ' PHE . 19.5 t -116.93 123.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.926 -0.768 . . . . 1.82 108.926 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.973 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.8 p -53.07 136.95 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.28 0.562 . . . . 1.6 110.322 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.527 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -112.11 156.59 22.0 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.647 -0.658 . . . . 2.59 109.809 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.76 -100.64 0.91 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.869 -1.692 . . . . 2.11 108.869 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.89 57.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.848 -0.795 . . . . 4.29 109.226 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.35 -52.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.594 -0.691 . . . . 3.09 109.366 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.1 m -93.47 166.77 15.33 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 2.6 110.007 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 36.2 Cg_endo -78.27 -32.87 2.16 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.488 2.126 . . . . 3.45 109.753 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.594 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -113.96 66.68 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.37 -0.604 . . . . 3.05 109.37 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.582 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -51.69 -55.43 29.96 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.282 -0.886 . . . . 3.52 109.322 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.2 Cg_endo -77.73 119.96 4.98 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.253 1.969 . . . . 2.2 109.545 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 82.8 m-85 68.0 159.45 0.16 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.345 0.593 . . . . 1.96 110.051 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 32.0 p -90.28 -35.4 15.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 1.4 110.0 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 165.6 24.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.455 -0.778 . . . . 1.98 109.543 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -72.4 -36.83 68.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.531 -0.73 . . . . 3.52 109.887 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -34.85 72.04 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.397 -0.814 . . . . 2.06 108.893 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.596 ' HA ' HG21 ' A' ' 11' ' ' THR . 33.8 m -66.85 -56.15 11.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -58.11 -33.7 69.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.103 -0.702 . . . . 2.27 109.103 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.56 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.9 tp -62.84 -65.77 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.734 -0.839 . . . . 2.11 108.734 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.5 -28.41 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.75 -0.593 . . . . 2.03 110.301 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -39.64 83.34 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.446 -0.784 . . . . 2.82 110.458 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -64.0 -60.0 3.8 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.793 -0.817 . . . . 2.95 108.793 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.7 24.63 5.19 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.912 -0.875 . . . . 2.71 110.912 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -126.1 40.6 3.7 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.329 -1.1 . . . . 3.4 109.215 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.5 m95 . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.537 -0.727 . . . . 2.8 109.681 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 121.176 0.512 . . . . 1.28 109.934 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.752 HG22 ' HA ' ' A' ' 17' ' ' VAL . 34.2 p -122.42 128.36 50.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 1.27 109.908 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.3 m -91.2 138.36 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.89 109.371 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.89 137.15 33.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.766 . . . . 1.96 110.097 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.68 120.72 75.48 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 109.095 -0.705 . . . . 1.07 109.095 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 -2.21 12.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.704 2.269 . . . . 1.33 112.05 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.6 m -98.78 -51.31 3.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.147 -0.971 . . . . 1.07 110.023 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.3 p -107.54 -30.03 8.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.617 -0.677 . . . . 1.51 110.763 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 71.16 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.814 -1.714 . . . . 1.65 108.814 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 135.08 40.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.786 -0.832 . . . . 2.03 109.66 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -76.54 112.27 12.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.566 -0.709 . . . . 1.59 109.685 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.26 127.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.853 -0.795 . . . . 0.9 108.853 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.752 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.6 p -60.68 137.86 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.705 . . . . 1.24 110.371 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.535 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.1 t-105 -106.92 156.02 19.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.776 -0.577 . . . . 1.24 109.543 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.33 -179.23 26.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.744 -1.342 . . . . 1.21 109.744 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.15 103.65 3.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.583 -0.951 . . . . 4.41 109.721 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 tt -174.99 -40.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.748 -0.595 . . . . 1.92 109.761 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.75 157.23 50.58 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 1.68 109.651 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.23 -35.61 2.23 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.579 2.186 . . . . 2.14 110.681 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.26 68.52 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.519 -0.738 . . . . 2.01 109.066 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.698 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -56.06 -54.17 55.32 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.599 -0.688 . . . . 1.63 109.854 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.698 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -78.0 128.69 9.3 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.291 1.994 . . . . 1.22 109.44 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 62.0 m-85 65.54 173.48 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.373 0.606 . . . . 0.96 109.661 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -104.08 -31.88 9.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.897 . . . . 1.16 110.341 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -138.41 164.21 29.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.328 -0.858 . . . . 1.2 110.419 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -38.66 90.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 2.07 109.487 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -42.0 98.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 2.29 109.897 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -59.38 -50.35 74.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.582 -0.699 . . . . 0.75 109.304 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.04 -35.32 78.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.169 -0.678 . . . . 1.65 109.169 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 10.5 tp -66.04 -66.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.24 -0.652 . . . . 1.78 109.24 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 mt -50.2 -30.93 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.634 -0.666 . . . . 0.88 110.542 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.8 -41.67 64.37 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.598 -0.688 . . . . 1.39 110.081 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.5 -59.11 4.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.943 -0.762 . . . . 2.0 108.943 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.05 26.71 5.39 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.992 -0.843 . . . . 1.65 110.992 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.32 47.21 2.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 2.51 109.118 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 7.7 m95 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.512 -0.743 . . . . 2.1 109.93 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.552 -0.536 . . . . 1.22 109.552 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 17' ' ' VAL . 45.1 p -126.17 130.68 51.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.408 -0.808 . . . . 1.17 110.046 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 18' ' ' TRP . 42.8 t -97.49 131.08 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.286 -0.635 . . . . 1.07 109.286 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.07 140.46 36.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.563 -0.711 . . . . 1.87 109.804 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 16.1 t -73.01 125.48 91.04 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.71 -0.619 . . . . 1.36 109.519 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.57 -3.71 13.54 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.809 2.339 . . . . 1.89 111.783 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HB ' ' A' ' 35' ' ' ILE . 55.5 m -97.39 -54.89 3.0 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.237 -0.914 . . . . 1.57 109.901 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.9 p -102.07 -30.71 11.02 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.585 -0.697 . . . . 1.59 110.688 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.45 62.59 1.09 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.346 -1.502 . . . . 1.46 109.346 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 140.46 46.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.877 -0.778 . . . . 2.79 109.341 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 m -73.71 116.61 14.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.45 109.827 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.7 t -116.0 137.47 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.136 -0.69 . . . . 0.96 109.136 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.6 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -58.87 139.46 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.429 -0.795 . . . . 0.92 110.256 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 57.5 t-105 -116.47 152.72 33.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 1.19 109.646 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 -145.46 16.61 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.686 -1.366 . . . . 1.19 109.686 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 89.02 2.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.454 -1.027 . . . . 1.99 109.344 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -153.8 -42.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.66 -0.65 . . . . 1.24 110.073 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 55.8 p -131.4 161.24 63.23 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.524 -0.735 . . . . 0.98 109.818 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.91 -15.82 18.59 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.737 2.291 . . . . 1.16 110.679 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 27' ' ' PHE . 61.8 m-85 -119.41 76.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.485 -0.931 . . . . 1.15 108.485 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.695 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -73.9 -48.91 6.18 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 2.1 110.483 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.69 -43.03 0.23 Allowed 'Trans proline' 0 C--N 1.326 -0.657 0 C-N-CA 122.171 1.914 . . . . 1.1 111.015 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 97.4 m-85 -99.08 163.66 12.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.671 -0.643 . . . . 1.17 109.809 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -80.38 -49.95 10.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.365 -0.834 . . . . 1.15 109.507 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.49 -172.8 3.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.669 -0.644 . . . . 1.23 110.074 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -36.13 82.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 2.46 110.165 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -64.57 -41.04 96.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.645 -0.66 . . . . 1.86 110.3 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 43.7 m -58.95 -48.23 82.27 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.122 -0.696 . . . . 1.22 109.122 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -66.4 -33.76 76.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.641 -0.662 . . . . 1.76 109.227 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -62.2 -66.63 0.51 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 1.36 109.328 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' HB ' HG21 ' A' ' 11' ' ' THR . 11.4 mt -50.13 -30.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.605 -0.684 . . . . 1.58 110.356 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -56.53 -43.54 79.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.452 -0.78 . . . . 1.62 110.289 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.69 -61.18 2.7 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.847 -0.797 . . . . 1.91 108.847 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.57 18.84 8.22 Favored Glycine 0 N--CA 1.499 2.85 0 C-N-CA 120.457 -0.878 . . . . 1.89 111.339 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.14 40.22 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -1.127 . . . . 2.52 109.284 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 8.2 m95 . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.814 -0.81 . . . . 1.85 108.814 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.139 -1.06 . . . . 1.62 108.139 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 25.3 p -88.41 121.3 30.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.06 110.385 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 26' ' ' PRO . 22.7 t -112.13 115.07 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.509 -0.923 . . . . 1.03 108.509 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 5.7 p-10 -81.59 145.23 30.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 1.09 110.335 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 8.6 t -74.85 121.79 86.05 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.709 -0.619 . . . . 0.79 109.331 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.87 -8.29 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.672 2.248 . . . . 1.38 111.537 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.0 m -93.6 -56.84 2.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 1.65 109.83 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.1 p -98.01 -31.56 12.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.441 -0.787 . . . . 1.34 110.755 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.34 69.96 1.03 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.258 -1.537 . . . . 1.11 109.258 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -139.78 117.33 11.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.839 -0.8 . . . . 1.48 109.389 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 9.0 m -69.36 107.15 3.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.596 -0.69 . . . . 0.77 109.517 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.997 HG21 ' HA ' ' A' ' 28' ' ' CYS . 87.7 t -104.65 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.925 -0.769 . . . . 0.79 108.925 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 7.3 p -63.72 114.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.439 0.637 . . . . 1.53 109.309 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.52 ' CZ3' ' HA ' ' A' ' 25' ' ' ARG . 14.5 t-105 -86.92 147.25 25.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.505 -0.747 . . . . 2.05 110.052 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.46 -87.54 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.011 -1.635 . . . . 2.34 109.011 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 35.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.801 -0.823 . . . . 3.02 109.796 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.27 -56.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 2.32 109.572 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.511 ' HB2' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -104.1 118.05 57.96 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.79 109.491 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.8 46.14 2.14 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.856 2.371 . . . . 1.84 110.479 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -117.72 24.25 11.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 1.74 109.741 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 63.26 174.37 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.638 -0.664 . . . . 1.48 110.631 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 31.7 Cg_endo -71.74 -18.33 28.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 122.153 1.902 . . . . 1.45 111.1 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.39 -69.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.181 -0.95 . . . . 1.34 108.803 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.997 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 167.59 -40.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.155 -0.683 . . . . 0.72 109.155 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.75 159.81 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.749 -0.594 . . . . 1.08 109.485 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -62.69 -38.6 91.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 3.0 109.875 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -38.0 62.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.659 -0.65 . . . . 2.22 110.185 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 4.3 m -60.23 -49.42 77.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.56 -0.713 . . . . 1.33 109.643 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 2.01 109.22 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 8.3 tp -63.86 -66.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.969 -0.752 . . . . 1.77 108.969 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 mt -50.28 -30.38 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.747 -0.596 . . . . 1.79 110.121 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -44.75 63.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.691 . . . . 1.9 110.299 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 4.7 mt -65.94 -58.09 6.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.757 -0.831 . . . . 2.47 108.757 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.44 26.0 6.1 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 111.001 -0.839 . . . . 2.55 111.001 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.71 42.77 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.391 -1.064 . . . . 2.95 108.823 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.503 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 6.8 m95 . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.676 -0.64 . . . . 2.63 109.446 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.166 -0.679 . . . . 1.76 109.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 17' ' ' VAL . 29.9 p -117.51 121.11 40.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.34 -0.85 . . . . 1.12 109.926 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.83 132.64 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.64 -0.662 . . . . 1.12 109.251 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.59 132.9 36.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.396 -0.815 . . . . 1.78 109.977 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 9.1 t -64.32 120.3 63.77 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.53 -10.37 17.3 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.694 2.262 . . . . 1.8 111.877 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.4 m -89.13 -51.0 5.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.242 -0.911 . . . . 1.74 110.194 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.21 -29.83 8.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.485 -0.76 . . . . 1.52 110.821 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.92 78.4 1.41 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.905 -1.678 . . . . 1.43 108.905 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -142.96 136.12 28.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.881 -0.776 . . . . 2.77 109.786 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -79.39 112.85 17.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.669 . . . . 0.99 109.681 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.56 132.27 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.828 -0.804 . . . . 0.77 108.828 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.605 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.2 p -60.5 139.01 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.704 . . . . 1.01 110.167 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.536 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.0 t-105 -118.58 148.26 42.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.776 -0.577 . . . . 1.72 109.546 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.09 -97.49 0.42 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.669 -1.372 . . . . 1.7 109.669 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.96 52.47 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.848 . . . . 2.82 109.573 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.422 HD13 ' CG2' ' A' ' 17' ' ' VAL . 3.3 mp -118.05 -59.59 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 1.57 109.645 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -91.77 164.76 22.7 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 1.26 109.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.68 -40.62 0.71 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.565 2.177 . . . . 1.33 110.358 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.92 64.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.981 -0.748 . . . . 1.02 108.981 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.612 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.3 mtm180 -56.61 -52.28 74.72 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.549 -0.72 . . . . 2.5 110.088 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.09 124.23 7.8 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.162 1.908 . . . . 1.02 109.459 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 47.2 m-85 65.96 173.95 0.23 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.469 -0.567 . . . . 1.31 109.469 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -102.15 -29.83 11.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 1.01 110.147 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.31 163.7 32.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.372 -0.83 . . . . 1.51 110.087 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -35.39 80.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.59 -0.694 . . . . 1.51 109.891 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -65.79 -44.71 84.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.667 -0.646 . . . . 4.05 110.129 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.408 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -57.59 -46.26 84.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.75 -0.833 . . . . 1.35 108.75 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -66.01 -34.81 78.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.127 -0.694 . . . . 1.54 109.127 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 9.9 tp -63.76 -67.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.125 -0.695 . . . . 1.94 109.125 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 mt -49.16 -33.08 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.759 -0.588 . . . . 1.84 110.298 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.78 -42.1 71.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 2.01 110.266 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.68 -60.84 3.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 2.92 109.015 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.15 22.35 5.93 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 120.407 -0.902 . . . . 2.52 111.353 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.75 41.35 3.5 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.29 -1.123 . . . . 3.06 109.212 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 . . . . . 0 N--CA 1.5 2.041 0 O-C-N 121.431 -0.793 . . . . 2.38 109.888 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.488 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.0 pt . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.675 -0.491 . . . . 2.2 109.675 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.777 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -121.38 126.48 49.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 2.62 109.801 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 18' ' ' TRP . 35.9 m -90.76 134.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 1.9 109.262 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.0 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.525 -0.735 . . . . 3.18 110.254 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 t -67.93 119.79 69.32 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.025 -0.731 . . . . 2.2 109.025 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.43 -10.1 17.44 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.71 2.274 . . . . 2.54 111.819 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 m -88.1 -52.05 5.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.168 -0.957 . . . . 2.06 110.044 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -109.26 -30.07 8.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.522 -0.737 . . . . 2.42 110.78 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.1 73.57 1.12 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.894 -1.682 . . . . 2.71 108.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 129.36 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.892 -0.77 . . . . 2.65 109.791 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -72.86 114.44 11.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.529 -0.732 . . . . 3.02 109.661 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 24' ' ' PHE . 23.8 t -116.18 127.35 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.151 -0.685 . . . . 1.89 109.151 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.5 p -58.43 138.81 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 1.96 110.453 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.549 ' HB2' HG13 ' A' ' 7' ' ' VAL . 76.7 t-105 -111.28 155.27 23.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.807 -0.558 . . . . 1.34 109.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.07 -103.82 0.97 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.258 -1.537 . . . . 1.18 109.258 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.82 51.46 0.55 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.807 . . . . 2.45 109.307 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.45 -55.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.764 . . . . 2.41 109.449 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 80.5 p -89.12 162.08 38.69 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.831 -0.543 . . . . 1.85 109.977 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.84 -30.52 5.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.567 2.178 . . . . 2.15 110.056 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.434 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -116.72 69.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.791 -0.818 . . . . 1.33 108.791 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -53.05 -54.64 42.04 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.412 -0.805 . . . . 2.31 110.044 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.14 123.02 6.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.226 1.951 . . . . 0.95 109.425 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 59.9 m-85 66.83 167.92 0.23 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.297 0.57 . . . . 1.68 109.689 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -96.41 -34.65 11.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -0.877 . . . . 1.21 110.448 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 160.98 36.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.387 -0.821 . . . . 1.15 109.866 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -38.06 88.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.682 -0.637 . . . . 3.25 109.48 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.754 -0.591 . . . . 2.96 109.604 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -61.51 -52.01 66.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.35 -34.2 72.08 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.055 -0.72 . . . . 1.96 109.055 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.54 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.3 tp -65.85 -67.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.04 -0.726 . . . . 2.25 109.04 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.15 -29.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.659 -0.65 . . . . 2.14 110.546 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -53.71 -43.99 69.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.48 -0.762 . . . . 2.52 109.766 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.72 -58.29 6.67 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.882 -0.784 . . . . 3.1 108.882 179.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.73 26.39 5.59 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.79 -0.924 . . . . 3.16 110.79 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -124.44 40.77 3.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -1.045 . . . . 3.73 109.505 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.54 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 5.0 m95 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.788 . . . . 3.03 109.473 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.661 HD11 ' CD1' ' A' ' 18' ' ' TRP . 1.8 pt . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 109.022 -0.732 . . . . 2.7 109.022 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 17' ' ' VAL . 30.8 p -126.23 119.92 28.69 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.248 -0.908 . . . . 3.26 110.903 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.71 136.23 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.905 -0.776 . . . . 1.87 108.905 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.08 135.69 34.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.882 . . . . 3.37 110.299 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 24.3 t -65.04 119.44 58.57 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.998 -0.741 . . . . 2.08 108.998 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.4 Cg_endo -76.6 -6.31 16.85 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.685 2.257 . . . . 1.83 111.91 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.6 m -93.16 -52.41 4.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 2.03 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -108.31 -26.66 10.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.539 -0.726 . . . . 3.16 110.912 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.49 76.73 1.34 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.369 -1.892 . . . . 3.5 108.369 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 129.48 28.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.997 -0.708 . . . . 5.36 109.704 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 m -74.1 107.04 6.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.58 -0.7 . . . . 3.99 109.409 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -110.07 126.31 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.735 -0.603 . . . . 2.59 109.48 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.922 ' HA ' HG22 ' A' ' 6' ' ' THR . 14.0 p -53.94 135.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.428 0.632 . . . . 2.85 110.461 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.661 ' CD1' HD11 ' A' ' 5' ' ' ILE . 74.2 t-105 -117.4 154.13 31.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.675 -0.64 . . . . 1.63 110.443 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.21 -114.68 2.65 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.127 -1.589 . . . . 2.45 109.127 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.71 93.6 2.58 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.542 -0.91 . . . . 4.68 108.542 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 tt -169.52 -42.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.6 -0.688 . . . . 3.93 110.353 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.46 162.9 18.62 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.518 -0.739 . . . . 3.46 110.211 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 -40.72 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.665 2.243 . . . . 4.15 110.184 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.99 65.61 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.674 -0.641 . . . . 2.99 109.37 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -53.54 -53.39 57.42 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 2.78 109.787 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.1 Cg_endo -76.57 127.32 9.55 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 122.38 2.054 . . . . 1.62 109.527 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 60.0 m-85 66.56 166.75 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.734 -0.604 . . . . 1.88 109.526 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.93 -29.43 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.298 -0.876 . . . . 2.88 110.617 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.77 161.65 37.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.342 -0.849 . . . . 3.22 109.969 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.91 92.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 3.21 109.42 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -42.82 99.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.825 -0.547 . . . . 2.69 109.7 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -60.99 -52.99 62.65 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.729 -0.841 . . . . 1.99 108.729 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 20.2 tt0 -58.54 -33.54 70.01 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.142 -0.688 . . . . 2.11 109.142 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 tp -68.03 -66.9 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.8 -0.815 . . . . 2.74 108.8 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.32 -28.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.737 -0.602 . . . . 1.44 110.313 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.17 -42.7 66.44 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.539 -0.726 . . . . 1.42 109.702 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.2 mt -65.09 -57.42 8.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 2.56 108.788 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.87 23.57 7.04 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.039 -0.824 . . . . 2.28 111.039 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -122.97 45.37 2.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.354 -1.086 . . . . 3.11 109.14 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m95 . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.305 -0.872 . . . . 3.23 110.215 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.502 2.131 0 N-CA-C 109.478 -0.564 . . . . 1.35 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 17' ' ' VAL . 8.6 p -135.94 127.24 28.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 1.27 109.995 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 18' ' ' TRP . 79.1 t -95.95 120.36 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 1.19 109.016 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.6 133.18 34.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.687 -0.633 . . . . 1.98 109.608 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 t -69.19 118.86 65.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.266 -0.642 . . . . 1.39 109.266 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.4 -12.33 15.55 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.8 2.333 . . . . 1.53 111.509 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.8 m -83.74 -54.75 4.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -0.875 . . . . 1.53 110.217 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.71 -30.39 9.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.552 -0.717 . . . . 1.67 110.658 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.36 77.41 1.35 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.072 -1.611 . . . . 1.64 109.072 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -146.65 129.25 16.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.837 -0.802 . . . . 2.04 109.616 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -74.99 116.26 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.65 -0.656 . . . . 1.55 109.705 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.31 139.62 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.734 -0.839 . . . . 1.15 108.734 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -62.79 143.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.45 -0.781 . . . . 1.03 110.179 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.601 ' HB2' HG23 ' A' ' 7' ' ' VAL . 72.7 t-105 -125.27 149.71 47.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.813 -0.554 . . . . 1.23 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.43 -100.9 0.53 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.32 -1.512 . . . . 1.1 109.32 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 83.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.72 -0.871 . . . . 2.4 109.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 tt -156.18 -43.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.542 -0.724 . . . . 1.18 109.844 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.96 162.48 19.79 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.677 . . . . 1.22 109.726 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.67 -39.76 0.92 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.694 2.263 . . . . 1.42 110.384 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.27 65.04 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 1.64 109.184 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mtm105 -58.11 -51.12 84.13 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.543 -0.723 . . . . 1.53 109.962 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.24 126.96 8.85 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.291 1.994 . . . . 0.97 109.315 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 38.0 m-85 65.53 175.31 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.526 -0.546 . . . . 1.03 109.526 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 p -103.49 -28.81 11.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.141 -0.975 . . . . 1.26 110.582 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.59 162.14 39.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.266 -0.896 . . . . 1.85 110.443 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -40.06 96.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 1.54 109.668 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.551 HH21 HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.29 -44.79 94.07 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.735 -0.603 . . . . 3.14 109.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.44 -50.03 75.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 1.33 109.428 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 18.2 tt0 -63.81 -34.3 77.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.638 -0.664 . . . . 1.69 109.39 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 HH21 ' A' ' 31' ' ' ARG . 7.0 tp -65.7 -67.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.424 -0.584 . . . . 1.2 109.424 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -49.9 -28.78 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.576 -0.702 . . . . 1.4 110.62 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.52 -43.46 71.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.46 -0.775 . . . . 1.23 110.33 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -63.95 -59.71 4.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.472 -0.768 . . . . 1.21 108.971 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.57 20.49 8.11 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.582 -0.818 . . . . 1.19 111.081 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.89 45.96 2.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.288 -1.125 . . . . 1.34 109.137 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m95 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.523 -0.735 . . . . 1.34 109.128 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 18' ' ' TRP . 5.3 pt . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.257 0.551 . . . . 1.9 110.004 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 17' ' ' VAL . 46.4 p -121.83 126.33 48.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 1.07 110.164 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.26 135.67 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.931 -0.766 . . . . 1.3 108.931 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -91.33 133.05 35.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 1.39 109.97 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' O ' ' HA2' ' A' ' 13' ' ' GLY . 8.7 t -64.69 121.52 73.69 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.196 -0.668 . . . . 1.4 109.196 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.05 -11.28 16.44 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.66 2.24 . . . . 1.88 111.881 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.9 m -88.71 -54.82 3.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.227 -0.92 . . . . 1.78 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 p -103.09 -31.05 10.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.526 -0.734 . . . . 1.62 110.278 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 9' ' ' CYS . . . 95.37 75.14 1.26 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.845 -1.302 . . . . 1.45 109.845 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -143.85 137.81 28.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.56 -0.965 . . . . 2.91 110.656 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.2 m -72.59 112.43 8.64 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.215 0.531 . . . . 0.94 110.571 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.69 131.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.486 -0.931 . . . . 0.84 108.486 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.68 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -56.18 140.98 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 0.76 110.6 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.541 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.0 t-105 -122.15 151.44 40.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.695 -0.628 . . . . 1.34 109.542 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.29 -98.43 0.55 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.375 -1.49 . . . . 1.06 109.375 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.5 52.74 0.37 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.902 . . . . 1.32 109.727 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 17' ' ' VAL . 3.4 mt -118.11 -55.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 1.04 109.434 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.3 163.66 22.5 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.76 -0.588 . . . . 1.0 109.664 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.18 -38.14 1.24 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.538 2.158 . . . . 1.3 110.528 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.31 66.58 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.122 -0.696 . . . . 1.31 109.122 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.5 mtm180 -56.51 -51.26 82.54 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.574 -0.704 . . . . 2.2 110.188 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -76.69 127.13 9.36 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 122.179 1.919 . . . . 1.19 109.53 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 71.3 m-85 65.71 172.64 0.22 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.35 0.595 . . . . 1.44 109.636 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.28 -29.69 12.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.256 -0.902 . . . . 1.26 110.247 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.1 p -145.42 162.99 35.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.321 -0.862 . . . . 1.46 110.427 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -34.94 77.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.311 -0.626 . . . . 1.7 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -47.08 84.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.797 -0.564 . . . . 3.25 109.855 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.74 -47.24 85.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.753 -0.592 . . . . 1.62 109.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -64.23 -34.88 79.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.606 -0.684 . . . . 1.75 109.183 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 10.4 tp -63.56 -67.2 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.161 -0.681 . . . . 2.12 109.161 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.15 -30.25 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.707 -0.621 . . . . 1.93 110.717 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.06 -42.6 65.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 1.83 110.199 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -64.51 -58.95 4.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.53 -0.732 . . . . 2.45 109.095 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 23.58 6.43 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.584 -0.817 . . . . 2.5 111.133 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.07 44.54 2.64 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.299 -1.118 . . . . 2.63 109.091 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 9.9 m95 . . . . . 0 N--CA 1.499 1.984 0 O-C-N 121.591 -0.693 . . . . 2.56 109.447 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.264 -0.643 . . . . 1.62 109.264 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 17' ' ' VAL . 7.0 p -137.48 126.51 24.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.56 -0.712 . . . . 1.3 109.866 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 58.8 t -96.62 124.45 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.01 -0.737 . . . . 1.16 109.01 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.45 134.02 33.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.605 -0.684 . . . . 2.05 109.868 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -68.87 120.35 75.56 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.172 -0.677 . . . . 1.2 109.172 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.74 -11.99 16.67 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.707 2.271 . . . . 1.35 111.734 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -85.64 -52.19 5.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.205 -0.935 . . . . 1.36 110.229 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.2 p -107.32 -29.58 9.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.507 -0.746 . . . . 1.6 110.954 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 78.17 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.657 -1.777 . . . . 1.64 108.657 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 134.12 24.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.834 -0.803 . . . . 2.17 109.882 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -78.61 110.8 14.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.444 -0.785 . . . . 1.54 109.239 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.96 135.49 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.8 p -63.71 138.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.423 -0.798 . . . . 1.32 110.005 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -111.26 153.45 25.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.748 -0.595 . . . . 1.44 109.49 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.41 -108.13 1.47 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.486 -1.446 . . . . 1.56 109.486 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.75 52.56 0.87 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.877 . . . . 2.56 109.485 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' CG2' ' A' ' 17' ' ' VAL . 2.8 mp -115.93 -51.23 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.499 -0.751 . . . . 1.86 109.505 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 84.2 p -94.57 162.67 25.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.733 -0.604 . . . . 1.76 109.899 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -76.28 -29.93 5.86 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.559 2.172 . . . . 2.21 110.334 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.0 72.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.72 -0.844 . . . . 1.73 108.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -54.32 -55.16 40.07 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.644 -0.66 . . . . 2.58 110.227 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.0 126.64 8.82 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 122.286 1.99 . . . . 1.5 109.75 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 42.9 m-85 65.56 172.45 0.22 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.282 0.563 . . . . 1.35 109.771 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -98.43 -31.63 11.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.352 -0.842 . . . . 1.62 110.333 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.49 164.34 30.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 1.94 110.283 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -40.77 92.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.656 -0.653 . . . . 1.95 109.655 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -61.52 -42.18 98.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.757 -0.589 . . . . 2.02 109.683 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.66 -49.21 78.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.546 -0.721 . . . . 1.39 109.336 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -63.5 -32.85 74.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.371 -0.603 . . . . 1.77 109.371 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.0 tp -64.74 -67.43 0.44 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 1.71 109.437 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.24 -30.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.675 -0.64 . . . . 1.34 110.408 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.13 -41.62 68.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.751 . . . . 1.35 110.236 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -65.15 -59.16 4.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.462 -0.774 . . . . 1.77 109.142 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.85 25.61 5.86 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.584 -0.817 . . . . 1.61 111.149 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.25 43.48 3.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.267 -1.137 . . . . 1.92 109.112 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.6 m95 . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.575 -0.703 . . . . 1.85 109.863 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.707 HD12 ' HD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.47 0 N-CA-C 109.442 -0.577 . . . . 2.01 109.442 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -132.2 122.48 25.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.628 -0.67 . . . . 1.32 109.827 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.34 136.68 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.166 -0.679 . . . . 1.09 109.166 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.05 135.42 34.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 1.96 109.681 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.2 t -68.14 117.96 54.18 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.739 -0.601 . . . . 1.21 109.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 36.7 Cg_endo -80.64 19.42 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.927 2.418 . . . . 1.9 112.007 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.6 m -122.16 -48.31 2.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 1.11 109.366 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 -25.84 10.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.692 -0.63 . . . . 1.18 110.35 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.81 75.02 1.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.599 -1.8 . . . . 1.36 108.599 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -144.31 137.63 27.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.801 -0.823 . . . . 2.19 109.838 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -81.29 115.02 20.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.448 -0.783 . . . . 1.5 109.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.2 t -115.3 137.16 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.7 p -61.78 141.09 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.491 -0.756 . . . . 1.0 110.07 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.707 ' HD1' HD12 ' A' ' 5' ' ' ILE . 75.7 t-105 -124.88 150.98 45.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.854 -0.529 . . . . 1.44 109.783 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.27 -98.77 0.53 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.347 -1.501 . . . . 1.1 109.347 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.68 92.84 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.752 -0.852 . . . . 1.74 109.202 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -165.64 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.689 -0.632 . . . . 1.37 109.842 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.52 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 88.5 p -102.65 160.59 25.82 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.658 -0.652 . . . . 0.98 109.818 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.6 Cg_endo -75.27 -31.58 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.592 2.195 . . . . 1.29 110.355 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.87 64.46 0.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.679 . . . . 1.84 109.344 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 29.3 mtm180 -60.12 -53.02 69.13 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.488 -0.757 . . . . 1.44 109.661 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.68 125.63 7.63 Favored 'Trans proline' 0 C--N 1.324 -0.717 0 C-N-CA 122.285 1.99 . . . . 1.01 109.398 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 63.9 m-85 65.61 165.98 0.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.396 0.617 . . . . 1.24 109.734 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.2 p -95.5 -27.98 15.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.83 110.508 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.12 157.07 44.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.278 -0.889 . . . . 1.39 110.513 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -36.1 78.11 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.241 -0.652 . . . . 2.15 109.241 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -48.53 68.97 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 3.67 109.681 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.72 -43.87 65.96 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.551 -0.718 . . . . 0.79 109.812 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.94 -34.57 78.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.687 . . . . 1.94 109.289 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 11.5 tp -62.32 -66.64 0.51 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.893 -0.78 . . . . 1.19 108.893 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.39 -27.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.55 -0.719 . . . . 1.0 110.167 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.76 -45.7 74.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.435 -0.791 . . . . 1.47 109.472 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 15.6 mt -62.97 -58.66 6.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.466 -0.938 . . . . 1.47 108.466 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.97 19.48 7.24 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 120.6 -0.81 . . . . 1.05 111.913 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.22 33.64 4.97 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.716 1.258 . . . . 1.76 109.113 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 108.999 -0.741 . . . . 1.25 108.999 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.6 pt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 17' ' ' VAL . 32.0 p -121.51 127.87 51.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.465 -0.772 . . . . 1.22 109.982 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.32 136.1 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.085 -0.709 . . . . 1.12 109.085 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.25 136.96 32.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 1.35 110.156 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.45 122.04 84.27 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.084 -0.71 . . . . 1.06 109.084 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.84 -5.06 15.06 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.723 2.282 . . . . 1.32 111.862 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -94.82 -52.04 4.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.253 -0.904 . . . . 1.22 109.931 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.0 p -107.14 -31.66 8.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.498 -0.751 . . . . 1.36 110.764 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.2 68.97 0.94 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.909 -1.676 . . . . 1.47 108.909 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 131.36 40.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.884 -0.774 . . . . 3.12 109.737 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -76.08 104.34 6.56 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.56 -0.712 . . . . 1.34 109.248 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.34 129.49 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.133 -0.691 . . . . 1.09 109.133 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.5 p -64.27 135.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.637 -0.664 . . . . 1.31 110.258 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 60.6 t-105 -109.92 153.14 24.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.75 -0.594 . . . . 1.08 109.435 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.03 -165.69 12.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.761 -1.335 . . . . 1.31 109.761 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.7 92.65 9.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.456 -1.026 . . . . 2.57 109.439 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 tt -165.48 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.751 -0.593 . . . . 1.61 109.961 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.52 158.6 46.64 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.55 -0.719 . . . . 1.52 109.814 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.49 -36.67 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.768 2.312 . . . . 1.59 110.619 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.77 68.59 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.572 -0.705 . . . . 1.12 109.244 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.728 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -58.52 -51.59 80.72 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.559 -0.713 . . . . 1.78 110.148 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -77.55 125.86 7.88 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.205 1.936 . . . . 0.74 109.626 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 61.9 m-85 65.55 172.31 0.22 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.34 0.59 . . . . 0.86 109.824 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.35 -32.72 11.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.248 -0.908 . . . . 1.06 110.092 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 p -140.49 163.35 33.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 1.04 110.239 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -31.79 72.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.665 -0.647 . . . . 1.52 110.276 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -34.94 72.05 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.399 -0.813 . . . . 2.29 109.655 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.57 -47.37 76.01 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.603 -0.888 . . . . 1.03 108.603 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.88 -33.64 76.49 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.979 -0.748 . . . . 1.23 108.979 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 8.1 tp -65.33 -67.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.213 -0.662 . . . . 0.93 109.213 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.66 -29.48 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.645 -0.659 . . . . 1.02 110.506 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -54.87 -42.43 72.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.415 -0.803 . . . . 1.03 110.208 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -64.52 -59.57 4.15 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.19 24.92 6.04 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.982 -0.847 . . . . 1.19 110.982 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -125.58 44.18 2.89 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.381 -1.07 . . . . 1.55 109.09 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 11.9 m95 . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.443 -0.785 . . . . 1.19 109.471 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 109.282 -0.636 . . . . 1.09 109.282 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 17' ' ' VAL . 4.1 p -138.43 124.14 19.78 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 1.21 109.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 18' ' ' TRP . 78.3 t -97.73 124.44 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.158 -0.682 . . . . 0.73 109.158 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.5 136.17 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.394 -0.816 . . . . 1.45 109.94 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.31 122.69 87.14 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.355 -0.609 . . . . 1.12 109.355 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -8.78 16.56 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.698 2.265 . . . . 1.39 111.621 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 m -88.93 -55.87 3.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.282 -0.887 . . . . 1.41 109.8 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.81 -27.12 13.19 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.485 -0.759 . . . . 1.8 110.653 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 73.23 1.27 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.944 -1.662 . . . . 1.9 108.944 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -140.86 135.29 31.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.76 -0.847 . . . . 3.07 109.687 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 109.55 10.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.604 -0.685 . . . . 1.66 109.933 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.93 129.17 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 1.24 108.732 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.683 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.3 p -58.1 135.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 1.58 110.448 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.634 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.2 t-105 -107.64 154.14 21.88 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.404 -0.591 . . . . 1.46 109.404 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.91 -167.88 13.62 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.72 -1.352 . . . . 1.44 109.72 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.79 97.94 10.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -1.081 . . . . 2.8 109.591 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 22' ' ' SER . 5.5 tt -169.35 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 2.65 110.318 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 75.7 p -107.47 159.85 28.74 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.512 -0.742 . . . . 2.48 110.125 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 35.6 Cg_endo -77.52 -32.35 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.784 2.323 . . . . 3.0 110.41 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.92 71.71 0.8 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.143 -0.688 . . . . 2.2 109.143 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.675 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -58.01 -54.29 57.04 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.541 -0.724 . . . . 3.51 109.983 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.675 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.07 124.89 8.24 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 122.263 1.976 . . . . 1.38 108.898 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.9 m-85 65.72 175.43 0.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.059 -0.719 . . . . 1.12 109.059 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 p -102.31 -32.86 9.83 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.986 -1.072 . . . . 1.89 110.265 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.39 165.84 26.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 2.43 110.274 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -62.74 -40.57 97.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.706 -0.621 . . . . 2.0 109.908 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -62.2 -39.9 94.29 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.7 -0.625 . . . . 1.47 110.075 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.52 -48.41 79.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 1.79 109.438 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -65.08 -33.78 76.84 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.931 -0.766 . . . . 1.61 108.931 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.1 tp -65.13 -66.3 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.083 -0.71 . . . . 1.24 109.083 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.4 mt -49.88 -29.36 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.79 -0.569 . . . . 1.23 110.563 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -54.12 -42.93 70.03 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.494 -0.754 . . . . 0.89 110.106 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 3.2 mt -66.0 -58.77 4.76 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.808 -0.812 . . . . 1.31 108.808 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.33 25.71 5.43 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 111.03 -0.828 . . . . 0.98 111.03 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -123.8 38.0 4.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.377 -1.072 . . . . 1.4 109.383 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 3.5 m95 . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.508 -0.745 . . . . 1.21 109.916 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.501 2.096 0 N-CA-C 109.077 -0.712 . . . . 2.45 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 p -102.85 125.15 49.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 1.88 110.469 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.98 139.79 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.197 -0.668 . . . . 1.76 109.197 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -88.27 135.76 33.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.265 -0.897 . . . . 2.16 110.412 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.36 120.28 73.86 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.053 -0.721 . . . . 1.25 109.053 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.03 3.02 7.38 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 122.832 2.355 . . . . 1.65 112.038 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.3 m -104.49 -50.9 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.118 -0.989 . . . . 1.21 109.847 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -107.97 -25.51 11.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.605 -0.684 . . . . 1.2 110.763 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.95 80.39 1.39 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.55 -1.82 . . . . 1.47 108.55 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -150.06 137.15 19.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.757 -0.849 . . . . 2.98 109.725 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -77.65 108.5 10.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.343 -0.848 . . . . 1.9 109.567 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -108.83 128.87 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.962 -0.755 . . . . 1.21 108.962 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.89 133.28 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.461 0.648 . . . . 1.33 110.214 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 28.5 t-105 -118.65 153.86 33.63 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.426 -0.583 . . . . 2.19 109.426 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 25' ' ' ARG . . . 122.6 -125.17 5.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.986 -1.245 . . . . 1.88 109.986 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.48 87.07 2.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.977 . . . . 2.35 109.049 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -166.19 -45.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.509 -0.744 . . . . 1.3 110.462 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -111.17 159.97 30.81 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.521 -0.737 . . . . 1.18 110.041 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.73 -32.07 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 122.824 2.349 . . . . 1.63 110.857 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.15 68.58 0.67 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.581 -0.699 . . . . 2.38 109.579 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.739 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 2.3 mtt180 -63.75 -50.31 71.91 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.307 -0.871 . . . . 3.07 110.227 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.77 119.16 4.69 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 122.194 1.93 . . . . 1.6 109.944 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 66.0 m-85 66.02 161.4 0.14 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.374 0.607 . . . . 1.71 110.019 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.54 -32.05 22.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.348 -0.845 . . . . 1.32 110.29 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -140.16 168.49 19.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.48 -0.763 . . . . 1.64 110.18 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -38.25 77.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.669 -0.645 . . . . 4.4 109.631 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.42 98.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.829 -0.544 . . . . 2.83 110.122 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.67 -51.29 70.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.571 -0.706 . . . . 1.6 109.414 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 19.2 tt0 -60.48 -34.99 74.83 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.156 -0.683 . . . . 2.91 109.156 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 34' ' ' LEU . 6.8 tp -63.44 -67.26 0.44 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.277 -0.638 . . . . 2.5 109.277 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.5 mt -49.43 -29.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.66 -0.65 . . . . 1.9 110.466 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -53.34 -45.25 69.02 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.52 -0.737 . . . . 2.0 110.374 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mt -63.58 -59.91 4.02 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.868 . . . . 2.83 108.655 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.21 22.47 6.49 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 120.575 -0.821 . . . . 2.64 111.107 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.23 40.73 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -1.149 . . . . 3.1 109.248 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 7.5 m95 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.504 -0.748 . . . . 3.02 109.445 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.1 pt . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 109.472 -0.566 . . . . 1.69 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -115.55 125.29 52.81 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 1.59 110.112 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.86 120.83 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.958 -0.756 . . . . 1.13 108.958 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.88 131.28 34.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.555 -0.715 . . . . 1.86 109.723 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.83 119.4 60.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.153 -0.684 . . . . 0.79 109.153 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.83 -7.86 16.63 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.769 2.312 . . . . 0.9 111.784 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.5 m -91.88 -50.82 5.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.18 -0.95 . . . . 1.11 110.068 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.0 p -108.72 -32.1 7.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 1.14 110.873 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.48 73.37 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.24 -1.544 . . . . 1.13 109.24 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 130.67 26.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.769 -0.842 . . . . 1.9 109.571 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -76.73 112.85 13.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.644 -0.66 . . . . 1.33 109.634 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.6 127.07 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.821 -0.807 . . . . 1.26 108.821 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.66 139.38 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -0.784 . . . . 1.74 110.429 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.518 ' HB3' HG13 ' A' ' 5' ' ' ILE . 66.3 t-105 -108.23 151.6 25.72 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.2 -0.667 . . . . 1.53 109.2 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.3 -119.21 1.75 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.002 -1.239 . . . . 1.35 110.002 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.1 32.25 1.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.92 -0.753 . . . . 2.77 109.162 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 tt -109.34 -34.23 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 2.4 110.042 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.6 153.66 39.04 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 2.08 109.974 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.29 -40.74 0.57 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.642 2.228 . . . . 2.02 110.005 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.57 68.21 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.694 -0.854 . . . . 1.53 108.694 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.651 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 22.9 mtm180 -59.34 -48.88 95.13 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.553 -0.717 . . . . 2.17 110.408 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.0 Cg_endo -76.18 118.83 5.1 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.992 1.795 . . . . 1.12 109.105 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 39.2 m-85 67.99 163.93 0.22 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.344 -0.613 . . . . 1.01 109.344 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -86.42 -31.45 21.42 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.195 -0.941 . . . . 1.44 110.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.68 157.35 43.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.431 -0.793 . . . . 2.02 109.876 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -63.7 -29.4 70.63 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.577 -0.702 . . . . 2.3 109.713 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -42.94 79.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 2.86 109.204 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.34 -46.79 88.79 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.005 -0.739 . . . . 1.32 109.005 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -61.75 -36.02 79.78 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.694 -0.854 . . . . 1.47 108.694 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 2.9 tp -61.96 -65.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.872 -0.788 . . . . 1.76 108.872 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.54 -33.24 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.693 -0.629 . . . . 1.9 110.156 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.38 -45.34 72.81 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.602 -0.686 . . . . 1.47 109.766 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.5 mt -62.04 -58.86 6.25 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.959 -0.756 . . . . 1.94 108.959 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.22 33.2 4.34 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.0 -1.24 . . . . 2.46 110.0 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.43 40.02 3.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.763 -0.845 . . . . 4.59 108.836 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 8.0 m95 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.89 . . . . 2.62 110.546 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 108.923 -0.769 . . . . 1.37 108.923 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 17' ' ' VAL . 33.9 p -109.77 120.71 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 1.21 110.169 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -88.34 136.2 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.817 -0.809 . . . . 1.06 108.817 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.45 134.9 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.371 -0.83 . . . . 1.65 110.072 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.66 120.65 67.65 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.4 -6.59 16.47 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.703 2.268 . . . . 1.04 111.865 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.1 m -93.35 -49.73 5.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.224 -0.923 . . . . 0.94 109.945 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -109.97 -33.87 6.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.465 -0.772 . . . . 1.18 110.756 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.77 74.0 1.07 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.117 -1.593 . . . . 1.2 109.117 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 132.29 31.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.804 -0.821 . . . . 1.76 109.695 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -75.02 113.43 12.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.668 -0.645 . . . . 1.34 109.71 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.72 131.82 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.133 -0.691 . . . . 0.92 109.133 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.2 p -60.05 140.05 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.73 -0.606 . . . . 1.06 110.389 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.503 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.5 t-105 -123.5 150.75 43.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.714 -0.616 . . . . 1.52 109.677 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.89 -97.61 0.49 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.276 -1.53 . . . . 1.3 109.276 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 91.65 0.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.801 -0.823 . . . . 2.72 109.337 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 tt -167.63 -42.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.631 -0.668 . . . . 1.74 110.031 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.0 161.91 21.52 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.535 -0.728 . . . . 1.61 109.809 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 -42.64 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.704 2.269 . . . . 2.09 110.451 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.98 65.36 0.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.698 . . . . 1.78 109.127 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.576 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 15.2 mtm105 -58.33 -49.87 91.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.502 -0.749 . . . . 1.69 110.098 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.25 125.64 7.94 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.188 1.926 . . . . 1.39 109.262 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 57.6 m-85 65.87 173.12 0.23 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.751 -0.593 . . . . 1.1 109.458 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.08 -26.78 12.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.2 -0.937 . . . . 1.22 110.511 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.78 159.97 42.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.257 -0.902 . . . . 1.75 110.4 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.38 88.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.507 -0.553 . . . . 1.96 109.507 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -43.58 94.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.865 -0.522 . . . . 2.19 109.684 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -59.3 -48.6 81.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.634 -0.666 . . . . 0.97 109.32 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -63.59 -35.98 82.31 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.165 -0.679 . . . . 1.75 109.165 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 9.6 tp -64.87 -67.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.397 -0.594 . . . . 1.61 109.397 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -49.03 -33.64 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.693 -0.63 . . . . 1.04 110.708 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -50.98 -41.37 59.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.487 -0.758 . . . . 1.3 110.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.36 -59.04 4.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.508 -0.745 . . . . 2.16 109.105 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.64 10.25 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.519 -0.848 . . . . 1.55 111.572 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 43.45 2.1 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.531 1.165 . . . . 2.76 109.161 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 4.4 m95 . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.564 -0.71 . . . . 1.82 109.41 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.181 0.515 . . . . 2.31 109.658 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -118.79 121.33 39.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.669 -0.644 . . . . 2.36 110.156 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 18' ' ' TRP . 75.8 t -83.5 115.68 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.601 -0.889 . . . . 2.24 108.601 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -83.45 129.97 35.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.458 -0.776 . . . . 2.51 109.704 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.6 t -68.75 118.55 61.82 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.293 -0.632 . . . . 2.27 109.293 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.92 -20.91 9.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.659 2.239 . . . . 2.32 111.068 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.595 HG21 ' HA ' ' A' ' 32' ' ' CYS . 20.7 m -71.83 -51.71 21.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 2.36 110.235 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.3 p -109.07 -34.01 6.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 2.51 110.856 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.9 74.32 1.05 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.105 -1.598 . . . . 2.54 109.105 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 127.1 15.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.678 -0.895 . . . . 2.96 109.714 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -74.34 117.22 15.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.664 -0.647 . . . . 2.46 109.604 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.6 131.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.985 -0.746 . . . . 2.42 108.985 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -60.84 141.23 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.497 -0.752 . . . . 2.57 110.291 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' VAL . 68.0 t-105 -120.85 149.8 42.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.788 -0.57 . . . . 2.38 109.675 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.11 -99.2 0.41 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.314 -1.515 . . . . 2.49 109.314 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.42 83.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.649 -0.912 . . . . 2.88 109.332 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tt -157.25 -41.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.704 -0.622 . . . . 2.85 109.941 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 70.3 p -106.54 161.11 23.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.453 -0.779 . . . . 2.69 109.66 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 33.0 Cg_endo -75.03 -38.99 1.33 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.607 2.205 . . . . 2.76 110.334 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.91 64.82 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.879 -0.785 . . . . 2.55 108.879 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.591 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.4 mtm105 -58.94 -50.82 85.95 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.588 -0.695 . . . . 2.61 110.331 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.8 Cg_endo -76.6 118.52 4.88 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.061 1.841 . . . . 2.28 109.369 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 37.0 m-85 66.4 -171.19 0.19 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.27 -0.641 . . . . 2.39 109.27 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -117.64 -31.66 5.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.037 -1.039 . . . . 2.62 111.447 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.14 166.46 23.35 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.023 -1.048 . . . . 2.69 110.887 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -42.26 93.24 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.614 -0.513 . . . . 3.11 109.614 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -40.42 95.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.692 -0.63 . . . . 2.67 109.761 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.595 ' HA ' HG21 ' A' ' 11' ' ' THR . 49.9 m -62.92 -48.4 79.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 2.37 109.372 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 29.3 tt0 -63.96 -36.58 84.42 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.118 -0.697 . . . . 3.01 109.118 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 12.2 tp -60.95 -64.97 0.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.453 -0.943 . . . . 2.55 108.453 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.81 -34.71 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.948 -0.47 . . . . 2.36 110.323 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -44.33 61.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.53 -0.731 . . . . 2.17 110.769 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.7 mt -57.99 -61.78 2.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.42 -0.8 . . . . 2.59 109.381 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.6 19.69 3.7 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 120.295 -0.955 . . . . 2.04 111.575 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.44 30.58 6.69 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.184 -1.186 . . . . 2.42 109.851 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.537 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 O-C-N 121.215 -0.928 . . . . 2.68 109.68 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.515 -0.55 . . . . 1.1 109.515 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 17' ' ' VAL . 36.1 p -88.46 119.8 29.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.411 -0.806 . . . . 1.07 109.622 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.57 123.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.047 -0.723 . . . . 0.94 109.047 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.01 130.78 34.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.571 -0.706 . . . . 2.12 110.019 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -59.67 119.31 39.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.318 -0.623 . . . . 1.58 109.318 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 35.5 Cg_endo -77.43 -10.9 17.43 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.72 2.28 . . . . 1.92 111.77 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 95.1 m -86.33 -46.99 9.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 1.88 109.838 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -118.03 -33.77 4.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.506 -0.746 . . . . 2.29 110.88 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.31 88.29 2.04 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.877 -1.689 . . . . 2.05 108.877 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HD2' ' HB2' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -149.63 126.59 11.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.966 -0.726 . . . . 3.97 109.701 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -70.25 115.25 9.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.534 -0.729 . . . . 1.67 109.18 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 25' ' ' ARG . 36.1 t -117.62 109.74 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.948 -0.76 . . . . 1.02 108.948 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.548 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.1 p -55.86 133.62 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.634 -0.666 . . . . 1.0 110.292 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.508 ' HZ3' ' HA ' ' A' ' 25' ' ' ARG . 69.6 t-105 -135.07 156.25 49.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.755 -0.591 . . . . 1.22 109.726 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.19 -105.36 0.92 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.684 -1.366 . . . . 1.16 109.684 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.74 22.79 8.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.626 -0.926 . . . . 1.43 109.893 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.3 tt -160.35 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.365 -0.976 . . . . 1.33 108.365 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -115.25 99.15 52.0 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.674 . . . . 1.3 109.582 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.56 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.7 2.267 . . . . 1.31 110.828 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.64 49.78 1.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.563 -0.711 . . . . 2.17 109.146 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.676 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 63.27 -176.83 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.661 -0.866 . . . . 3.35 108.661 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' ARG . 32.2 Cg_endo -74.27 -12.49 23.14 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.094 1.862 . . . . 0.72 110.678 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 27.0 m-85 -93.45 154.31 18.0 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.839 -0.8 . . . . 1.05 108.839 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 19.5 p -69.67 -33.56 72.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.296 -0.878 . . . . 1.33 109.699 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 166.76 25.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 1.65 109.773 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -70.34 -38.01 74.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.59 -0.694 . . . . 3.5 109.672 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -41.67 95.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.212 -0.662 . . . . 2.82 109.212 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.29 -48.09 82.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.102 -0.703 . . . . 1.27 109.102 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 25.2 tt0 -62.11 -35.87 80.03 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.906 -0.776 . . . . 1.16 108.906 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 4.7 tp -63.19 -65.53 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.976 -0.75 . . . . 0.96 108.976 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.4 mm -51.02 -32.0 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.596 -0.69 . . . . 1.39 110.219 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.09 -40.94 74.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.744 . . . . 1.52 109.913 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mm? -65.23 -58.49 5.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.082 -0.71 . . . . 1.65 109.082 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 29.34 5.23 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.683 -0.967 . . . . 1.41 110.683 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -130.67 40.74 3.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.504 -0.998 . . . . 2.31 109.286 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.501 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.439 -0.788 . . . . 1.19 109.613 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.11 -0.7 . . . . 1.9 109.11 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 17' ' ' VAL . 21.5 p -124.85 123.37 39.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.346 -0.846 . . . . 1.16 109.796 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.89 133.12 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.306 -0.627 . . . . 0.93 109.306 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -93.3 136.91 33.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.557 -0.714 . . . . 1.35 110.15 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 12.2 t -65.05 118.02 45.15 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.307 -0.627 . . . . 0.89 109.307 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 -7.7 16.23 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.676 2.251 . . . . 1.17 111.425 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.9 m -94.92 -56.08 2.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.268 -0.895 . . . . 1.18 110.091 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -104.77 -29.86 10.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.412 -0.805 . . . . 1.35 110.905 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.01 86.17 1.87 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.324 -1.511 . . . . 1.16 109.324 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.47 124.83 8.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.836 -0.803 . . . . 1.53 109.73 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.5 m -75.2 110.95 9.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.563 -0.711 . . . . 1.12 109.841 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 28' ' ' CYS . 73.2 t -113.42 119.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.656 -0.868 . . . . 0.61 108.656 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 6' ' ' THR . 13.9 p -63.66 137.69 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.465 0.65 . . . . 0.62 109.635 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 22' ' ' SER . 73.9 t-105 -133.52 154.6 50.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 1.33 109.634 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 21' ' ' ILE . . . 100.69 93.88 2.15 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.434 -1.467 . . . . 1.07 109.434 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.57 24.81 14.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.929 -0.748 . . . . 2.59 110.364 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 6.4 tt -177.53 103.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.732 -0.84 . . . . 1.18 108.732 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 18' ' ' TRP . 16.7 p -127.81 91.7 44.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 1.65 110.107 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 -38.27 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.662 2.241 . . . . 0.92 110.128 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.78 35.26 4.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.746 -0.596 . . . . 1.57 109.716 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' O ' HG11 ' A' ' 16' ' ' VAL . 2.4 mtm105 65.77 178.28 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.62 -0.675 . . . . 2.98 110.859 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 36.4 Cg_endo -78.21 14.05 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.807 2.338 . . . . 0.97 111.47 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' A' ' 33' ' ' GLN . 26.2 m-85 -131.03 -69.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 1.27 109.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.702 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 0.4 OUTLIER 168.74 -38.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.179 -0.674 . . . . 0.92 109.179 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.31 174.35 11.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.729 -0.607 . . . . 1.11 109.953 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -46.74 70.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 3.45 109.519 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -43.19 93.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.92 -0.487 . . . . 3.39 109.933 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.7 m -59.85 -44.75 93.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.654 . . . . 0.87 109.322 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CD2' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -66.32 -33.17 75.13 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.074 -0.713 . . . . 1.46 109.074 179.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.595 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.0 tp -61.53 -62.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.403 -0.962 . . . . 0.82 108.403 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mt -50.9 -29.93 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.825 -0.547 . . . . 1.14 110.128 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -30.83 70.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 1.49 110.558 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.4 mt -72.33 -58.98 2.97 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.353 -0.842 . . . . 1.52 109.055 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.68 24.67 5.74 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.464 -0.874 . . . . 1.19 111.335 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 42.02 3.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.217 -1.167 . . . . 1.81 109.035 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.595 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 11.8 m95 . . . . . 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 1.16 109.567 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.394 -0.595 . . . . 1.69 109.394 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.544 HG22 ' HA ' ' A' ' 17' ' ' VAL . 6.7 p -140.68 123.6 16.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.537 -0.727 . . . . 1.01 109.897 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 71.6 t -97.86 123.99 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.981 -0.748 . . . . 1.11 108.981 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.95 134.23 34.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.556 -0.715 . . . . 1.33 110.027 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.9 t -68.78 120.26 74.74 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 109.162 -0.681 . . . . 0.81 109.162 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -9.05 16.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.712 2.274 . . . . 1.21 111.781 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.7 m -89.15 -51.47 5.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.244 -0.91 . . . . 1.27 110.071 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.77 -23.68 12.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.515 -0.741 . . . . 1.42 110.844 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.9 79.03 1.27 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.464 -1.855 . . . . 1.29 108.464 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -147.73 134.26 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.886 -0.773 . . . . 3.85 109.886 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -76.63 111.58 12.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 1.08 109.691 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.19 138.48 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.7 p -64.1 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.396 -0.815 . . . . 0.89 110.039 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.489 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -115.55 153.13 31.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.468 -0.568 . . . . 1.52 109.468 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.58 -104.89 1.08 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.484 -1.447 . . . . 1.61 109.484 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 53.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.743 -0.857 . . . . 3.62 109.652 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.84 -53.69 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.406 -0.809 . . . . 1.52 109.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.4 m -94.19 165.72 17.04 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.684 -0.635 . . . . 1.41 109.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 34.7 Cg_endo -76.47 -23.83 11.1 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.705 2.27 . . . . 1.77 110.702 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' HZ ' ' HG2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -120.48 74.36 1.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.708 . . . . 1.78 109.181 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -58.17 -55.97 39.86 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.606 -0.684 . . . . 1.97 109.947 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.67 123.9 6.65 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 122.363 2.042 . . . . 1.12 109.721 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 43.9 m-85 66.01 167.1 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.334 0.588 . . . . 0.75 109.653 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.79 -31.37 15.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 1.09 110.208 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -144.15 163.97 32.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 1.32 110.24 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.14 -32.01 73.29 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 2.05 109.323 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -50.43 70.17 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.913 -0.492 . . . . 5.45 109.979 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 2.7 m -56.44 -48.44 77.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.692 -0.63 . . . . 1.13 109.815 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -64.15 -37.52 87.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 1.82 109.44 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.6 tp -62.3 -66.9 0.47 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.89 -0.781 . . . . 1.33 108.89 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.2 mt -50.43 -29.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.828 -0.545 . . . . 1.38 110.697 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.85 -42.5 68.61 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.454 -0.779 . . . . 1.21 110.287 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.41 -58.34 6.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.494 -0.754 . . . . 1.54 109.056 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.49 22.39 6.77 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 120.624 -0.798 . . . . 1.49 111.277 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.65 40.01 3.62 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.349 -1.089 . . . . 2.07 109.224 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.496 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 2.6 m95 . . . . . 0 N--CA 1.5 2.073 0 O-C-N 121.581 -0.699 . . . . 1.41 109.318 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HE2' ' HB2' ' A' ' 3' ' ' GLU . 16.3 ttp . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.161 0.505 . . . . 6.33 109.685 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.85 39.28 0.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.795 -1.187 . . . . 3.38 107.795 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 0.4 OUTLIER -60.71 121.73 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 3.34 111.598 -178.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.7 m -100.71 101.03 11.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.65 -1.611 . . . . 1.98 106.65 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 18' ' ' TRP . 4.3 pt -77.22 149.3 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.618 -0.882 . . . . 2.46 108.618 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.973 HG22 ' HA ' ' A' ' 17' ' ' VAL . 20.1 p -120.41 120.57 36.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.674 . . . . 2.59 110.474 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.34 132.93 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.495 -0.928 . . . . 2.14 108.495 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -91.41 135.28 33.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 3.63 110.286 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.4 t -66.68 118.27 52.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.791 -0.818 . . . . 2.51 108.791 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.9 Cg_endo -76.35 -15.65 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.524 2.149 . . . . 3.02 111.849 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.84 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 87.7 m -81.17 -50.39 9.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.227 -0.921 . . . . 2.59 110.708 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.9 p -110.78 -26.1 9.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.37 -0.831 . . . . 3.12 110.789 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.18 74.4 1.26 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.839 -1.705 . . . . 3.36 108.839 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 28' ' ' CYS . 6.2 tmtt? -140.08 128.62 22.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.063 -0.669 . . . . 3.22 109.521 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 m -70.6 115.86 10.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.635 -0.666 . . . . 3.42 109.75 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 24' ' ' PHE . 19.5 t -116.93 123.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.926 -0.768 . . . . 1.82 108.926 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.973 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.8 p -53.07 136.95 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.28 0.562 . . . . 1.6 110.322 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.527 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.7 t-105 -112.11 156.59 22.0 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.647 -0.658 . . . . 2.59 109.809 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.76 -100.64 0.91 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.869 -1.692 . . . . 2.11 108.869 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.89 57.42 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.848 -0.795 . . . . 4.29 109.226 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.35 -52.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.594 -0.691 . . . . 3.09 109.366 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.1 m -93.47 166.77 15.33 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 2.6 110.007 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 36.2 Cg_endo -78.27 -32.87 2.16 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.488 2.126 . . . . 3.45 109.753 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.594 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -113.96 66.68 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.37 -0.604 . . . . 3.05 109.37 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.582 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -51.69 -55.43 29.96 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.282 -0.886 . . . . 3.52 109.322 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.2 Cg_endo -77.73 119.96 4.98 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.253 1.969 . . . . 2.2 109.545 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 82.8 m-85 68.0 159.45 0.16 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.345 0.593 . . . . 1.96 110.051 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 32.0 p -90.28 -35.4 15.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 1.4 110.0 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.83 165.6 24.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.455 -0.778 . . . . 1.98 109.543 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -72.4 -36.83 68.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.531 -0.73 . . . . 3.52 109.887 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -34.85 72.04 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.397 -0.814 . . . . 2.06 108.893 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.596 ' HA ' HG21 ' A' ' 11' ' ' THR . 33.8 m -66.85 -56.15 11.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -58.11 -33.7 69.39 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.103 -0.702 . . . . 2.27 109.103 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.56 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 6.9 tp -62.84 -65.77 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.734 -0.839 . . . . 2.11 108.734 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.685 HG21 ' HB2' ' A' ' 60' ' ' SER . 40.2 mt -49.5 -28.41 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.75 -0.593 . . . . 2.03 110.301 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HA ' ' OE1' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -59.22 -39.64 83.34 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.446 -0.784 . . . . 2.82 110.458 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -64.0 -60.0 3.8 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.793 -0.817 . . . . 2.95 108.793 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.7 24.63 5.19 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.912 -0.875 . . . . 2.71 110.912 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -126.1 40.6 3.7 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.329 -1.1 . . . . 3.4 109.215 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.5 m95 -137.43 -179.14 5.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.537 -0.727 . . . . 2.8 109.681 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.47 84.94 2.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -0.789 . . . . 1.72 109.595 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB3' HG12 ' A' ' 35' ' ' ILE . . . -162.71 59.36 0.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 1.46 109.512 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.91 77.85 0.2 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.55 -0.719 . . . . 2.23 109.666 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -167.73 -38.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.324 -0.86 . . . . 2.02 110.858 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.52 117.95 12.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 3.86 109.646 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 128.08 41.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.633 -0.667 . . . . 2.71 110.024 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.56 99.1 51.49 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.796 -0.565 . . . . 2.96 109.588 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HG3' ' HB2' ' A' ' 53' ' ' LEU . 31.2 Cg_endo -75.33 171.05 19.01 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.887 2.391 . . . . 1.76 111.91 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.29 -32.79 74.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.879 -0.513 . . . . 3.11 110.03 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.13 -41.33 83.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.281 -0.887 . . . . 3.38 108.793 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.76 -104.74 0.25 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.029 -1.628 . . . . 3.3 109.029 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 124.53 36.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.821 -0.811 . . . . 3.77 109.658 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -126.65 139.46 53.15 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.521 -0.737 . . . . 4.99 110.876 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.74 81.28 0.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.455 0.645 . . . . 4.3 110.393 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.37 129.95 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.484 -0.932 . . . . 4.82 108.484 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 59' ' ' TRP . 0.6 OUTLIER 67.29 67.73 0.39 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.465 0.65 . . . . 3.47 109.662 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -136.82 112.16 9.19 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.802 . . . . 3.41 108.985 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 66.57 94.98 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.401 0.62 . . . . 1.35 109.5 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.417 ' HE1' ' HA ' ' A' ' 56' ' ' SER . 7.1 m-90 -100.64 167.79 10.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.532 -0.73 . . . . 2.04 109.732 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.685 ' HB2' HG21 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -67.33 -39.44 85.82 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.754 -0.832 . . . . 2.27 108.754 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.84 ' HG3' ' HA ' ' A' ' 11' ' ' THR . 2.4 mp0 -67.98 -57.82 5.54 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.577 0.703 . . . . 2.99 109.18 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -124.82 107.45 28.73 Favored Pre-proline 0 N--CA 1.485 1.312 0 CA-C-N 116.169 -0.469 . . . . 1.88 109.867 -178.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.547 ' O ' ' HD2' ' A' ' 64' ' ' LYS . 30.3 Cg_endo -76.11 -49.11 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.367 2.045 . . . . 2.49 110.768 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 63' ' ' PRO . 8.4 tptt -154.48 133.32 12.26 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.478 -0.764 . . . . 4.48 110.257 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 2.8 tt0 . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 117.768 -1.11 . . . . 3.73 109.864 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.66 -0.496 . . . . 4.49 109.66 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.76 -50.54 5.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.292 -0.88 . . . . 3.08 109.034 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.8 OUTLIER -102.28 120.17 40.03 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.574 -0.899 . . . . 2.7 108.574 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 88.4 m 68.13 130.67 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.314 0.578 . . . . 1.43 109.836 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt -79.17 150.17 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.288 -0.882 . . . . 1.28 109.934 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.752 HG22 ' HA ' ' A' ' 17' ' ' VAL . 34.2 p -122.42 128.36 50.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 1.27 109.908 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.3 m -91.2 138.36 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.89 109.371 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.89 137.15 33.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.766 . . . . 1.96 110.097 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.68 120.72 75.48 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 109.095 -0.705 . . . . 1.07 109.095 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 -2.21 12.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.704 2.269 . . . . 1.33 112.05 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.6 m -98.78 -51.31 3.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.147 -0.971 . . . . 1.07 110.023 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.3 p -107.54 -30.03 8.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.617 -0.677 . . . . 1.51 110.763 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 71.16 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.814 -1.714 . . . . 1.65 108.814 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 135.08 40.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.786 -0.832 . . . . 2.03 109.66 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -76.54 112.27 12.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.566 -0.709 . . . . 1.59 109.685 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.26 127.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.853 -0.795 . . . . 0.9 108.853 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.752 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.6 p -60.68 137.86 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.705 . . . . 1.24 110.371 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.535 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 76.1 t-105 -106.92 156.02 19.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.776 -0.577 . . . . 1.24 109.543 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.33 -179.23 26.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.744 -1.342 . . . . 1.21 109.744 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.15 103.65 3.96 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.583 -0.951 . . . . 4.41 109.721 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 tt -174.99 -40.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.748 -0.595 . . . . 1.92 109.761 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.75 157.23 50.58 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 1.68 109.651 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.23 -35.61 2.23 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.579 2.186 . . . . 2.14 110.681 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -110.26 68.52 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.519 -0.738 . . . . 2.01 109.066 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.698 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -56.06 -54.17 55.32 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.599 -0.688 . . . . 1.63 109.854 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.698 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -78.0 128.69 9.3 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.291 1.994 . . . . 1.22 109.44 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 62.0 m-85 65.54 173.48 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.373 0.606 . . . . 0.96 109.661 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -104.08 -31.88 9.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.897 . . . . 1.16 110.341 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -138.41 164.21 29.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.328 -0.858 . . . . 1.2 110.419 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -38.66 90.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.661 . . . . 2.07 109.487 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -42.0 98.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 2.29 109.897 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -59.38 -50.35 74.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.582 -0.699 . . . . 0.75 109.304 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.04 -35.32 78.23 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.169 -0.678 . . . . 1.65 109.169 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 10.5 tp -66.04 -66.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.24 -0.652 . . . . 1.78 109.24 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 mt -50.2 -30.93 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.634 -0.666 . . . . 0.88 110.542 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -52.8 -41.67 64.37 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.598 -0.688 . . . . 1.39 110.081 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.5 -59.11 4.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.943 -0.762 . . . . 2.0 108.943 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.05 26.71 5.39 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.992 -0.843 . . . . 1.65 110.992 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.32 47.21 2.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 2.51 109.118 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 7.7 m95 -140.02 -54.4 0.53 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.512 -0.743 . . . . 2.1 109.93 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 58.08 53.1 6.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.906 -0.775 . . . . 1.58 108.906 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.5 -37.18 7.69 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.858 -0.793 . . . . 1.63 108.858 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.79 103.37 12.97 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.224 -0.658 . . . . 3.75 109.224 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -147.5 88.83 1.73 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.327 -0.858 . . . . 3.72 110.587 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -118.19 78.05 1.22 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.508 -0.923 . . . . 3.62 108.508 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.41 173.89 9.81 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.241 0.543 . . . . 3.65 110.019 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pt -91.8 128.66 45.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.579 -0.897 . . . . 4.06 108.579 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' HD2' HD13 ' A' ' 53' ' ' LEU . 32.0 Cg_endo -72.63 -41.41 1.61 Allowed 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 122.535 2.157 . . . . 3.4 110.704 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.38 130.78 21.02 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.964 -0.754 . . . . 3.27 108.964 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.1 p -82.59 160.25 22.56 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 3.48 109.604 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 55' ' ' GLU . . . 97.41 -36.36 3.97 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.182 -1.567 . . . . 2.51 109.182 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.66 -39.24 5.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.758 -0.848 . . . . 2.9 109.797 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -98.19 -59.4 1.76 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.586 -0.696 . . . . 4.01 109.832 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.49 -55.39 18.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.833 -0.542 . . . . 4.51 110.229 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -86.88 126.07 34.42 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.332 0.587 . . . . 3.27 110.559 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.18 -51.67 2.93 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.751 -0.833 . . . . 4.11 108.751 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 96.55 7.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 4.44 108.785 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.88 135.61 57.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 2.25 108.379 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.588 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 7.4 m95 -96.85 56.34 1.44 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.657 -0.817 . . . . 5.18 112.414 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 61' ' ' GLU . 9.2 p -77.68 59.44 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.055 -1.461 . . . . 3.63 107.055 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.537 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 2.0 mp0 -10.17 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 113.011 0.745 . . . . 7.25 113.011 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -107.5 91.25 6.86 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 121.329 -0.857 . . . . 5.92 111.069 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 61' ' ' GLU . 34.0 Cg_endo -75.49 -22.28 14.14 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.246 1.297 . . . . 3.91 110.117 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 168.61 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 118.714 0.688 . . . . 6.91 111.112 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.817 -1.087 . . . . 5.82 110.464 178.059 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.79 -0.448 . . . . 3.12 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -103.25 -48.11 4.11 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.638 -0.664 . . . . 1.87 110.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 64.18 94.11 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.379 0.609 . . . . 1.84 109.747 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 m -96.52 124.7 40.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.569 -0.707 . . . . 1.21 109.476 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.2 pt -95.44 165.69 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.686 . . . . 1.22 109.552 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 17' ' ' VAL . 45.1 p -126.17 130.68 51.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.408 -0.808 . . . . 1.17 110.046 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 18' ' ' TRP . 42.8 t -97.49 131.08 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.286 -0.635 . . . . 1.07 109.286 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.07 140.46 36.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.563 -0.711 . . . . 1.87 109.804 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 16.1 t -73.01 125.48 91.04 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.71 -0.619 . . . . 1.36 109.519 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.57 -3.71 13.54 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.809 2.339 . . . . 1.89 111.783 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HB ' ' A' ' 35' ' ' ILE . 55.5 m -97.39 -54.89 3.0 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.237 -0.914 . . . . 1.57 109.901 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.9 p -102.07 -30.71 11.02 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.585 -0.697 . . . . 1.59 110.688 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.45 62.59 1.09 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.346 -1.502 . . . . 1.46 109.346 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 140.46 46.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.877 -0.778 . . . . 2.79 109.341 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 m -73.71 116.61 14.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.45 109.827 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.7 t -116.0 137.47 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.136 -0.69 . . . . 0.96 109.136 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.6 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -58.87 139.46 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.429 -0.795 . . . . 0.92 110.256 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 57.5 t-105 -116.47 152.72 33.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 1.19 109.646 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 -145.46 16.61 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.686 -1.366 . . . . 1.19 109.686 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.75 89.02 2.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.454 -1.027 . . . . 1.99 109.344 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -153.8 -42.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.66 -0.65 . . . . 1.24 110.073 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 55.8 p -131.4 161.24 63.23 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.524 -0.735 . . . . 0.98 109.818 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.91 -15.82 18.59 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.737 2.291 . . . . 1.16 110.679 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 27' ' ' PHE . 61.8 m-85 -119.41 76.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.485 -0.931 . . . . 1.15 108.485 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.695 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -73.9 -48.91 6.18 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 2.1 110.483 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.69 -43.03 0.23 Allowed 'Trans proline' 0 C--N 1.326 -0.657 0 C-N-CA 122.171 1.914 . . . . 1.1 111.015 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' PHE . 97.4 m-85 -99.08 163.66 12.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.671 -0.643 . . . . 1.17 109.809 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -80.38 -49.95 10.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.365 -0.834 . . . . 1.15 109.507 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.49 -172.8 3.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.669 -0.644 . . . . 1.23 110.074 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -36.13 82.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.532 -0.73 . . . . 2.46 110.165 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -64.57 -41.04 96.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.645 -0.66 . . . . 1.86 110.3 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 43.7 m -58.95 -48.23 82.27 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.122 -0.696 . . . . 1.22 109.122 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -66.4 -33.76 76.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.641 -0.662 . . . . 1.76 109.227 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.8 tp -62.2 -66.63 0.51 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 1.36 109.328 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 48' ' ' PRO . 11.4 mt -50.13 -30.27 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.605 -0.684 . . . . 1.58 110.356 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -56.53 -43.54 79.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.452 -0.78 . . . . 1.62 110.289 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.69 -61.18 2.7 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.847 -0.797 . . . . 1.91 108.847 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.57 18.84 8.22 Favored Glycine 0 N--CA 1.499 2.85 0 C-N-CA 120.457 -0.878 . . . . 1.89 111.339 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.14 40.22 3.37 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.284 -1.127 . . . . 2.52 109.284 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 8.2 m95 -132.36 133.03 43.49 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.814 -0.81 . . . . 1.85 108.814 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . . . -96.14 153.28 17.88 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.537 -0.727 . . . . 1.8 111.113 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . . . -91.67 -45.03 8.68 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.986 -0.746 . . . . 3.35 108.986 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.01 -48.46 57.99 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 120.988 0.423 . . . . 5.57 110.371 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -58.52 -46.07 87.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.801 -0.562 . . . . 4.37 111.271 -178.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -174.37 142.56 0.79 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.415 -0.803 . . . . 2.28 110.977 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 5.0 ttp180 64.62 122.12 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.422 0.629 . . . . 2.16 110.362 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.29 113.29 59.64 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.441 -0.787 . . . . 2.06 109.706 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 35.0 Cg_endo -77.63 56.25 5.52 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.737 2.291 . . . . 2.21 109.866 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.21 137.26 28.86 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.04 -0.726 . . . . 2.27 109.04 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.49 -59.56 2.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.647 -0.658 . . . . 4.55 109.335 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.7 85.21 0.39 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.079 -1.208 . . . . 2.66 110.079 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.89 155.92 17.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.743 -0.857 . . . . 2.41 109.426 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.63 80.67 1.98 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.415 -0.803 . . . . 2.78 110.058 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 -53.4 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.518 -0.919 . . . . 3.14 108.518 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -78.38 115.67 18.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.407 -0.59 . . . . 4.54 109.407 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.3 171.31 0.26 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.518 0.675 . . . . 3.21 110.353 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 -12.95 17.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.699 -0.626 . . . . 3.12 110.581 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.26 27.25 8.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.287 -0.883 . . . . 5.03 110.001 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -96.51 131.0 43.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.064 -1.022 . . . . 4.03 109.739 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -41.88 81.77 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.29 -0.633 . . . . 2.39 109.29 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 0.6 OUTLIER 55.69 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.78 -0.822 . . . . 3.1 108.78 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.3 mp0 66.54 79.69 0.23 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.98 -1.118 . . . . 4.47 107.98 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.75 93.5 0.78 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.475 2.116 . . . . 4.67 110.332 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -133.14 124.34 27.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.054 -0.721 . . . . 5.92 109.054 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.903 -1.046 . . . . 6.4 109.631 -179.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 109.295 -0.631 . . . . 5.3 109.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 3' ' ' GLU . 8.7 m 52.85 84.76 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.263 0.554 . . . . 4.2 109.654 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -37.19 106.46 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.593 0.711 . . . . 3.32 110.193 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.607 HG22 ' CG2' ' A' ' 17' ' ' VAL . 1.6 m -65.0 95.27 0.15 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.384 0.611 . . . . 2.42 111.26 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.67 123.79 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.139 -1.06 . . . . 1.62 108.139 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 25.3 p -88.41 121.3 30.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.06 110.385 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 26' ' ' PRO . 22.7 t -112.13 115.07 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.509 -0.923 . . . . 1.03 108.509 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 5.7 p-10 -81.59 145.23 30.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 1.09 110.335 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 8.6 t -74.85 121.79 86.05 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.709 -0.619 . . . . 0.79 109.331 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.87 -8.29 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.672 2.248 . . . . 1.38 111.537 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.0 m -93.6 -56.84 2.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 1.65 109.83 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.1 p -98.01 -31.56 12.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.441 -0.787 . . . . 1.34 110.755 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.34 69.96 1.03 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.258 -1.537 . . . . 1.11 109.258 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -139.78 117.33 11.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.839 -0.8 . . . . 1.48 109.389 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 9.0 m -69.36 107.15 3.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.596 -0.69 . . . . 0.77 109.517 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.997 HG21 ' HA ' ' A' ' 28' ' ' CYS . 87.7 t -104.65 105.84 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.925 -0.769 . . . . 0.79 108.925 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 4' ' ' THR . 7.3 p -63.72 114.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.439 0.637 . . . . 1.53 109.309 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.52 ' CZ3' ' HA ' ' A' ' 25' ' ' ARG . 14.5 t-105 -86.92 147.25 25.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.505 -0.747 . . . . 2.05 110.052 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.46 -87.54 0.21 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.011 -1.635 . . . . 2.34 109.011 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 35.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.801 -0.823 . . . . 3.02 109.796 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -117.27 -56.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 2.32 109.572 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.511 ' HB2' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -104.1 118.05 57.96 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.641 -0.662 . . . . 1.79 109.491 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.8 46.14 2.14 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.856 2.371 . . . . 1.84 110.479 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -117.72 24.25 11.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 1.74 109.741 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 63.26 174.37 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.638 -0.664 . . . . 1.48 110.631 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 31.7 Cg_endo -71.74 -18.33 28.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 122.153 1.902 . . . . 1.45 111.1 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.39 -69.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.181 -0.95 . . . . 1.34 108.803 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.997 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 167.59 -40.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.155 -0.683 . . . . 0.72 109.155 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.75 159.81 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.749 -0.594 . . . . 1.08 109.485 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -62.69 -38.6 91.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 3.0 109.875 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -38.0 62.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.659 -0.65 . . . . 2.22 110.185 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 4.3 m -60.23 -49.42 77.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.56 -0.713 . . . . 1.33 109.643 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 2.01 109.22 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 8.3 tp -63.86 -66.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.969 -0.752 . . . . 1.77 108.969 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 mt -50.28 -30.38 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.747 -0.596 . . . . 1.79 110.121 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -44.75 63.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.691 . . . . 1.9 110.299 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 4.7 mt -65.94 -58.09 6.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.757 -0.831 . . . . 2.47 108.757 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.44 26.0 6.1 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 111.001 -0.839 . . . . 2.55 111.001 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.71 42.77 3.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.391 -1.064 . . . . 2.95 108.823 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.503 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 6.8 m95 -138.12 -58.4 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.676 -0.64 . . . . 2.63 109.446 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.81 120.79 43.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.438 -0.578 . . . . 2.54 109.438 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.46 73.99 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.442 -0.786 . . . . 3.71 109.489 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 50' ' ' SER . 1.6 mp0 -98.03 -53.35 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.434 -0.791 . . . . 3.85 109.427 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -149.93 62.4 0.99 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 3.02 108.876 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -103.95 110.47 22.63 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.698 -0.626 . . . . 4.05 109.553 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.17 19.41 10.0 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.673 -0.642 . . . . 4.58 111.075 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 pt -133.47 149.27 71.82 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.978 -1.076 . . . . 2.58 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.27 -42.12 0.41 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.887 2.391 . . . . 2.19 109.972 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -139.18 144.81 38.72 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.787 -0.82 . . . . 2.44 108.787 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 1.5 p -96.57 -69.47 0.75 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.309 -0.869 . . . . 3.74 110.559 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.61 -79.78 0.09 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.522 -1.431 . . . . 2.76 109.522 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 7.9 t70 -110.28 149.89 29.52 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.294 -1.002 . . . . 2.42 108.294 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.69 143.6 29.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.437 -0.789 . . . . 2.52 111.821 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.83 74.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.681 0.753 . . . . 2.59 109.224 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.66 151.2 32.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.798 -0.564 . . . . 4.13 110.474 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.88 82.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.571 0.7 . . . . 3.41 110.059 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.48 109.3 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.665 -0.865 . . . . 3.08 108.665 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -115.08 153.94 29.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.435 -0.791 . . . . 3.57 110.969 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -123.49 -49.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.692 -0.485 . . . . 5.23 109.692 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 p -67.51 130.11 42.0 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.767 -0.827 . . . . 2.8 108.767 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.67 125.2 18.92 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.586 -0.696 . . . . 3.1 110.248 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.17 91.93 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.259 -0.645 . . . . 3.9 109.259 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 37.1 Cg_endo -75.77 150.17 34.6 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.912 2.408 . . . . 4.03 110.663 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -52.2 -31.32 31.23 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.043 -0.725 . . . . 5.62 109.043 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.492 -0.755 . . . . 7.37 109.119 178.208 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.42 -0.585 . . . . 5.79 109.42 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.85 74.48 1.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.175 -0.676 . . . . 3.74 109.175 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.3 112.65 24.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.532 -0.73 . . . . 2.62 109.162 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -75.98 98.73 4.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.683 -0.636 . . . . 1.72 109.477 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 pt -83.56 156.71 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.493 -0.754 . . . . 1.76 109.166 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 17' ' ' VAL . 29.9 p -117.51 121.11 40.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.34 -0.85 . . . . 1.12 109.926 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.83 132.64 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.64 -0.662 . . . . 1.12 109.251 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.59 132.9 36.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.396 -0.815 . . . . 1.78 109.977 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 t -64.32 120.3 63.77 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.036 -0.727 . . . . 1.39 109.036 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.53 -10.37 17.3 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.694 2.262 . . . . 1.8 111.877 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.4 m -89.13 -51.0 5.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.242 -0.911 . . . . 1.74 110.194 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.9 p -108.21 -29.83 8.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.485 -0.76 . . . . 1.52 110.821 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.92 78.4 1.41 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.905 -1.678 . . . . 1.43 108.905 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -142.96 136.12 28.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.881 -0.776 . . . . 2.77 109.786 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.7 m -79.39 112.85 17.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.669 . . . . 0.99 109.681 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.56 132.27 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.828 -0.804 . . . . 0.77 108.828 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.605 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.2 p -60.5 139.01 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.574 -0.704 . . . . 1.01 110.167 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.536 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.0 t-105 -118.58 148.26 42.86 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.776 -0.577 . . . . 1.72 109.546 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.09 -97.49 0.42 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.669 -1.372 . . . . 1.7 109.669 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.96 52.47 0.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.848 . . . . 2.82 109.573 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.422 HD13 ' CG2' ' A' ' 17' ' ' VAL . 3.3 mp -118.05 -59.59 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 1.57 109.645 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -91.77 164.76 22.7 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.737 -0.602 . . . . 1.26 109.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.68 -40.62 0.71 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.565 2.177 . . . . 1.33 110.358 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.92 64.61 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.981 -0.748 . . . . 1.02 108.981 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.612 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.3 mtm180 -56.61 -52.28 74.72 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.549 -0.72 . . . . 2.5 110.088 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.09 124.23 7.8 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.162 1.908 . . . . 1.02 109.459 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 47.2 m-85 65.96 173.95 0.23 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.469 -0.567 . . . . 1.31 109.469 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -102.15 -29.83 11.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.246 -0.909 . . . . 1.01 110.147 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.31 163.7 32.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.372 -0.83 . . . . 1.51 110.087 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -35.39 80.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.59 -0.694 . . . . 1.51 109.891 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -65.79 -44.71 84.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.667 -0.646 . . . . 4.05 110.129 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.59 -46.26 84.26 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.75 -0.833 . . . . 1.35 108.75 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -66.01 -34.81 78.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.127 -0.694 . . . . 1.54 109.127 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' A' ' 40' ' ' TRP . 9.9 tp -63.76 -67.28 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.125 -0.695 . . . . 1.94 109.125 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.853 HG23 ' HB3' ' A' ' 44' ' ' GLU . 14.1 mt -49.16 -33.08 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.759 -0.588 . . . . 1.84 110.298 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.78 -42.1 71.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 2.01 110.266 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -61.68 -60.84 3.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 2.92 109.015 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.15 22.35 5.93 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 120.407 -0.902 . . . . 2.52 111.353 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.75 41.35 3.5 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.29 -1.123 . . . . 3.06 109.212 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD1' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 -139.34 168.25 20.26 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.431 -0.793 . . . . 2.38 109.888 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.61 72.88 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.479 -0.763 . . . . 2.28 109.311 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.55 50.2 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.561 -0.712 . . . . 1.73 109.467 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.43 76.37 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.6 0.714 . . . . 2.96 110.02 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.853 ' HB3' HG23 ' A' ' 35' ' ' ILE . 7.2 pt-20 -150.33 26.61 0.77 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.664 -0.647 . . . . 2.12 109.646 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -123.04 145.73 48.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 2.34 110.397 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -49.85 39.67 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.381 -0.97 . . . . 6.25 108.381 178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.87 152.47 84.74 Favored Pre-proline 0 N--CA 1.498 1.931 0 CA-C-N 116.423 -0.353 . . . . 2.48 110.202 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 58' ' ' ASP . 35.9 Cg_endo -77.32 118.2 4.58 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.768 2.312 . . . . 2.33 109.989 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -62.54 -50.21 72.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.566 -0.709 . . . . 2.67 109.806 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -82.65 -43.45 16.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.604 . . . . 2.16 109.808 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.24 -78.38 0.35 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.931 -1.268 . . . . 2.22 109.931 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.55 43.26 3.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.69 -0.888 . . . . 2.7 109.585 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 50' ' ' SER . 0.2 OUTLIER -106.62 122.88 47.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 3.39 109.525 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.8 -170.06 0.15 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.319 0.58 . . . . 2.93 110.473 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.855 ' HG2' ' HB3' ' A' ' 65' ' ' GLN . 2.0 mt-10 -86.71 129.99 34.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.548 -0.72 . . . . 4.01 110.476 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER 67.01 117.25 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.513 0.673 . . . . 2.91 110.848 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -117.61 92.83 3.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.668 . . . . 2.09 109.203 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER 74.91 -14.65 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.961 -0.462 . . . . 2.49 111.386 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -131.08 128.46 40.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.981 -1.074 . . . . 3.12 109.328 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -77.55 -32.58 54.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.805 -0.559 . . . . 2.71 110.414 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.13 85.35 5.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.412 -0.805 . . . . 2.74 110.163 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.86 129.56 24.91 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.297 -0.877 . . . . 3.73 108.939 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -73.25 -19.38 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.507 2.138 . . . . 5.18 110.892 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.77 -54.77 3.01 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.4 -0.812 . . . . 7.86 109.534 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.855 ' HB3' ' HG2' ' A' ' 55' ' ' GLU . 2.6 mm100 . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 117.902 -1.047 . . . . 4.59 110.512 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.156 0.503 . . . . 3.66 109.698 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 p -81.27 -50.65 9.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.512 -0.743 . . . . 3.3 109.404 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.48 95.07 7.39 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.035 -0.728 . . . . 3.06 109.035 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 m -110.09 116.65 31.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.635 -0.666 . . . . 2.25 109.738 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.488 HD11 ' CD1' ' A' ' 18' ' ' TRP . 2.0 pt -84.52 152.94 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 2.2 109.675 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.777 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -121.38 126.48 49.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.625 -0.672 . . . . 2.62 109.801 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 18' ' ' TRP . 35.9 m -90.76 134.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 1.9 109.262 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.0 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.525 -0.735 . . . . 3.18 110.254 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 t -67.93 119.79 69.32 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.025 -0.731 . . . . 2.2 109.025 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.43 -10.1 17.44 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 122.71 2.274 . . . . 2.54 111.819 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 m -88.1 -52.05 5.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.168 -0.957 . . . . 2.06 110.044 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.5 p -109.26 -30.07 8.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.522 -0.737 . . . . 2.42 110.78 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.1 73.57 1.12 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 108.894 -1.682 . . . . 2.71 108.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 129.36 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.892 -0.77 . . . . 2.65 109.791 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -72.86 114.44 11.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.529 -0.732 . . . . 3.02 109.661 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 24' ' ' PHE . 23.8 t -116.18 127.35 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.151 -0.685 . . . . 1.89 109.151 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.5 p -58.43 138.81 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 1.96 110.453 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.549 ' HB2' HG13 ' A' ' 7' ' ' VAL . 76.7 t-105 -111.28 155.27 23.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.807 -0.558 . . . . 1.34 109.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.07 -103.82 0.97 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.258 -1.537 . . . . 1.18 109.258 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.82 51.46 0.55 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.807 . . . . 2.45 109.307 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.45 -55.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.764 . . . . 2.41 109.449 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 80.5 p -89.12 162.08 38.69 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.831 -0.543 . . . . 1.85 109.977 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -75.84 -30.52 5.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.567 2.178 . . . . 2.15 110.056 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.434 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -116.72 69.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.791 -0.818 . . . . 1.33 108.791 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -53.05 -54.64 42.04 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.412 -0.805 . . . . 2.31 110.044 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.14 123.02 6.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.226 1.951 . . . . 0.95 109.425 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 59.9 m-85 66.83 167.92 0.23 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.297 0.57 . . . . 1.68 109.689 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -96.41 -34.65 11.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.296 -0.877 . . . . 1.21 110.448 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.08 160.98 36.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.387 -0.821 . . . . 1.15 109.866 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -38.06 88.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.682 -0.637 . . . . 3.25 109.48 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.754 -0.591 . . . . 2.96 109.604 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -61.51 -52.01 66.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.35 -34.2 72.08 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.055 -0.72 . . . . 1.96 109.055 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.54 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.3 tp -65.85 -67.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.04 -0.726 . . . . 2.25 109.04 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.15 -29.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.659 -0.65 . . . . 2.14 110.546 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -53.71 -43.99 69.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.48 -0.762 . . . . 2.52 109.766 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -64.72 -58.29 6.67 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.882 -0.784 . . . . 3.1 108.882 179.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.73 26.39 5.59 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.79 -0.924 . . . . 3.16 110.79 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 23.1 mm-40 -124.44 40.77 3.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.424 -1.045 . . . . 3.73 109.505 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.54 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 5.0 m95 -137.23 -63.41 0.6 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.788 . . . . 3.03 109.473 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.78 121.04 42.8 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.235 -0.654 . . . . 2.78 109.235 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 59.22 85.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.546 0.688 . . . . 3.29 109.188 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -83.06 118.07 23.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.735 . . . . 3.83 109.984 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 46' ' ' ARG . 1.0 OUTLIER -89.97 102.56 15.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.03 -0.73 . . . . 4.06 109.03 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -119.6 106.76 12.49 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.613 -0.884 . . . . 4.61 108.613 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -95.66 94.95 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.346 0.593 . . . . 6.66 110.591 -178.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.83 97.01 21.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.578 -1.267 . . . . 3.1 107.578 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 29.2 Cg_endo -70.6 -20.46 30.87 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.921 1.748 . . . . 3.07 110.782 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.7 -144.88 0.51 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.931 -1.137 . . . . 1.88 107.931 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.75 ' OG ' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -111.45 121.59 45.61 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.068 -1.086 . . . . 2.78 108.068 178.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' SER . . . -35.7 -65.52 0.46 Allowed Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.435 -1.066 . . . . 3.51 110.435 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 57' ' ' ASP . 15.6 t70 -149.33 138.91 21.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.712 -0.875 . . . . 3.99 109.075 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.75 HD11 ' OG ' ' A' ' 50' ' ' SER . 3.8 mp -114.3 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 3.37 109.501 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -71.83 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.812 -0.44 . . . . 4.13 109.812 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.48 -53.77 1.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.565 -0.71 . . . . 4.21 110.266 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.05 133.33 42.91 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.583 -0.698 . . . . 3.65 110.337 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -71.57 -41.34 69.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.887 -0.508 . . . . 4.37 109.853 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.45 168.48 18.92 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.713 -0.617 . . . . 4.91 110.489 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -75.68 98.09 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.822 -1.177 . . . . 3.47 107.822 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.74 27.3 7.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.277 -0.89 . . . . 4.37 111.243 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.608 ' OE1' HD22 ' A' ' 53' ' ' LEU . 7.4 mp0 -89.44 -64.96 1.07 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.904 -1.122 . . . . 2.87 110.088 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 2.9 mp0 68.05 116.47 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.618 -1.253 . . . . 3.81 107.618 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.93 -48.72 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.374 2.05 . . . . 3.39 111.87 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -44.53 10.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.395 -0.816 . . . . 5.72 110.304 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.112 -0.946 . . . . 4.85 110.06 -179.671 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.458 -0.571 . . . . 5.05 109.458 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 126.89 39.65 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 3.64 109.252 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -105.61 130.94 53.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.607 . . . . 6.82 110.745 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 m -99.08 113.95 26.42 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.263 -1.014 . . . . 3.05 108.263 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.661 HD11 ' CD1' ' A' ' 18' ' ' TRP . 1.8 pt -78.44 163.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.396 -0.815 . . . . 2.7 109.022 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 17' ' ' VAL . 30.8 p -126.23 119.92 28.69 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.248 -0.908 . . . . 3.26 110.903 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.71 136.23 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.905 -0.776 . . . . 1.87 108.905 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -93.08 135.69 34.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.882 . . . . 3.37 110.299 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 24.3 t -65.04 119.44 58.57 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.998 -0.741 . . . . 2.08 108.998 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.429 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 34.4 Cg_endo -76.6 -6.31 16.85 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.685 2.257 . . . . 1.83 111.91 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.6 m -93.16 -52.41 4.57 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 2.03 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -108.31 -26.66 10.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.539 -0.726 . . . . 3.16 110.912 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.49 76.73 1.34 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.369 -1.892 . . . . 3.5 108.369 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.52 129.48 28.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.997 -0.708 . . . . 5.36 109.704 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 m -74.1 107.04 6.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.58 -0.7 . . . . 3.99 109.409 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -110.07 126.31 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.735 -0.603 . . . . 2.59 109.48 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' HA ' HG22 ' A' ' 6' ' ' THR . 14.0 p -53.94 135.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.428 0.632 . . . . 2.85 110.461 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.661 ' CD1' HD11 ' A' ' 5' ' ' ILE . 74.2 t-105 -117.4 154.13 31.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.675 -0.64 . . . . 1.63 110.443 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.21 -114.68 2.65 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.127 -1.589 . . . . 2.45 109.127 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.71 93.6 2.58 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.542 -0.91 . . . . 4.68 108.542 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 tt -169.52 -42.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.6 -0.688 . . . . 3.93 110.353 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.46 162.9 18.62 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.518 -0.739 . . . . 3.46 110.211 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.21 -40.72 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.665 2.243 . . . . 4.15 110.184 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.99 65.61 0.62 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.674 -0.641 . . . . 2.99 109.37 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -53.54 -53.39 57.42 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 2.78 109.787 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.1 Cg_endo -76.57 127.32 9.55 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 122.38 2.054 . . . . 1.62 109.527 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 60.0 m-85 66.56 166.75 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.734 -0.604 . . . . 1.88 109.526 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -97.93 -29.43 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.298 -0.876 . . . . 2.88 110.617 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.77 161.65 37.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.342 -0.849 . . . . 3.22 109.969 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -38.91 92.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 3.21 109.42 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -42.82 99.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.825 -0.547 . . . . 2.69 109.7 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.482 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 1.8 m -60.99 -52.99 62.65 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.729 -0.841 . . . . 1.99 108.729 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 20.2 tt0 -58.54 -33.54 70.01 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.142 -0.688 . . . . 2.11 109.142 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 9.2 tp -68.03 -66.9 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.8 -0.815 . . . . 2.74 108.8 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.32 -28.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.737 -0.602 . . . . 1.44 110.313 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.17 -42.7 66.44 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.539 -0.726 . . . . 1.42 109.702 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.49 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.2 mt -65.09 -57.42 8.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 2.56 108.788 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.87 23.57 7.04 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.039 -0.824 . . . . 2.28 111.039 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -122.97 45.37 2.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.354 -1.086 . . . . 3.11 109.14 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m95 -138.78 117.6 12.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.305 -0.872 . . . . 3.23 110.215 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.21 130.6 49.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.565 -0.71 . . . . 2.75 109.757 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 65.1 71.06 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.216 0.532 . . . . 3.26 111.129 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.13 -58.18 1.94 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.508 -0.923 . . . . 3.08 108.508 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.57 118.56 13.52 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.01 0.433 . . . . 3.23 110.343 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.5 132.77 56.18 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 3.31 109.194 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -65.7 -54.76 22.98 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.443 -0.786 . . . . 7.5 109.497 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mt -93.71 108.33 33.67 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.508 -0.923 . . . . 2.68 108.508 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 32.7 Cg_endo -72.53 -24.81 18.52 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.032 1.821 . . . . 3.42 110.326 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.22 76.08 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.669 -0.644 . . . . 3.77 109.657 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.4 -85.7 0.23 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -0.944 . . . . 3.7 108.925 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.22 84.49 1.27 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 107.226 -2.35 . . . . 2.38 107.226 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 14.2 m-20 -88.84 147.86 24.18 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.192 0.996 . . . . 5.12 112.95 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.83 128.61 34.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.537 -0.912 . . . . 3.72 108.537 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.46 53.58 12.68 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.597 -0.689 . . . . 4.88 109.723 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -138.64 44.83 2.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.816 . . . . 5.23 109.777 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER 53.71 34.51 19.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.662 -0.649 . . . . 4.31 109.992 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.96 -66.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.268 -0.895 . . . . 3.19 109.861 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.25 153.98 21.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.483 -0.761 . . . . 3.07 109.901 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.67 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 4.2 m-90 -152.56 160.85 43.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.645 . . . . 5.18 109.667 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.72 -41.51 21.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.75 . . . . 3.1 109.126 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -31.25 68.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.654 -0.654 . . . . 3.97 110.398 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -70.22 125.34 91.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.629 -0.67 . . . . 4.09 110.274 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -35.85 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.571 2.18 . . . . 3.57 110.402 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -72.14 -65.27 0.8 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.478 -0.764 . . . . 5.18 109.484 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 117.879 -1.058 . . . . 3.29 109.408 179.679 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HB3' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.397 0.618 . . . . 3.48 110.173 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -45.63 7.45 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.54 -0.725 . . . . 4.02 109.815 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.85 -48.84 11.85 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.638 -0.664 . . . . 2.49 109.882 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 1' ' ' MET . 54.8 m -111.81 108.5 17.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.526 -0.734 . . . . 1.41 109.452 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.46 158.18 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.234 -0.916 . . . . 1.35 109.478 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 17' ' ' VAL . 8.6 p -135.94 127.24 28.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 1.27 109.995 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 18' ' ' TRP . 79.1 t -95.95 120.36 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 1.19 109.016 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.6 133.18 34.43 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.687 -0.633 . . . . 1.98 109.608 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 t -69.19 118.86 65.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.266 -0.642 . . . . 1.39 109.266 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.4 -12.33 15.55 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.8 2.333 . . . . 1.53 111.509 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.8 m -83.74 -54.75 4.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.3 -0.875 . . . . 1.53 110.217 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.71 -30.39 9.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.552 -0.717 . . . . 1.67 110.658 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.36 77.41 1.35 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.072 -1.611 . . . . 1.64 109.072 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -146.65 129.25 16.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.837 -0.802 . . . . 2.04 109.616 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -74.99 116.26 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.65 -0.656 . . . . 1.55 109.705 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.31 139.62 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.734 -0.839 . . . . 1.15 108.734 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -62.79 143.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.45 -0.781 . . . . 1.03 110.179 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.601 ' HB2' HG23 ' A' ' 7' ' ' VAL . 72.7 t-105 -125.27 149.71 47.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.813 -0.554 . . . . 1.23 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.43 -100.9 0.53 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.32 -1.512 . . . . 1.1 109.32 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 83.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.72 -0.871 . . . . 2.4 109.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 tt -156.18 -43.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.542 -0.724 . . . . 1.18 109.844 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.96 162.48 19.79 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.618 -0.677 . . . . 1.22 109.726 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.67 -39.76 0.92 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.694 2.263 . . . . 1.42 110.384 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.27 65.04 0.61 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.694 . . . . 1.64 109.184 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mtm105 -58.11 -51.12 84.13 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.543 -0.723 . . . . 1.53 109.962 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.24 126.96 8.85 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.291 1.994 . . . . 0.97 109.315 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 38.0 m-85 65.53 175.31 0.22 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 109.526 -0.546 . . . . 1.03 109.526 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 p -103.49 -28.81 11.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.141 -0.975 . . . . 1.26 110.582 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.59 162.14 39.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.266 -0.896 . . . . 1.85 110.443 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -40.06 96.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 1.54 109.668 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.551 HH21 HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.29 -44.79 94.07 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.735 -0.603 . . . . 3.14 109.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.1 m -58.44 -50.03 75.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 1.33 109.428 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 18.2 tt0 -63.81 -34.3 77.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.638 -0.664 . . . . 1.69 109.39 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 HH21 ' A' ' 31' ' ' ARG . 7.0 tp -65.7 -67.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.424 -0.584 . . . . 1.2 109.424 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -49.9 -28.78 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.576 -0.702 . . . . 1.4 110.62 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.52 -43.46 71.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.46 -0.775 . . . . 1.23 110.33 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -63.95 -59.71 4.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.472 -0.768 . . . . 1.21 108.971 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.57 20.49 8.11 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.582 -0.818 . . . . 1.19 111.081 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.89 45.96 2.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.288 -1.125 . . . . 1.34 109.137 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m95 -132.43 118.82 19.82 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.523 -0.735 . . . . 1.34 109.128 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.97 99.05 12.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.679 -0.638 . . . . 1.77 110.506 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.37 -43.65 12.68 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.795 -0.817 . . . . 2.27 108.795 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 53.46 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.276 0.56 . . . . 3.02 110.521 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -24.59 14.9 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.198 -0.939 . . . . 5.34 111.031 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.91 129.61 51.45 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.197 -0.94 . . . . 5.37 111.645 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -88.99 176.92 6.8 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.609 -0.682 . . . . 4.26 109.322 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 27.4 mm 67.59 104.29 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.665 -0.647 . . . . 3.6 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 52' ' ' ASP . 32.8 Cg_endo -72.69 90.06 0.83 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.488 2.125 . . . . 2.78 110.008 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.8 p -150.64 -49.24 0.13 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.935 -0.478 . . . . 3.23 109.85 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.28 -59.54 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.555 -0.715 . . . . 4.25 110.724 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.19 -34.09 64.57 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.789 -0.924 . . . . 4.15 110.789 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 2.0 t70 -55.57 137.67 48.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.661 -0.905 . . . . 3.62 110.566 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -41.64 84.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.712 -0.847 . . . . 2.88 108.712 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.17 104.44 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.775 -0.824 . . . . 2.18 108.775 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 137.69 32.13 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.004 -0.739 . . . . 2.77 109.004 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.98 102.69 10.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 3.8 110.416 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.26 -45.58 19.48 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.663 -0.866 . . . . 2.41 108.663 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 58.54 -173.08 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.189 0.519 . . . . 4.12 110.778 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.535 ' HA ' ' CE3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -91.28 118.18 30.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.455 -0.778 . . . . 4.46 109.697 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.82 90.28 4.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.722 -0.844 . . . . 3.27 108.722 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -42.25 82.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.659 -0.651 . . . . 3.92 109.806 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.89 129.61 43.61 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.652 -0.655 . . . . 6.43 109.744 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.65 126.83 6.86 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.732 2.288 . . . . 4.43 109.598 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.4 122.79 47.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 5.6 110.29 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.383 -0.818 . . . . 5.08 109.185 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.268 -0.642 . . . . 5.21 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.05 89.77 3.2 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.51 0.671 . . . . 5.29 111.369 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -94.56 -32.8 13.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 106.594 -1.632 . . . . 2.91 106.594 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.545 HG21 HD13 ' A' ' 21' ' ' ILE . 32.5 m -106.62 117.87 35.18 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.504 -0.924 . . . . 1.77 108.504 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 18' ' ' TRP . 5.3 pt -88.43 155.43 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.51 -0.744 . . . . 1.9 110.004 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 17' ' ' VAL . 46.4 p -121.83 126.33 48.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 1.07 110.164 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -88.26 135.67 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.931 -0.766 . . . . 1.3 108.931 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -91.33 133.05 35.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 1.39 109.97 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' O ' ' HA2' ' A' ' 13' ' ' GLY . 8.7 t -64.69 121.52 73.69 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.196 -0.668 . . . . 1.4 109.196 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.05 -11.28 16.44 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.66 2.24 . . . . 1.88 111.881 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.9 m -88.71 -54.82 3.97 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.227 -0.92 . . . . 1.78 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.1 p -103.09 -31.05 10.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.526 -0.734 . . . . 1.62 110.278 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 9' ' ' CYS . . . 95.37 75.14 1.26 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.845 -1.302 . . . . 1.45 109.845 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -143.85 137.81 28.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.56 -0.965 . . . . 2.91 110.656 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.2 m -72.59 112.43 8.64 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.215 0.531 . . . . 0.94 110.571 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.69 131.16 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.486 -0.931 . . . . 0.84 108.486 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.68 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.4 p -56.18 140.98 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 0.76 110.6 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.541 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 75.0 t-105 -122.15 151.44 40.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.695 -0.628 . . . . 1.34 109.542 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.29 -98.43 0.55 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.375 -1.49 . . . . 1.06 109.375 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.5 52.74 0.37 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.902 . . . . 1.32 109.727 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.545 HD13 HG21 ' A' ' 4' ' ' THR . 3.4 mt -118.11 -55.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 1.04 109.434 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.3 163.66 22.5 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.76 -0.588 . . . . 1.0 109.664 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.18 -38.14 1.24 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.538 2.158 . . . . 1.3 110.528 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -107.31 66.58 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.122 -0.696 . . . . 1.31 109.122 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.5 mtm180 -56.51 -51.26 82.54 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.574 -0.704 . . . . 2.2 110.188 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -76.69 127.13 9.36 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 122.179 1.919 . . . . 1.19 109.53 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 71.3 m-85 65.71 172.64 0.22 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.35 0.595 . . . . 1.44 109.636 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.28 -29.69 12.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.256 -0.902 . . . . 1.26 110.247 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.1 p -145.42 162.99 35.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.321 -0.862 . . . . 1.46 110.427 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -34.94 77.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.311 -0.626 . . . . 1.7 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -47.08 84.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.797 -0.564 . . . . 3.25 109.855 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.74 -47.24 85.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.753 -0.592 . . . . 1.62 109.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -64.23 -34.88 79.11 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.606 -0.684 . . . . 1.75 109.183 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 10.4 tp -63.56 -67.2 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.161 -0.681 . . . . 2.12 109.161 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.15 -30.25 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.707 -0.621 . . . . 1.93 110.717 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.06 -42.6 65.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 1.83 110.199 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -64.51 -58.95 4.98 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.53 -0.732 . . . . 2.45 109.095 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 23.58 6.43 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.584 -0.817 . . . . 2.5 111.133 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.07 44.54 2.64 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.299 -1.118 . . . . 2.63 109.091 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 9.9 m95 -136.26 145.64 45.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.591 -0.693 . . . . 2.56 109.447 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.45 25.75 11.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.535 -0.728 . . . . 2.92 110.455 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.97 -53.05 3.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.245 -0.909 . . . . 2.61 108.745 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 1.2 mp0 53.18 61.54 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.376 0.608 . . . . 2.15 110.599 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.61 129.86 35.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.268 -0.895 . . . . 2.98 109.145 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -147.93 89.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.653 -0.655 . . . . 5.15 110.463 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER 63.65 34.0 12.67 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.871 -0.518 . . . . 3.67 112.384 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mt -93.39 112.73 57.77 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.036 -1.098 . . . . 3.36 108.036 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 36.0 Cg_endo -77.26 -53.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.473 2.115 . . . . 3.16 111.028 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -120.57 110.09 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.508 -0.745 . . . . 2.52 109.919 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 -42.95 8.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.68 -0.637 . . . . 3.19 109.402 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.69 85.2 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.381 -1.488 . . . . 2.75 109.381 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.78 159.0 16.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.745 -0.856 . . . . 2.87 109.947 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD22 ' OD1' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -80.37 118.21 21.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.674 -0.641 . . . . 3.79 109.774 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -38.61 85.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.681 -0.489 . . . . 4.35 109.681 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.03 164.42 25.6 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.491 -0.755 . . . . 5.41 110.274 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.83 111.4 2.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.883 -0.784 . . . . 3.4 108.883 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 53' ' ' LEU . 2.6 t70 -123.21 138.93 54.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.66 -0.65 . . . . 4.04 109.915 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.5 118.55 10.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.7 -0.852 . . . . 4.57 108.7 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 60.84 81.72 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.472 0.654 . . . . 2.84 109.433 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -65.36 131.47 46.55 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 2.67 108.026 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.76 101.6 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.527 -0.733 . . . . 3.06 109.164 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER 52.07 76.43 0.54 Allowed Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.527 -0.545 . . . . 2.42 109.527 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 60' ' ' SER . 34.4 Cg_endo -74.69 81.13 2.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.967 2.445 . . . . 3.35 109.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.79 143.69 30.78 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.555 0.693 . . . . 3.99 110.524 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.719 -1.134 . . . . 6.48 108.907 179.057 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.485 -0.561 . . . . 4.46 109.485 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.19 36.13 26.91 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.127 -0.694 . . . . 2.26 109.127 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -56.67 3.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 3.02 110.038 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 m 64.83 108.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.306 -0.627 . . . . 1.32 109.306 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.95 159.22 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.465 -0.772 . . . . 1.62 109.264 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 17' ' ' VAL . 7.0 p -137.48 126.51 24.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.56 -0.712 . . . . 1.3 109.866 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 58.8 t -96.62 124.45 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 109.01 -0.737 . . . . 1.16 109.01 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.45 134.02 33.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.605 -0.684 . . . . 2.05 109.868 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -68.87 120.35 75.56 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.172 -0.677 . . . . 1.2 109.172 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.74 -11.99 16.67 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.707 2.271 . . . . 1.35 111.734 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.5 m -85.64 -52.19 5.97 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.205 -0.935 . . . . 1.36 110.229 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.2 p -107.32 -29.58 9.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.507 -0.746 . . . . 1.6 110.954 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.87 78.17 1.4 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.657 -1.777 . . . . 1.64 108.657 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 134.12 24.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.834 -0.803 . . . . 2.17 109.882 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -78.61 110.8 14.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.444 -0.785 . . . . 1.54 109.239 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.96 135.49 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.8 p -63.71 138.33 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.423 -0.798 . . . . 1.32 110.005 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -111.26 153.45 25.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.748 -0.595 . . . . 1.44 109.49 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.41 -108.13 1.47 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.486 -1.446 . . . . 1.56 109.486 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.75 52.56 0.87 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.877 . . . . 2.56 109.485 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' CG2' ' A' ' 17' ' ' VAL . 2.8 mp -115.93 -51.23 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.499 -0.751 . . . . 1.86 109.505 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 84.2 p -94.57 162.67 25.02 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.733 -0.604 . . . . 1.76 109.899 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.4 Cg_endo -76.28 -29.93 5.86 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.559 2.172 . . . . 2.21 110.334 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.0 72.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.72 -0.844 . . . . 1.73 108.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HB3' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -54.32 -55.16 40.07 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.644 -0.66 . . . . 2.58 110.227 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.6 Cg_endo -77.0 126.64 8.82 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 122.286 1.99 . . . . 1.5 109.75 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 42.9 m-85 65.56 172.45 0.22 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.282 0.563 . . . . 1.35 109.771 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.4 p -98.43 -31.63 11.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.352 -0.842 . . . . 1.62 110.333 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.49 164.34 30.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.412 -0.805 . . . . 1.94 110.283 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -40.77 92.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.656 -0.653 . . . . 1.95 109.655 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -61.52 -42.18 98.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.757 -0.589 . . . . 2.02 109.683 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.66 -49.21 78.43 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.546 -0.721 . . . . 1.39 109.336 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -63.5 -32.85 74.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.371 -0.603 . . . . 1.77 109.371 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.0 tp -64.74 -67.43 0.44 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 1.71 109.437 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.24 -30.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.675 -0.64 . . . . 1.34 110.408 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.13 -41.62 68.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.751 . . . . 1.35 110.236 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.2 mt -65.15 -59.16 4.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.462 -0.774 . . . . 1.77 109.142 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.85 25.61 5.86 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.584 -0.817 . . . . 1.61 111.149 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.25 43.48 3.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.267 -1.137 . . . . 1.92 109.112 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.464 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.6 m95 -137.49 -47.72 0.57 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.575 -0.703 . . . . 1.85 109.863 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 59.5 59.65 2.53 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.315 0.579 . . . . 1.99 110.261 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.82 -61.44 1.97 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.281 -0.887 . . . . 1.77 108.613 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.14 113.07 24.95 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.507 -1.294 . . . . 3.02 107.507 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 140.57 50.78 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.47 -0.769 . . . . 3.44 111.312 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -66.25 0.57 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.814 -0.81 . . . . 4.71 108.814 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.27 37.75 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.17 -0.678 . . . . 5.58 109.17 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.445 HG13 ' HB3' ' A' ' 55' ' ' GLU . 1.5 pt -119.39 149.33 47.41 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.381 -0.824 . . . . 2.5 110.332 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.48 122.83 6.69 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.025 2.484 . . . . 3.69 111.007 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -75.07 81.49 2.25 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.081 -0.711 . . . . 3.99 109.081 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.37 47.2 2.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.863 -0.791 . . . . 4.92 108.863 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.34 16.58 26.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.044 -1.222 . . . . 4.26 110.044 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -133.97 33.07 3.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -1.01 . . . . 3.47 109.543 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 74.3 150.89 0.11 Allowed 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.499 0.666 . . . . 4.61 110.518 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.16 129.71 42.17 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.805 -0.559 . . . . 2.36 110.193 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' HB3' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -72.01 147.94 46.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.666 -0.646 . . . . 3.5 110.298 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.48 78.56 1.38 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.611 -0.68 . . . . 2.95 110.013 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.09 118.87 20.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.818 . . . . 3.04 109.25 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 57.25 39.65 28.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.267 -0.642 . . . . 4.6 109.267 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.563 ' NE1' ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -139.39 131.68 28.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.71 . . . . 5.19 109.41 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 m -132.08 -52.45 0.97 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.099 -0.704 . . . . 2.78 109.099 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -58.57 0.19 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.374 -0.972 . . . . 3.37 108.374 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -146.3 110.03 4.27 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.69 -0.856 . . . . 3.77 108.69 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.563 ' HG3' ' NE1' ' A' ' 59' ' ' TRP . 37.7 Cg_endo -79.21 -30.06 2.84 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.813 2.342 . . . . 4.01 111.494 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 -57.4 2.2 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.489 -0.757 . . . . 5.04 111.013 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 117.702 -1.142 . . . . 4.63 110.337 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' N ' ' HA ' ' A' ' 5' ' ' ILE . 1.4 mtp . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.09 -0.707 . . . . 4.91 109.09 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 73.41 -70.52 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 109.556 -0.535 . . . . 2.74 109.556 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 4' ' ' THR . 1.1 mp0 -120.09 98.36 6.04 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.668 -0.864 . . . . 3.98 108.668 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 96.8 m 71.91 132.14 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.294 0.569 . . . . 1.62 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.707 HD12 ' HD1' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -89.74 158.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.47 0 O-C-N 121.44 -0.788 . . . . 2.01 109.442 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -132.2 122.48 25.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.628 -0.67 . . . . 1.32 109.827 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -91.34 136.68 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.166 -0.679 . . . . 1.09 109.166 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.05 135.42 34.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 1.96 109.681 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.2 t -68.14 117.96 54.18 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.739 -0.601 . . . . 1.21 109.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 36.7 Cg_endo -80.64 19.42 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.927 2.418 . . . . 1.9 112.007 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.6 m -122.16 -48.31 2.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 1.11 109.366 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 -25.84 10.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.692 -0.63 . . . . 1.18 110.35 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.81 75.02 1.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.599 -1.8 . . . . 1.36 108.599 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -144.31 137.63 27.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.801 -0.823 . . . . 2.19 109.838 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -81.29 115.02 20.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.448 -0.783 . . . . 1.5 109.43 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.2 t -115.3 137.16 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.967 -0.753 . . . . 1.0 108.967 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.7 p -61.78 141.09 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.491 -0.756 . . . . 1.0 110.07 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.707 ' HD1' HD12 ' A' ' 5' ' ' ILE . 75.7 t-105 -124.88 150.98 45.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.854 -0.529 . . . . 1.44 109.783 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.27 -98.77 0.53 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.347 -1.501 . . . . 1.1 109.347 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.68 92.84 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.752 -0.852 . . . . 1.74 109.202 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -165.64 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.689 -0.632 . . . . 1.37 109.842 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.52 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 88.5 p -102.65 160.59 25.82 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.658 -0.652 . . . . 0.98 109.818 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 34.6 Cg_endo -75.27 -31.58 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.592 2.195 . . . . 1.29 110.355 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.87 64.46 0.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.614 -0.679 . . . . 1.84 109.344 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 29.3 mtm180 -60.12 -53.02 69.13 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.488 -0.757 . . . . 1.44 109.661 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.0 Cg_endo -77.68 125.63 7.63 Favored 'Trans proline' 0 C--N 1.324 -0.717 0 C-N-CA 122.285 1.99 . . . . 1.01 109.398 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 63.9 m-85 65.61 165.98 0.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.396 0.617 . . . . 1.24 109.734 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.2 p -95.5 -27.98 15.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.83 110.508 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.12 157.07 44.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.278 -0.889 . . . . 1.39 110.513 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -36.1 78.11 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.241 -0.652 . . . . 2.15 109.241 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -48.53 68.97 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.917 -0.489 . . . . 3.67 109.681 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.72 -43.87 65.96 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.551 -0.718 . . . . 0.79 109.812 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.94 -34.57 78.06 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.687 . . . . 1.94 109.289 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 11.5 tp -62.32 -66.64 0.51 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.893 -0.78 . . . . 1.19 108.893 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.451 HD13 ' CG ' ' A' ' 44' ' ' GLU . 3.0 mt -52.39 -27.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.55 -0.719 . . . . 1.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 16.5 t70 -54.76 -45.7 74.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.435 -0.791 . . . . 1.47 109.472 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 15.6 mt -62.97 -58.66 6.57 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.466 -0.938 . . . . 1.47 108.466 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' HG ' ' A' ' 54' ' ' SER . . . 111.97 19.48 7.24 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 120.6 -0.81 . . . . 1.05 111.913 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.22 33.64 4.97 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.716 1.258 . . . . 1.76 109.113 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -143.71 -59.51 0.4 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.999 -0.741 . . . . 1.25 108.999 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.66 149.99 33.52 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.235 0.54 . . . . 0.95 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.77 -37.85 48.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.633 -0.667 . . . . 1.62 110.034 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.23 169.32 13.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.601 -0.687 . . . . 1.82 110.546 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' CG ' HD13 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -97.61 150.3 21.29 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.371 -0.603 . . . . 2.47 109.371 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -60.78 -56.19 24.16 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.42 -0.8 . . . . 3.57 109.793 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -58.27 -60.98 2.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.696 -0.627 . . . . 3.29 109.534 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 109.29 53.23 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.582 -0.525 . . . . 2.53 109.582 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.41 77.31 3.3 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.253 1.969 . . . . 1.96 109.562 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.9 96.13 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.593 -0.692 . . . . 2.71 109.7 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.2 p -87.05 129.98 34.67 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.992 -0.744 . . . . 2.81 108.992 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.97 64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.271 -1.531 . . . . 2.55 109.271 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -126.51 110.7 13.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.829 -0.807 . . . . 2.23 109.097 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.76 79.56 1.26 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.655 . . . . 3.54 109.827 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.45 ' HG ' ' HA3' ' A' ' 38' ' ' GLY . 20.9 p -148.5 126.07 11.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.543 -0.723 . . . . 1.98 109.299 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -96.53 -35.78 10.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.55 -0.719 . . . . 2.22 110.361 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.86 93.1 1.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.177 -0.952 . . . . 1.9 109.846 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.63 67.58 0.98 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.592 0.711 . . . . 2.67 110.052 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -118.43 -46.55 2.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.64 -0.662 . . . . 2.59 109.299 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.506 ' HZ3' ' HA ' ' A' ' 64' ' ' LYS . 6.8 m0 -88.99 121.62 31.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.614 -0.679 . . . . 3.02 109.316 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 -50.71 0.67 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.58 -0.7 . . . . 1.93 110.933 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.6 42.83 2.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.263 -0.898 . . . . 3.4 110.667 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -136.71 141.44 35.25 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.184 -0.947 . . . . 2.73 109.95 179.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 34.7 Cg_endo -76.88 153.99 33.5 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 122.684 2.256 . . . . 2.24 111.483 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -71.98 126.08 28.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.737 -0.602 . . . . 2.83 109.767 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 12.6 mt-30 . . . . . 0 N--CA 1.505 2.278 0 CA-C-O 117.73 -1.128 . . . . 4.01 110.507 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.795 -0.446 . . . . 2.89 109.795 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 p -67.44 -46.52 72.88 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.156 -0.683 . . . . 2.5 109.156 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 128.39 36.69 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.652 -0.87 . . . . 2.08 108.652 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -82.65 90.31 6.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.499 -0.751 . . . . 1.74 109.651 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.6 pt -90.96 162.36 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 17' ' ' VAL . 32.0 p -121.51 127.87 51.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.465 -0.772 . . . . 1.22 109.982 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.0 m -101.32 136.1 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.085 -0.709 . . . . 1.12 109.085 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.25 136.96 32.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 1.35 110.156 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.45 122.04 84.27 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.084 -0.71 . . . . 1.06 109.084 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.84 -5.06 15.06 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.723 2.282 . . . . 1.32 111.862 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.9 m -94.82 -52.04 4.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.253 -0.904 . . . . 1.22 109.931 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.0 p -107.14 -31.66 8.16 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.498 -0.751 . . . . 1.36 110.764 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.2 68.97 0.94 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.909 -1.676 . . . . 1.47 108.909 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 131.36 40.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.884 -0.774 . . . . 3.12 109.737 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -76.08 104.34 6.56 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.56 -0.712 . . . . 1.34 109.248 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.34 129.49 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.133 -0.691 . . . . 1.09 109.133 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 6' ' ' THR . 10.5 p -64.27 135.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.637 -0.664 . . . . 1.31 110.258 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 60.6 t-105 -109.92 153.14 24.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.75 -0.594 . . . . 1.08 109.435 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.03 -165.69 12.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.761 -1.335 . . . . 1.31 109.761 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.7 92.65 9.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.456 -1.026 . . . . 2.57 109.439 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 tt -165.48 -40.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.751 -0.593 . . . . 1.61 109.961 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.52 158.6 46.64 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.55 -0.719 . . . . 1.52 109.814 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.49 -36.67 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.768 2.312 . . . . 1.59 110.619 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.77 68.59 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.572 -0.705 . . . . 1.12 109.244 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.728 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -58.52 -51.59 80.72 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.559 -0.713 . . . . 1.78 110.148 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.3 Cg_endo -77.55 125.86 7.88 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.205 1.936 . . . . 0.74 109.626 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 61.9 m-85 65.55 172.31 0.22 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.34 0.59 . . . . 0.86 109.824 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.35 -32.72 11.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.248 -0.908 . . . . 1.06 110.092 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 p -140.49 163.35 33.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.498 -0.751 . . . . 1.04 110.239 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -31.79 72.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.665 -0.647 . . . . 1.52 110.276 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -34.94 72.05 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.399 -0.813 . . . . 2.29 109.655 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.57 -47.37 76.01 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.603 -0.888 . . . . 1.03 108.603 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.88 -33.64 76.49 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.979 -0.748 . . . . 1.23 108.979 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 8.1 tp -65.33 -67.28 0.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.213 -0.662 . . . . 0.93 109.213 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mt -50.66 -29.48 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.645 -0.659 . . . . 1.02 110.506 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -54.87 -42.43 72.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.415 -0.803 . . . . 1.03 110.208 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -64.52 -59.57 4.15 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.19 24.92 6.04 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.982 -0.847 . . . . 1.19 110.982 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -125.58 44.18 2.89 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.381 -1.07 . . . . 1.55 109.09 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 11.9 m95 -135.53 123.37 22.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.443 -0.785 . . . . 1.19 109.471 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.87 -43.72 10.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.66 -0.65 . . . . 1.67 109.732 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.6 54.75 10.47 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.694 0.759 . . . . 2.17 109.153 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.97 102.77 4.92 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.723 -0.843 . . . . 3.04 108.723 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.22 -40.49 9.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.505 -0.747 . . . . 3.99 110.963 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -131.59 137.86 48.6 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.272 -0.892 . . . . 6.39 110.333 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.49 103.16 15.07 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.337 -0.852 . . . . 4.07 109.673 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.38 118.9 72.93 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 3.13 108.341 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -71.42 113.49 3.63 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.294 1.996 . . . . 2.86 109.964 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.0 141.89 28.01 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.283 0.563 . . . . 3.08 110.475 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.24 128.6 35.15 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.018 -0.734 . . . . 2.04 109.018 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.49 64.21 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.988 -1.245 . . . . 2.42 109.988 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.34 124.18 50.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.554 -0.968 . . . . 3.03 109.507 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.7 160.5 40.19 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.674 -0.641 . . . . 2.27 109.56 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.91 115.48 27.98 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.429 -0.795 . . . . 2.31 109.84 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.03 -60.72 1.73 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.657 -0.652 . . . . 3.75 109.467 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.15 114.03 25.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.643 -0.661 . . . . 2.92 109.664 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -124.89 117.95 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.635 . . . . 2.5 109.284 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 133.22 42.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.664 -0.648 . . . . 2.8 109.734 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -109.7 124.11 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.653 . . . . 3.97 109.311 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.5 m -120.07 83.02 1.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.44 109.773 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -55.37 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.727 . . . . 1.96 109.356 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 55.53 79.05 0.35 Allowed Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.794 -0.566 . . . . 1.82 109.876 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.11 114.36 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.775 2.317 . . . . 1.47 110.74 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 1.7 mppt? -92.72 -51.92 4.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.623 -0.673 . . . . 2.88 109.393 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.329 -0.843 . . . . 2.78 109.718 179.809 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.839 -0.43 . . . . 2.67 109.839 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -96.58 129.69 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 2.48 109.837 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.68 114.91 27.73 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.337 -0.616 . . . . 2.02 109.337 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -93.8 122.49 36.32 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.449 -0.782 . . . . 1.5 109.489 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -90.97 161.07 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 1.09 109.282 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 17' ' ' VAL . 4.1 p -138.43 124.14 19.78 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 1.21 109.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 18' ' ' TRP . 78.3 t -97.73 124.44 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.158 -0.682 . . . . 0.73 109.158 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -86.5 136.17 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.394 -0.816 . . . . 1.45 109.94 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.31 122.69 87.14 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.355 -0.609 . . . . 1.12 109.355 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -8.78 16.56 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.698 2.265 . . . . 1.39 111.621 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 m -88.93 -55.87 3.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.282 -0.887 . . . . 1.41 109.8 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.81 -27.12 13.19 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.485 -0.759 . . . . 1.8 110.653 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 73.23 1.27 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.944 -1.662 . . . . 1.9 108.944 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -140.86 135.29 31.2 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.76 -0.847 . . . . 3.07 109.687 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 109.55 10.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.604 -0.685 . . . . 1.66 109.933 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.93 129.17 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 1.24 108.732 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.683 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.3 p -58.1 135.13 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 1.58 110.448 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.634 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.2 t-105 -107.64 154.14 21.88 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.404 -0.591 . . . . 1.46 109.404 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.91 -167.88 13.62 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.72 -1.352 . . . . 1.44 109.72 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.79 97.94 10.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -1.081 . . . . 2.8 109.591 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 22' ' ' SER . 5.5 tt -169.35 -45.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.512 -0.743 . . . . 2.65 110.318 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 75.7 p -107.47 159.85 28.74 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.512 -0.742 . . . . 2.48 110.125 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 35.6 Cg_endo -77.52 -32.35 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.784 2.323 . . . . 3.0 110.41 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.92 71.71 0.8 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.143 -0.688 . . . . 2.2 109.143 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.675 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -58.01 -54.29 57.04 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.541 -0.724 . . . . 3.51 109.983 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.675 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.2 Cg_endo -76.07 124.89 8.24 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 122.263 1.976 . . . . 1.38 108.898 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 60.9 m-85 65.72 175.43 0.22 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.059 -0.719 . . . . 1.12 109.059 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 p -102.31 -32.86 9.83 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.986 -1.072 . . . . 1.89 110.265 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.39 165.84 26.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.321 -0.862 . . . . 2.43 110.274 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -62.74 -40.57 97.63 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.706 -0.621 . . . . 2.0 109.908 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -62.2 -39.9 94.29 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.7 -0.625 . . . . 1.47 110.075 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.52 -48.41 79.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 1.79 109.438 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -65.08 -33.78 76.84 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.931 -0.766 . . . . 1.61 108.931 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 6.1 tp -65.13 -66.3 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.083 -0.71 . . . . 1.24 109.083 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.4 mt -49.88 -29.36 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.79 -0.569 . . . . 1.23 110.563 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -54.12 -42.93 70.03 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.494 -0.754 . . . . 0.89 110.106 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.472 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 3.2 mt -66.0 -58.77 4.76 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.808 -0.812 . . . . 1.31 108.808 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.33 25.71 5.43 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 111.03 -0.828 . . . . 0.98 111.03 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -123.8 38.0 4.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.377 -1.072 . . . . 1.4 109.383 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 3.5 m95 -138.2 169.23 18.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.508 -0.745 . . . . 1.21 109.916 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.98 88.79 5.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.54 -0.725 . . . . 1.82 109.286 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.85 -57.17 8.54 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.498 -0.751 . . . . 2.32 109.717 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -134.72 120.73 19.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.13 -0.693 . . . . 2.48 109.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.19 -40.13 12.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.734 -0.604 . . . . 2.74 110.202 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.96 148.82 51.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.627 -0.671 . . . . 5.63 109.501 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 61.08 0.61 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.5 -0.75 . . . . 3.26 109.136 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.57 111.77 34.51 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.204 -0.935 . . . . 4.01 110.902 -178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.61 82.68 2.34 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.754 2.303 . . . . 4.53 110.852 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 p -172.68 -52.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.421 -0.955 . . . . 3.76 108.421 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m -142.12 92.28 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.626 -0.879 . . . . 2.66 108.626 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.34 65.39 0.78 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.255 -1.538 . . . . 2.91 109.255 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -107.28 121.71 45.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.965 -0.727 . . . . 3.39 109.685 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.53 62.31 0.92 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 3.81 109.882 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.98 -41.9 3.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.476 -0.765 . . . . 3.68 109.101 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.47 115.88 21.01 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.393 -0.595 . . . . 3.72 109.393 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.12 -57.26 2.06 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.634 -0.666 . . . . 3.62 109.945 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -118.89 121.65 40.48 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.595 -0.691 . . . . 3.12 110.26 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 124.47 25.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.486 -0.561 . . . . 4.59 109.486 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.06 116.38 30.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.711 -0.618 . . . . 3.03 109.389 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.4 p -94.32 -10.34 33.03 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.566 -0.709 . . . . 3.84 110.892 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.62 170.93 8.24 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 3.3 110.274 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 1.7 mm-40 -103.18 118.4 58.02 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.257 -0.646 . . . . 4.52 109.257 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.63 120.69 6.85 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.403 2.069 . . . . 2.93 109.793 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.3 mttt 65.99 43.83 2.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.632 0.729 . . . . 3.64 109.214 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.65 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.336 -0.84 . . . . 3.92 109.586 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.846 -0.427 . . . . 3.03 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 57.1 83.18 0.11 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.166 -0.679 . . . . 2.51 109.166 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 68.84 104.05 0.06 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.804 -0.813 . . . . 2.65 108.804 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 58.65 1.76 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.357 -0.839 . . . . 2.28 109.849 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.62 147.53 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.352 -0.843 . . . . 2.45 109.077 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 p -102.85 125.15 49.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 1.88 110.469 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.98 139.79 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.197 -0.668 . . . . 1.76 109.197 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -88.27 135.76 33.3 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.265 -0.897 . . . . 2.16 110.412 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.36 120.28 73.86 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.053 -0.721 . . . . 1.25 109.053 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.03 3.02 7.38 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 122.832 2.355 . . . . 1.65 112.038 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.3 m -104.49 -50.9 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.118 -0.989 . . . . 1.21 109.847 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.6 p -107.97 -25.51 11.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.605 -0.684 . . . . 1.2 110.763 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.95 80.39 1.39 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.55 -1.82 . . . . 1.47 108.55 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -150.06 137.15 19.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.757 -0.849 . . . . 2.98 109.725 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 m -77.65 108.5 10.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.343 -0.848 . . . . 1.9 109.567 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.3 t -108.83 128.87 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.962 -0.755 . . . . 1.21 108.962 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.89 133.28 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.461 0.648 . . . . 1.33 110.214 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 28.5 t-105 -118.65 153.86 33.63 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.426 -0.583 . . . . 2.19 109.426 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 25' ' ' ARG . . . 122.6 -125.17 5.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.986 -1.245 . . . . 1.88 109.986 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.48 87.07 2.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.977 . . . . 2.35 109.049 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.2 tt -166.19 -45.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.509 -0.744 . . . . 1.3 110.462 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 m -111.17 159.97 30.81 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.521 -0.737 . . . . 1.18 110.041 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.73 -32.07 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 122.824 2.349 . . . . 1.63 110.857 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.15 68.58 0.67 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.581 -0.699 . . . . 2.38 109.579 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.739 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 2.3 mtt180 -63.75 -50.31 71.91 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.307 -0.871 . . . . 3.07 110.227 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.77 119.16 4.69 Favored 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 122.194 1.93 . . . . 1.6 109.944 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 66.0 m-85 66.02 161.4 0.14 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.374 0.607 . . . . 1.71 110.019 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.54 -32.05 22.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.348 -0.845 . . . . 1.32 110.29 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -140.16 168.49 19.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.48 -0.763 . . . . 1.64 110.18 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -38.25 77.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.669 -0.645 . . . . 4.4 109.631 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -41.42 98.59 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.829 -0.544 . . . . 2.83 110.122 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.67 -51.29 70.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.571 -0.706 . . . . 1.6 109.414 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HG3' ' CE1' ' A' ' 27' ' ' PHE . 19.2 tt0 -60.48 -34.99 74.83 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.156 -0.683 . . . . 2.91 109.156 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 34' ' ' LEU . 6.8 tp -63.44 -67.26 0.44 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.277 -0.638 . . . . 2.5 109.277 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.5 mt -49.43 -29.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.66 -0.65 . . . . 1.9 110.466 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -53.34 -45.25 69.02 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.52 -0.737 . . . . 2.0 110.374 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mt -63.58 -59.91 4.02 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.868 . . . . 2.83 108.655 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.21 22.47 6.49 Favored Glycine 0 N--CA 1.498 2.777 0 C-N-CA 120.575 -0.821 . . . . 2.64 111.107 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -121.23 40.73 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -1.149 . . . . 3.1 109.248 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 7.5 m95 -134.89 113.68 11.79 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.504 -0.748 . . . . 3.02 109.445 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.29 -175.07 2.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 3.2 109.657 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.76 -32.46 69.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.56 -0.713 . . . . 2.96 109.31 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.11 161.52 25.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.267 0.555 . . . . 2.24 109.865 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.14 -69.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 2.27 109.714 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.25 96.12 2.73 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.257 -1.016 . . . . 4.78 108.257 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 66.09 158.67 0.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.148 -1.056 . . . . 4.58 108.148 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.549 HG12 ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -114.41 112.28 46.3 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.81 -1.181 . . . . 3.55 109.394 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.37 -33.75 5.24 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.709 2.273 . . . . 4.51 109.941 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.2 p -74.14 123.97 25.45 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.362 -0.977 . . . . 3.8 108.362 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.57 139.42 17.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.255 -0.903 . . . . 2.45 109.83 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.57 -126.13 5.8 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.031 -1.628 . . . . 1.91 109.031 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 47.1 -131.18 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.075 -0.662 . . . . 2.55 109.292 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.99 113.22 14.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.991 -1.068 . . . . 2.22 108.916 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 56.36 46.79 20.3 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.759 0.79 . . . . 2.9 109.09 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.66 136.19 50.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 2.75 109.388 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.549 ' OG ' HG12 ' A' ' 47' ' ' ILE . 2.4 m 62.85 80.34 0.23 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.368 0.604 . . . . 3.49 110.221 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.93 90.28 8.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.884 -0.784 . . . . 4.76 108.884 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -45.74 1.63 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.65 -0.656 . . . . 4.7 110.213 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.8 121.66 2.52 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 3.76 110.541 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.88 81.42 0.07 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.276 0.56 . . . . 4.63 111.281 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 1.9 mp0 -101.41 -59.8 1.64 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.431 -0.951 . . . . 4.11 108.431 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 3.2 mt-10 68.44 160.45 0.14 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.775 -0.578 . . . . 5.84 110.541 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.25 -7.78 15.13 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.071 2.514 . . . . 4.55 111.569 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -33.74 20.31 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.353 -0.842 . . . . 5.33 110.744 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 CA-C-O 117.813 -1.089 . . . . 7.63 110.068 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.191 0.519 . . . . 2.94 109.708 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.85 129.5 36.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.933 -0.48 . . . . 1.75 110.044 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.84 100.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.439 0.638 . . . . 3.89 110.063 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -85.54 106.97 17.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.571 -0.706 . . . . 1.98 109.539 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 18' ' ' TRP . 1.1 pt -80.84 168.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.593 -0.692 . . . . 1.69 109.472 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -115.55 125.29 52.81 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 1.59 110.112 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.86 120.83 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.958 -0.756 . . . . 1.13 108.958 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.88 131.28 34.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.555 -0.715 . . . . 1.86 109.723 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.83 119.4 60.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.153 -0.684 . . . . 0.79 109.153 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.83 -7.86 16.63 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.769 2.312 . . . . 0.9 111.784 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.5 m -91.88 -50.82 5.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.18 -0.95 . . . . 1.11 110.068 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.0 p -108.72 -32.1 7.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 1.14 110.873 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.48 73.37 1.07 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.24 -1.544 . . . . 1.13 109.24 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 130.67 26.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.769 -0.842 . . . . 1.9 109.571 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 m -76.73 112.85 13.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.644 -0.66 . . . . 1.33 109.634 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.6 127.07 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.821 -0.807 . . . . 1.26 108.821 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.66 139.38 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -0.784 . . . . 1.74 110.429 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.518 ' HB3' HG13 ' A' ' 5' ' ' ILE . 66.3 t-105 -108.23 151.6 25.72 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.2 -0.667 . . . . 1.53 109.2 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 138.3 -119.21 1.75 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.002 -1.239 . . . . 1.35 110.002 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.1 32.25 1.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.92 -0.753 . . . . 2.77 109.162 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 tt -109.34 -34.23 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.573 -0.704 . . . . 2.4 110.042 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.6 153.66 39.04 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 2.08 109.974 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.29 -40.74 0.57 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.642 2.228 . . . . 2.02 110.005 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.57 68.21 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.694 -0.854 . . . . 1.53 108.694 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.651 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 22.9 mtm180 -59.34 -48.88 95.13 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.553 -0.717 . . . . 2.17 110.408 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.0 Cg_endo -76.18 118.83 5.1 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.992 1.795 . . . . 1.12 109.105 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 39.2 m-85 67.99 163.93 0.22 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.344 -0.613 . . . . 1.01 109.344 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -86.42 -31.45 21.42 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.195 -0.941 . . . . 1.44 110.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.68 157.35 43.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.431 -0.793 . . . . 2.02 109.876 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -63.7 -29.4 70.63 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.577 -0.702 . . . . 2.3 109.713 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -42.94 79.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.537 -0.727 . . . . 2.86 109.204 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.34 -46.79 88.79 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.005 -0.739 . . . . 1.32 109.005 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -61.75 -36.02 79.78 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.694 -0.854 . . . . 1.47 108.694 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.604 ' HG ' ' CE2' ' A' ' 40' ' ' TRP . 2.9 tp -61.96 -65.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.872 -0.788 . . . . 1.76 108.872 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.54 -33.24 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.693 -0.629 . . . . 1.9 110.156 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.38 -45.34 72.81 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.602 -0.686 . . . . 1.47 109.766 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 2.5 mt -62.04 -58.86 6.25 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.959 -0.756 . . . . 1.94 108.959 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.22 33.2 4.34 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.0 -1.24 . . . . 2.46 110.0 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.43 40.02 3.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.763 -0.845 . . . . 4.59 108.836 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 8.0 m95 -137.45 127.35 25.68 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.89 . . . . 2.62 110.546 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.56 -52.59 1.17 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.279 -0.638 . . . . 3.04 109.279 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.77 82.31 1.72 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.609 -0.682 . . . . 2.85 110.077 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -80.33 -69.92 0.56 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.966 -1.124 . . . . 2.52 107.966 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -78.16 120.78 23.45 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.055 -1.091 . . . . 2.96 108.055 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -103.87 128.45 51.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.199 -0.938 . . . . 4.97 111.503 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -49.58 2.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.265 -1.013 . . . . 3.87 108.265 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pt -76.08 147.87 80.64 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.893 -0.504 . . . . 2.21 109.644 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.67 -48.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.848 2.365 . . . . 2.19 110.956 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.16 -53.63 0.85 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.635 -0.665 . . . . 2.66 109.699 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.91 146.63 49.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.623 -0.673 . . . . 2.21 109.372 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.66 69.28 2.74 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.577 -1.009 . . . . 2.42 110.577 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 53' ' ' LEU . 6.3 m-20 -91.9 -142.18 0.19 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.767 -0.827 . . . . 3.32 108.767 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' H ' ' HB3' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -70.63 164.62 24.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.061 -1.024 . . . . 3.06 109.602 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.15 73.74 1.24 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.247 -1.02 . . . . 5.17 108.247 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.45 79.61 1.48 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.644 -0.66 . . . . 4.08 111.258 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 63.97 5.71 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.101 -0.999 . . . . 6.31 108.556 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.05 -49.16 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.738 -0.601 . . . . 6.86 109.458 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -127.21 154.58 44.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.266 -0.896 . . . . 4.88 109.893 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -67.14 -43.39 82.46 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.429 -0.795 . . . . 4.08 109.526 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -78.48 86.43 4.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.008 -0.433 . . . . 4.62 112.094 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -62.89 -52.5 62.84 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.294 -1.373 . . . . 2.61 107.294 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 66.66 146.57 0.1 Allowed Pre-proline 0 N--CA 1.5 2.038 0 CA-C-O 121.117 0.484 . . . . 4.54 112.106 177.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 33.5 Cg_endo -79.14 112.27 3.03 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.947 2.432 . . . . 3.39 108.413 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 2.7 tttp 83.14 116.33 0.05 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.478 -0.934 . . . . 5.59 108.478 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 117.972 -1.013 . . . . 3.59 109.733 -179.207 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.297 -0.631 . . . . 7.72 109.297 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t 55.4 28.32 11.35 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.874 -0.787 . . . . 4.69 108.874 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.46 106.66 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.764 -0.585 . . . . 5.1 109.657 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 94.12 8.9 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.693 -0.855 . . . . 1.91 108.693 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pt -78.94 149.79 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.923 -0.769 . . . . 1.37 108.923 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 17' ' ' VAL . 33.9 p -109.77 120.71 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 1.21 110.169 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -88.34 136.2 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.817 -0.809 . . . . 1.06 108.817 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.45 134.9 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.371 -0.83 . . . . 1.65 110.072 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.66 120.65 67.65 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.4 -6.59 16.47 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.703 2.268 . . . . 1.04 111.865 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.1 m -93.35 -49.73 5.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.224 -0.923 . . . . 0.94 109.945 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -109.97 -33.87 6.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.465 -0.772 . . . . 1.18 110.756 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.77 74.0 1.07 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.117 -1.593 . . . . 1.2 109.117 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.4 132.29 31.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.804 -0.821 . . . . 1.76 109.695 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -75.02 113.43 12.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.668 -0.645 . . . . 1.34 109.71 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.72 131.82 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.133 -0.691 . . . . 0.92 109.133 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' HG22 ' A' ' 6' ' ' THR . 8.2 p -60.05 140.05 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.73 -0.606 . . . . 1.06 110.389 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.503 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 73.5 t-105 -123.5 150.75 43.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.714 -0.616 . . . . 1.52 109.677 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.89 -97.61 0.49 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.276 -1.53 . . . . 1.3 109.276 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 91.65 0.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.801 -0.823 . . . . 2.72 109.337 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 tt -167.63 -42.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.631 -0.668 . . . . 1.74 110.031 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.0 161.91 21.52 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.535 -0.728 . . . . 1.61 109.809 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 -42.64 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.704 2.269 . . . . 2.09 110.451 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.98 65.36 0.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.698 . . . . 1.78 109.127 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.576 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 15.2 mtm105 -58.33 -49.87 91.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.502 -0.749 . . . . 1.69 110.098 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 35.0 Cg_endo -77.25 125.64 7.94 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.188 1.926 . . . . 1.39 109.262 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 57.6 m-85 65.87 173.12 0.23 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.751 -0.593 . . . . 1.1 109.458 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.08 -26.78 12.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.2 -0.937 . . . . 1.22 110.511 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.78 159.97 42.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.257 -0.902 . . . . 1.75 110.4 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.38 88.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.507 -0.553 . . . . 1.96 109.507 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -43.58 94.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.865 -0.522 . . . . 2.19 109.684 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -59.3 -48.6 81.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.634 -0.666 . . . . 0.97 109.32 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -63.59 -35.98 82.31 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.165 -0.679 . . . . 1.75 109.165 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 9.6 tp -64.87 -67.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.397 -0.594 . . . . 1.61 109.397 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -49.03 -33.64 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.693 -0.63 . . . . 1.04 110.708 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -50.98 -41.37 59.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.487 -0.758 . . . . 1.3 110.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.36 -59.04 4.45 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.508 -0.745 . . . . 2.16 109.105 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.64 10.25 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.519 -0.848 . . . . 1.55 111.572 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 43.45 2.1 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.531 1.165 . . . . 2.76 109.161 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 4.4 m95 -139.79 -56.63 0.56 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.564 -0.71 . . . . 1.82 109.41 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.4 131.05 55.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.816 -0.553 . . . . 1.55 109.672 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.04 62.98 0.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.847 -0.797 . . . . 2.11 108.847 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.91 132.19 34.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.535 -0.728 . . . . 3.66 109.938 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 60' ' ' SER . 0.3 OUTLIER -66.75 -61.21 2.08 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.061 -0.718 . . . . 2.48 109.061 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.6 -61.27 2.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 122.131 -0.356 . . . . 4.31 110.968 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.34 165.3 14.37 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.764 0.792 . . . . 3.99 111.502 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.39 112.88 55.28 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 108.744 -0.836 . . . . 1.76 108.744 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.72 -41.26 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.466 2.111 . . . . 1.24 111.383 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 2.8 m -81.37 -63.83 1.32 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 1.64 109.036 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.56 93.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.405 0.621 . . . . 1.75 110.19 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.37 -45.05 1.51 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.647 -1.381 . . . . 2.2 109.647 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -91.94 134.08 35.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.703 -0.881 . . . . 2.45 109.846 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -47.8 27.94 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.61 -0.885 . . . . 2.29 108.61 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m 56.02 -173.12 0.06 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.355 0.598 . . . . 3.31 111.031 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.92 -40.84 2.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 4.43 109.862 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.38 94.58 5.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.355 -0.84 . . . . 5.65 109.124 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -155.28 143.03 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.037 -0.727 . . . . 3.66 109.037 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.24 111.66 6.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.501 -0.749 . . . . 3.03 109.612 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.97 79.24 8.54 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.301 -0.629 . . . . 3.41 109.301 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -98.34 100.16 11.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.397 -0.815 . . . . 2.01 110.386 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.34 123.79 32.68 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.476 -0.935 . . . . 5.66 108.476 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 68.32 85.14 0.14 Allowed Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.734 -0.839 . . . . 3.19 108.734 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.17 -32.59 6.62 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 123.017 2.478 . . . . 3.22 111.007 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.96 -51.8 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.235 -0.654 . . . . 4.05 109.235 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 117.689 -1.148 . . . . 4.52 110.227 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttm . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 121.451 0.643 . . . . 8.17 109.949 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.87 61.78 3.01 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.721 0.772 . . . . 4.28 108.94 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.03 145.93 50.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 4.12 110.211 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.0 m -93.26 102.93 15.22 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.636 -1.246 . . . . 2.51 107.636 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.04 159.44 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.692 -0.63 . . . . 2.31 109.658 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 17' ' ' VAL . 27.1 p -118.79 121.33 39.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.669 -0.644 . . . . 2.36 110.156 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 18' ' ' TRP . 75.8 t -83.5 115.68 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.601 -0.889 . . . . 2.24 108.601 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -83.45 129.97 35.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.458 -0.776 . . . . 2.51 109.704 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.6 t -68.75 118.55 61.82 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 109.293 -0.632 . . . . 2.27 109.293 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.92 -20.91 9.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.659 2.239 . . . . 2.32 111.068 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.595 HG21 ' HA ' ' A' ' 32' ' ' CYS . 20.7 m -71.83 -51.71 21.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 2.36 110.235 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.3 p -109.07 -34.01 6.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.473 -0.767 . . . . 2.51 110.856 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.9 74.32 1.05 Allowed Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.105 -1.598 . . . . 2.54 109.105 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 127.1 15.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.678 -0.895 . . . . 2.96 109.714 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -74.34 117.22 15.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.664 -0.647 . . . . 2.46 109.604 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.6 131.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.985 -0.746 . . . . 2.42 108.985 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 6' ' ' THR . 11.2 p -60.84 141.23 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.497 -0.752 . . . . 2.57 110.291 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' VAL . 68.0 t-105 -120.85 149.8 42.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.788 -0.57 . . . . 2.38 109.675 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.11 -99.2 0.41 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.314 -1.515 . . . . 2.49 109.314 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.42 83.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.649 -0.912 . . . . 2.88 109.332 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tt -157.25 -41.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.704 -0.622 . . . . 2.85 109.941 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 70.3 p -106.54 161.11 23.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.453 -0.779 . . . . 2.69 109.66 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 22' ' ' SER . 33.0 Cg_endo -75.03 -38.99 1.33 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.607 2.205 . . . . 2.76 110.334 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.91 64.82 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.879 -0.785 . . . . 2.55 108.879 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.591 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 10.4 mtm105 -58.94 -50.82 85.95 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.588 -0.695 . . . . 2.61 110.331 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 25' ' ' ARG . 34.8 Cg_endo -76.6 118.52 4.88 Favored 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 122.061 1.841 . . . . 2.28 109.369 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 37.0 m-85 66.4 -171.19 0.19 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.27 -0.641 . . . . 2.39 109.27 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -117.64 -31.66 5.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.037 -1.039 . . . . 2.62 111.447 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.14 166.46 23.35 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.023 -1.048 . . . . 2.69 110.887 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -42.26 93.24 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.614 -0.513 . . . . 3.11 109.614 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.43 ' HD2' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.08 -40.42 95.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.692 -0.63 . . . . 2.67 109.761 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.595 ' HA ' HG21 ' A' ' 11' ' ' THR . 49.9 m -62.92 -48.4 79.08 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.657 -0.652 . . . . 2.37 109.372 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 27' ' ' PHE . 29.3 tt0 -63.96 -36.58 84.42 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.118 -0.697 . . . . 3.01 109.118 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 12.2 tp -60.95 -64.97 0.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.453 -0.943 . . . . 2.55 108.453 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.81 -34.71 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.948 -0.47 . . . . 2.36 110.323 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -44.33 61.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.53 -0.731 . . . . 2.17 110.769 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.7 mt -57.99 -61.78 2.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.42 -0.8 . . . . 2.59 109.381 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' HA2' ' HG2' ' A' ' 46' ' ' ARG . . . 120.6 19.69 3.7 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 120.295 -0.955 . . . . 2.04 111.575 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.44 30.58 6.69 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.184 -1.186 . . . . 2.42 109.851 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.537 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.89 128.92 18.58 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.215 -0.928 . . . . 2.68 109.68 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.24 82.32 2.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.557 -0.715 . . . . 1.75 109.453 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.73 -64.2 1.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.146 -0.687 . . . . 2.31 109.146 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -100.97 -31.28 11.19 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.6 -0.688 . . . . 2.69 109.95 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.8 151.55 31.87 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 3.18 109.254 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -103.74 111.1 23.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.359 -0.838 . . . . 3.04 109.607 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.53 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -101.59 -50.67 3.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.709 -0.619 . . . . 2.79 109.72 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 49' ' ' SER . 5.6 pt -70.94 141.4 86.8 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 121.463 -0.773 . . . . 3.0 110.426 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.56 -46.11 0.14 Allowed 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.335 2.023 . . . . 3.58 110.423 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.592 ' O ' HD12 ' A' ' 47' ' ' ILE . 46.1 p -94.58 117.87 30.79 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.495 -0.753 . . . . 2.79 109.009 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.49 -40.3 6.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.736 . . . . 3.81 110.638 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.16 72.0 1.2 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.785 -1.726 . . . . 2.63 108.785 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.94 -41.95 5.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.937 -0.743 . . . . 4.19 110.414 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -127.25 19.46 6.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.23 -0.919 . . . . 2.83 110.771 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.1 -53.18 8.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.043 -1.036 . . . . 3.34 109.709 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.01 48.32 2.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.611 -0.68 . . . . 5.81 109.558 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.05 92.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.449 0.643 . . . . 5.63 109.71 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -129.35 -44.12 1.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.049 -0.722 . . . . 6.0 109.049 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -44.23 2.39 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.065 -0.717 . . . . 5.76 109.065 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.599 ' HB2' HD11 ' A' ' 53' ' ' LEU . 8.5 t-105 -79.64 131.99 36.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.558 -0.714 . . . . 6.11 109.654 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.01 21.94 3.17 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.817 -0.552 . . . . 6.4 109.984 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.2 104.8 1.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.839 . . . . 6.95 108.832 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.04 108.48 58.82 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 109.164 -0.68 . . . . 8.14 109.164 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.68 128.83 13.81 Favored 'Trans proline' 0 C--N 1.324 -0.716 0 C-N-CA 122.196 1.931 . . . . 8.69 108.602 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -107.23 140.43 40.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.717 0.77 . . . . 11.31 111.267 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.327 -0.844 . . . . 10.65 109.307 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.971 -0.381 . . . . 2.63 109.971 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -123.5 83.35 2.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.086 -0.709 . . . . 2.49 109.086 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -126.46 112.03 15.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.623 -0.673 . . . . 1.43 109.279 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -136.73 66.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.084 -0.71 . . . . 0.96 109.084 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.06 127.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.406 -0.809 . . . . 1.1 109.515 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 17' ' ' VAL . 36.1 p -88.46 119.8 29.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.411 -0.806 . . . . 1.07 109.622 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.57 123.79 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.047 -0.723 . . . . 0.94 109.047 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.01 130.78 34.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.571 -0.706 . . . . 2.12 110.019 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -59.67 119.31 39.29 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.318 -0.623 . . . . 1.58 109.318 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' CE2' ' A' ' 27' ' ' PHE . 35.5 Cg_endo -77.43 -10.9 17.43 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.72 2.28 . . . . 1.92 111.77 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 95.1 m -86.33 -46.99 9.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 1.88 109.838 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.7 p -118.03 -33.77 4.34 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.506 -0.746 . . . . 2.29 110.88 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.31 88.29 2.04 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 108.877 -1.689 . . . . 2.05 108.877 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HD2' ' HB2' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -149.63 126.59 11.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.966 -0.726 . . . . 3.97 109.701 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -70.25 115.25 9.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.534 -0.729 . . . . 1.67 109.18 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 25' ' ' ARG . 36.1 t -117.62 109.74 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.948 -0.76 . . . . 1.02 108.948 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' HA ' HG22 ' A' ' 6' ' ' THR . 7.1 p -55.86 133.62 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.634 -0.666 . . . . 1.0 110.292 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.508 ' HZ3' ' HA ' ' A' ' 25' ' ' ARG . 69.6 t-105 -135.07 156.25 49.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.755 -0.591 . . . . 1.22 109.726 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.19 -105.36 0.92 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.684 -1.366 . . . . 1.16 109.684 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.74 22.79 8.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.626 -0.926 . . . . 1.43 109.893 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.3 tt -160.35 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.365 -0.976 . . . . 1.33 108.365 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -115.25 99.15 52.0 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.674 . . . . 1.3 109.582 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.56 -49.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.7 2.267 . . . . 1.31 110.828 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.64 49.78 1.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.563 -0.711 . . . . 2.17 109.146 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.676 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 63.27 -176.83 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.661 -0.866 . . . . 3.35 108.661 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' ARG . 32.2 Cg_endo -74.27 -12.49 23.14 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 122.094 1.862 . . . . 0.72 110.678 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CE2' ' HD2' ' A' ' 10' ' ' PRO . 27.0 m-85 -93.45 154.31 18.0 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.839 -0.8 . . . . 1.05 108.839 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 14' ' ' LYS . 19.5 p -69.67 -33.56 72.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.296 -0.878 . . . . 1.33 109.699 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 166.76 25.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 1.65 109.773 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -70.34 -38.01 74.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.59 -0.694 . . . . 3.5 109.672 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -41.67 95.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.212 -0.662 . . . . 2.82 109.212 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.2 m -61.29 -48.09 82.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.102 -0.703 . . . . 1.27 109.102 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 25.2 tt0 -62.11 -35.87 80.03 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.906 -0.776 . . . . 1.16 108.906 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' CD2' ' A' ' 40' ' ' TRP . 4.7 tp -63.19 -65.53 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.976 -0.75 . . . . 0.96 108.976 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.4 mm -51.02 -32.0 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.596 -0.69 . . . . 1.39 110.219 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.09 -40.94 74.39 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.744 . . . . 1.52 109.913 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.3 mm? -65.23 -58.49 5.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.082 -0.71 . . . . 1.65 109.082 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 29.34 5.23 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.683 -0.967 . . . . 1.41 110.683 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -130.67 40.74 3.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.504 -0.998 . . . . 2.31 109.286 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.501 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 4.8 m95 -138.68 -59.28 0.61 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.439 -0.788 . . . . 1.19 109.613 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.0 138.58 53.28 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.62 -0.511 . . . . 1.48 109.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 60.83 77.81 0.31 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.508 0.67 . . . . 1.97 109.674 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.61 120.37 36.79 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.734 -0.839 . . . . 1.83 108.734 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.61 7.99 21.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.57 -0.706 . . . . 3.09 110.706 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 101.19 11.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.108 -0.995 . . . . 3.19 108.624 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.66 127.68 37.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.283 -0.886 . . . . 4.36 110.991 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -126.77 86.17 59.22 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.168 -1.049 . . . . 2.52 108.168 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.16 155.29 37.61 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.919 2.412 . . . . 2.64 111.494 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.66 -41.49 42.99 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.414 -0.587 . . . . 3.35 109.414 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 p -102.87 127.38 50.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.599 -0.889 . . . . 3.35 108.599 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.79 -68.17 0.76 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.133 -1.587 . . . . 3.18 109.133 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.49 70.16 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 122.036 -0.685 . . . . 2.57 109.548 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.95 117.36 21.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.349 -0.844 . . . . 4.24 109.673 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.29 114.69 19.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.774 -0.579 . . . . 2.72 110.167 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.26 117.56 12.94 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.939 -1.134 . . . . 4.77 107.939 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.73 120.03 10.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 3.02 111.69 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -120.48 -54.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.81 -0.811 . . . . 3.43 108.81 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' TRP . 0.9 OUTLIER 56.51 70.72 0.62 Allowed 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.19 -0.67 . . . . 4.71 109.19 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.678 ' CE3' ' HB2' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 71.54 132.3 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.057 -1.09 . . . . 4.61 108.057 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.17 50.64 0.77 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.755 -1.215 . . . . 4.85 110.801 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.678 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 1.1 tm-20 -104.21 -45.39 4.71 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.747 -1.205 . . . . 3.83 107.747 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 65' ' ' GLN . 1.7 mm-40 -126.05 148.74 64.14 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 108.449 -0.945 . . . . 5.78 108.449 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HG2' ' CD ' ' A' ' 64' ' ' LYS . 34.8 Cg_endo -78.56 -28.32 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.04 1.826 . . . . 6.71 109.834 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.16 101.93 10.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.65 -0.656 . . . . 7.39 110.227 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 CA-C-O 118.485 -0.769 . . . . 4.79 109.958 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.292 0.568 . . . . 2.23 110.175 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -48.51 26.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.726 -0.608 . . . . 2.86 109.576 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.51 -54.49 7.42 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 2.09 109.367 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 m -86.68 98.5 11.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.655 -0.653 . . . . 1.24 109.514 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.41 159.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.11 -0.7 . . . . 1.9 109.11 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 17' ' ' VAL . 21.5 p -124.85 123.37 39.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.346 -0.846 . . . . 1.16 109.796 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.89 133.12 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.306 -0.627 . . . . 0.93 109.306 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -93.3 136.91 33.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.557 -0.714 . . . . 1.35 110.15 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 12.2 t -65.05 118.02 45.15 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.307 -0.627 . . . . 0.89 109.307 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 -7.7 16.23 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.676 2.251 . . . . 1.17 111.425 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.427 ' O ' HD13 ' A' ' 47' ' ' ILE . 52.9 m -94.92 -56.08 2.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.268 -0.895 . . . . 1.18 110.091 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.4 p -104.77 -29.86 10.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.412 -0.805 . . . . 1.35 110.905 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.01 86.17 1.87 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.324 -1.511 . . . . 1.16 109.324 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.47 124.83 8.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.836 -0.803 . . . . 1.53 109.73 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.5 m -75.2 110.95 9.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.563 -0.711 . . . . 1.12 109.841 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 28' ' ' CYS . 73.2 t -113.42 119.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.656 -0.868 . . . . 0.61 108.656 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 6' ' ' THR . 13.9 p -63.66 137.69 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.465 0.65 . . . . 0.62 109.635 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 22' ' ' SER . 73.9 t-105 -133.52 154.6 50.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.662 -0.649 . . . . 1.33 109.634 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 21' ' ' ILE . . . 100.69 93.88 2.15 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.434 -1.467 . . . . 1.07 109.434 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.57 24.81 14.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.929 -0.748 . . . . 2.59 110.364 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.4 tt -177.53 103.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.732 -0.84 . . . . 1.18 108.732 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 18' ' ' TRP . 16.7 p -127.81 91.7 44.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 1.65 110.107 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 -38.27 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.662 2.241 . . . . 0.92 110.128 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.78 35.26 4.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.746 -0.596 . . . . 1.57 109.716 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' O ' HG11 ' A' ' 16' ' ' VAL . 2.4 mtm105 65.77 178.28 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.62 -0.675 . . . . 2.98 110.859 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' ARG . 36.4 Cg_endo -78.21 14.05 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.807 2.338 . . . . 0.97 111.47 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' A' ' 33' ' ' GLN . 26.2 m-85 -131.03 -69.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 1.27 109.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER 168.74 -38.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.179 -0.674 . . . . 0.92 109.179 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.31 174.35 11.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.729 -0.607 . . . . 1.11 109.953 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -46.74 70.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.596 -0.69 . . . . 3.45 109.519 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -43.19 93.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.92 -0.487 . . . . 3.39 109.933 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.7 m -59.85 -44.75 93.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.654 . . . . 0.87 109.322 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CD2' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -66.32 -33.17 75.13 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.074 -0.713 . . . . 1.46 109.074 179.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.73 HD23 ' HG3' ' A' ' 43' ' ' GLU . 6.0 tp -61.53 -62.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.403 -0.962 . . . . 0.82 108.403 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' ' 44' ' ' GLU . 9.0 mt -50.9 -29.93 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.825 -0.547 . . . . 1.14 110.128 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -30.83 70.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 1.49 110.558 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 1.4 mt -72.33 -58.98 2.97 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.353 -0.842 . . . . 1.52 109.055 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.68 24.67 5.74 Favored Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.464 -0.874 . . . . 1.19 111.335 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 42.02 3.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.217 -1.167 . . . . 1.81 109.035 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.595 ' CE2' ' HG ' ' A' ' 34' ' ' LEU . 11.8 m95 -134.98 138.78 44.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.386 -0.821 . . . . 1.16 109.567 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.13 -46.36 5.09 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 1.51 110.233 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.35 19.7 6.86 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.51 -0.744 . . . . 1.48 110.774 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.73 ' HG3' HD23 ' A' ' 34' ' ' LEU . 23.3 mm-40 -109.42 -66.13 1.09 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.039 -1.038 . . . . 1.46 109.03 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.836 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.8 pt-20 -73.93 126.93 31.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.268 -1.012 . . . . 1.27 108.268 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -57.69 1.07 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.688 . . . . 3.91 109.881 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.469 HH21 HD11 ' A' ' 47' ' ' ILE . 7.9 mtp180 -83.58 -52.37 6.52 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.59 -0.444 . . . . 3.24 109.963 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HH21 ' A' ' 46' ' ' ARG . 3.1 mt -114.03 121.82 35.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.784 -0.572 . . . . 1.96 109.984 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.44 -56.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.568 2.178 . . . . 1.92 109.952 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.31 175.48 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.336 0.589 . . . . 2.16 110.818 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 69.54 108.38 0.06 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.41 -0.589 . . . . 3.17 109.41 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.0 -59.17 4.93 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.936 -1.666 . . . . 1.72 108.936 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.81 152.16 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.764 -0.845 . . . . 1.4 109.427 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.06 120.06 24.81 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 3.26 108.919 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -103.83 -75.93 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.718 -0.614 . . . . 2.41 110.034 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 169.12 19.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.47 -0.769 . . . . 2.18 110.84 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 p -149.1 36.47 0.76 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.515 -0.55 . . . . 2.16 109.515 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.13 155.08 46.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.295 -0.878 . . . . 2.58 110.209 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -46.63 28.18 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.406 -0.59 . . . . 2.6 109.406 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -94.46 -48.46 6.11 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.774 -0.578 . . . . 1.51 109.477 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.04 101.91 0.74 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.719 -0.613 . . . . 1.62 109.55 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HB3' HH22 ' A' ' 46' ' ' ARG . 0.5 OUTLIER -107.24 136.16 47.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.667 -0.646 . . . . 1.54 109.68 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -145.12 126.27 7.6 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.539 -0.725 . . . . 3.7 110.307 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.549 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 36.4 Cg_endo -79.47 -49.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 123.098 2.532 . . . . 1.56 111.447 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -147.19 -58.44 0.27 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.723 -0.611 . . . . 3.28 109.402 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.948 -1.025 . . . . 4.99 109.443 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.438 -0.578 . . . . 4.81 109.438 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.23 117.86 30.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.583 -0.698 . . . . 2.24 110.065 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.38 -47.62 9.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.617 -0.883 . . . . 3.89 108.617 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 m -113.08 124.11 51.84 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.047 -0.723 . . . . 1.46 109.047 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.29 159.73 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.732 . . . . 1.69 109.394 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.544 HG22 ' HA ' ' A' ' 17' ' ' VAL . 6.7 p -140.68 123.6 16.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.537 -0.727 . . . . 1.01 109.897 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 18' ' ' TRP . 71.6 t -97.86 123.99 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.981 -0.748 . . . . 1.11 108.981 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.95 134.23 34.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.556 -0.715 . . . . 1.33 110.027 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 32' ' ' CYS . 8.9 t -68.78 120.26 74.74 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 109.162 -0.681 . . . . 0.81 109.162 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -9.05 16.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.712 2.274 . . . . 1.21 111.781 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.7 m -89.15 -51.47 5.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.244 -0.91 . . . . 1.27 110.071 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.77 -23.68 12.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.515 -0.741 . . . . 1.42 110.844 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.9 79.03 1.27 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.464 -1.855 . . . . 1.29 108.464 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -147.73 134.26 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.886 -0.773 . . . . 3.85 109.886 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -76.63 111.58 12.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.466 -0.771 . . . . 1.08 109.691 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.19 138.48 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 6' ' ' THR . 9.7 p -64.1 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.396 -0.815 . . . . 0.89 110.039 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.489 ' CE3' ' HB3' ' A' ' 25' ' ' ARG . 77.1 t-105 -115.55 153.13 31.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.468 -0.568 . . . . 1.52 109.468 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.58 -104.89 1.08 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.484 -1.447 . . . . 1.61 109.484 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 53.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.743 -0.857 . . . . 3.62 109.652 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.84 -53.69 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.406 -0.809 . . . . 1.52 109.487 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 1.4 m -94.19 165.72 17.04 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.684 -0.635 . . . . 1.41 109.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 22' ' ' SER . 34.7 Cg_endo -76.47 -23.83 11.1 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.705 2.27 . . . . 1.77 110.702 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' HZ ' ' HG2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -120.48 74.36 1.05 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.568 -0.708 . . . . 1.78 109.181 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CB ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -58.17 -55.97 39.86 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.606 -0.684 . . . . 1.97 109.947 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 25' ' ' ARG . 36.2 Cg_endo -77.67 123.9 6.65 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 122.363 2.042 . . . . 1.12 109.721 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 43.9 m-85 66.01 167.1 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.334 0.588 . . . . 0.75 109.653 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.79 -31.37 15.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 1.09 110.208 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -144.15 163.97 32.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 1.32 110.24 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -63.14 -32.01 73.29 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 2.05 109.323 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -50.43 70.17 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.913 -0.492 . . . . 5.45 109.979 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 2.7 m -56.44 -48.44 77.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.692 -0.63 . . . . 1.13 109.815 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -64.15 -37.52 87.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 1.82 109.44 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HG ' ' CG ' ' A' ' 40' ' ' TRP . 10.6 tp -62.3 -66.9 0.47 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.89 -0.781 . . . . 1.33 108.89 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 HG23 ' CD ' ' A' ' 44' ' ' GLU . 43.2 mt -50.43 -29.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.828 -0.545 . . . . 1.38 110.697 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.85 -42.5 68.61 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.454 -0.779 . . . . 1.21 110.287 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB2' ' HE1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -65.41 -58.34 6.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.494 -0.754 . . . . 1.54 109.056 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.49 22.39 6.77 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 120.624 -0.798 . . . . 1.49 111.277 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.65 40.01 3.62 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.349 -1.089 . . . . 2.07 109.224 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.496 ' HE1' ' HB2' ' A' ' 37' ' ' LEU . 2.6 m95 -139.77 -60.24 0.55 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.581 -0.699 . . . . 1.41 109.318 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.51 55.36 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.277 -0.638 . . . . 1.46 109.277 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.43 -43.87 59.47 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 1.91 110.272 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.01 122.38 43.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.562 -0.711 . . . . 2.35 109.656 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CD ' HG23 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -97.09 -42.96 7.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 3.48 109.981 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -140.4 129.02 22.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.642 -0.661 . . . . 4.55 109.969 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -136.47 157.16 47.43 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.606 -0.684 . . . . 3.29 109.942 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.46 HG13 ' HD2' ' A' ' 48' ' ' PRO . 2.3 tt -67.63 125.95 91.93 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.402 -0.811 . . . . 2.13 110.278 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 47' ' ' ILE . 34.3 Cg_endo -77.87 99.63 1.3 Allowed 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 122.987 2.458 . . . . 2.44 110.2 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.74 104.05 15.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.743 -0.598 . . . . 2.4 109.851 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 p -111.53 108.5 18.04 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.09 -0.707 . . . . 3.35 109.09 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.09 -67.91 3.07 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.588 -1.405 . . . . 2.6 109.588 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.38 142.54 33.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.615 -0.932 . . . . 1.9 110.113 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 172.73 8.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.79 . . . . 2.06 109.935 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 p -57.06 -47.85 79.99 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.147 -0.686 . . . . 1.55 109.147 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.78 87.36 2.7 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.324 -0.991 . . . . 2.67 108.324 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 104.09 6.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 3.03 109.95 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -138.19 137.23 37.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.666 -0.646 . . . . 2.09 109.35 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.37 132.79 35.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.69 . . . . 2.25 109.592 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -87.6 -29.4 21.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.557 -0.714 . . . . 2.57 110.057 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.06 -56.37 3.59 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.431 -0.793 . . . . 2.6 109.146 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.32 -163.66 0.65 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.207 -0.664 . . . . 2.85 109.207 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 122.61 85.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.336 -0.853 . . . . 3.75 109.595 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.92 98.14 1.2 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.819 2.346 . . . . 2.51 110.193 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -89.04 118.02 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.913 -0.773 . . . . 4.18 108.913 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.789 -1.101 . . . . 5.24 109.711 -179.853 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_